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Abstract 
Part I: Studies toward the Total Synthesis of Psammaplysin A 
Psammaplysin A is a bromotyrosine alkaloid isolated from the marine sponges Verongida and 
Dictyoceratida and shows broad biological activities ranging from antibiotic, antimalarial, anti-
HIV to antitumor activities. Apart from its intriguing physiological properties, psammaplysin A 
possesses an unique and highly-decorated dihydrooxepin which is fused to an isoxazoline via a 
spiroacetal. Amide linkage to a sidechain derived from bromotyramine ultimately distinguishes 
psammaplysin A from more than 40 natural congeners. Moreover, this linker was identified to be 
important for its biological and physiochemical properties. Despite its remarkable bioactivities and 
fascinating structural features, no total synthesis has been reported to date. By facing this highly 
challenging target, we envision two main approaches to achieve a modular, scalable and convergent 
synthetic entry to psammaplysin A.  
 
Our first approach is based on the bromine induced spirocyclization of isoxazoles to provide rapid 
access to the designed spiroacetal motif of psammaplysin A. Herein, variation of the alkyl chain 
bearing the terminal alcohol will shine light on the potential and limitations of this cyclization step. 
In contrast to this, a second strategy will focus on the initial construction of an already 
functionalized dihydrooxepin moiety. For this purpose, the Ferrier-type ring-expansion of 
cyclopropanes is investigated to access the seven-membered oxacycle with the desired substitution 
pattern. With the tetrahydrooxepin in hand, we imagine fast access to different valuable 
intermediates for the construction of the missing spiro motif. 
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Part II: Acid-catalyzed Cycloisomerization of Neopentylic Epoxides  
In the second part of this thesis, we describe the development of a powerful cycloisomerization 
reaction of 2,2-disubstituted neopentylic epoxides. Herein, the practical and efficient acid-catalyzed 
cascade enabled rapid access to highly functionalized tetralins and chromanes featuring vicinal all-
carbon quaternary centers. These skeletons are common motifs in natural products and its 
construction still represents a major challenge for organic chemists.  
 
Due to our mild reaction conditions, several functional groups and electron-rich to -neutral arenes 
are tolerated. Further investigations by variation of the substitution pattern in the starting material 
provided detailed insights into migration tendencies and gave access to further tricyclic compounds. 
In addition, a competing disproportionation pathway of dihydronaphthalene to its corresponding 
tetralin und naphthalene was discovered, which depend on the stability of the formed cationic 
intermediates.  
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Studies toward the Total Synthesis of 
Psammaplysin A 
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1 Introduction 
1.1 Natural Products 
All compounds produced in living organisms are defined as natural products, ranging from simple 
molecules to highly complex structures.[1] These molecules have a specific function within the 
organism and some may be essential for the maintance of the organism. For instance, amino acids, 
carbohydrates, lipids and nucleic acids are some of the essential molecules for life and called 
primary metabolites. In contrast, secondary metabolites are often only found in certain organism 
and not absolutely required for growth and survival. These molecules serve a distinct purpose and 
have therefore a specialized function in the metabolic process.[2] 
 
Figure 1: A) Selected primary metabolites. B) Selected secondary metabolites. 
In Figure 1 A an example is illustrated for each subclass of primary metabolites. Tryptophan (1.1), 
also abbreviated Trp or W, is in its natural L-form a proteinogenic α-amino acid possessing an 
aromatic indole framework and a component of more complex structures. Cytosine (1.2), also 
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abbreviated Cyt or C, is one of the four nucleic bases in DNA and RNA, together with adenine (A), 
guanine (G) and thymine (T) (uracil in RNA). An anomeric junction of these nucleobases to the 
five-membered sugar pentose (ribose in RNA and deoxyribose in DNA) build the nucleoside. 
Phosphorylation on the 5’-postion of sugar backbone finally gives the nucleotide. Nucleotides play 
the central role in metabolism at a fundamental, cellular level and are the buildings blocks for 
nucleic acids, which contain the genetic information in all organisms. The most abundant 
monosaccharide is glucose (1.3), which naturally occurs as D-glucose and is produced by plants 
through photosynthesis, in which water and carbon dioxide are converted in a light-dependent 
reaction to oxygen and glucose. The latter is used as an energy and carbon source by living 
organisms. However, most of the glucose does not occur in its free form, but is found in polymers 
and belongs therefore to the class of carbohydrates. Apart from this, linoleic acid (1.4) is an omega-
3, essential fatty acid, which plays an important role as an ingredient in many seeds and oils. 
2600 B.C are the earliest records the use of natural products depicted on clay tablets from 
Mesopotamia. These display extracts of cypress and myrrh, which were used against diseases and 
still play a crucial role in traditional medicine for the treatment of coughs, colds and 
inflammations.[3] Natural products have become part of our culture and traditions, for example 
almost everyone knows the about the awakening effect of coffee triggered by the secondary 
metabolite caffeine (1.5), a stimulating alkaloid. penicillin G (1.6), morphine (1.7) or cocaine (1.8) 
are among to natural products that have been extensively applied in the field of traditional medicine. 
The highly oxidized natural product tetrodotoxin (1.9) is a potent neurotoxin of the fugu fish. The 
structure was eluciaded by Woodward[4] in 1964 and finally fully confirmed by X-ray 
crystallography in 1970[5]. A further complex natural product is paclitaxel (Taxol) (1.10), which 
has been established for the treatment of breast cancer. Taxol (1.10) was initially isolated from the 
bark of Taxus brevifolia. For 1 g Taxol® (1.10), the bark of about three fully-grown 100-years-old 
trees are required. By a current demand of 100 to 200 kg per annum and in respect to the low natural 
abundance, chemical (semi)synthesis turned out as a suitable method to produce sufficient amounts 
of the natural product.[6]  
 
1.2 Natural Products of Marine Origin 
As described in a report by Snader et al., around 80% of new approved drugs between 1983 and 
1994 are of natural origin, while 62% of approved anticancer drugs are of natural origin or are 
derived from natural products parents.[7] However, natural based drugs have been identified to be a 
promising source in the drug discovery in the 1990s high throughput screening, post genomics 
techniques and combinatorially synthesis gained attention in the development of drugs in 
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pharmaceutical industry. Thereby, natural products-based drug discovery depends on the 
identification of novel compounds, especially with novel scaffolds. In a comparative analysis, Kong 
and coworkers[8] came to the conclusion that marine natural products are superior in terms of 
bioactivity and scaffolds motives. For example, approximately 1% of the tested marine samples 
and only approximately 0.1% of the tested terrestrial samples exhibit anti-tumor potential.[9] Further 
comparison of marine and terrestrial natural products demonstrated that marine organisms 
exclusively utilized 71% of the molecular scaffolds in the Dictionary of Marine Natural Products.[8] 
For this reason marine origin natural products are a promising for the discovery of novel medically 
relevant scaffolds.  
 
1.3 Halogenated Natural Products of Marine Origin 
Interestingly, less than 50 examples of halogenated marine natural products have been reported 
until 1968. However, the amount was increased to more than 5000 compounds by 2015 and is 
steadily increasing up to date.[10] This result is attributed to new isolation and cultivation techniques, 
like marine bioprocessing, and remote submersibles, which are able to access into further depths in 
the oceans. It is not surprising, that most of the halogenated natural products arise from marine 
organisms, due to high halide concentration in the oceans compared to a terrestrial environment. 
Sources of these natural products are organism such as sponges, cyanobacteria, molluscs, sea hares, 
mussels, bryozoans (moss animals), tunicates, soft corals, symbiotic bacteria, marine 
phytoplankton, macroalgae, marine bacteria and marine fungi.[11] 
Thus, the exploration of the biosynthesis of those organohalogens is an important research field. In 
general, there are three different types of halogenases. The classification was carried out according 
to the chemical nature of active halogen species (Table 1). The primary halogen sources for all 
halogenases are solvated halide anions.[12] 
 
Table 1: Biohalogenation pathways. 
class C−X bond forming reaction 
halogenating agent 
(enzymes) 
nucleophilic 
 
halide X− 
(SAM fluorinase, SAM 
chlorinase, SAM-dependent 
halide methyl transferase) 
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electrophilic 
 
hypohalite XO− 
(Haem-dependent Halo-
peroxidases, Vanadate-dependent 
Halo-peroxidases, Flavin-
dependent halogenases) 
radical 
 
halogenradical X• 
(Non-haem iron/2-oxoglutarate 
dependent halogenases) 
 
Halide anions especially, fluoride and chloride, are not known for nucleophilic substitution reaction 
in water, but a few halogenases are able to use solvated halide anions for nucleophilic substitutions 
reactions on carbon centers. In all reported cases, SAM (1.11) is a decisive factor in this 
transformation. The α-position of the sulfonium ion is highly electrophilic due to its positive charge 
on sulfur and the formed thioether is a good leaving group, which make these positions convenient 
for nucleophilic substitutions.  
 
Scheme 1: Nucleophilic halogenation via SAM-dependent halogenases. 
While SAM-dependent halide methyl transferases exclusively attack on the terminal methyl group 
to produce halogenated methane (MeX) others halogenate the adenosine moiety by releasing 
L-methionine (1.12), illustrated in Scheme 1. However, these enzymes are only able to incorporate 
chlorides, bromides and iodides the SAM fluorinase is able to implement fluorides. So far, this is 
the only native fluorinating enzyme, which has been identified to date. This transformation is 
impressive, due to the fact that a free fluoride ion is difficult to generate, particular in an aqueous 
medium. Herein, SAM (1.11) is not the cofactor for this SN2 substitution but serves as a substrate. 
While the fluorinase accepts chlorides, the structurally related chlorinase accepts chlorides, 
bromides, and iodides but not fluorides. For instance the formation of 5’-chloro-5’-deoxyadenosine 
(1.13b) is used under physiological conditions to generate chloroethylmalonyl-CoA (1.15), which 
is then incorporated into salinosporamide A (1.16).[12-13] 
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Scheme 2: Biosynthesis of salinosporamide A (1.16) involves nucleophilic halogenation via SAM-dependent 
halogenases. 
Compared to the nucleophilic substitution, the electrophilic substitution of halogens is performed 
on electrophilic systems such as aromatic or alkene systems. The decisive factor is the 
electrophilicity of the halogen source, which nature achieves by oxidation of halides using oxygen 
or hydrogen peroxide. As a result of the difference in the electronegativity of oxygen, the halogen 
possesses a partial positive charge, which then can undergo electrophilic substitution. Under these 
circumstances, no fluorine can be incorporated, since fluorine has the highest electronegativity. For 
that reason haem- and vanadium-dependent haloperoxidases and flavin dependent halogenases are 
not able to incorporate fluorine by using hydrogen peroxide or oxygen in. In the proposed 
mechanism of the haem-dependent haloperoxidase, the first step is the binding of hydrogen 
peroxide to the redox active haem factor Fe(III) (1.17). In this redox transformation the Fe(III) 
active center is oxidized to the Fe(IV) species (1.18), while hydrogen peroxide is reduced to water. 
The activated species (1.19) now is able to oxidize the halide to the corresponding hypohalous acid 
(Scheme 3). Due to the missing binding side for organic substrates in these enzymes, a low substrate 
specificity and regio-/stereoselectivity was observed. The formed hypohalous acid are highly 
reactive and quickly reacts in an electrophilic substitution or addition with any substrate which is 
around.[12] 
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Scheme 3: A) Proposed mechanism of Haem-dependent Halo-peroxidases. B) Proposed catalytic cycle of a 
vanadium-dependent haloperoxidases (V-HPO). C) Example of selective bromination in the biosynthesis of 
α-snyderol (1.27). 
Vanadium-dependent haloperoxidases also utilize hydrogen peroxide, but in contrast to the haem-
dependent haloperoxidases, in a catalytic cycle without changing the oxidation state of the metal 
center, which is illustrated in Scheme 3B. Vanadate (1.21) binds to the histidine residue of the 
corresponding enzyme in the active site. Activation by hydrogen peroxide forming a vanadium(V)-
peroxide complex (1.22). In the oxidation step the halide is oxidized to the vanadium(V) bounded 
hypohalous acid (1.23). In comparison with the haem-dependent haloperoxidases, the vanadium-
dependent analogue exhibit a higher substrate specificity and regio-/stereoselectivity. Therefore, it 
is assumed that the halogenation species stays at least in close proximity to the enzyme. For 
example V-BrPOs are involved in the biosynthesis of α-snyderol (1.27) by an enantioselective 
bromination of (E)-(+)-nerolidol (1.26) which is displayed in Scheme 3C.[14-15] 
During the flavin-dependent halogenases (Scheme 4) the flavin cofactor (1.29) binds oxygen to 
form the hydroperoxyflavin intermediate. This step is recognized also for other FAD-dependent 
monooxygenases. The peroxide species 1.30 is capable of oxidizing the halide anion, which is 
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located in proximity to the intermediate. Here the hypohalous acid 1.32 is not released but reacts 
in a second step active center with the organic substrates which are also bound within the active 
side. In the proposed mechanism, the hypohalous acid 1.32 is initially bound to a lysine residue, 
which is transferred to the second active site. The active electrophilic halogenation reagent in this 
mechanism is a N-haloanime 1.33, which undergoes the desired substitution.[12] 
 
Scheme 4: Electrophilic halogenation via flavin-dependent halogenases within the biosynthesis of bromo 
tryptophan. 
The permanent binding of all substrates, flavin-dependent halogenases show high substrate-, regio- 
and stereoselective. So for example electrophilic substitution of tryptophan (1.34) at the 
C7-position. However, this proposed mechanism includes several species that can exist in different 
protonation states, so Scheme 4 only represents a general reaction mechanism.[12] 
The third way of the insertion of halogens is the radical pathway via non-haem iron/2-oxoglutarate 
dependent halogenases, which are restricted to chlorides and bromides. During this process oxygen 
and 2-oxoglutarate (2-OG) serves as cosubstrates. In the first step, oxygen is bounded to histidine 
and 2-oxoglutaric acid coordinated iron by the release of water. The oxygen-bound structure is 
commonly described as Fe(III) superoxido complex, which is then transformed to a peroxy 
structure. After the oxidative decarboxylation and peracid cleavage, the Fe(IV) oxido species 
generates the reactive species, which is abstracting a hydrogen atom from an aliphatic carbon atom. 
The proximity of the formed carbon radical directly allows the recombination with the iron bound 
chloride forming the desired halogen carbon bond. Regeneration of the active enzyme by addition 
of chloride and 2-oxoglutarate closes the catalytic cycle catalytic cycle.[12] 
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Scheme 5: A) Proposed catalytic cycle of a 2-OG-dependent halogenases. B) Biosynthesis of Styringomycin 
E (1.48) from serine (1.46). 
In general, non-haem iron/2-OG-dependent halogenases halogenate α-amino acids on the aliphatic 
chain, mainly at a terminal C-atom. For example the halogenase SyrB2 chlorinates selectively the 
terminal position of L-threonine (1.46), as depicted in Scheme 5B. This chlorinated amino acid 
(1.47) constitutes the natural product Styringomycin E (1.48).[12, 16] 
 
1.4 Bromotyrosine Natural Products 
The halogenated aromatic amino acids 3,5-diiodotyrosine was described by Dreschel and 
coworkers in 1907, as one of first marine natural products. Six years later, the corresponding 
3,5-bromotyrosine derivative (1.49) was isolated by Morner and coworkers from two coral species. 
Further secondary metabolites of this class were discovered in 1967, when Sharma and Burkholder 
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isolated 2,6-dibromo-4-acetamide-4-hydroxy-cyclohexadienone (1.50). Since that time, the 
number of reports on these marine natural products has steadily increased and to date more than 
280 second metabolites are known to be biologically active with a variety of biological activities 
including anti-microbial, anti-cancer, anti-fouling, anti-viral, ATPase regulator, calcium channel 
modulator, etc.[17] 
 
Figure 2: First isolated bromotyrosine natural products. 
For convenience, the bromotyrosine derivatives are divided into six categories: simple 
bromotyrosine derivatives, spirocyclohexadienyl-isoxazolines, spirooxepin-isoxazolines, oximes, 
bastadins, and other structural classes. Simple bromotyrosine derivatives are based on one 
bromotyrosine with further degradation, reduction, hydroxylation, alkylation or esterification with 
simple substrates. Spirocyclohexadienyl-isoxazoline bromotyrosine derivatives possess one or two 
spiro-cyclohexadienyl-isoxazoline motifs, generated in the arene oxide biosynthetic pathway out 
of bromotyrosine derivatives. Members within this class include one two three bromotyrosine units 
and further functional groups like histamine. In the oxime class, the amine function of tyrosine is 
oxidized to an oxime. The geometry of the oxime function was reported to the E-configuration in 
almost every case. Additionally functional groups like histamine, disulfide, cysteine or tyramine 
are found this class. The bastadins are a series of predominantly macrocyclic bromotyrosine 
derivatives, which are biogenetically derived from four bromotyrosines by the oxidative phenolic 
coupling of two tyramine–tyrosine units connected through an amide bond. The outstanding feature 
of the last class is the spirooxepin-isoxazoline motif. However, there are also members of bromo 
tyrosine derived products, which do not fit in any of the already mentioned classes. 
 
1.5 Spiro Isoxazoline Dihydrooxepin Family of Natural Products 
1.5.1 Spiro Isolation of Isoxazoline Dihydrooxepin Natural Products 
The first isolated members of the isoxazoline-oxepin spiro family of natural products were 
psammaplysin A (1.53) and B (1.54), which have been discovered in 1883 by Kashman and co-
workers from a marine sponge Psammaplysilla purpurea (order Verongida).[18] Additionally, they 
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isolated the known natural products aerothionin (1.55)[19] and fistularin-3 (1.56)[20]. Based on the 
spectroscopic data of psammaplysin A (1.53) and B (1.54) and in comparison to the spirocyclic 
ring motif present in aerothionin (1.55) and fistularin-3 (1.56), Kashman and coworkers predict an 
incorrect structure of psammaplysin A (1.51) and B (1.52), respectively (see Scheme 6). 
 
Scheme 6: A) Previously incorrect assignment of psammaplysin structures and the revised structures. B) 
Related other bromotyrosine derived natural products. 
In 1985, psammaplysin A (1.53) and B (1.54) were isolated by Clary and coworkers. By the mean 
of 2D-NMR-spectroscopy (13C–13C-connectivity plot) and single-crystal X-ray crystallography, 
they succeeded in identifying a novel spirocyclic dihydrooxepin-isoxazoline structure of 
psammaplysin A. Although Clardy was able to obtain crystals of psammaplysin A acetamide by 
acetylation of psammaplysin A (1.53), the resolution was not refined enough to determine the 
absolute stereochemistry, but the relative stereochemistry.[21] In 2012, Motti and coworkers isolated 
several compounds, which belong to the psammaplysin family including psammaplysin A (1.53). 
Based on 2D-NOESY data, no interaction between the protons attached to the C5 and H7 was 
observed. Therefore, they assigned the stereochemistry to 6R,7R, as for this no NOE interactions 
between H5 and H7 were visible in the spectrum.[22] In 2015, investigation by Garson and 
coworkers about the absolute stereochemistry of psammaplysin A (1.53) was performed. In their 
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work, they compared earlier reports using X-Ray crystallographic data[21], NOESY correlation[22], 
modelling studies[22] and ECD spectra of psammaplysin with the ECD spectra of known 
bromotyrosine derived spirocyclic hexadienyl-isoxazolines[23-25] of which the absolute 
configuration is known, like aerothionin (1.55). Furthermore, this stereochemistry was also 
supported by time-dependent density functional theory ECD calculations and NMR analysis of 
methoxyphenylacetic ester.[26]  
 
Figure 3: All possible stereoconfigurations of psammaplysin A (1.53) and B (1.54). 
Some members of the natural product family possess an additional C19 stereocenter. Chiral HPLC 
purification of psammaplysin B acetamide revealed two compounds, each possessing a negative 
optical rotation and therefore suggesting the presence of diastereomers differing in configuration 
at the C19 position. Additional hydrolysis afforded carbamate, which showed an optical rotation 
close to zero. This also indicate a racemic mixture, but enantioselective HPLC failed to distinguish 
two enantiomers. Further investigation using methoxyphenylacetic esters also failed due to 
hydrolysis of the ester.[27] Therefore, the racemic nature of this product was not verified. Certainly, 
it is worthy to note, that the benzylic positions are known for isomerization during preparation 
and/or purification isomerization can be occur. 1H-NMR signals of psammaplysin B (1.54) and its 
derivatives did not indicate diastereomers. Enantioselective HPLC studies on psammaplysin B 
(1.53) revealed only a single broadened peak, which does not guarantee the presence of a single 
diastereomer.[26]  
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In 2019, for the first time Hou-Wen and coworkers reported the isolation of frondoplysin A (1.55). 
Their X-ray crystallographic analysis data revealed the absolute configuration of frondoplysin A 
(1.55) as 6R,7R configuration in the spirooxepin-isoxazoline ring system and additionally the 
benzylic hydroxy moiety as 19R.  
 
Figure 4: Structure of frondoplysin A and its crystal structure. 
All isolated members within the spirooxepin isoxazoline family of natural products show a negative 
optical rotation. Obviously, it is assumed that all share the same absolute configuration and the 
biosynthetic pathway of this spiro ring system.[27-30] 
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1.5.2 Classes of Isoxazoline Dihydrooxepin Natural Products 
 
Scheme 7: Framework of isoxazoline dihydrooxepin spiro natural products and their different classes. 
The unique spiro-oxepin-isoxazoline ring structure is a common motif in the four different natural 
classes of psammaplysin, ceratinamides, ceratinadins and frondoplysins. To date, 43 natural 
products were mainly isolated with this particular backbone (36 psammaplysin[18, 21-22, 27-28, 30-35], 
three ceratinamides[28, 36], two ceratinadins[37] and two frondoplysins[38]) isolated and characterized.  
 
1.5.2.1 Psammaplysin Family of Natural Products 
Since the first isolation in 1983, 36 derivatives of the psammaplysin family have been identified so 
far. The class of psammaplysin have been reported over the last decade and describes as followed 
(psammaplysin A (1.53)[18, 21-22, 27-28, 31-32, 34-36], B (1.54)[18, 21-22, 27-28, 31-32], C (1.56)[31-32], D (1.57)[27, 
34], E (1.58)[27, 32, 34-36], hydroxy-E (1.59)[27], F (1.60)[32, 37], G (1.61)[30], H (1.62)[39], I (1.62) – 
J (1.63)[22], K – hydroxy-W (1.64 – 1.84)[27], X (1.85) – Y (1.87)[28] and Z (1.88) and hydroxy-Z 
(1.89)[35]). These compounds have been mainly isolated from the orders Verongida (genera 
Aplysinella, Psammaplysinella, Pseudoceratina, and Suberea)[21-22, 27-29, 31-32, 34-37] and 
Dictyoceratida (genera Hyatella sp.[30] and Dysidea frondosa[38]) and characterized via NMR, mass 
spectroscopy and optical rotation. 
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Figure 5: Chemical structures of the different psammaplysin derivatives (part 1). 
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Figure 6: Chemical structures of the different psammaplysin derivatives (part 2). 
The modification of the different members are mainly located at the terminal ethylamine residue 
(C19 and C20 positions) of the moloka’iamine subunit, except for psammaplysin I (1.63) and 
J (1.64), in which each have a mono-brominated aromatic ring.[22] Furthermore, psammaplysin 
K (1.65) and dimethoxy acetal K (1.66), exhibit a benzaldehyde moiety or a dimethoxy acetal, 
respectively.[27] While the benzylic position has either a hydroxy or an aliphatic residue, amines, 
substituted amines, amides (mainly coupled fatty acids), ureas, cyclic carbamates and enamines are 
substitutions at the C20 position [18, 21-22, 27-28, 30-35]  
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The compounds were evaluated towards their biological activities and demonstrated multiple 
effects such as cytotoxicity, anti-malarial, anti-viral, anti-fouling, anti-microbial, and anti-oxidant 
activity. Psammaplysins A (1.53) and B (1.54) displayed anti-bacterial in vitro activity against gram 
positive bacteria and Escherichia coli (E. Coli) and cell growth inhibition in human colon tumor 
cell-line colorectal carcinoma cells (HCT116) (IC50 = 6.0 µg/mL), psammaplysin C (1.56) 
pronounced cytotoxic effect and reduced IC50 values to 3.0 µg/mL.
[18, 31] Further psammaplysin A 
(1.53) displayed cytotoxicity against triple-negative breast cancer (MDA-MB-231) (IC50 = 3.9 µM) 
and cervical carcinoma (HeLa) (IC50 = 8.5 µM) cell lines.
[35] 
Psammaplysin D (1.57) was found to be highly active against human immunodeficiency virus 
(HIV-1) at concentration of 0.1 µM.[34] Psammaplysin E (1.58) inhibited the cell growth of human 
colon adenocarcinoma (LoVo) (IC50 = 5.0 µg/mL)
[34], oral epidermoid carcinoma (KB) (IC50 = 
5.0 µg/mL)[34], MDA-MB-231 (IC50 = 0.21-0.29 µM)
[35, 40] and HeLa (IC50 = 2.19-3.7 µM)
[35, 40] 
cancer cell lines and revealed moderate immunosuppressive activity[34-35]. Hydroxy-psammaplysin 
E (1.59) displayed a moderate antimalarial activity against the 3D7 drug-sensitive strain of P. 
falciparum with an IC50 value of 6.4 µM.
[27] Furthermore, psammaplysin F (1.60) inhibited up to 
80% of four bacterial strains at a concentration of 50 µM[33] and showed antiplasmodial activity in 
3D7 and Dd2 strains of P. falciparum with IC50 values of 0.87 µM and 1.4 µM, respectively.
[30] 
When comparing drug-resistant (K1) and drug-sensitive (FCR3) strains of P. falciparum, 
psammaplysin F (1.60) was active in low concentration (IC50 values of 3.77 and 2.45 µg/mL), but 
without a significantly observed selectivity towards the R1 strain.[37] Recently, psammaplysin F 
(1.60) was identified to regulate the synthesis of stress granules in MCF7, HeLa and MCF7MDR 
cells. The combination with bortezomib and sorafenib led to an enhanced effect of cell viability 
inhibition.[41] Psammaplysin G (1.61) showed an inhibition of 98% the in Dd2 cell strain of P. 
falciparum at a concentration of 40 µM.[30] Similarly, psammaplysin H (1.62) possesses potent 
antiplasmodial potency in the 3D7 strain (IC50 = 0.41 µM) and was also selective towards the 3D7 
strain with a selectivity index (SI) of >97%.[29] Psammaplysins X (1.85) and Y (1.87) and 19-
hydroxy-psammaplysin X (1.86) showed potent cytotoxicity against six cancer cell lines (HCT-15 
, PC-3 ACHN MDA-MB-231 NUGC-3 NCI-H23) with a GI50 values down to concentrations of 
0.8 µM.[28] Psammaplysin Z (1.88) and 19-hydroxy-psammaplysin (1.89) demonstrated low 
efficiency against MDA-MB-231 and HeLa cancer cells with IC50 values ranging from 
concentration of 13.2 to 22.2 µM. However, in cytotoxic studies in colon carcinoma HCT-116, both 
substances reduced the cell growth to 50% at a concentration of 8.2 and 7.0 µM.[35] 
Lee and coworkers reported the spirooxepin-isoxazoline ring moiety as a crucial factor of the 
cytotoxic activity. Their investigation on the molok’iamines (1.90), ceratinamines (1.92) and their 
corresponding hydroxy derivatives (1.91 and 1.93), revealed no cytotoxic activity in human cancer 
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lines (HCT-15 , PC-3 ACHN MDA-MB-231 NUGC-3 NCI-H23) of the used compounds in 
concentrations up to 70 µM.[28] Shaala and coworkers confirmed these results in further 
investigations.[42] 
 
Figure 7: General structure of the side chain of psammaplysin members. 
However, the potency of the pharmaceutical activity of these spirooxepin-isoxazoline natural 
products mainly depends on the bromotyramine moiety. In particular, the substitution pattern of the 
terminal amine. For example, psammaplysin E (1.59) (terminal 2-(methylene)cyclopent-4-ene-1,3-
dione moiety) displayed a higher potency to inhibit cell growth as psammaplysin A (1.53) (free 
terminal amine) against MDA-MB-231 and HeLa cancer cells lower than 0.20 µM. Moreover, 
psammaplysin Z (1.88) and 19-hydroxy-psammaplysin Z (1.89) showed an even significant lower 
activity against these cells lines caused by the presence of the terminal urea moiety in both 
compounds.[35] However, psammaplysin D (1.57) with its 12-methyl myristic acid sidechain as a 
further example demonstrated a lack in activity (GI50 > 10 μM) based to the high lipophilic 
character of the compound compared to psammaplysin A (1.53) possessing the free amine.  
 
1.5.2.2 Ceratinamides Family of Natural Products 
Ceratinamides A (1.94) and B (1.96) were isolated from marine sponge Pseudoceratina purpurea 
collected from the Hachijo-jima in 1996 by Fusetani and coworkers.[36] Hydroxy ceratinamide A 
(1.95) was obtained from the micronesian subarea marine sponge (order Verongida, family 
Aplysinellidae) by Lee and coworkers in 2013.[28] Almost two years later ceratinamide A (1.94) and 
hydroxy-ceratinamide A (1.95) were extracted by El Sayed and coworkers.[40] Isolation of 
ceratinamides was always described with the isolation of known members of the psammaplysin 
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family. Therefore, the main structural motif is represented as the formamide functionality[28] within 
the sidechain. However, ceratinamide B (1.96) contains as only member a fatty acid amid group.[28, 
36] 
 
Figure 8: Members within the ceratinamide family. 
Ceratinamides A (1.94) and B (1.96) exhibit antifouling activity through the inhibition of the 
metamorphosis and settlement of the barnacle B. amphitrite ranging from ED50 to 0.10 and 
2.4 mg/mL and a low cytotoxic effect against P33 cancer cells with IC50 values with a concentration 
of more than 10 µM.[36] So far hydroxy-ceratinamide A (1.95) has not been evaluated for its 
biological activity yet. 
 
1.5.2.3 Ceratinadins Family of Natural Products 
In 2018, two new bromotyrosine alkaloids, named ceratinadins E (1.97) and F (1.98), were 
extracted from an Okinawan marine sponge Pseudoceratina sp. in Okinawa by Kubota and 
coworkers together with psammaplysin A (1.53) and F (1.60). The characteristic feature of 
ceratinadin family is the repetitive moloka’iamine motifs in the sidechain. The Absolute 
configuration was assigned to 6R,7R isomer by the means of NMR and ECD spectroscopy the 
comparison with already isolated and characterized psammaplysin A (1.53).[37] 
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Figure 9: Structure of ceratinadin E (1.97) and F (1.98) Members within the ceratinadin family. 
In vitro studies of ceratinadin E (1.97) and F (1.98) were conducted in drug-resistant (K1) and drug-
sensitive (FCR3) strains of Plasmodium falciparum to evaluate antimalarial activity. It was found 
that ceratinadin E (1.97) requires almost half of the concentration in the drug-sensitive as drug-
resistant in the drug- resistant strains. Conversely, ceratinadin F (1.98) did not show any significant 
antimalarial activity.[37] 
 
1.5.2.4 Frondoplysins Family of Natural Products 
Two frondoplysins derivatives were described by Hou-Wen and coworkers, isolated from the 
sponge Dysidea frondosa (no. XD1506A) from the South China Sea.[38] This was also the first time 
the absolute configuration of this class of natural products was fully determined by X-ray 
crystallography and validated the proposed 6R,7R isomer. The characteristic feature of the 
frondoplysin derived products is their avarone and neoavarone motif in the side chain. 
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Figure 10: Structures of frondoplysin A (1.55) and B (1.99).  
Frondoplysin A (1.55) was found to be a potent inhibitor of the targeting protein-tyrosine 
phosphatase 1B (PTP1B) with an (IC50 = 0.39 μM) while frondoplysin B (1.99) demonstrated a 
lower activity (IC50 = 0.65 μM).
[38] Moreover, frondoplysin A revealed a higher inhibitory activity 
compared to thiazolidinediones (IC50 of 5.0 μM)
[43] and similar reducing properties as benzofurane 
and benzothiophene biphenyls (IC50 = 0.36 μM)
[44]. An enzymatic kinetic study outlined that 1.55 
acts as a mixed PTP1B inhibitor, but the mode of action is still unknown. Additionally, it displayed 
significant higher antioxidant activity compared to vitamin C in the zebrafish model, but cytotoxic 
effects were not observed. [38] 
 
1.5.3 Biosynthesis of Bromotyrosine derived Natural Products 
The spirooxepin-isoxazoline family of natural products feature are derived from bromotyrosine and 
include members such as aerothionin, fistularin and further analogues. These natural products were 
mainly isolated from marine sponges of the order Verongida.[14, 45] The spirooxepin-isoxazoline is 
a unique structure and is rarely found in natural products. 
The biosynthesis of oximinotyrosine derived natural products are widely unexplored based on their 
extreme difficult investigation of secondary metabolites from marine sponges, which are always 
associated with microorganism. Today, two different proposed mechanism are available as reported 
by Rogers[46] in 2007 and by Lindel[45] in 2010 are discussed in the following sections.  
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1.5.3.1 Proposed Biosynthesis of Bromotyrosine Natural Products 
The biosynthesis, the bromination of tyrosine (1.100) is catalyzed by the bromooxiperoxidase, a 
vanadium-dependent haloperoxidases (compare chapter 1.3 Halogenated Natural Products) to 
generate the bromo tyrosine buildings block 1.49 for further modifications.[38, 46]  
 
Scheme 8: Proposed biosynthesis of isoxazoline oxepin natural products (part 1). 
The O-alkylation of phenol 1.49 is still not fully understood. The currently accepted mechanism 
includes either SAM (1.11) or glutamate (1.101) as candidates for the linker chain formation. SAM 
as cofactor is known for alkylation, in which carboxylic acid 1.104 is generated. Dual 
decarboxylation afforded the moloka’iamine (1.103).[46] Another proposed biosynthesis starts with 
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the degradation of glutamate (1.101) to generate the propanol linker 1.102, which then is connected 
by etherification to the phenol 1.49 and subsequent decarboxylation afforded moloka’iamine 
(1.103).[38] Finally, amide formation with a second bromotyrosine 1.49 affords the common 
intermediate for both proposed biosynthesis pathways.[38, 46]  
 
1.5.3.2 Proposed Ring-Expansion Mechanism by Roll 
The first proposed biosynthesis was reported by Roll in 1985.[21] In the first steps, the amine 1.104 
is oxidized to an oxime 1.106, which can be also found in already mentioned other marine natural 
products. Based on the experimentally demonstrated biosynthesis of aranotin published by Neuss 
et al.[47] and Brannon et al.[48], Roll postulated an arene oxide intermediate 1.107, which then 
underwent a ring-expansion to afford the desired oxepin-isoxazoline spiro structure 1.110. For this 
step, a concerted or cationic mechanism is plausible. With this proposed biosynthesis, also the 
biosynthesis of further spiro marine natural products might be explained by a SN2 like opening of 
the arene oxide 1.107. 
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Scheme 9: Proposed biosynthesis of isoxazoline-oxepin natural products by Roll (part 2). 
The illustrated mechanism in Scheme 9 was also referenced by Jiao and coworkers in 2019 for the 
biosynthesis of frondoplysin A (1.55) and B (1.99).[38] Methylation by the cosubstrate SAM finally 
generated the enol ether motif and a following diastereoselective oxidation generates the hydroxy-
isoxazoline structure.[38] Another pathway was suggested with already methylated dibromotyrosine 
1.104 as starting material, which followed the same mechanism as described above.[49] 
Introduction 
25 
 
 
Scheme 10: Final modification of isoxazoline-oxepin natural products. 
 
1.5.3.3 Proposed Ring-Expansion Mechanism by Lindel 
Lindel proposed a similar biosynthesis as Roll, however, formation of the spiro is built in a different 
way.[45] In the first step, phenol 1.104 is methylated via SAM dependent methylase. The epoxidation 
is achieved by a monooxygenase (possible a cytochrome P450[50]) providing the arene oxide 1.111. 
Subsequently, the latter can undergo either an oxime mediated ring-opening to the spiro-
cyclohexadiene system (1.112) (Scheme 11, blue arrows), as already described by Roll or a 6π 
disrotatory electrocyclic ring-opening to the oxepin 1.113 (Scheme 11, red arrows). The spiro-
cyclohexadiene precursor 1.112, which is present in natural products like fistularins and areothions 
can additionally act as a building block for further bromotyrosine natural products. In the case of 
the oxepin a 1,3-hydride shift induces isomerization to the conjugated oxime 1.114, followed by a 
second oxidation to provide the asymmetric epoxide 1.115. In the final step, the epoxide opening 
by the oxime generates the spiro 1.53, already including the hydroxy-isoxazoline. Nevertheless, 
Lindel also mentioned that there could be also a direct pathway from oxime 1.106.[49, 51] 
In 2017, Karuso and coworkers isolated several bromotyrosine alkaloids including an enantiomer 
of a known carboxylic acid. This report suggested an enantiodivergent step in the biosynthesis of 
bromotyrosine alkaloids resulting in an increased structural diversity. However, this step occurs 
during arene oxide 1.111 formation. The enantiotopic epoxidation is an interesting enantiodivergent 
desymmetrization that leads to enantiomers of natural products, which might be produced by 
different species.[52]  
 
Introduction 
26 
 
 
Scheme 11: Proposed biosynthesis of isoxazoline-oxepin natural products by Lindel (part 2). 
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2 Previous Efforts toward the Synthesis of Psammaplysin A 
While there are many total synthesis of spiro[4;5]-cyclohexadiene isoxazoline containing natural 
products[45], there are only few model substrates for spiro[4;6]-cycloheptadiene isoxazoline core 
motif. Despite their promising biological activity, there are no published syntheses of any member 
of the hydroxy-isoxazoline-dihydrooxepin natural products to date. Due to the lack of naturally 
occurring material, a concise synthesis will be necessary to establish a comprehensive biological 
evaluation of the psammaplysins and shine light on structure–activity relationships by the 
investigation of fully synthetic analogs. 
Mioskowski reported the first approach for spiro[4;6]-cycloheptadiene isoxazoline synthesis by the 
condensation of hydroxylamine onto the more electron deficient ketone and direct spiro 
cyclization.[53] Although a single example of a low functionalized [4;6] spiro 2.2 exist in this report 
(Scheme 12 A), Lindel describes this methodology as the most promising model study towards 
isoxazoline-oxepin natural products.[45]  
 
Scheme 12: A) Spiro isoxazoline ring formation via condensation. B) Spiro isoxazoline ring formation via 
bromonium cyclization. C) Spiro isoxazoline ring formation via [1,3]-dipolar cycloaddition. 
Hamme and coworkers demonstrated a spirocyclation via an electrophilic bromination step. 
Intramolecular opening of the bromonium by primary alcohols or carboxylic acids afforded the 
desired spiro product. Nevertheless, they reported only the formation of five- and six-membered 
spiro-isoxazolines (Scheme 12 B).[54] In the work of Lieberknecht and coworkers the utility of [1,3]-
dipolar cycloaddition reactions to synthesize spiro isoxazoline starting from a terminal enol ether 
2.5 was described.[55] 
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In 2015, a dissertation towards the total synthesis of psammaplysin was provided by the Vanderwal 
group.[56] Their basic strategy was the installation of a donor acceptor cyclopropane and its ring-
expansion to directly build up the [4;6] spiro moiety. The addition of silyl enol ether 2.7 to acid 
chloride afforded in enol 2.8, which was then condensed with tert-butyldimethylsilyl protected 
hydroxylamine. Thermal ketene formation and trapping n-butyl vinyl ether yielded the pyranone 
2.10. In their work, they also demonstrated that the direct cyclopropanation of dihydropyrone 2.10 
was not possible. However, a three step sequence including reduction (lithium borohydride), 
cyclopropanation (Simmons−Smith), and oxidation (Swern) allowed them to access the desired 
cyclopropane 2.13.  
 
Scheme 13: Synthesis towards the psammaplysin family starting from silyl ketene acetal 2.7 to access 
cyclopropane 2.13. 
However, ketone 2.13 did not undergo the desired spiro cyclization, while addition of Lewis acid 
resulted in the formation of hydrooxepin 2.14, Brønsted acids formed hemiacetal 2.15 and acetal 
2.16 or 2.17, depending on the solvent.   
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Scheme 14: Attempted synthesis of spiro 2.18 from dihydropyrone 2.13. 
Although, this thesis demonstrated the successful synthesis of the spiro 2.20 from alcohol 2.12, the 
obtained hydrooxepin moiety was still lacking in the correct substitution pattern. Formation of the 
enone motif under acidic conditions resulted in the undesired opening of the spiro residue, which 
evidenced the acid lability of this spiro motif. 
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Scheme 15: Synthesis of spiro 2.20 and undesired subsequent side reaction. 
An attempted bio-inspired oxidation of the aromatic core was reported by Clardy to directly access 
the seven-membered ring.[49] However, oxidation of the aromatic core is performed on simple 
benzene or anisole derivatives with short reactions times to prevent undesired side reactions. 
Although, reactions were run for up to 37 days only low yields were obtained of the oxidized 
products 2.25 to 2.29. A low yielding biomimetic synthesis of areothionin 2.29 was accomplished 
by this method, showing that in general an oxidation of the aromatic ring is possible, but further 
oxidation studies are required to develop better methods to generate the necessary arene oxide, 
which might gave the desired spirocycles. 
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Scheme 16: A) Planned oxidation of the aromatic ring to access spirohydrooxepin. B) Isolated products of 
different oxidations protocols. 
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3 Results and Discussion 
3.1 Retrosynthetic Analysis of Psammaplysin A 
Even almost 40 years after the first isolation of psammaplysin A (3.1)[18], there are only two 
synthetic studies known (Clardy[49], Vanderwal[56]). This already indicates that the synthesis of this 
structural motif represents a great challenge for synthetic chemists. Furthermore, the spirocyclic 
nature of the natural product brings in sterical hindrance which could cause reactivity issues for 
planned synthetic (post)-modifications.[57-58]  
 
Figure 11: Structure of psammaplysin A (3.1) 
Psammaplysin A (3.1) has two vicinal stereocenters, one can be classified as a spiro acetal and the 
other as a secondary alcohol within the isoxazoline structure. Another prominent feature is the 1,3-
dibromo-2-methoxy substitution pattern on the dihydrooxepin motif. This dense substitution 
pattern on the seven-membered ring significantly increases the difficulty of the synthesis. 
Furthermore, this particular dihydrooxepin includes a bis-enolether system, which is known to 
hydrolyze easily.[59] The surprising stability of the brominated enol ethers is based on electron 
withdrawing groups at the β-position as demonstrated in pioneering work of Schwarte et al..[60] 
Isoxazoline structure is the second ring structure of the spiro and itself a common structure in 
chemistry. However, syntheses of spiroisoxazolines are limited to few methods. Furthermore, 
acetal spiro center in psammaplysin was expected to open up under acidic conditions. This opening 
of the isoxazoline motif was demonstrated by studies toward the synthesis of psammaplysin.[56] 
Finally bis-brominated tyramine derivative is linked to the scaffold via an amide bond.  
To realize a convergent synthetic entry for the psammaplysin family, the retrosynthetic 
disconnection of the amide bond will allow late-stage diversification to access different members 
of bromotyrosine natural products. Additionally, this strategy will allow rapid entry to synthetic 
analogs of 3.1 to shine light on their structure-activity-relationships. Herein, the amine 3.3 will be 
easily accessible from tyramine 3.5 within a few steps via bromination, modification of the 
phenethylamine functionality and phenol coupling with the propane linker.[49, 61] 
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Scheme 17: Retrosynthetic analysis of psammaplysin A (3.1). 
In contrast to this, the highly oxidized spiro-dihydrooxepin-isoxazoline ring structure 3.2 displays 
a unique heterocyclic skeleton for which we envisioned a stepwise bromination with final enol 
ether formation. This strategy was also successfully applied on related compounds by Guy and 
coworkers.[62] Our first approach commenced with the linear substituted isoxazoline 3.6, which 
might give access to spiro 3.4 after spiro cyclization with the primary alcohol. The second approach 
already included a substituted dihydrooxepin aldehyde 3.7. After enol formation or elimination to 
the terminal double bond, [1,3]-dipolar cycloaddition with a nitrile oxide would afford our key 
intermediate 3.4. 
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Scheme 18: Condensation disconnections of spiro 3.4 to linear pentacarbonyl 3.8. 
A further retrosynthetic disconnection of spiro 3.4 to linear pentacarbonyl 3.8 envisioned by a series 
of condensation reactions with hydroxylamine is illustrated in Scheme 18. However, this 
disconnection may not be practical in the forward sensesense as it requires a 1,2,4,7,9-
pentacarbonyl moiety as a key structural feature of the psammaplysins. 
 
3.2 First-Generation Approach: Spiro Cyclization 
3.2.1 Bromo Spiro-Cyclization to the [6;4] Spiro System 
Our initial survey through the literature revealed a methodology of Hamme Li and coworkers, 
which relied on a highly efficient oxidative spirocyclization via dearomatization of linear isoxazole 
3.9.[54] However, their report was limited to aliphatic and primary alcohols as well carboxylic acids 
to afford [5;4] and [4;4] spiro systems 3.10. By enhancing this strategy, we imagine to directly 
access the desired [6;4] spiro system 3.12 bearing the ketone functionality on the oxepin moiety. 
 
Scheme 19: A) Spiro cyclization of isoxazole 3.9. B) Planned synthesis of spiro 3.11 from isoxazole 3.11. 
For the synthesis of cyclization precursor 3.11, commercially available acetoacetate 3.13 was 
converted into alkyne 3.14 in four steps. Finally, DABCO-catalyzed [1,3]-dipolar cycloaddition of 
alkyne 3.14 with ethyl nitro acetate afforded the desired isoxazole 3.11 in excellent yield.[63-64] 
Results and Discussion 
35 
 
 
Scheme 20: Synthesis of isoxazole 3.11 from acetoacetate 3.13. 
The proposed mechanism[64] of this DABCO-catalyzed (10-20 mol%) [1,3]-dipolar cycloaddition 
is illustrated in Scheme 21. Nitro compound 3.15 enters the catalytic cyclic via deprotonation of 
the α-acidic nitro position by DABCO to unmask its [1,3]-dipolar character. In polar protic solvents 
like ethanol both ions exist as single ions. Dipole 3.16 undergoes the [3+2]-cycloaddition with 
alkyne 3.18 to form five-membered cycle 3.19. 3.20 is generated by the protonation by the 
protonated DBACO species 3.17. Deprotonation protonation sequence of 3.20 catalyzed by 
DABCO 2.21 afforded isoxazole 3.24, water and the free DABCO 2.21. DABCO 2.21 reenter the 
catalytic cycle by deprotonation of the next nitro compound 3.15.[64-65]  
 
Scheme 21: Proposed mechanism for the DABCO catalyst [1,3]-dipolar cycloaddition with nitro compounds. 
Unfortunately, linear precursor 3.11 did not undergo the desired bromo-cyclization. However, 
α-bromination was observed as the major side reaction. By the formation of hydrogen bromide, 
primary alcohol is substituted by bromide and directly eliminate to the corresponding enone system 
(Scheme 22). 
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Scheme 22: Attempted synthesis of 3.12 and isolated ketone 3.25. 
To avoid α-bromination in the cyclization step, the ketone moiety was protected as its 
corresponding acetal. For this purpose, alkyne 3.27 was subjected to the previously used reaction 
conditions to yield isoxazole 3.28 in excellent yield (Scheme 23). 
 
Scheme 23: Synthesis of acetal protected isoxazole 3.28 and 3.29. 
Unfortunately, acetal 3.29 turned out to be unstable upon exposure to bromine in dichloromethane 
leading again to bromoketone 3.25, presumably via initial deprotection of the ketone moiety 
followed by alpha-bromination. 
 
Scheme 24: Attempted synthesis of spiro 3.12 and isolated ketone 3.25. 
For this reason, reduction of ketone and subsequent protection with stable tert-butyldiphenylsilyl 
group was chosen. Starting from acetoacetate 3.13, primary alcohol 3.30 was accessed by sodium 
borohydride reduction, tert-tutyldiphenylsilyl protection and diisobutylaluminium hydride 
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reduction. [1,3]-dipolar cycloaddition delivered isoxazole 3.31 in 91% yield. However, even up to 
25 equivalents of bromine still showed no conversion toward any cyclized products.  
 
Scheme 25: Attempted synthesis of spiro 3.32. 
 
3.2.2 Isoxazole Reduction to 1,3-Diketone 
With isoxazole 3.33 in hand, we envisioned to directly reduce the isoxazole motif to the 
corresponding diketone 3.34. In our envisioned synthetic route, spiro 3.35 can be constructed by 
series of condensations with hydroxylamine and diketone 3.34. The chemoselective condensation 
of hydroxylamine onto the more electron-deficient ketone with the formation of similar seven-
membered ring systems was reported by Smietana and coworkers.[53] 
 
Scheme 26: Planned synthetic route towards spiro 3.35. 
However, reduction of isoxazoles bearing an ester at the group on 3-position to the corresponding 
1,3-ketone are mainly known in literature. Nevertheless many conditions are known for aliphatic-
substituted isoxazole at the 3-position.[66-68] Conditions on substrate 3.11, 3.28 and 3.29 resulted in 
no reaction except for condition with molybdenum hexacarbonyl at 90 °C (Table 2, entry 9) 
affording a complex reaction mixture. 
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Table 2: Screening for reduction of isoxazole 3.36−3.38. 
 
entry X R conditions solvent result 
1 O H Raney Nickel, H2 MeOH no reaction 
2 O H Raney Nickel, H2 EtOH no reaction 
3 O H Raney Nickel, H2, AcOH EtOH no reaction 
3 -OCH2CH2O- H Raney Nickel, H2 MeOH no reaction 
4 -OCH2CH2O- H Raney Nickel, H2,  EtOH no reaction 
5 -OCH2CH2O- H Raney Nickel, H2, AcOH MeOH no reaction 
6 -OCH2CH2O- TBS Raney Nickel, H2, AcOH MeOH no reaction 
7 OTBDPS H Raney Nickel, H2 EtOH no reaction 
8 OTBDPS H Raney Nickel, H2, AcOH MeOH no reaction 
9 OTBDPS H Mo(CO)6, 90 °C MeCN complex mixture 
 
With these results in hands, this approach was not continued, as an alternative synthetic access 
would include multistep synthesis with several protection and deprotection steps.  
3.2.3 Bromo Spiro-Cyclization and Ring-Expansion  
Spiro cyclization to afford the seven-membered ring was not accessible under our previous 
conditions. Therefore, we designed a ring-expansion strategy to access the key-motif from six-
membered ring systems, which are fused to a cyclopropane.  
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Scheme 27: Retrosynthetic analysis of spiro 3.39 based on a ring-expansion of cyclopropane 3.40. 
Advantage of this retrosynthetic route would the direct installation of the first bromine in enone 
3.39 by the opening the dibromocyclopropane 3.40. Bromoform is a well-known precursor for the 
synthesis of dibromocarbenes, reacts with silyl protected enol ether to generate the cyclopropane.[69] 
Regioselective conditions for silyl enol protection were described by Wanner[70] from pyranons. 
Isoxazole 3.42 can undergo the already mentioned bromo induced spiro-cyclization with the more 
reactive primary alcohol and subsequent oxidation of the secondary alcohol and could be tracked 
back to commercially available glycidol 3.43. 
Our new synthetic route commenced with the conversion of glycidol 3.43 into diol 3.45 upon 
treatment with propargylmagnesium bromide in the presence of catalytic amounts of mercury 
chloride to avoid allene formation.[71-72] Subsequent [1,3]-dipolar cycloaddition with ethyl nitro 
acetate gave the desired isoxazole 3.46 in excellent yield. Initial attempts for the oxidative 
spirocyclization delivered only the undesired [4;4]-spiro motif as mixture of two diastereomers, 
which could be separated via HPLC. 
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Scheme 28: Synthesis of spiro 3.47 as diastereomeric mixture from glycidol 3.44. 
Primary and secondary alcohols only slightly differ in their reactivity and nucleophilicity. Further 
aspects like ring size and steric hindrance should also influence the outcome of this reaction. 
However, exclusively formation of the five-membered ring was observed. The 5-exo-tet cyclization 
is more favored compared to the 6-exo-tet cyclization for kinetic reasons.[73] Comparing the 
formation of five- and six-membered ring systems, the smaller ring is formed more rapidly. The 
strain engendered in reaching the transition state leading to a six-membered ring is higher than 
compared to five-member rings, although the six-membered ring is the thermodynamic more stable 
product.[73-74] Efforts to tune the thermodynamic or kinetic parameters by varying the nucleophilic 
character, temperatures and reaction times did not improve the reaction outcome. Nevertheless, 
attempt to shift the reaction to the 6-exo-tet cyclization were unsuccessful.  
 
Scheme 29: Attempted synthesis of spiro 3.48 under modified conditions or transacetalization. 
Opening of the spiro acetal was observed under acidic conditions on similar spiro systems.[56] By 
the addition of p-toluenesulfonic acid to 3.47 in ethanol, we aimed to shift the equilibrium to the 
more thermodynamic product. However, we only recovered our starting material. For that reason, 
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we envisioned to use protecting group to achieve the desired reactivity to access the six-membered 
ring system. Starting with tert-butyldimethylsilyl-protected glycidol 3.50, we synthesized alkyne 
3.51 in good yield. Surprisingly, tert-butyldimethylsilyl-group was not stable under the DABCO 
catalyzed [1,3]-dipolar cycloaddition conditions, yielding diol 3.46 in 78% yield.  
 
Scheme 30: Synthesis of diol 3.46. 
Based on this result, oxidation of alcohol 3.51 under Swern conditions quantitatively afforded 
ketone 3.51, which readily underwent the [1,3]-dipolar cycloaddition with ethyl nitroactetae to 
yield isoxazole 3.53 in only moderate yield. However, addition of bromine to a solution of isoxazole 
3.53 in dichloromethane resulted in a complex reaction mixture without any detection of spiro 
compound 3.54. 
 
Scheme 31: Synthesis of isoxazole 3.53 and attempted synthesis of bromide 3.54. 
Due to the observed previous reaction outcome with ketones and protected ketones, we went one 
step back to diol 3.46 that we had used before. Although the five-membered ring was the only 
product observed, we aimed to use the protecting group chemistry to force the system to form the 
six-membered ring system. Commercially available protected glycidol 3.56 including the 
p-methoxy phenol protecting group on the primary alcohol was found to be an excellent substrate 
for our synthesis. Removal of the p-methoxy phenol under oxidative conditions tolerated a variety 
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of further functionalization of the secondary alcohol and was expected to not cleaved in the 
DABCO catalyzed [1,3]-dipolar cycloaddition.  
 
Scheme 32: Orthogonal protecting group approach to afford spiro 3.55. 
Grignard addition under already used conditions with p-methoxy phenol-protected glycidol 3.56 
afforded alcohol 3.57 in excellent yield. Subsequent [1,3]-dipolar cycloaddition yielded isoxazole 
3.57 in 78% yield. 
 
Scheme 33: Synthesis of isoxazole 3.58 
Acetyl protection was found to be problematic due to the migration of the acetyl group in oxidative 
cleavage step yielding a mixture of protected primary and secondary alcohols. Therefore, 
triisopropylsilyl- as well tert-tutyldiphenylsilyl-protecting groups were investigated to mask the 
secondary alcohol 3.58. Oxidative cleavage of phenol ether worked afforded primary alcohol 3.61 
and 3.62 in 96% and almost quantitative yield, respectively. However, no spiro cyclization was 
observed upon exposure to bromine and only starting material was recovered. These results might 
be explained by the bulky silyl protection groups leading to steric hindrance in the transition state. 
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Scheme 34: Attempted synthesis of spiro 3.63 and 3.64. 
Exposure of the alcohol 3.58 to Apple conditions afforded afforded bromide 3.65 in good yields. 
Removal of the paramethoxy phenyl afford yielded bromohydrin 3.66 in excellent yield without 
the observation of any epoxide formation. Interestingly, bromide 3.67 underwent the bromine 
induced spirocyclidsation in acceptable yield (33%).  
 
Scheme 35: Synthesis of spiro 3.67 as a mixture of diastereomers. 
We envisioned to selectively oxidize the more accessible bromide under Kornblum conditions.[75] 
While low temperatures (entry 1, Table 3) showed no reaction, higher temperatures (entry 2 to 4, 
Table 3) led to decomposition of the starting material, as well the addition of silver nitrate (entry 5, 
Table 3). 
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Table 3: Oxidation screening for bromide 3.67. 
 
entry conditions result 
1 DMSO, KHCO3, 60 °C, 16 h no reaction 
2 DMSO, KHCO3, 100 °C, 5 h decomposition 
3 DMSO, K2CO3, 100 °C, 5 h decomposition 
4 DMSO, TEA, 100 °C, 5 h decomposition 
5 DMSO, NaHCO3, AgNO3, 100 °C, 6 h decomposition 
6 DMSO, Ag2CO3, 75 °C, 16 h no reaction 
7 DMSO, Ag2CO3, 90 °C, 16 h complex mixture 
8 DMSO, Ag2CO3, 100 °C, 16 h decomposition 
 
With these results in hand, synthesis of ketone 3.68 was found to be highly challenging from 3.58. 
Further investigation were focus on the synthesis of diol 3.71 and its further modification for the 
synthesis ketone 3.69 (Scheme 37) 
 
Scheme 36: Retrosynthetic analysis of ketone 3.70. 
Synthesis of ketone 3.68 would be realized by an elimination/oxidation sequence of alcohol 3.70, 
which was tracked back to isoxazole 3.71. Isoxazole can be finally synthesized via a [1,3]-dipolar 
cycloaddition with ethyl nitro acetate and alkyne 3.72. 
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Scheme 37: Synthesis of spiro 3.72 as diastereomeric mixture. 
Starting from alkyne 3.73, alcohol was converted in to the iodide under Appel conditions. 
Substitution under basic conditions with diethylmalonate and lithium aluminium reduction gave 
diol 3.72 in 44% over three steps. Subsequent DABCO catalyzed [1,3]-dipolar cycloaddition 
afforded isoxazole 3.71 in good yield. Bromine induced spiro cyclization afforded the desired spiro 
compounds as mixture of diastereomers, which could only be separated by HPLC.  
However, classic Criego elimination protocols[76] were not successful and resulted in 
decomposition. Tosylation of the alcohol afforded an inseperate mixture of diastereomers 3.74. 
 
Scheme 38: Synthesis of tosyl 3.74 and attempted elimination of alcohol to terminal alkene 3.73. 
Conversion of tosyl 3.74 into the iodide in situ and adding a base resulted in complex reaction 
mixtures (entry 1 and 2, Table 4), while direct elimination showed no reactivity (entry 6−9, Table 
4). Interestingly, nucleophilic bases like sodium ethanolate did no undergo nucleophilic substitution 
of the bromide. Substitution of bromide was a further planned step in our envisioned synthetic 
route.[77-79] 
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Table 4: Conditions for the elimination of tosylate 3.75. 
 
entry conditions result 
1 NaI, DMF, 55 °C, then DBU, 80 °C, 3 h complex mixture 
2 NaI, DMF, 55 °C, then DBU, 60 °C, 3 h complex mixture 
3 DBU, DMF, 40 °C, 6 h no reaction 
4 DBU, DMF, 80 °C, 6 h no reaction 
5 DBU, DMF, 100 °C, 6 h complex mixture 
6 KOtBu, DMF, 80 °C, 6 h no reaction 
7 DABCO, DMF, 80 °C, 6 h no reaction 
8 DIPEA, DMF, 80 °C, 6 h no reaction 
9 EtONa, DMF, 80 °C, 6 h no reaction 
 
Attempted substitution of bromide 3.72 are summarized in Table 5. Bromide 3.72 showed no 
reaction with silver acetate (entry 1, Table 5) at 60 °C, while higher temperatures gave complex 
reactions mixtures. Additionally, potassium superoxide led to consumption of the starting material 
but only a complex mixture without formation of the desired compound was observed.[80] While 
ketone synthesis and hydroxylation of bromide were found to be challenging, we reconsidered a 
different synthetic route towards the natural product. 
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Table 5: Conditions for the substitution reaction of bromide 3.72 
 
entry conditions R result 
1 AcOAg, AcOH, 60 °C, 4 h OAc no reaction 
2 AcOAg, AcOH, 100 °C, 4 h OAc complex mixture 
3 KO2, 18-crown-6, DMSO, 23 °C, 1 h OH complex mixture 
 
3.3 Second Generation: Lactonisation 
Our previous synthetic studies towards the construction of the spiro scaffold in psammaplysin A 
(3.1) were found to be challenging. In addition, setting the absolute stereochemistry of the spiro 
center was an unsolved issue. While isoxazolines are well-known building block in synthesis, 
synthesis of 4-hydroxy-isoxazoline is limited to some reported examples.[81-84] Moreover for the 
asymmetric synthesis of this particular motif, only few reports exist, which can be basically reduced 
to two approaches (Scheme 40)[84-88] An enantioselective synthesis of hydroxy-isoxazolines 3.80 
was reported by Jørgensen and coworkers[85] starting from aldehyde 3.72 in a pot procedure.  
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Scheme 39: A) Synthesis of chiral hydroxy-isoxazoline 3.81 by enantioselective bromination and cyclization 
and reduction. B) Synthesis of isoxazoline 3.83 and hydroxylation. 
Alternative protocols promoted the elimination of the primary alcohol to the corresponding double 
bond, which after [1,3]-dipolar cycloaddition with nitrile oxide afforded the desired isoxazoline 
3.83.[89-90] Isoxazoline are acidic enough to be deprotonated and hydroxylated.[88, 91-92] 
Although seven-membered ring system are a challenging motif in organic synthesis, we aimed to 
synthesize the high substituted dihydrooxepin 3.85 with a primary alcohol for further modification, 
i.e. elimination to the terminal double bond. Substituted dihydrooxepin 3.85 should be synthesized 
from enone 3.86 by bromination and enol ether formation. Enone 3.86 was envisioned to be 
synthesized from lactone 3.87 (Scheme 41). For the desired ketone functionality, we considered 
acetal as a suitable protecting group for our synthetic route. Lactone 3.87 could be either 
synthesized by Baeyer−Villiger oxidation of ketone 3.88 or by lactonisation of carboxylic acid 
3.89.  
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Scheme 40: Retrosynthetic analysis of alcohol 3.85 from ketone 3.88 and carboxylic acid 3.89. 
Baeyer−Villiger oxidation[93-96] is a known protocol for the synthesis of seven-membered lactones, 
although the was only a single example in literature[97], which possess an acetal functionality in the 
β-position of the ketone. Simple alkylation of ketone 3.90 would probably form a mixture of the 
desired regioisomer 3.88 and undesired regioisomer 3.90. To overcome this regioselectivity issue, 
we aimed to reduce isoxazoline 3.92 to directly access ketone 3.93 (Scheme 42).  
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Scheme 41: A) Constructions of ketone 3.91 and 3.88 by alkylation of ketone 3.90. B) Synthesis of ketone 
3.93 by reduction of isoxazoline 3.92. 
Commercially inexpensive acetoacetate 3.90 was converted into literature known aldehyde 3.94 
within three steps.[98] Condensation with hydroxylamine afforded intermediate oxime 3.95 which 
was purified by simple extraction and directly oxidized with sodium hypochlorite forming the 
reactive nitrile oxide in situ. An intramolecular [1,3]-dipolar cycloaddition with the terminal alkene 
in 3.95 yielded the desired isoxazoline in 83% yield over two steps. Reduction by Raney®-Nickel 
under hydrogen atmosphere afforded ketone 3.88 in 81% yield. 
 
Scheme 42: Synthesis of ketone 3.88 from acetoacetate 3.13. 
Screening of different bases for the Bayer–Villiger oxdiation with meta-chloroperbenzoic acid 
yielded lactone 3.97 in good yields on small scale. However, we were not able to reproduce these 
results on larger scale for unknown reason. To verify these results, different batches of meta-
chloroperbenzoic acid, dichloromethane and potassium carbonate were tested. Finally, reaction 
temperature (entry 10, Table 6) and time (entry 11, Table 6) were increased with no effect on the 
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conversion. Further tests on cyclohexanone with different batches under these conditions were still 
successful. 
Table 6: Conditions for Baeyer−Villiger Oxidation of ketone 3.88 and 3.96 
 
entry R conditions scale yield 
1 H m-CPBA, CH2Cl2, 23 °C, 4 h 0.05 mmol no conversion 
2 H m-CPBA, CH2Cl2, Na2CO3, 23 °C, 4 h 0.05 mmol 66% 
3 H m-CPBA, CH2Cl2, Li2CO3, 23 °C, 4 h 0.05 mmol 38% 
4 H m-CPBA, CH2Cl2, K2CO3, 23 °C, 4 h 0.05 mmol 93% 
5 H m-CPBA, CH2Cl2, Cs2CO3, 23 °C, 4 h 0.05 mmol 90% 
6 H m-CPBA, CH2Cl2, NaOAc, 23 °C, 0 °C to4 h 0.05 mmol no conversion 
7 H m-CPBA, CH2Cl2, NaHCO3, 0 °C to 23 °C, 4 h 0.05 mmol no conversion 
9 H m-CPBA, CH2Cl2, K2CO3, 0 °C to 23 °C, 4 h 0.5 mmol no conversion 
10 H m-CPBA, CH2Cl2, K2CO3, 0 °C to 40 °C, 4 h 0.5 mmol no conversion 
11 H m-CPBA, CH2Cl2, K2CO3, 0 °C to 40 °C, 24 h 0.5 mmol no conversion 
12 TBDPS m-CPBA, CH2Cl2, 23 °C, 4 h 0.05 mmol no conversion 
13 TBDPS m-CPBA, CH2Cl2, K2CO3, 23 °C, 4 h 0.05 mmol no conversion 
 
With these results of the Baeyer−Villiger Oxidation this route was found be ineffective for further 
investigation. 
In parallel, lactonisation was under investigation. Starting from acetoacetate 3.13 alkene 3.99 was 
obtained in two steps.[98] Dihydroxylation afforded diol 3.100 in only moderate yield. Tert-
butyldiphenylsilyl was chosen as stable protection group for the protection of the primary alcohol. 
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Hydrolysis of ester 3.101 under different basic conditions resulted either in no reaction, migration 
or cleavage of the tert-tutyldiphenylsilyl group, affording a complex mixture. 
 
Scheme 43: Synthesis of ester 3.101 and attempted hydrolysis. 
To avoid this undesired isomerization and cleavage, alkene 3.99 was oxidized to aldehyde 3.103 
by Lemieux–Johnson oxidation protocol.[99] Slow addition of vinyl magnesium bromide afforded 
vinyl alcohol 3.103 in acceptable yields. Instead of hydrolysis and subsequent lactonisation, which 
may require high dilution to avoid dimerization a selective protocol for the formation of seven-
membered lactones was found by Ebine and coworkers[100]. Lithium aluminium hydride reduction 
afforded the desired diol 3.105, which underwent the desired oxidative lactonisation.  
 
Scheme 44: Synthesis of lactone 3.107 and further modification to access lactone 3.108. 
Alkene 3.106 was also converted under same Lemieux–Johnson oxidation conditions to the 
corresponding aldehyde 3.107 in acceptable yields. Nevertheless, upscaling of this reaction resulted 
in lower yields. 
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Reduction of ester 3.109 was also found to be problematic and resulted again in complex reaction 
mixture in which migration or cleavage was observed for the tert-tutyldiphenylsilyl group 
migration or cleavage was observed. 
 
Scheme 45: Attempted reduction of 3.109. 
While reductive conditions later in the synthesis proved to be challenging, ester 3.99 was directly 
reduced on an early stage and alcohol 3.111 was benzyl protected. Dihydroxylation of alkene 3.112 
yielded diol 3.113 in 95% yield. Subsequent selective silyl protection of the primary alcohol 3.113 
was accomplished in good yield with minor amounts of the bis-protected product. Unfortunately, 
benzyl deprotection was found to be more challenging. After optimization of the conditions 
(mixture of ethyl acetate and methanol), alcohol 3.115 was fromed in 65% yield. Lactone 3.116 
was finally obtained in good yield under oxidative lactonisation conditions. 
 
Scheme 46: Synthesis of lactone 3.116. 
In the literature several protocols for the synthesis of cyclic enol ethers from six-membered lactones 
are known.[101-103] mainly by reduction and subsequent elimination. For a seven-membered ring 
system, no reported examples of this transformation are known in the literature, which is mainly 
due to the fact that seven-membered lactols open more easily into the acyclic chain, which would 
then lead to several side reactions. For that reasons protocols for seven-membered enol ether 
formation include enol formation with subsequent reduction.[103-105] 
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Scheme 47 A) General synthesis of enol ether 3.120 from six membered lactones 3.117. B) General 
synthesis of enol ether 3.124 from seven membered lactones 3.121. C) Alternative synthesis of enol ether 
3.127 seven-membered lactones 3.125. 
Attempts of direct enol ether formation resulted in complex products mixtures in which no enol 
ether formation was observed (entry 1 and 2, Table 7). Triflation of 3.128 was also unsuccessful 
resulting in complex reaction mixtures (entry 3 to 5, Table 7). Phosphorylation, which were 
described to be more promising on seven-membered ring systems[106] afforded also complex 
reaction mixtures. 
Table 7: Conditions for enol ether formation of lactone 3.116. 
 
entry conditions R result 
1 DIBAL-H, CH2Cl2, −78 °C, 20 min 
then MsCl, NEt3, 45 °C, 1 h 
H decomposition 
2 DIBAL-H, CH2Cl2, −78 °C, 20 min 
then MsCl, NEt3, DCE, 75 °C, 10 min 
H decomposition 
3 LiHMDS, Comins reagent, THF, −78 °C to 23 °C, 2 h OTf complex mixture 
Results and Discussion 
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4 NaHMDS, Comins reagent, THF, −78 °C to 23 °C, 2 h OTf complex mixture 
5 LDA, Comins reagent, THF, −78 °C to 23 °C, 2 h OTf complex mixture 
6 LDA, (PhO)2P(O)Cl, THF, −78 °C to 23 °C, 2 h P(O)(OPh)2 complex mixture 
 
Attempts to access this enol ether were unsuccessful and demonstrate the complexity of the enol 
ether formation from seven-membered lactones.   
 
3.4 Third-Generation: Cyclobutane Ring-Expansion 
Previous efforts required multi-step synthesis to install the desired substitution pattern before 
closing the seven-membered ring. In our third generation approach we envisioned to directly access 
the seven-membered ring system with subsequent modification of the substitution pattern. Inspired 
by the ring-expansion of cyclobutane 3.129 to the corresponding seven membered-ring systems 
3.130[107], we envisioned to use this ring-expansion on a modified compound 3.131, for which the 
tertiary alcohol is replaced by a ether functionality affording the desired oxepanone 3.132. 
 
Scheme 48: A) Literature known synthesis of diketone 3.130. B) Planned synthesis of ketone 3.132. 
Starting our synthesis with lactone 3.134 was the first limiting factor. Although synthesis from 
glutamate 3.135 was possible within three steps, this route included complicated work-up protocols 
and was plagued by varying yields. Therefore, we opted for a slightly longer route that began with 
acetonide 3.133. Cyclic enol ether 3.136 was obtained by diisobutylaluminium hydride reduction 
and subsequent mesylation and elimination. Up to 66% yields were obtained by increasing the 
deactivation time for the silica used in the flash column chromatography (up to 24 h), while shorter 
deactivations times resulted in significant lower yields due to decomposition pathways.  
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Scheme 49: Two different synthetic entries for gamma-lactone 3.135 and its conversion to 2,3-dihydrofuran 
3.136. 
Preparation of dichloroketene by reduction of the trichloro acetyl 3.137a with zinc copper couple 
(entry 1−6, Table 8) gave only trace amounts of the desired cyclobutane. Generation of 
dichloroketene via dichloroacetyl chloride 3.137b afforded cyclobutane 3.318 after short improved 
reaction conditions in quantitative yield. Attempts to access brominated cyclobutanone (entry 10 
to 13, Table 8) were unsuccessful and only traces of the desired product were detected, 
Table 8: Screening for ketene formation and [2+2]-cycloaddition 
 
entry R R‘ R‘‘ X conditions result 
1 Cl Cl Cl Cl Zn/Cu, Et2O, 23 °C, 4 h no reaction 
2 Cl Cl Cl Cl Zn/Cu, TMSCl, Et2O, 23 °C, 4 h no reaction 
3 Cl Cl Cl Cl Zn/Cu, POCl3, Et2O, 23 °C, 4 h traces 
4 Cl Cl Cl Cl Zn/Cu, POCl3, n-hexane, 23 °C, 4 h traces 
5 Cl Cl Cl Cl Zn/Cu, POCl3, n-hexane, 65 °C, 4 h no reaction 
6 Cl Cl Cl Cl Zn/Cu, acid chloride freshly distilled, 
n-hexane, 65 °C, 4 h 
traces 
7 Cl Cl H Cl NEt3, Et2O, 23 °C, 1 h traces 
8 Cl Cl H Cl NEt3, hexane, 68 °C, 1 h 3.138 (66%)  
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9 Cl Cl H Cl NEt3, hexane, 68 °C, 15 min 3.138 >99%, d.r. 4.6/1 
10 Br Br Br Br Zn/Cu, Et2O, 23 °C, 1 h no reaction 
11 Br Br H Br NEt3, hexane, 68 °C, 15 min traces 
12 Br H H Br NEt3, hexane, 68 °C, 15 min traces 
13 Br Br Br OTMS PPh3, toluene, 110 °C, 8 h traces 
 
With dichlorobutane in hand, same conditions for the desired ring-expansion were screened. In all 
cases, we either observed only (partial) dehalogenation and/or complex product mixtures were 
formed.  
Table 9: Conditions for attempted ring-expansion  
 
entry conditions result 
1 Zn, NH4Cl, MeOH 3.140 (28%), 3.139 (7%)  
2 Zn, AcOH complex mixture 
3 Zn, AcOH, MeOH complex mixture 
4 SmI2, MeOH, THF complex mixture 
 
The driving force of the reported ring-expansion in Scheme 49, is beside the strain release of the 
four membered ring system the formation of the carbonyl functionality. Further investigations to 
activate the carbonyl in the cyclobutane 3.140 or increased temperatures to overcome the activation 
barrier may also induce the desired ring-expansion. 
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Scheme 50: Proposed mechanism for the ring-expansion of cyclobutane 3.141 to access seven-membered 
oxacycles. 
Our proposed ring-expansion would start with the activation of carbonyl 3.141, which opens to a 
seven-membered cycle forming a zwitterionic species, which after tautomerization leads to the 
formation of enone 3.146 or can be trapped by a nucleophile to afford oxepanone 3.145. 
Table 10: Conditions for ring expansion of cyclobutane 3.140. 
 
entry conditions results 
1 sulfolane, 23 °C to 180 °C no reaction 
2 AcOH, sulfolane, 23 °C to 180 °C no reaction 
3 TEA, sulfolane, 23 °C to 180 °C no reaction 
4 DMAP, sulfolane, 23 °C to 180 °C no reaction 
5 AcONH4, sulfolane, 23 °C to 180 °C no reaction 
6 AcOH, 23 °C to 120 °C no reaction 
7 TFA, sulfolane, 23 °C to 120 °C no reaction 
8 pTSA, sulfolane, 23 °C to 120 °C no reaction 
9 TMSOTf, CH2Cl2, −20 °C then water no reaction 
10 TMSOTf, CH2Cl2,  –20 °C then MeOH no reaction 
11 BF3∙OEt2, CH2Cl2, –20 °C to 23 °C no reaction 
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12 TESH, BF3∙OEt2,  CH2Cl2, –20 °C to 23 °C no reaction 
13 TESH, TMSOTf, CH2Cl2, –20 °C to 23 °C no reaction 
14 TESH, TMSOTf, MeCN, –20 °C to 23 °C no reaction 
15 TMSOTf, CH2Cl2, –20 °C then water no reaction 
 
In all cases even under harsh reaction with Lewis or Brønsted acids no desired reactivity was 
observed, only partial cleavage of the protecting group took place. With this attempted 
ring-expansion we turned our further investigation towards a retro [2+2]-approach, in which 
cyclobutane 3.149 would significantly increases the ring strain to push the system to the desired 
seven-membered ring-expansion. Especially, if the methoxy group can be installed, this would give 
a fast access to the desired dihydrooxepin motif. 
 
Scheme 51: Planned synthesis of dihydrooxepin 3.150. 
However, formation of the desired enol ether formation was not observed under any tested 
conditions (entry 1 to 6, Table 11). Only orthoester (entry 7, Table 11) under acidic conditions 
showed conversion, but resulted in a complex reaction mixture.  
Table 11: Reaction conditions for the enol ether formation. 
 
entry conditions R result 
1 LiHMDS, TMSOTf, THF, –78 °C to 23 °C, 2 h TMS no reaction 
2 KHMDS, TMSOTf, THF, –78 °C to rt, 2 h  TMS no reaction 
3 LDA, TMSOTf, THF, –78 °C to rt, 2 h  TMS no reaction 
4 NEt3, TMSOTf, THF, –78 °C to rt, 2 h TMS no reaction 
5 NEt3, TMSCl, NaI, MeCN, –78 °C to 23 °C, 4 h TMS no reaction 
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6 LDA, Comins reagent, –78 °C to 23 °C Tf no reaction 
7 pTSA, HC(OMe)3, MeOH, 65 °C Me complex mixture 
 
Since silyl enol formation, triflation or enol ether formation failed for our system 3.140 (Table 11), 
we turned our efforts to a bioinspired synthesis of toward the synthesis of psammaplysin A (3.1). 
 
3.5 Fourth-Generation: Bioinspired Synthesis 
The oxidation dearomatization of aromatic systems displays a challenging hurdle for organic 
chemists to access functionalized cyclohexadienes. However, in recent years different groups have 
demonstrated the possibility directly oxidation of the aromatic framework. Already in 2002 
Hudlicky and coworkers reported an enzymatic oxidation of simple aromatic structures 3.154 to 
the corresponding diols.[108] In 2017, Sarlah and coworkers published a total synthesis of 
(+)-pancratistatins (3.159) from benzene 3.156 employing an enantioselective, dearomative trans-
carboamination.[109] Although, there are several oxidation protocols described in the literature,[110-
112] these reactions are mainly limited to simple substituted aromatic systems.  
 
Scheme 52: A) Enzymatic oxidation of simple aromatic systems 3.156. B) Photochemical oxidation of 
benzene 3.156 and further modification toward (+)-pancratistatins (3.159). 
For that reason we envisioned a more bioinspired synthesis. In our synthetic route oxepin 3.162 
should be in in equilibrium with enone 3.162, which is a suitable precursor for selective 
epoxidation, condensation with hydroxylamine and finally cyclization. Key-intermediate would be 
the arene oxide 3.163. While direct epoxidation of the aromatic core was envision to be 
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problematic, we envisioned to synthesize spiro 3.164. Reduction of the nitron-oxygen bond would 
afford a tertiary alcohol, which can undergo the epoxide formation. 
 
 
Scheme 53: Retrosynthetic analysis of spiro 3.160 from spiro 3.164. 
Methoxymethyl acetal protection of phenol 3.165 followed by Wittig-olefination gave the desired 
enol ether 3.167 in good yield as a mixture of (E)- and (Z)-isomers. Tert-butyldimethylsilyl-
cleavage afforded a ketone, which was directly converted into oxime in a one-pot procedure in 
good yield without the need of flash column chromatography. Treatment with p-toluenesulfonic 
acid in methanol gave the desired phenol 3.169 in quantitative yield. 
 
Scheme 54: Synthesis of oxime 3.169 from aldehyde 3.165. 
After a short screening including different hypervalent iodine reagents or electrochemistry, 
(bis(trifluoroacetoxy)iodo)benzene (PIFA) in acetonitrile was found to be best reagent for this 
oxidative cyclization.  
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Scheme 55: Synthesis of spiro 3.170. 
Attempts to reduce the ketone or isoxazoline functionality in 3.170 were unsuccessful and gave 
only decomposition of the starting material. 
 
Scheme 56: Attempted ketone or isoxazoline reduction of spiro 3.170. 
Selective reduction of dienone 3.170 is known to be a challenging transformation.[45] Attempts to 
mask the diene motif by Diels−Alder reaction with maleimide 3.173 were unsuccessful. While 
maleimide 3.173 was recovered quantitatively, spiro 3.170 led to complete decomposition 
pathways.  
 
Scheme 57: Attempted Diels−Alder reaction of ketone 3.174 with maleimide 3.173. 
Due to the thermal instability of isoxazoline 3.170, we turned our attention to a more reliable 
synthesis. In the Alder−Becker oxidation phenols are oxidized with their benzylic alcohols to 
epoxide ketones. These fairly unknown reaction has been used for the synthesis of complex natural 
products (i.e. (±)-ovalicin[113] and calicheamicinone[114]). In our case, the highly substituted phenol 
would undergo oxidation followed by Payne rearrangement[115]. 
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Scheme 58: Synthesis plan involving Alder−Becker oxidation to access arene oxide 3.178 from phenol 
3.175. 
Phenol 3.180 was synthesized in two steps (bromination and reduction) of aldehyde 3.179. 
Alder−Becker oxidation afforded epoxide 3.180 in 59% yield. Unfortunately, epoxide 3.180 slow 
decomposed upon purification on silica and over time. 
 
Scheme 59: Synthesis of epoxide 3.181. 
With epoxide 3.181 in hand, conditions for the selective ketone reduction were investigated. 
Unfortunately, we found that all reductions conditions favored consecutive rearomatization of the 
substrate to the benzylic alcohol 3.180, together with decomposition of the starting material (Table 
12). 
Table 12: Conditions for the reduction of ketone 3.180. 
 
entry conditions result 
1 NaBH4, MeOH, 0 °C 3.180 
2 NaBH4, THF, 0 °C 3.180 
3 NaBH4, CeCl3, MeOH, 0 °C 3.180 
4 LiBH4, MeOH, 0 °C 3.180 
5 Zn(BH4) 2, THF, 0 °C 3.180 
6 LiAlH4, THF, 0 °C decomposition 
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7 DIBAL-H, THF, 0 °C decomposition 
8 DIBAL-H, THF, − 78 °C decomposition 
9 Red-Al, 0 °C decomposition 
 
Epoxide 3.181 was found to be highly reactive although reduction often resulted in reduction of the 
epoxide and subsequent aromatization. This undesired behavior was attributed to the high 
activation of the diene system of compound 3.181. We hypothesized that blocking the diene of this 
system could be beneficial to allow further transformations bypassing undesired reaction pathways. 
Diene 3.181 could eventually be temporary protected by a Diels−Alder reaction with a suitable 
dienophile of choice. The latter could then undergo retro Diels−Alder in a subsequent step to access 
the desired oxepin building block (Scheme 61). 
 
Scheme 60: Planned synthesis of oxepin 3.186 from ketone 3.181. 
Inspired by work by Good and coworkers[116] nitrosyloxide reagents were selected first. In a one 
pot procedure oxidation of the aromatic core and Diels−Alder reaction afforded a ketone 
intermediate, which was directly reduced to the more stable alcohol 3.187.  
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Scheme 61: Synthesis of alcohol 3.187. 
With alcohol 3.187 in hand, we investigated conditions for for the formation of epoxide 3.188. At 
this point the realtive stereochemistry of the alcohol 3.187 was not fully determined. As 
summarized in Table 13, all conditions investigated to rearrange epoxide 3.187 to desired epoxide 
3.188 and gave either decomposition (entry 1, 2) no reaction (entry 3) or addition of solvent to the 
Cbz (entry 4). Addition of sodium hydride afforded an unexpected crystalline side product 14 (entry 
5). After full conversion (more than 56 h) carbonate 3.189 was isolated in 32% yield (entry 6). The 
carbonate structure was confirmed by X-ray crystallography. 
Table 13: Conditions for Payne rearrangement of epoxide 3.187. 
 
entry conditions result 
1 LiHBEt3, THF decomposition 
2 KOH powdered, THF decomposition 
3 NaOH (1M), THF, 0 °C no reaction 
4 NaOH (1 M), MeOH complex mixture 
5 NaH, THF, 16 h traces of 3.188 
6 NaH, THF, 56 h 3.188 (32%) 
 
Even if the mechanism for the formation of carbonate 3.188 in presence of sodium hydride is still 
unclear, useful information about the reactivity of the system was obtained. By the addition of 
lithium bromide carbonate was obtained in 47% yield. In our proposed reaction mechanism 
bromide opens the epoxide 3.187. The resulting alkoxide 3.190 attacks the carabamte motif of the 
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Cbz group to generate the cyclic carbamate 3.191. Final step is the attack of the free alcohol in 
3.191 to generate the carbonate 3.189 (Scheme 63).  
 
Scheme 62: Proposed mechanism for the synthesis of carbonate 3.189. 
The hydrolysis of the carbonate 3.189 by the use of methanol and potassium carbonate or sodium 
hydroxide in mixtures of tetrahydrofuran and water resulted in decomposition of the starting 
material. In all cases, decomposition of the starting material was observed. Modification of the 
bromide in dimethyl sulfoxide to synthesize the aldehyde resulted in decomposition of the starting 
material too. While the free NH bond was seen crucial for further modification, attempted tosylation 
resulted also in decomposition. 
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Scheme 63: Attempted synthesis of tosyl 3.192, hydrolysis of carbonate and Kornblum oxidation of bromide 
3.189. 
To avoid carbonate formation, reduction of ketone 3.195 would require the other isomer. 
Conditions for the attempted selective reduction of ketone 3.195 to access the equatorial alcohol 
are summarized in Table 14.  
Table 14: Conditions for the reduction of ketone 3.195. 
 
entry conditions result 
1 LiHBEt3, THF, 0 °C 3.187 (33%) 
2 DIBAL-H, THF, 0 °C decomposition 
3 DIBAL-H, THF, −78 °C decomposition 
4 K-Selectride®, THF, 0 °C complex mixture 
5 LiBH4, THF decomposition 
6 Bu4NBH4, THF, 0 °C 3.187 (25%) 
7 NaBH(OAc)3,, THF, 0 °C 3.187 (74%) 
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While reduction of ketone 3.195 to set the right stereochemistry was unsuccessful and attempted 
modification of the carbonate 3.189 of carbonate resulted in decomposition, we aimed to use 
another functional group on the nitrogen. For that reasons other NO-reagents, which are suitable 
for this reactions-cascade were investigated. 
 
Scheme 64: Attempted synthesis of ketone 3.197 and 3.198 and isolated ketone 3.181. 
Nitrosobenzene or a tosylated derivative thereof did not undergo the desired Diels−Alder reaction 
with 3.181. Modification with nitrosobenzene under high pressure conditions (14 kbar) turned out 
unsuccessful as well and resulted in a complex mixture. Additionally, a variety of solvents also 
revealed no desired product formation. However, nitrosobenzene showed almost quantitative yields 
with cyclohexadiene. Due to its complex synthesis and instable intermediates we turned our 
attention to a more robust route, which also would allow to work on larger scales. 
 
3.6 Fifth-Generation: Cyclopropane Ring-expansion 
In early work, Hoberg and coworkers[117] demonstrated a Ferrier type ring-expansion of 
cyclopropane 3.199. Activation of cyclopropane 3.199 with TMSOTf afforded oxonium ion 3.200, 
which can be trapped by nucleophile to afford 3.201 or undergo elimination to afford dihydrooxepin 
3.202. A change of protecting group yielded a bicyclic derivative 3.205. 
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Scheme 65: A) Ring-expansion of access the seven-membered oxacycle 3.201 and 3.202. B) Ring 
expansion of acetate 3.203 to bicycle 3.205. 
As a model substrate nitrile 3.201a was synthesized within five steps. After oxidation of the double 
bond in nitrile 3.201a nitrile should be eliminated under basic conditions to afford enone 3.207. 
However, attempted oxidation with borane/hydrogen peroxide or meta-chloroperbenzoic acid of 
the double bond were unsuccessful.  
 
Scheme 66: Synthesis of nitrile 3.201a and attempted synthesis of ketone 3.206. 
With side product 3.202 bromination was investigated. Although different conditions afforded no 
brominated products, insight about the reactivity of hydrooxepin 3.202 were obtained.  
 
Scheme 67: Attempted synthesis of bromide 3.203. 
However, the chosen model substrate 3.201a lacked on the desired substitution pattern, we 
envisioned an optimized route towards our desired seven-membered ring from cyclopropane 3.209. 
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There we envision to synthesize acetate 3.209. Ring expansion would with same conditions would 
afford nitrile 3.210, where nitrile function can be used for the synthesis of the isoxazoline structure 
present in the core of isoxazoline-dihydrooxepine 3.208.  
 
Scheme 68: Ring-expansion strategies to access nitrile 3.201a and 3.210. 
Starting from inexpensive α-D-xylose 3.211 cyclic enol ether 3.212 was obtained in three steps. 
Direct Simmons−Smith cyclopropanation of acetate 3.212 showed no reactions. While free alcohol 
3.213 gave a complex mixture. Benzyl protected alcohol 3.214 afforded the desired cyclopropane 
3.215 in excellent yields as a single diastereomer. Cleavage of the benzyl ether protecting groups 
was achieved by catalytic hydrogenolysis using palladium on activated charcoal as catalyst. 
Debenzylation was successful on a 14 mmol scale employing of 10 mol% catalyst. However, 
running the reaction on 67 mmol scale, only traces of free alcohol were observed. Attempts to 
improve the yield by increasing the reaction time were also not successful. Finally increasing the 
amount of palladium up to 20 mol% afforded the desired alcohol by simple filtration over celite in 
almost quantitative yield. Subsequent acetylation afforded the desired cyclopropane 3.209. 
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Scheme 69: Synthesis of cyclopropane 3.209. 
Key ring-expansion was successful to afforde the nitrile 3.210 on a 14 mmol scale in 82% , however 
with no diastereoselectivity. Seperation of the both diastereomers was accomplished by HPLC.  
 
Scheme 70: Synthesis of nitrile 3.210 as a diastereomeric mixture. 
Under mild basic conditions acetyl deprotection of 3.210 was successful, but purification was found 
to be challenging. Several conditions to hydrolyze ester 3.210 were investigated, but using the crude 
material for the next oxidation step (Dess−Martin oxidation) afforded pure ketone 3.216. Addition 
of bromine or iodine to 3.216 showed no desired α-halogenation of the enone system. Halogenation 
occurred at the the α-position of the nitrile and subsequent elimination took place to generate the 
nitrile 3.217. Scheffer−Weitz epoxidations were also problematic with nitrile 3.216. 
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Scheme 71: Synthesis of ketone 3.216 and attempted further modification. 
Improved acetate deprotection under acidic conditions delivered alcohol 3.221 as an inseperate 
mixture of diastereomers. By changing the sequence to bromination of the double and subsequent 
oxidation ketone 3.222 was obtained in 85% yield over two steps.  
 
Scheme 72: Synthesis of bromide 3.222. 
Attempts for methanol coupling under known protocols [118-120] did only result in no reaction or 
dehalogenated products. While palladium catalyzed reaction showed insertion into the carbon 
bromide bond (entry 1 and 4, Table 15) copper catalyzed reaction showed no reaction at all.  
Table 15: Conditions for methoxylation of bromide 3.222. 
 
entry conditions results 
1 KB(OMe)4, SPhos, Pd(MeCN)2Cl2, 1,4-dioxane, 90 °C, 4 h dehalogenation 
2 MeOH, CuI, Me4Phen, Cs2CO3, toluene, 80 °C, 24 h no reaction 
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3 MeOH, CuI, Phen, Cs2CO3, MeCN, 80 °C, 8 h no reaction 
4 MeOH, BINAP, Pd(OAc)2, Cs2CO3, THF, 65 °C, 48 h dehalogenation 
 
In a second attempt to install of the desired methoxy functionality, we investigated the 
dihydroxylation of nitrile 3.221. However, we only obtained a complex mixture of several 
diastereomers, which were partially separated by HPLC chromatography. Methylation of the 
mixture of diol 3.225, tert-butyldimethylsilyl deprotection and subsequent Dess−Martin oxidation 
gave inseperate mixture of diastereomers of ketone 3.228. Elimination of the β-methoxy under 
basic conditions to give ketone 3.228 was unsuccessful.  
 
Scheme 73: Synthesis of ketone 3.228 from alcohol 3.221 and attempted synthesis of ketone 3.229. 
In parallel, the modification of the nitrile function was under investigation. Many examples are 
known in literature for this transformation. Surprisingly, the nitrile function turned out to be stable 
and showed no reaction under reductive conditions (i.e. lithium aluminium hydride or 
diisobutylaluminium hydride) at low temperatures, while increasing temperatures led to 
decomposition. Acidic conditions were also not successful for the modification of the nitrile 
function. The only observed reaction was the cleavage of the acetyl group or silyl group at higher 
temperatures with partial decomposition. 
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Scheme 74: Attempted synthesis of aldehyde 3.230 and 3.231, amine 3.232 and 3.233 or ester 3.234 and 
3.235. 
Reduction or hydrolysis conditions were found to be problematic for this modification of nitrile. 
Surprisingly, Ghaffar−Parkins catalyst converted nitrile 3.220 and 3.224 to amide 3.236 and 3.237 
in 61% and 58% yield, respectively.   
 
Scheme 75: Synthesis of amide 3.236 and 3.237. 
With amide 3.236 and 3.237 in hand, same conditions already tested for nitriles 3.220 and 3.224 
were investigated, with almost similar results. While reduction at low temperatures showed no 
reaction, higher temperatures afforded complex reactions mixtures. Hydrolysis under acidic or 
basic conditions was unsuccessful at lower temperatures and resulted also in decomposition at higer 
temperatures, 
Results and Discussion 
75 
 
 
Scheme 76: Attempted synthesis of amine 3.238 and 3.239 or ester 3.240 and 3.241. 
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4 Summary and Outlook 
Progress toward the total synthesis of psammaplysin A (4.7) was reported in this thesis. At first, 
several spiro isoxazolines were synthesized via a bromine spiro-cyclization. However, direct access 
to the desired seven-membered-ring framework as well as ring-expansion reactions were found to 
be challenging. Thus, the synthesis of the seven-membered ring from linear and cyclic precursors 
was studied in detail. These studies resulted in the development of a ring expansion and versatile 
route for the synthesis of the seven-membered ring core of psammaplysin A (4.7). 
Starting from commercially and inexpensive α-D-xylose (4.1), we prepared cyclic enol ether 4.2 
within five steps (Scheme 78). Diastereoselective Simmons−Smith cyclopropanation installed the 
required cyclopropane moiety. Further modifications of the hydroxy-groups afforded acetate 4.3, 
as optimal compound for our envisioned Ferrier-type ring expansion.  
 
Scheme 77: Convergent synthesis of the seven-membered ring of psammaplysin A (4.7) and nitrile 4.5. 
Activation via trimethyl triflate resulted in the ring-expanded oxacyle 4.4, which was trapped with 
trimethylsilyl cyanide to afford nitrile 4.4 as a mixture of two diastereomers (d.r. 1:1) in good yield. 
With an established route toward the seven-membered ring of the natural product in hand, we 
extensively investigated modifications towards our target spiro compound 4.6. The desired 
methoxy group was successfully installed via dihydroxylation and methylation in 4.5. Further 
directions include the elimination of the β-methoxy group, ketone reduction and elimination of the 
corresponding alcohol. Finally, bromination of the enol ether systems afford the desired subsitution 
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opattern in psammaplysin A (4.7).  Spirocyclization can occur via two different pathways. Either 
elimination to afford terminal alkene, which can undergo a [1,3]-dipolar cycloaddition or selective 
bromination and Henry reaction to afford the desired hydroxy-isoxazoline structure. In both cases 
transformation of the nitrile group to the corresponding aldehyde is required. However, nitrile 
reductions or hydrolysis proved to be challenging. For that reasons an alternative route would 
include Ferrier type ring-expansion with trimethylsilyl ketene acetal instead of trimethylsilyl nitrile 
(4.8) and cyclopropane 4.3. 
 
Scheme 78: Alternative route towards key intermediate 4.12 via Ferrier-type ring-expansion to afford ester 4.9 
and further modification to aldehyde 4.10 or oxime 4.11. 
Degradation of ester 4.9 would give aldehyde 4.10 as an important structure in our synthesis, which 
then can be cyclized and further functionalized to our key intermediate 4.12. Alternatively, ester 
4.9 could be converted into oxime 4.11, which also would be a suitable precursor toward the 
synthesis of psammaplysin A (4.7). 
Overall, the pursued strategies presented in this thesis constitute significant progress toward the 
first total synthesis of psammaplysin A (4.7). Further studies on the completion of the total 
synthesis of psammaplysin A are currently under investigation in the Magauer laboratories. 
 
 
 
 
 
 
 
 
 
 
PART II 
Acid-catalyzed Cycloisomerization of 
Neopentylic Epoxides 
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5 Introduction 
One element of structure that unexceptionally increases the difficulty of a chemical synthesis is the 
presence of all-carbon quaternary center. The difficulty to synthesize such centers arises from the 
steric hindrance imposed by the four attached carbons and the limited number of carbon-carbon 
bond-forming reactions that reliably assemble quaternary carbons. Despite the tremendous 
development within the last decades such as alkylation, radical reaction, photochemical reaction, 
pericyclic reaction, and many others their synthetic efficiency is hampered by the scope limitations 
and deficiency in enantioselective control.[121-122] The challenge is exacerbated further when two 
all-carbon quaternary stereocenter are adjacent. Despite the remarkable advances that have been 
made in the formation of all-carbon quaternary stereocenters, the construction of such these motif 
remains a significant challenge. Previously, a number of methods have been developed to directly 
synthesize vicinal all-carbon quaternary centers, including Nazarov cyclization[123] or iridium-
catalyzed alkylation[124] just to name a few.[125-126] 
 
Scheme 79: A) Nazarov cyclization of ketone 5.1 to afford enone 5.2 containing vicinal all‐carbon quaternary 
center. B) Iridium‐catalyzed allylic alkylation of malononitrile derivative 5.3 with allylic carbonate 5.4 to afford 
bis-nitrile 5.6 containing vicinal all‐carbon quaternary center. 
Echinopine B (5.9), a sesquiterpenes is isolated from the root of the plant Echinops spinosus.[127] 
With its novel structure bearing a vicinal all carbon highly strained cyclopropane, several groups 
developed different strategies for the formation of this highly challenging structure motif. The first 
total synthesis was accomplished by Magauer and coworkers in 2009, in which they confirmed also 
the proposed structure.[128] In their approach, regioselective cyclopropanation of ester 5.7 using a 
modified Furukawa–Simmons–Smith's reagent afforded the tetracyclic intermediate, which bears 
the desired cyclopropane with the vicinal all quaternary carbon center. Additionally, they 
accomplished the synthesis of this cyclopropane 5.8 by Corey–Chaykovsky cyclopropanation. 
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Several subsequent transformations delivered the natural product. One year later Nicolaou and 
coworkers reported the second total synthesis.[129] In their key step diazo ester 5.10 reacts with 
rhodium acetate to generate an carbenoid, which subsequently undergo an intramolecular 
cyclopropanation. 
 
Scheme 80: A) Magauer’s synthesis of echinopine B (5.9) with key intermediate 5.8. B) Nicolaou’s synthesis 
of echinopine B (5.9) with key intermediate 5.13. C) Chen’s synthesis of echinopine B (5.9) with key 
intermediate 5.13. D) Vanderwal synthesis of echinopine B (5.9) with key intermediate 5.15. 
In 2011, Chen and coworkers reported another total synthesis.[130] The key reaction in this 
bioinspired synthesis is an ruthenium-catalyzed redox bicycloisomerization of enynol 5.12. The 
synthesis was completed by oxidation of aldehyde 5.13 and subsequent methylation. Vanderwal 
and coworkers reported a concise total synthesis of echinopine B (5.9) in 2012. In their key step 
platinum(II) chloride‐catalyzed enyne cycloisomerization, bicycle 5.14 was converted into enol 
ether 5.15 which afforded echinopine B (5.9) after pyridinium chlorochromate oxidation. 
Although current methods give access to the desired vicinal all carbon quaternary centers, these 
often are only working with specific substrates, conditions or include multistep procedures. 
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Especially, benzylic positions are challenging and often resulted in low yielding multistep 
transformation. To address these issues, novel protocols are required.[131-132]  
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6 Previous Efforts 
The accomplished total synthesis of salimabromide (6.3), included an elegant step for the synthesis 
of vicinal all carbon quaternary centers via an acid-catalytic cycloisomerization of 2,2-disubstituted 
neopentylic epoxide 6.1. This powerful reaction afforded tetrahydronaphthalene 6.2 in a single step 
via a Wagner−Meerwein rearrangement and subsequent Friedel−Crafts alkylation in moderate 41% 
yield from linear precursors under mild conditions.[133] 
 
Scheme 81: Key-step in the total synthesis of salimabromide (6.3) by cycloisomerization of linear epoxide 
6.1 to afford teralin 6.2. 
However, the scope and limitation of this powerful ring-formation were not available at this stage 
of the project. For that reasons further investigations and optimization for this 
rearrangement/cyclization reaction cascade of 2,2-disubstituted neopentylic epoxides were 
initiated.  
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7 Results and Discussion 
 
Reprinted from submitted manuscript Matthias Schmid†[a], Kevin Rafael Sokol†[a], Lukas Anton 
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8 Conclusion and Further Directions 
Intensive optimization of the cycloisomerization of 2,2-disubstituted neopentylic epoxides revealed 
the highest yields for substituted tetralins at 0 °C in HFIP as solvent in catalytic amount of sulfuric 
acid. Thereby, a competing disproportionation pathway of dihydronaphthalen was discovered.  
Mechanistically, we suggest that the reaction proceeds through protonation of epoxide 8.1. 
Subsequently opening of protonated epoxide 8.3 generated the tertiary cation 8.4. While empirical 
data showed no evidence of the trapping of this cationic species, we assume that the 
Wagner−Meerwein shift is favored or the nucleophilic intramolecular attack is repressed by steric 
hindrance or an unfavoured transition state. After the [1,2] shift tertiary cation 8.5 is formed and 
terminated the reaction cascade by an intramolecular Friedel−Craft alkylation to afford tetralin 8.2. 
This was also supported by DFT calculations. 
 
Scheme 82: A) Proposed reaction pathway for the cycloisomerization of epoxide 8.1 to alcohols 8.2. B) 
Proposed reaction pathway for side reaction of epoxides to naphthalene 8.6 and tetralin 8.7. 
In the competitive pathway protonated epoxide 8.3, undergoes nucleophilic attack by less 
substituted carbon center by an intramolecular nucleophile in a 6-exo-tet fashion generating a 
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tertiary alcohol 8.8 Under acidic conditions elimination occurs to hydronaphthalene 8.9 which 
undergoes a disproportion reaction to naphthalene 8.6 and tetralin 8.7. 
This work was mainly focused on the synthesis of tetralin derivatives. The mild reaction conditions 
tolerated a variety of functional groups, like ethers, alkyls, boronic esters, esters and halides as well 
several different nucleophiles like electron rich to electron neutral aromatic system, hetereoarenes 
and other nucleophiles like alcohols. Furthermore, chromanones, bearing vicinal quaternary all 
carbon centers were able to be prepared by this methodology. Modification of the tert-butyl group 
by replacing one of the three methyl groups also gave insight in the migrations tendencies and 
showed limitation for this cascade reaction. These results were finally used for ring-expansions to 
access tricyclic compounds. 
Nevertheless, this work also demonstrated that less-substituted epoxides exclusively delivered 
naphthalene 8.6 and tetralin 8.7 in excellent yields. Although there are only a few examples for the 
synthesis of functionalized naphthalene at the two position from similar starting material, these 
require often harsh reaction conditions such as long reactions times, strong acidic conditions or 
toxic reagents such as DDQ.[134-136]  
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Scheme 83: A) Literature synthesis of naphthalene 8.11 from tertiary alcohols 8.10. B) Current synthesis 
naphthalene 8.13 from alkene 8.12. C) Future work on the synthesis of naphthalene 8.15 from epoxide 8.14. 
With our results in hand, we envision to further expand this methodology for the synthesis of 
naphthalenes 8.17 from epoxides 8.14, hydronaphthelenes 8.15 and tertiary alcohols 8.16 by the 
addition of strained alkene, which undergo the observed disproportionation.
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9 Experimental Section  
9.1 General Experimental Details 
General Working Methods 
All reactions were performed in glassware fitted with rubber septa under a positive pressure of 
argon, unless otherwise noted. All glassware was dried in an oven at 130 °C prior to use. Air‐ and 
moisture‐sensitive liquids were transferred via syringe or stainless-steel cannula through rubber 
septa. Solids were added under inert gas or were dissolved in appropriate solvents. High pressure 
reactions were conducted in a miniclave steel apparatus from BÜCHI AG. Low temperature‐
reactions were carried out in a Dewar vessel filled with a cooling agent: acetone/dry ice (−78 °C), 
H2O/ice (0 °C). Reaction temperatures above 23 °C were conducted in a heated oil bath. The 
reactions were magnetically stirred and monitored by NMR spectroscopy or analytical thin‐layer 
chromatography (TLC), using glass plates precoated with silica gel (0.25 mm, 60 Å pore size, 
Merck) impregnated with a fluorescent indicator (254 nm). TLC plates were visualized by exposure 
to ultraviolet light (UV), were stained by submersion in aqueous basic potassium permanganate 
solution (KMnO4), aqueous acidic ceric ammonium molybdate solution (CAM), or an aqueous 
acidic p-anisaldehyde solution and were developed by heating with a heat gun. Flash‐column 
chromatography on silica gel was performed as described by Still et al.,159 employing silica gel (60 
Å, 40–63 μm, Merck KGaA). Flash column chromatography on silica gel using triethylamine 
pretreated silica gel was performed by preparing the silica gel slurry with triethylamine (7.5% v/v 
in corresponding eluent mixture) and flushing the column with the eluent prior to loading the 
compound on the column. The yields refer to chromatographically and spectroscopically (1H and 
13C NMR) pure material. 
 
Solvents and Reagents 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from sodium/benzophenone prior 
to use. Dichloromethane (CH2Cl2), triethylamine (Et3N), diisopropylamine (DIPA) and N,N-
diisopropylethylamine (DIPEA) were distilled under nitrogen atmosphere from calcium hydride 
prior to use. Benzene (PhH), Chlorobenzene (PhCl), toluene (PhMe), 1,4-dioxane, 
dimethylformamide (DMF), dimethyl sulfoxide (DMSO), acetonitrile (MeCN), ethanol (EtOH) 
and methanol (MeOH) were purchased from Acros Organics as 'extra dry' reagents and used as 
received. All other reagents and solvents were purchased from chemical suppliers (Sigma‐
Aldrich, Acros Organics, Alfa Aesar, Strem Chemicals, TCI Europe, carbolution, ABCR) and 
were used as received. Solvents for extraction, crystallization and flash column chromatography 
on silica gel were purchased in technical grade and distilled under reduced pressure prior to use. 
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Lithium chloride and lithium bromide were dried at 100 °C under vacuum (0.1 mmHg) for 12 h 
and stored in a drying oven at 130 °C (760 mmHg); the hot, dried solid was flame dried under 
vacuum (0.1 mmHg) for 4–5 min immediately prior to use. 4 Å molecular sieves were washed 
(methanol, acetone, dichloromethane) and then dried at 100 °C under vacuum (0.1 mmHg) for 12 
h and stored in a drying oven at 130 °C (760 mmHg); the molecular sieves were flame dried under 
vacuum (0.1 mmHg) for 4–5 min immediately prior to use. The molarity of n‐butyllithium 
solutions was determined by titration against diphenylacetic acid as an indicator (average of three 
determinations).160 
 
NMR Spectroscopy 
NMR spectra were measured on a Bruker Avance III HD 800 MHz spectrometer equipped with a 
CryoProbeTM, Bruker Avance III HD 400 MHz spectrometer equipped with a CryoProbeTM, 
Bruker AXR300, Varian VXR400 S and Bruker AMX600 spectrometers operating at 800 MHz, 
400 MHz, 300 MHz, 400 MHz and 600 MHz for proton nuclei (200 MHz, 100 MHz, 75 MHz, 100 
MHz, 150 MHz for carbon nuclei), respectively. Proton chemical shifts are expressed in parts per 
million (ppm, δ scale) and are referenced to residual protium in the NMR solvent (CHCl3: δ 7.26, 
CDHCl2: δ 5.32, C6HD5: 7.16). Carbon chemical shifts are expressed in parts per million (δ scale, 
assigned carbon atom) and are referenced to the carbon resonance of the NMR solvent (CDCl3: δ 
77.16, CD2Cl2: δ 54.00, C6D6: 128.06, acetone‐d6: 29.84). 
1H NMR spectroscopic data are reported 
as follows: Chemical shift in ppm (multiplicity, coupling constants J (Hz), integration intensity, 
assigned proton) (e.g. “5.21 (t, 3J9/8 = 7.3 Hz, 1H, H-9)”). The multiplicities are abbreviated with s 
(singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet), p (pentet), se (sextet), h (heptet) 
and m (multiplet). In case of combined multiplicities, the multiplicity with the larger coupling 
constant is stated first. Except for multiplets, the chemical shift of all signals, as well for 
centrosymmetric multiplets, is reported as the center of the resonance range. Protons of 
diastereotopic methylene groups are reported as H-Xa and H-Xb, where H-Xa is the more 
downfield shifted proton. The nomenclature is arbitrarily and does not correspond to the spin 
system. Furthermore, the numbering of the proton and carbon atoms does not correspond to the 
IUPAC nomenclature. 13C NMR spectroscopic data are reported as follows: Chemical shift in ppm 
(assigned carbon) (e.g. “159.22 (C‐21)”). In cases were resonances overlap or cannot be 
unambiguously assigned to a single proton or carbon atom, multiple assignments are listed (e.g. the 
13C NMR assignment “18.29 (C‐16, C‐17), 17.84 (C‐16, C‐17)” indicates that the resonance at 
18.29 is either C‐16 or C‐17). In addition to 1H and 13C NMR measurements, 2D NMR techniques 
such as homonuclear correlation spectroscopy (COSY), heteronuclear single quantum coherence 
(HSQC) and heteronuclear multiple bond coherence (HMBC) were used to assist signal 
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assignment. For further elucidation of 3D structures of the products, nuclear Overhauser 
enhancement spectroscopy (NOESY) was conducted. All raw FID files were processed and the 
spectra analyzed using the program MestReNova 9.0.1 from Mestrelab Research S. L. 
 
Mass Spectrometry 
All mass spectra were measured by the analytic section of the Department of Chemistry, Ludwig‐
Maximilians‐Universität München. Mass spectra were recorded on the following spectrometers 
(ionisation mode in brackets): MAT 95 (EI) and MAT 90 (ESI) from Thermo Finnigan gmbH. 
Mass spectra were recorded in high‐resolution. The method used is reported at the relevant section 
of the experimental section. 
 
IR Spectroscopy 
IR spectra were recorded on a PerkinElmer Spectrum BX II FT‐IR system. Data are represented in 
frequency of absorption (cm−1). 
 
Optical Rotation 
Optical rotation values were recorded on a PerkinElmer 241 or Anton Paar MCP 200 polarimeter. 
The specific rotation is calculated as follows: 
 
[𝛼]λ
𝜑
=  
𝛼
𝛽 ∙ 𝑑
 
 
α: recorded optical rotation 
β: concentration of the analyte in 10 mg/mL 
d: length of the cuvette in dm 
φ: measuring temperature in °C 
λ: wave length in nm  
 
The respective concentration and the solvent are denoted in the analytical part of the experimental 
description. 
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Melting Point Ranges 
Melting point ranges were measured on a B-540 melting point apparatus from BÜCHI Labortechnik 
AG and are uncorrected. 
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9.2 Experimental Procedures, X-Ray Crystallographic and Spectroscopic data  
9.2.1 Supporting Information for Chapter I 
9.2.1.1 Experimental procedures 
 
 
Synthesis of alkyne PS1: To a solution of diisopropylamine (15.5 mL, 110 mmol, 2.20 equiv) in 
tetrahydrofuran (200 mL) was added a solution of n-butyllithium (2.44 M in hexanes, 42.0 mL, 
105 mmol, 2.10 equiv) at −78 °C. After 10 min, ethyl acetoacetate (3.13) (6.32 mL, 49.9 mmol, 
1 equiv) was added dropwise at −78 °C. After complete addition, the reaction mixture was slowly 
allowed to warm to 0 °C and stirring for 1 h before a solution of propargyl bromide (80% in toluene, 
5.68 mL, 59.9 mmol, 1.20 equiv) was added at 0 °C. After complete addition, the resulting yellow 
reaction mixture was allowed to warm to 23 °C. After 1 h, saturated aqueous ammonium chloride 
solution (200 mL) was added to quench excess of base. The reaction mixture was extracted with 
ethyl acetate (3×100 mL), the combined organic phases were washed with water (100 mL) and 
saturated aqueous sodium chloride solution (100 mL), the washed solution was dried over sodium 
sulfate, the dried solution was filtered and the filtrate was carefully concentrated (>200 mbar, 
42 °C) to afford alkyne PS1 (5.69 g, 33.8 mmol, 68%) as a yellow oil, which was pure enough to 
use without further purification.  
All analytical data were in agreement with the literature. [137]  
 
 
Synthesis of alcohol 3.27: To a solution of alkyne PS1 (5.69 g, 33.8 mmol, 1 equiv) in benzene 
(100 mL) in a dean-stark trap apparatus. Ethylene glycol (3.77 mL, 67.6 mmol, 2.00 equiv) and p-
toluene sulfonic acid monohydrate (644 mg, 3.38 mmol, 10.0 mol%) were added and the reaction 
mixture was heat to 100 C. After 16 h, the reaction mixture was allowed to cool to 23 C and acid 
was neutralized with saturated aqueous sodium hydrogen carbonate solution (100 mL) and the 
phases were separated. The aqueous phase was extracted with diethyl ether (3×100 mL) and the 
combined organic phases were washed with water (100 mL) and saturated aqueous sodium chloride 
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solution (100 mL), the washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated to afford acetal PS2 as a pale yellow oil, which was pure 
enough without further purification. 
The acetal PS2 was dissolved in tetrahydrofuran (50 mL) and added dropwise to a suspension of 
lithium aluminum hydride (2.56 g, 67.6 mmol, 2.00 equiv) in tetrahydrofuran (100 mL) at 0 °C. 
After 2 h stirring at 0 °C, excess of lithium aluminum hydride was quenched carefully by the 
dropwise addition ethyl acetate (100 mL) at 0 °C and saturated aqueous solution of sodium 
potassium tartrate (100 mL). After phase separation (around 4 h), the phases were separated and 
the aqueous phase was extracted with ethyl acetate (3×100 mL) and the combined organic phases 
were washed with water (100 mL) and saturated aqueous sodium chloride solution (100 mL). The 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated to yield alcohol 3.27 (2.32 g, 13.5 mmol, 40% over two steps) a pale yellow oil. 
All analytical data were in agreement with the literature.[137]  
 
 
Synthesis of ketone PS4: To a solution of acetal 3.27 (1.00 g, 5.88 mmol, 1 equiv) in acetone 
(16 mL) was added p-toluenesulfonic acid monohydrate (279 mg, 1.47 mmol, 25.0 mol%) at 23 °C. 
After 16 h, the reaction mixture was diluted with water (20 mL) and diethyl ether (20 mL). The 
organic phases were separated, the aqueous phase extracted with diethyl ether (3×30 mL), the 
combined organic phases were washed with saturated aqueous sodium hydrogen carbonate solution 
(30 mL) and the washed solution was dried over sodium sulfate, the dried solution was filtered and 
the filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (50% ethyl acetate in n-hexane) to afford ketone PS4 (392 mg, 3.11 mmol, 53%) as a 
colorless oil. 
All analytical data were in agreement with the literature. [137] 
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Synthesis of isoxazole 3.11: To a solution of alkyne PS4 (380 mg, 3.01 mmol, 1 equiv) in ethanol 
(5 mL) was added DABCO (33.8 mg, 301 µmol, 10.0 mol%) and ethyl nitroacetate (836 µL, 
7.53 mmol, 2.50 equiv) and the resulting yellow solution was heated to 80 °C. After 2 d, the 
reaction mixture was allowed to cool to 23 °C and the solution was concentrated. The crude product 
was purified by flash column chromatography on silica gel (1% methanol in dichloromethane) to 
afford isoxazole 3.11 (709 mg, 2.94 mmol, 98%) as a yellow oil.  
TLC (80% ethyl acetate in hexane): Rf: 0.26 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.42 (t, J = 1.0 Hz, 1H), 4.40 (qt, J = 7.1, 2.0 Hz, 2H), 3.87 (tt, J = 
5.4, 1.8 Hz, 2H), 3.24 – 3.05 (m, 2H), 2.91 (t, J = 7.2 Hz, 2H), 2.69 (td, J = 5.5, 2.4 Hz, 2H), 2.19 
(s, 1H), 1.39 (tt, J = 7.1, 1.9 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 208.3, 173.8, 160.1, 156.6, 102.2, 62.3, 57.8, 44.7, 40.2, 20.6, 14.2. 
HRMS (ESI): calcd. for C11H16NO5 [M+H]
+: 242.1023 ; found: 242.0935. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3429, 2983, 2940, 2904, 1712, 1593, 1556, 1460, 1424, 1388, 1219, 1099, 
1019, 929, 859, 833, 779. 
 
 
Synthesis of enone 3.25: To a solution of alcohol 3.11 (25.0 mg, 104 µmol, 1 equiv) in 
dichloromethane (2 mL) was added bromine (53.4 µL, 1.04 mmol, 10.00 equiv) at 0 °C. The 
resulting brown solution was slowly allowed to warm to 23 °C. After 16 h, excess of bromine was 
quenched with saturated aqueous thiosulfate solution (10 mL) and the phases were separated. The 
aqueous phase was extracted with dichloromethane (3×5 mL), the combined phases were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give a yellow 
solid. The crude product was purified by flash column chromatography on silica gel (3% methanol 
in dichloromethane) to afford enone 3.25 (11.8 mg, 31.1 µmol, 30%) as pale yellow oil. Analytical 
data were provides by Dr. Lara Weisheit. 
TLC (20% ethyl acetate in n-hexane): Rf: 0.23 (UV, CAM) 
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1
H NMR (800 MHz, CDCl3) δ 6.98 (d, J = 2.8 Hz, 1H), 6.59 (t, J = 0.8 Hz, 1H), 6.48 (d, J = 2.7 
Hz, 1H), 5.32 (dd, J = 7.8, 6.7 Hz, 1H), 4.44 (q, J = 7.2 Hz, 2H), 3.69 (ddd, J = 15.9, 6.7, 0.8 Hz, 
1H), 3.57 – 3.50 (m, 1H), 1.42 (t, J = 7.1 Hz, 3H). 
13
C NMR (201 MHz, CDCl3) δ 186.7, 169.9, 159.9, 156.8, 131.6, 126.9, 104.3, 62.5, 40.6, 31.2, 
14.3. 
HRMS (ESI): calcd. for C11H12
79Br2NO4 [M+H]
+: 379.9128.; found: 379.9134. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2980, 1731, 1599, 1462, 1421, 1225, 1100, 1021, 941, 835, 780. 
 
 
Synthesis of isoxazole 3.28: To a solution of alcohol 3.27 (1.00 g, 5.88 mmol, 1 equiv) in ethanol 
(12 mL) was added DABCO (65.9 mg, 588 µmol, 10.0 mol%) and ethyl nitroacetate (1.43 mL, 
12.9 mmol, 2.20 equiv). The resulting yellow solution was heated to 80 °C. After 3 d, the yellow 
reaction mixture was allowed to cool to 23 °C and was concentrated. The crude product was 
purified by flash column chromatography on silica gel (2% methanol in dichloromethane) to afford 
isoxazole 3.28 (1.53 g, 5.35 mmol, 91%) as a colorless oil. 
TLC (2% methanol in dichloromethane): Rf: 0.19 (UV, CAM) 
1
H NMR (599 MHz, CDCl3) δ 6.42 (t, J = 0.9 Hz, 1H), 4.43 (q, J = 7.1 Hz, 2H), 4.06 – 4.02 (m, 
2H), 4.02 – 3.98 (m, 2H), 3.77 (q, J = 5.1 Hz, 2H), 2.95 – 2.81 (m, 2H), 2.54 (s, 1H), 2.17 – 2.07 
(m, 2H), 1.97 – 1.88 (m, 2H), 1.41 (t, J = 7.1 Hz, 3H). 
13
C NMR (151 MHz, CDCl3) δ 175.0, 160.3, 156.6, 111.0, 101.6, 65.2, 62.2, 58.8, 38.6, 34.7, 21.4, 
14.3. 
HRMS (ESI): calcd. for C13H20O6N [M+H]
+: 286.1285 ; found: 286.1289. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3440, 2959, 2889, 1729, 1593, 1460, 1425, 1390, 1367, 1212, 1132, 1102, 
1023, 949, 897, 834, 779.  
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Synthesis of isoxazole 3.29: To a solution of alcohol 3.28 (150 mg, 526 µmol, 1 equiv) in 
dichloromethane (3 mL)) was added imidazole (43.0 mg, 631 µmol, 1.2 equiv), DMAP (6.4 mg, 
52.6 µmol, 10.0 mol%) and tert-butyldimethylsilyl chloride (83.2 mg, 552 µmol, 1.05 equiv) were 
added in sequence. After 16 h, the reaction mixture was diluted with dichloromethane (10 mL) and 
water (10 mL) to hydrolyze unreacted tert-butyldimethylsilyl chloride. The phases were seperated 
and the aqueous phase was extracted with dichloromethane (3×10 mL), the combined organic 
phases were dried over sodium sulfate, the dried solution was filtered and concentrated. The crude 
product flash column chromatography on silica gel (25% diethyl ether in petrol ether) to afford 
isoxazole 3.29 (208 mg, 522 mmol, 99%) as a colorless oil. 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.19 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.38 (d, J = 1.0 Hz, 1H), 4.41 (q, J = 7.1 Hz, 2H), 3.94 (s, 4H), 3.72 
(t, J = 6.6 Hz, 2H), 2.95 – 2.85 (m, 2H), 2.16 – 2.06 (m, 2H), 1.87 (t, J = 6.6 Hz, 2H), 1.40 (t, J = 
7.1 Hz, 3H), 0.86 (s, 9H), 0.04 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 175.6, 160.4, 156.5, 109.8, 101.4, 65.1, 62.1, 59.1, 40.0, 35.2, 26.0, 
21.4, 18.4, 14.3, -5.3, -5.4. 
HRMS (ESI): calcd. for C19H33NNaO6Si [M+Na]
+: 422.1969; found: 422.1948. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2955, 2930, 2884, 2857, 1732, 1594, 1463, 1425, 1390, 1362, 1251, 1213, 
1160, 1098, 1056, 1025, 949, 836, 777.  
 
 
Synthesis of alkyne 3.30: To a solution of ketone PS1 (500 mg, 2.97 mmol, 1 equiv) in methanol 
(14 mL) was added sodium borohydride (169 mg, 4.46 mmol, 1.50 equiv) at 0 °C and the reaction 
mixture was allowed to warm to 23 °C. After 30 min, the reaction mixture was diluted with diethyl 
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ether (20 mL) and sat aqueous ammonium chloride solution (20 mL) was added to quench excess 
of sodium borohydride. The organic phases were separated and the aqueous phase extracted with 
diethyl ether (3×30 mL). The combined organic phases were dried over sodium sulfate, the dried 
solution was filtered and concentrated. The alcohol PS5 was pure enough to use without further 
purification. 
To a solution of crude alcohol PS5 (506 mg, 2.97 mmol, 1 equiv) in dichloromethane (14 mL) was 
added DMAP (36.3 mg, 297 µmol, 10.0 mol%), imidazole (303 mg, 4.46 mmol, 1.50 equiv) and 
tert-butyl(chloro)diphenylsilane (801 µL, 3.12 mmol, 1.05 equiv) in sequence and the resulting 
mixture was stirred at 23 °C. After 16 h, the mixture was diluted with water (50 mL) to hydrolyze 
unreacted tert-butyl(chloro)diphenylsilane and the aqueous phase was extracted with 
dichloromethane (3×50 mL). The combined organic phases were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated to give a colorless oil. The crude ester 
PS6 was used without further purification in the next step. 
To a solution of ester PS6 in dichloromethane (28 mL) was added a solution of diisobutyl aluminum 
hydride (1.00 M in toluene, 5.94 mL, 5.94 mmol, 2.00 equiv) at 0 °C. After 1 h, the reaction 
mixture was allowed to warm to 23 °C. Excess of hydride was quenched by the addition of ethyl 
acetate (50 mL) und saturated aqueous potassium sodium tartrate solution (50 mL) was added. 
After 2 h, phases were seperated, the aqueous phase was extracted with diethyl ether (3×30 mL). 
The combined organic phases were dried over sodium sulfate, the dried solution was filtered and 
the filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (10% diethyl ether in hexane) to afford alkyne 3.30 (720 mg, 2.00 mmol, 66% over three 
steps) as a colorless oil. 
TLC (20% ethyl acetate in hexane): Rf: 0.30 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.77 – 7.63 (m, 4H), 7.49 – 7.34 (m, 6H), 4.11 – 4.00 (m, 1H), 3.68 
(q, J = 8.8, 6.6 Hz, 1H), 3.62 (t, J = 5.2 Hz, 1H), 2.14 (tdd, J = 7.2, 2.7, 1.4 Hz, 2H), 1.83 (t, J = 
2.7 Hz, 1H), 1.81 – 1.72 (m, 3H), 1.72 – 1.64 (m, 1H), 1.07 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 136.1, 136.1, 133.9, 133.9, 130.0, 130.0, 127.8, 127.8, 84.0, 70.8, 
68.5, 59.7, 38.1, 35.3, 27.2, 19.5, 14.5. 
HRMS (ESI): calcd. for C13H20O6N [M+H]
+: 286.1285 ; found: 286.1289. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3305, 2931, 2889, 2857, 1472, 1463, 1427, 1390, 1362, 1259, 1189, 1158, 
1104, 1090, 1027, 1006, 997, 937, 909, 821, 739, 696.  
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Synthesis of isoxazole 3.31: To a solution of diol alkyne 3.30 (324 mg, 884 µmol, 1 equiv) in 
ethanol (3.0 mL) was added DABCO (9.90 mg, 88.4 µmol, 10.0 mol%) and ethyl nitroacetate 
(196 µL, 1.77 mmol, 2.00 equiv) and the resulting yellow solution was heated to 80 °C. After 2 d, 
the reaction mixture was allowed to cool to 23 °C and the solution was concentrated. The crude 
product was purified by flash column chromatography on silica gel (1% methanol in 
dichloromethane) to afford isoxazole 3.31 (388 mg, 806 µmol, 91%) as a pale yellow oil. 
TLC (1% methanol in dichloromethane): Rf: 0.27 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.67 – 7.56 (m, 4H), 7.42 – 7.27 (m, 6H), 6.08 (d, J = 0.9 Hz, 1H), 
4.36 (q, J = 7.1 Hz, 2H), 3.94 (p, J = 5.6 Hz, 1H), 3.61 (dp, J = 15.7, 5.5 Hz, 2H), 2.75 – 2.58 (m, 
2H), 1.92 – 1.60 (m, 4H), 1.42 (s, 1H), 1.34 (t, J = 7.1 Hz, 3H), 1.00 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ 175.1, 160.3, 156.4, 136.0, 136.0, 133.8, 133.6, 130.1, 130.1, 127.9, 
127.9, 101.5, 70.4, 62.2, 59.6, 38.3, 34.2, 27.2, 22.4, 19.5, 14.3. 
HRMS (EI): calcd. for C27H36NO5Si [M+H]
+: 482.2357; found: 482.2364. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3478, 2932, 2858, 1797, 1732, 1591, 1462, 1427, 1390, 1212, 1104, 1023, 
822, 779, 741, 703, 612. 
 
 
Synthesis of isoxazole 3.46: To a solution of alkyne 3.51 (100 mg, 441 µmol, 1 equiv) in ethanol 
(1.0 mL) was added DABCO (4.95 mg, 44.2 µmol, 10.0 mol%) and ethyl nitroacetate (98.1 µL, 
883 µmol, 2.00 equiv) and the resulting yellow solution was heated to 80 °C. After 2 d, the reaction 
mixture was allowed to cool to 23 °C and the solution was concentrated. The crude product was 
purified by flash column chromatography silica gel (4% methanol in dichloromethane) to afford 
isoxazole 3.46 (78.9 mg, 344 µmol, 78%) as a colorless oil. 
TLC (40% ethyl acetate in cyclohexane): Rf: 0.07 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 6.55 – 6.31 (m, 1H), 4.40 (q, J = 7.1 Hz, 2H), 3.77 – 3.68 (m, 1H), 
3.65 (dd, J = 11.1, 3.1 Hz, 1H), 3.47 (dd, J = 11.1, 7.3 Hz, 1H), 3.07 – 2.83 (m, 4H), 1.88 – 1.75 
(m, 2H), 1.38 (t, J = 7.2 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 175.17, 160.3, 156.5, 101.9, 70.9, 66.6, 62.3, 30.6, 23.1, 14.2. 
HRMS (ESI): calcd. for C10H16O5N [M+H]
+: 230.1023; found: 230.1025. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3410, 2936, 1733, 1593, 1462, 1213, 1100, 1023, 835, 780.  
 
 
Synthesis of spiro 3.47: To a solution of alcohol 3.46 (100 mg, 436 µmol, 1 equiv) in 
dichloromethane (4.4 mL) was added bromine (112 µL, 2.18 mmol, 5.00 equiv) at 0 °C. The 
resulting brown solution was slowly allowed to warm to 23 °C. After 16 h, excess of bromine was 
quenched with saturated aqueous thiosulfate solution (15 mL) and the phases were separated. The 
aqueous phase was extracted with dichloromethane (3×5 mL), the combined phases were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give a yellow 
solid. The crude product was purified by flash column chromatography silica gel (3% methanol in 
dichloromethane) to afford a mixture of diastereomers of spiro 3.47 (34.2 mg, 149 µmol, 34%, d.r. 
1:1) as pale yellow oil. 
A small sample was purified by HPLC chromatography (40% ethyl acetate in n-hexane grading to 
50% ethyl acetate in n-hexane in 30 min) to isolate two diastereomers as a colorless oil. 
 
less polar diastereomer 
TLC (3% methanol in dichloromethane): Rf: 0.14 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 5.04 (s, 1H), 4.52 (dddd, J = 8.2, 6.0, 5.2, 3.1 Hz, 1H), 4.46 – 4.34 
(m, 2H), 3.75 (dd, J = 12.0, 3.1 Hz, 1H), 3.58 (dd, J = 12.0, 5.2 Hz, 1H), 2.60 (ddd, J = 14.1, 10.3, 
8.6 Hz, 1H), 2.49 (ddd, J = 14.1, 8.6, 4.3 Hz, 1H), 2.28 (dq, J = 12.6, 8.5 Hz, 1H), 1.94 (dddd, J = 
12.6, 10.4, 6.0, 4.3 Hz, 1H), 1.62 (s, 1H), 1.39 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 158.9, 153.3, 120.0, 82.9, 64.6, 62.7, 47.2, 33.0, 25.3, 14.2. 
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HRMS (ESI): calcd. for C10H15
79BrNO5 [M+H]
+: 308.0128; found: 308.0130. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3433, 2937, 1727, 1569, 1462, 1406, 1381, 1329, 1256, 1212, 1179, 1114, 
1066, 1015, 919, 782, 757.  
 
more polar diastereomer 
TLC (3% methanol in dichloromethane): Rf: 0.14 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 5.03 (s, 1H), 4.56 – 4.48 (m, 1H), 4.46 – 4.35 (m, 2H), 3.73 (dd, J 
= 12.2, 2.9 Hz, 1H), 3.58 (dd, J = 12.2, 5.3 Hz, 1H), 2.65 – 2.45 (m, 2H), 2.26 – 2.04 (m, 2H), 2.00 
– 1.85 (m, 1H), 1.39 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 158.8, 153.0, 119.7, 84.7, 65.0, 62.7, 47.0, 34.7, 25.1, 14.2. 
HRMS (ESI): calcd. for C10H15
79BrNO5 [M+H]
+: 308.0128; found: 308.0130. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3457, 2983, 2937, 1727, 1569, 1458, 1405, 1381, 1328, 1258, 1210, 1174, 
1121, 1096, 1068, 1016, 969, 921, 903, 840, 783, 759, 728.  
 
 
Synthesis of ketone 3.52: To a solution of oxalyl chloride (3.00 mL, 6.00 mmol, 3.00 equiv) in 
dichloromethane (9.0 mL) was added a solution of dimethyl sulfoxide (1.00 M in dichloromethane, 
10.0 mL, 10.0 mmol, 5.00 equiv) at −78 °C. After 15 min, a solution of alcohol 3.51 (1.00 M in 
dichloromethane, 2.00 mL, 2.00 mmol, 1 equiv) was added dropwise and the resulting solution was 
stirred at −78 °C. After further 30 min, triethylamine (2.78 mL, 20.0 mmol, 10.0 equiv) was added 
at −78 °C and the temperature was kept for 15 min before the reaction mixture was slowly allowed 
to warm to 23 °C. After 1 h, the mixture was diluted with puffer-solution (pH = 7). The phases 
were separated and the aqueous solution was extracted with diethyl ether (3×40 mL). The combined 
organic phases were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (10% 
diethyl ether in n-hexane) to afford ketone 3.52 (453 mg, 2.00 mmol, >99%) as a yellow oil. 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.63 (KMnO4) 
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1
H NMR (400 MHz, CDCl3) δ 4.18 (s, 2H), 2.77 (dd, J = 7.6, 6.9 Hz, 2H), 2.56 – 2.37 (m, 2H), 
1.94 (t, J = 2.7 Hz, 1H), 0.93 (s, 9H), 0.09 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 209.1, 83.2, 69.5, 68.8, 37.6, 25.9, 18.4, 12.7, -5.4. 
HRMS (EI): calcd. for C8H13O2Si [M-t-Bu]
∙ +: 169.0679; found: 169.0678. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3313, 2954, 2930, 2888, 2858, 1723, 1472, 1464, 1434, 1406, 1390, 1362, 
1254, 1157, 1103, 1081, 1006, 939, 835, 816, 777, 736, 669.  
 
 
Synthesis of isoxazole 3.53: To a solution of diol 3.52 (100 mg, 442 µmol, 1 equiv) in ethanol 
(1.0 mL) was added DABCO (4.95 mg, 44.2 µmol, 10.0 mol%) and ethyl nitroacetate (98.1 µL, 
883 µmol, 2.00 equiv) and the resulting yellow solution was heated to 80 °C. After 2 d, the reaction 
mixture was allowed to cool to 23 °C and the solution was concentrated. The crude product was 
purified by flash column chromatography on silica gel (1% methanol in dichloromethane) to afford 
isoxazole 3.53 (33.3 mg, 147 µmol, 33%) as a pale yellow oil. 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.21 (UV, CAM) 
1
H NMR (599 MHz, CDCl3) δ 6.44 (t, J = 0.9 Hz, 1H), 4.41 (q, J = 7.1 Hz, 2H), 4.28 (t, J = 0.8 
Hz, 2H), 3.17 (td, J = 7.2, 0.9 Hz, 2H), 2.87 (tt, J = 7.3, 0.8 Hz, 2H), 1.39 (t, J = 7.2 Hz, 3H). 
13
C NMR (151 MHz, CDCl3) δ 207.2, 173.2, 160.0, 156.7, 102.3, 68.3, 62.3, 35.5, 20.5, 14.2. 
HRMS (EI): calcd. for C8H11NO3 [M-HOCH2C(O)]
∙ +: 169.0733; found: 169.0732. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3451, 339, 2985, 2915, 1724, 1594, 1461, 1425, 1391, 1367, 1211, 1103, 
1070, 1019, 933, 860, 835, 780.  
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Synthesis of alkyne 3.57: To a suspension of magnesium turnings (1.08 g, 44.4 mmol, 8.00 equiv) 
and mercury chloride (90.4 mg, 333 µmol, 6.00 mol%) in diethyl ether (30 mL) was added one 
grain of iodine. The orange solution was stirred for 30 min at 23 °C, before a solution of propargyl 
bromide (80%wt in toluene, 1.67 mL, 19.4 mmol, 3.50 equiv) in diethyl ether (13.0 mL) was added 
dropwise over 30 min. The exothermic reaction was particularly cooled with an ice bath. After 
complete addition, the reaction mixture was stirred for 1 h at 23 °C, before the black reaction 
mixture was added dropwise to a solution of epoxide 3.56 (1.00 g, 5.55 mmol, 1 equiv) in diethyl 
ether (100 mL) at −78 °C over 1 h. After complete addition, the grey suspension was slowly 
allowed to warm to 23 °C. After 3 h, ethyl acetate (50 mL) was added to quench excess of the 
Grignard reagent at 0 °C and saturated aqueous ammonium chloride solution was added (100 mL). 
The phases were separated and the aqueous phase was extracted with diethyl ether (3×40 mL). The 
combined organic phases were dried over sodium sulfate and the filtrate was concentrated to give 
a yellow oil. The crude product was purified by flash column chromatography on silica gel (30% 
ethyl acetate in n-hexane) to afford alkyne 3.57 (1.22 g, 5.55 mmol, >99%) as a colorless solid. 
TLC (20% ethyl acetate in hexane): Rf: 0.08 (UV, CAM) 
mp: 82.5 – 83.2 °C 
1
H NMR (400 MHz, CDCl3) δ 6.93 – 6.73 (m, 4H), 4.14 (dddd, J = 9.8, 5.8, 2.7, 0.9 Hz, 1H), 3.96 
(dd, J = 9.3, 3.3 Hz, 1H), 3.82 (dd, J = 9.3, 7.2 Hz, 1H), 3.77 (s, 3H), 2.47 – 2.37 (m, 3H), 1.99 (t, 
J = 2.7 Hz, 1H), 1.79 (td, J = 7.4, 5.9 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 154.3, 152.8, 115.7, 114.8, 83.9, 72.8, 69.1, 69.0, 55.9, 31.9, 14.9. 
HRMS (EI): calcd. for C13H16O3 [M]
∙ +: 220.1094; found: 220.1093. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3418, 3290, 2937, 1515, 1455, 1338, 1290, 1243, 1179, 1105, 1043, 878, 826, 
745, 628.  
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Synthesis of isoxazole 3.58: To a solution of alkyne 3.57 (250 mg, 1.13 mmol, 1 equiv) in ethanol 
(2.0 mL) was added DABCO (12.7 mg, 113 µmol, 10.0 mol%) and ethyl nitroacetate (139 µL, 
1.25 mmol, 1.10 equiv) and the resulting yellow solution was heated to 80 °C. After 4 d, the 
reaction mixture was allowed to cool to 23 °C and the solution was concentrated. The crude product 
was purified by flash column chromatography on silica gel (30% ethyl acetate in hexane) to afford 
isoxazole 3.58 (299 mg, 881 µmol, 78%) as a colorless solid. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.08 (UV, CAM) 
mp: 61.4 – 64.2 °C 
1
H NMR (400 MHz, CDCl3) δ 6.83 (s, 4H), 6.46 (t, J = 0.8 Hz, 1H), 4.42 (q, J = 7.2 Hz, 2H), 4.05 
– 3.94 (m, 1H), 3.93 (dd, J = 9.3, 3.3 Hz, 1H), 3.81 (dd, J = 9.3, 7.1 Hz, 1H), 3.76 (s, 3H), 3.15 – 
2.92 (m, 2H), 2.50 (d, J = 4.0 Hz, 1H), 1.96 (tdd, J = 8.6, 5.2, 3.1 Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 174.9, 160.3, 156.6, 154.4, 152.6, 115.7, 114.9, 102.0, 72.7, 69.1, 
62.2, 55.9, 30.8, 23.0, 14.3. 
HRMS (ESI): calcd. for C17H25N2O6 [M+NH4]
+: 353.1707; found: 353.1707. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3451, 3137, 2934, 2836, 1732, 1593, 1508, 1462, 1390, 1230, 1182, 1105, 
1030, 928, 826, 780, 748.  
 
 
Synthesis of isoxazole 3.59: To a solution of alcohol 3.58 (150 mg, 447 µmol, 1 equiv) in 
dichloromethane (1 mL) was added DMAP (5.46 mg, 44.7 µmol, 10 mol%), imidazole (45.7 mg, 
671 µmol, 1.50 equiv) and tert-butyl(chloro)diphenylsilane (174 µL, 671 µmol, 1.50 equiv) in 
sequence and the resulting mixture was stirred at 23 °C. After 16 h, the reaction mixture was diluted 
with water (5 mL) to hydrolyze unreacted tert-butyl(chloro)diphenylsilane. The aqueous phase was 
extracted with dichloromethane (3×5 mL), the combined organic phases were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to give a colorless oil. The 
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crude product was purified by flash column chromatography on silica gel (10% ethyl acetate in n-
hexane) to afford isoxazole 3.59 (222 mg, 386 µmol, 86%) as a colorless oil. 
TLC (10% ethyl acetate in n-hexane): Rf: 0.14 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.74 – 7.62 (m, 4H), 7.49 – 7.29 (m, 6H), 6.78 – 6.69 (m, 2H), 6.61 
– 6.53 (m, 2H), 6.24 (s, 1H), 4.43 (q, J = 7.1 Hz, 2H), 4.08 (p, J = 5.6 Hz, 1H), 3.84 (dd, J = 9.6, 
5.1 Hz, 1H), 3.75 (m, 4H), 2.89 (hept, J = 7.9 Hz, 2H), 2.08 – 1.96 (m, 2H), 1.42 (t, J = 7.1 Hz, 
3H), 1.08 (s, 9H). 
13
C NMR (151 MHz, CDCl3) δ 175.3, 160.3, 156.4, 154.0, 152.6, 136.0, 133.8, 133.5, 130.1, 129.9, 
128.0, 127.8, 115.3, 114.7, 101.6, 71.1, 70.4, 62.2, 55.9, 32.0, 27.2, 22.3, 19.5, 14.3. 
HRMS (ESI): calcd. for C33H43O6N2Si [M+NH4]
+: 591.2885; found: 591.2883. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3136, 3071, 3048, 2932, 2858, 1730, 1592, 1507, 1462, 1428, 1390, 1363, 
1303, 1230, 1210, 1181, 1030, 997, 934, 822, 778, 740, 701, 689.  
 
 
Synthesis of isoxazole 3.61: To a solution of alcohol 3.58 (70.0 mg, 209 µmol, 1 equiv) in 
dichloromethane (420 µL) was added DMAP (2.55 mg, 20.9 µmol, 10.0 mol%), imidazole 
(21.3 mg, 313 µmol, 1.50 equiv) and triiso-propylsilyl chloride (53.5 µL, 250 µmol, 1.20 equiv) in 
sequence and the resulting mixture was stirred at 23 °C. After 16 h, the mixture was diluted with 
water (5 mL) to hydrolyze unreacted triiso-propylsilyl chloride and the aqueous phase was 
extracted with dichloromethane (3×5 mL) and the combined organic phases were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to give a colorless oil. The 
crude product was purified by flash column chromatography on silica gel (10% ethyl acetate in n-
hexane) to afford isoxazole 3.60 (98.5 mg, 200 µmol, 96%) as a colorless oil. 
TLC (15% ethyl acetate in n-hexane): Rf: 0.34 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.87 – 6.77 (m, 4H), 6.43 (s, 1H), 4.43 (q, J = 7.1 Hz, 2H), 4.27 (t, 
J = 5.6 Hz, 1H), 3.94 (dd, J = 9.3, 5.3 Hz, 1H), 3.77 (s, 4H), 2.98 (dt, J = 8.5, 6.4 Hz, 2H), 2.16 – 
2.02 (m, 2H), 1.41 (t, J = 7.1 Hz, 3H), 1.07 (d, J = 5.3 Hz, 21H). 
13
C NMR (151 MHz, CDCl3) δ 175.6, 160.3, 156.5, 154.1, 152.8, 115.4, 114.8, 101.6, 71.6, 69.8, 
62.2, 55.9, 32.5, 21.9, 18.3, 14.3, 12.7. 
Experimental Section 
 
111 
 
HRMS (EI): calcd. for C26H41NO6Si [M]
∙+:491.2698; found: 491.2691. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥:2942, 2866, 1731, 1594, 1508, 1462, 1389, 1366, 1302, 1230, 1211, 1181, 
1125, 1105, 1036, 1014, 921, 883, 824, 778, 736, 680.  
 
 
Synthesis of alcohol 3.61: To a solution of isoxazole 3.59 (19.0 mg, 33.1 µmol, 1 equiv) in 
acetonitrile (800 µL) and water (200 µL) was added ammonium cerium(IV) nitrate (39.9 mg, 
72.9 µmol, 2.20 equiv) in one portion at 0 °C and the resulting orange mixture was slowly allowed 
to warm to 23 °C. After 1 h, the reaction mixture was diluted with diethyl ether (10 mL) and water 
(10 mL) and the phases were separated and the aqueous phase was extracted with diethyl ether 
(3×5 mL). The combined organic phases were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated to give a yellow oil. The crude product was purified by 
flash column chromatography on silica gel (20% ethyl acetate in hexane) to afford alcohol 3.61 
(15.6 mg, 33.1 µmol, >99%) as a yellow oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.13 (UV, CAM) 
1
H NMR (599 MHz, CDCl3) δ 7.70 – 7.62 (m, 4H), 7.48 – 7.41 (m, 2H), 7.42 – 7.36 (m, 4H), 6.18 
(d, J = 0.9 Hz, 1H), 4.43 (q, J = 7.1 Hz, 2H), 3.86 – 3.79 (m, 1H), 3.61 – 3.47 (m, 2H), 2.82 – 2.70 
(m, 2H), 1.97 – 1.82 (m, 2H), 1.70 (dd, J = 7.0, 5.7 Hz, 1H), 1.41 (t, J = 7.2 Hz, 3H), 1.08 (s, 9H). 
13
C NMR (151 MHz, CDCl3) δ 175.0, 160.3, 156.4, 135.9, 135.8, 133.7, 133.3, 130.2, 130.2, 128.0, 
101.5, 72.8, 65.8, 62.2, 31.3, 27.2, 22.6, 19.5, 14.3. 
HRMS (ESI): calcd. for C26H34NO5Si [M+H]
+: 468.2201; found: 468.2210. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3459, 3072, 3050, 2931, 2893, 2858, 1732, 1591, 1472, 1462, 1428, 1390, 
1363, 1303, 1244, 1212, 1160, 1105, 1055, 1023, 998, 937, 862, 822, 779, 741, 702.  
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Synthesis of alcohol 3.62: To a solution of isoxazole (15.0 mg, 30.5 µmol, 1 equiv) in acetonitrile 
(800 µL) and water (200 µL) was added ammonium cerium(IV) nitrate (36.8 mg, 67.1 µmol, 
2.20 equiv) in one portion at 0 °C and the resulting orange mixture was slowly allowed to warm to 
23 °C. After 1 h, the mixture was diluted with diethyl ether (10 mL) and water (10 mL) and the 
phases were separated. The aqueous phase was extracted with diethyl ether (3×5 mL). The 
combined organic phases were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated to give a yellow oil. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in n-hexane) to afford alcohol 3.62 (14.9 mg, 
30.5 µmol, >99%) as a yellow oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.31 (UV, CAM) 
1
H NMR (599 MHz, CDCl3) δ 6.42 (d, J = 0.8 Hz, 1H), 4.43 (q, J = 7.2 Hz, 2H), 3.98 (dt, J = 6.3, 
4.5 Hz, 1H), 3.67 (dd, J = 11.2, 4.4 Hz, 1H), 3.59 (dd, J = 11.2, 3.9 Hz, 1H), 2.90 (dq, J = 15.8, 9.5 
Hz, 2H), 2.06 (ddt, J = 12.9, 9.9, 6.4 Hz, 1H), 1.99 (dtd, J = 15.4, 5.8, 5.0, 3.5 Hz, 1H), 1.81 (s, 
1H), 1.41 (td, J = 7.3, 2.0 Hz, 3H), 1.27 – 0.99 (m, 21H). 
13
C NMR (151 MHz, CDCl3) δ 175.2, 160.3, 156.5, 101.6, 71.6, 65.5, 62.2, 31.7, 22.5, 18.2, 14.3, 
12.6. 
HRMS (ESI): calcd. for C19H36NO5Si [M+H]
+: 386.2357; found: 386.2351. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3475, 2925, 2857, 1732, 1595, 1461, 1380, 1245, 1214, 1091, 1017, 891, 780.  
 
 
Synthesis of bromide 3.65: To a solution of alcohol 3.65 (50.0 mg, 149 µmol, 1 equiv) in 
dichloromethane (1.0 mL) was added imidazole (13.2 mg, 194 µmol, 1.30 equiv), triphenylphosine 
(43.0 mg, 164 µmol, 1.10 equiv) and carbon tetrabromide (59.3 mg, 179 µmol, 1.20 equiv) at 0 °C 
and the resulting reaction mixture was allowed to warm to 23 °C. After 3 h, a saturated aqueous 
solution of thiosulfate (5 mL) was added to quench unreacted triphenylphosphine and the aqueous 
phase was extracted with dichloromethane (3×5 mL). The combined organic phases were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give a pale 
Experimental Section 
 
113 
 
yellow oil. The crude product was purified by flash column chromatography on silica gel (20% 
ethyl acetate in hexane) to afford bromide 3.65 (46.2 mg, 116 µmol, 78%) as a colorless oil. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.35 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.84 (s, 4H), 6.48 (s, 1H), 4.44 (q, J = 7.2 Hz, 2H), 4.31 – 4.20 (m, 
1H), 4.24 – 4.13 (m, 1H), 4.15 – 4.04 (m, 1H), 3.77 (s, 3H), 3.16 (ddd, J = 14.9, 9.0, 5.1 Hz, 1H), 
3.04 (ddd, J = 15.8, 9.0, 7.1 Hz, 1H), 2.54 (dddd, J = 14.6, 9.0, 7.1, 3.2 Hz, 1H), 2.24 (dtd, J = 14.5, 
9.2, 5.1 Hz, 1H), 1.41 (t, J = 7.2 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 173.7, 160.2, 156.6, 154.7, 152.2, 116.1, 114.9, 102.3, 72.6, 62.3, 
55.9, 50.0, 33.0, 24.9, 14.3. 
HRMS (EI): calcd. for C17H20O5N
79Br [M]∙+: 397.0519; found: 397.0506. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2925, 2853, 1731, 1654, 1594, 1507, 1461, 1389, 1287, 1228, 1106, 1025, 
928, 826, 780, 752. 
  
 
Synthesis of alcohol 3.66: To a solution of bromide 3.65 (48.5 mg, 122 µmol, 1 equiv) in 
acetonitrile (800 µL) and water (200 µL) was added ammonium cerium(IV) nitrate (147 mg, 
268 µmol, 2.20 equiv) at 0 °C. After 20 min, the orange solution was allowed to warm to 23 °C. 
After 2 h, the solution was diluted with diethyl ether (10 mL) and the phases were separated. The 
aqueous phase was extracted with diethyl ether (3×5 mL) and the combined organic phases were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give 
a yellow oil. The crude product was purified by flash column chromatography on silica gel (20% 
ethyl acetate in n-hexane) to afford alcohol 3.66 (33.4 mg, 114 µmol, 94%) as a yellow oil. 
TLC (40% ethyl acetate in cyclohexane): Rf: 0.32 (UV, CAM) 
1
H NMR (599 MHz, CDCl3) δ 6.60 – 6.31 (s, 1H), 4.43 (q, J = 7.1 Hz, 2H), 4.17 – 3.96 (m, 1H), 
3.84 (t, J = 5.0 Hz, 2H), 3.12 (ddd, J = 15.7, 8.8, 5.1 Hz, 1H), 3.01 (dt, J = 15.9, 8.1 Hz, 1H), 2.33 
(dddd, J = 14.4, 8.6, 7.3, 3.6 Hz, 1H), 2.21 (dtd, J = 18.6, 9.0, 4.5 Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H). 
13
C NMR (151 MHz, CDCl3) δ 173.6, 160.1, 156.6, 102.4, 67.1, 62.3, 56.9, 32.5, 25.0, 14.3. 
HRMS (EI): calcd. for C10H14O4N
79Br [M]+: 291.0106; found: 291.0097. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3434, 3138, 2934, 1731, 1594, 1462, 1428, 1390, 1366, 1213, 1103, 1021, 
933, 860, 835, 780.  
 
 
Synthesis of spiro 3.67: To a solution of alcohol 3.66 (100 mg, 342 µmol, 1 equiv) in 
dichloromethane (4.4 mL) was added bromine (112 µL, 2.18 mmol, 5.00 equiv) at 0 °C. The 
resulting brown solution was slowly allowed to warm to 23 °C. After 16 h, excess of bromine was 
quenched by the addition of saturated aqueous thiosulfate solution (15 mL) and the phases were 
separated and the aqueous phase was extracted with dichloromethane (3×5mL). The combined 
phases were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated to give a yellow solid. The crude product was purified by flash column 
chromatography on silica gel (3% methanol in dichloromethane) to afford spiro 3.67 (42.5 mg, 
115 µmol, 34%, d.r. 2.3:1) as pale yellow oil. 
An analytical sample was purified by HPLC chromatography (40% ethyl acetate in n-hexane 
grading to 50% ethyl acetate in n-hexane in 30 min) to isolate both diastereomers. 
less polar diastereomer 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.28 (UV, CAM) 
1
H NMR (599 MHz, CDCl3) δ 4.87 (d, J = 0.5 Hz, 1H), 4.49 – 4.29 (m, 2H), 4.16 – 3.98 (m, 2H), 
3.92 – 3.80 (m, 1H), 2.43 (dddd, J = 14.0, 12.2, 4.1, 2.4 Hz, 2H), 2.38 – 2.30 (m, 1H), 2.12 – 2.03 
(m, 1H), 1.40 (td, J = 7.2, 0.5 Hz, 3H). 
13
C NMR (151 MHz, CDCl3) δ 158.7, 154.0, 108.8, 67.9, 62.9, 50.4, 42.4, 32.2, 31.1, 14.2. 
HRMS (EI): calcd. for C10H12
79BrNO4 [M-Br]
+: 290.0022; found: 289.9813. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2983, 2938, 2869, 1730, 1578, 1440, 1405, 1380, 1369, 1349, 1334, 1311, 
1286, 1248, 1224, 1182, 1126, 1110, 1100, 1060, 1016, 1002, 956, 918, 882, 860, 841, 798, 775, 
732, 701.  
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more polar diastereomer 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.25 (UV, CAM) 
1
H NMR (599 MHz, CDCl3) δ 5.01 (s, 1H), 4.44 – 4.33 (m, 4H), 3.90 – 3.73 (m, 1H), 2.59 – 2.34 
(m, 2H), 2.34 – 2.05 (m, 2H), 1.39 (t, J = 7.1 Hz, 3H). 
13
C NMR (151 MHz, CDCl3) δ 158.7, 154.3, 109.6, 68.8, 62.8, 50.5, 46.4, 29.0, 25.4, 14.2. 
HRMS (EI): calcd. for C10H12
79BrNO4 [M-Br]
+: 290.0022; found: 289.9813. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2983, 2938, 2869, 1730, 1578, 1440, 1405, 1380, 1369, 1349, 1334, 1311, 
1286, 1248, 1224, 1182, 1126, 1110, 1100, 1060, 1016, 1002, 956, 918, 882, 860, 841, 798, 775, 
732, 701.  
 
 
Synthesis of diol 3.72: To a solution of alcohol 3.73 (1.75 g, 25.0 mmol, 1 equiv), imidazole 
(2.04 g, 30.0 mmol, 1.20 equiv) and triphenylphosphine (7.21 g, 27.5 mmol, 1.10 equiv) in 
dichloromethane (40 mL) was added iodine (8.25 g, 32.5 mmol, 1.30 equiv) at 0 °C. After 5 min, 
the reaction mixture was allowed to warm to 23 °C. After 1 h, the reaction mixture was diluted with 
pentane (200 mL) and excess of iodine was quenched by the addition of saturated aqueous 
thiosulfate solution and the organic phase was washed with water (2×100 mL) and saturated 
aqueous sodium chloride solution (100 mL). The washed solution was dried over sodium sulfate, 
the dried solution was filtered and the filtrate was concentrated. The residue was dissolved in 
dichloromethane (1 mL), filtered over a plug of silica, washed with pentane (2×40 mL) and the 
filtrate was concentrated to iodide PS7 as give a colorless oil, which was pure enough to use without 
further purification. 
To a suspension of diethylmalonate (4.22 mL, 27.5 mmol, 1.10 equiv) and sodium hydride (60% 
in mineral oil, 1.10 g, 27.5 mmol, 1.10 equiv) in tetrahydrofuran (65 mL) was added a solution of 
iodide PS7 in tetrahydrofuran (25 mL). The reaction mixture was heat to 65 °C. After 16 h, the 
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reaction mixture was allowed to cool to 23 °C and diluted with diethyl ether (100 mL). Excess of 
base was quenched by saturated aqueous solution of ammonium chloride (200 mL) and the phases 
were separated. The aqueous phase was extracted with diethyl ether (3×100 mL), the combined 
organic phases were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated to give a pale yellow oil, which was used without further purification. 
To a suspension of lithium aluminum hydride (7.58 g, 200 mmol, 8.00 equiv) in tetrahydrofuran 
(200 mL) was added dropwise a solution of crude alkyne PS8 in tetrahydrofuran (25 mL) at 0 °C. 
After 2 h, excess of lithium aluminum hydride was quenched carefully by dropwise addition of 
ethyl acetate (200 mL) at 0 °C and saturated aqueous sodium potassium tartrate solution (100 mL) 
was added. After phase separation (approximately 8 h), the phases were separated and the aqueous 
phase was extracted with ethyl acetate (3×200 mL) and the combined organic phases were washed 
saturated aqueous sodium chloride solution (200 mL), the washed solution was dried over sodium 
sulfate , the dried solution was filtered and the filtrate was concentrated to give a pale yellow oil. 
The crude product was purified by flash column chromatography on silica gel (7% methanol in 
dichloromethane) to afford diol 3.72 (1.41 g, 11.0 mmol, 44% over 3 steps) as a pale yellow oil. 
TLC (7% methanol in dichloromethane): Rf: 0.23 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 3.75 (dd, J = 10.9, 4.0 Hz, 2H), 3.62 (dd, J = 10.8, 6.8 Hz, 2H), 3.43 
(s, 2H), 2.24 (td, J = 7.2, 2.6 Hz, 2H), 1.97 (t, J = 2.6 Hz, 1H), 1.85 (ddp, J = 10.2, 6.9, 3.5 Hz, 
1H), 1.51 (q, J = 7.1 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 84.1, 69.0, 64.7, 41.0, 26.5, 16.3. 
HRMS (ESI): calcd. for C7H12NaO2 [M+Na]
+: 151.0730; found: 151.0729. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3301, 2937, 2884, 1430, 1051, 983, 940.  
 
 
Synthesis of isoxazole 3.71: To a solution of diol 3.72 (1.00 g, 7.81 mmol, 1 equiv) in ethanol 
(13 mL) was added DABCO (87.6 mg, 781 µmol, 10.0 mol%) and ethyl nitroacetate (2.43 mL, 
21.9 mmol, 2.80 equiv) and the resulting yellow solution was heat to 80 °C. After 3 d, the reaction 
mixture was allowed to cool to 23 °C and the solution was concentrated. The crude product was 
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purified by flash column chromatography on silica gel (5% methanol in dichloromethane) to yield 
isoxazole 3.71 (1.43 g, 5.88 mmol, 75%) as a colorless solid. 
Crystals were good enough for X-Ray analysis 
TLC (4% methanol in dichloromethane): Rf: 0.14 (UV, CAM) 
mp: 64.1 – 64.4 °C 
1
H NMR (400 MHz, CDCl3) δ 6.44 (s, 1H), 4.42 (q, J = 7.2 Hz, 2H), 3.83 (dd, J = 10.6, 3.2 Hz, 
2H), 3.71 (dd, J = 10.7, 5.6 Hz, 2H), 2.93 – 2.84 (m, 2H), 1.77 (t, J = 6.4 Hz, 3H), 1.40 (t, J = 7.1 
Hz, 3H). 
 13C NMR (151 MHz, CDCl3) δ 175.2, 160.3, 156.5, 101.8, 65.4, 62.3, 41.3, 25.6, 24.6, 14.3. 
HRMS (ESI): calcd. for C11H18NO5 [M+H]
+: 244.1179; found: 244.1181. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3881, 2933, 2884, 1731, 1592, 1462, 1427, 1391, 1366, 1462, 1427, 1391, 
1366, 1300, 1210, 1102, 1022, 1103, 1022, 931, 860, 834. 
 
 
Synthesis of spiro 3.72: To a solution of diol 3.71 (100 mg, 441 µmol, 1 equiv) in dichloromethane 
(400 µL) was added a solution of bromine (1.00 M in dichloromethane, 4.11 mL, 4.11 mmol, 
10.0 equiv) dropwise at 0 °C. The resulting red-brown solution was stirred for 1 h at 0 °C, before 
it was allowed to warm to 23 °C. After 6 h, excess of bromine was quenched by the addition of 
saturated aqueous thiosulfate solution (5 mL). The phases were separated and the aqueous solution 
was extracted with dichloromethane (3×10 mL). The combined organic phases were dried over 
magnesium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (2% methanol in 
dichloromethane) to afford spiro 3.72 (58.6 mg, 182 µmol, 44%, d.r. 2.2:1) as a colorless oil. 
An analytical sample was purified by HPLC chromatography (40% ethyl acetate in n-hexane 
grading to 50% ethyl acetate in n-hexane in 30 min) to isolate both diasteromers. 
less polar diastereomer 
TLC (3% methanol in dichloromethane): Rf: 0.17 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 4.89 (s, 1H), 4.40 (qd, J = 7.1, 3.7 Hz, 2H), 3.86 (ddd, J = 11.3, 4.9, 
1.9 Hz, 1H), 3.77 (t, J = 11.3 Hz, 1H), 3.59 (dd, J = 10.7, 5.5 Hz, 1H), 3.51 (dd, J = 10.7, 7.3 Hz, 
1H), 2.42 – 2.29 (m, 1H), 2.02 – 1.84 (m, 3H), 1.74 – 1.59 (m, 1H), 1.39 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 159.0, 153.9, 110.1, 66.7, 64.4, 62.7, 50.8, 37.2, 29.9, 23.0, 14.2. 
HRMS (ESI): calcd. for C11H17BrNO5 [M+H]
+: 322.0285; found: 322.0287. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3436, 2936, 1729, 1575, 1467, 1450, 1380, 1349, 1334, 1250, 1226, 1124, 
1079, 1054, 1011, 920, 881, 856, 787, 765, 679.  
 
more polar diastereomer 
TLC (3% methanol in dichloromethane): Rf: 0.17 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 4.88 (s, 1H), 4.40 (qd, J = 7.1, 3.3 Hz, 2H), 4.18 (dd, J = 11.8, 3.2 
Hz, 1H), 3.88 – 3.79 (m, 1H), 3.76 – 3.69 (m, 2H), 2.20 – 2.09 (m, 2H), 2.09 – 2.00 (m, 1H), 1.93 
– 1.78 (m, 1H), 1.55 (s, 1H), 1.39 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 159.0, 153.9, 110.4, 64.4, 62.7, 62.2, 50.6, 34.6, 26.1, 21.0, 14.2. 
HRMS (ESI): calcd. for C11H17BrNO5 [M+H]
+: 322.0285; found: 322.0287. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3440, 2979, 2939, 2876, 1729, 1729, 1574, 1469, 1405, 1381, 1335, 1256, 
1231, 1193, 1131, 1077, 1013, 941, 921, 880, 787, 763.  
 
 
Synthesis of tosyl PS8: To a solution of diol 3.71 (100 mg, 441 µmol, 1 equiv) in dichloromethane 
(4.1 mL) was added pyridine (40.0 µL, 493 µmol, 1.20 equiv), DMAP (5.02 mg, 41.1 µmol, 
10 mol%) and p-toluenesulfonyl chloride (78.4 mg, 441 µmol, 1.00 equiv) in sequence at 0 °C. The 
pale yellow solution was stirred for 15 min at 0 °C before the mixture was allowed to warm to 
23 °C. After 16 h, the mixture was diluted with aqueous hydrogen chloride solution (1.0 M, 10 mL) 
and the aqueous phase was extracted with dichloromethane (3×10 mL). The combined organic 
phases were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated to give a colorless oil. The crude product was purified by flash column 
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chromatography on silica gel (3% methanol in dichloromethane) to afford, tosyl PS8 (129 mg, 
325 µmol, 79%) as a colorless solid. 
TLC (1% methanol in dichloromethane): Rf: 0.17 (UV, CAM) 
mp: 74.3 – 75.5 °C 
1
H NMR (400 MHz, CDCl3) δ 7.81 – 7.74 (m, 2H), 7.39 – 7.32 (m, 2H), 6.39 (s, 1H), 4.42 (q, J = 
7.1 Hz, 2H), 4.16 – 4.04 (m, 2H), 3.71 – 3.56 (m, 2H), 2.85 – 2.75 (m, 2H), 2.44 (s, 3H), 1.93 – 
1.66 (m, 4H), 1.40 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 174.5, 160.1, 156.5, 145.3, 132.8, 130.1, 128.0, 101.9, 69.7, 62.3, 
61.4, 39.8, 25.3, 24.2, 21.8, 14.3. 
HRMS (ESI): calcd. for C18H23NNaO7S [M+Na]
+: 420.1087; found: 420.1094. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3450, 2933, 1731, 1596, 1494, 1462, 1426, 1390, 1356, 1306, 1292, 1243, 
1211, 1189, 1174, 1097, 1019, 964, 939, 832, 814, 779, 706, 687, 666.  
 
 
Synthesis of tosyl 3.74: To a solution of alcohol 3.72 (11.4 mg, 31.8 µmol, 1 equiv) in 
dichloromethane (300 µL) was added triethylamine (5.31 µL, 38.2 µmol, 1.20 equiv), DMAP 
(3.89 mg, 3.18 µmol, 10 mol%) and p-toluenesulfonyl chloride (7.29 mg, 38.2 µmol, 1.00 equiv) 
in sequence at 0 °C. The pale yellow solution was stirred for 15 min at 0 °C, before the mixture 
was allowed to warm to 23 °C. After 16 h, the reaction mixture was diluted with aqueous hydrogen 
chloride (1.0 M, 10 mL) and the aqueous phase was extracted with dichloromethane (3×10 mL). 
The combined organic phases were dried over sodium sulfate, the dried solution was filtered and 
the filtrate was concentrated to give a colorless oil. The crude product was purified by flash column 
chromatography on silica gel (100% dichloromethane) to afford tosyl 3.74 (7.50 mg, 0.157 µmol, 
49%, d.r. 2.2:1) as a colorless oil. 
major diastereomer 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.29 (UV, CAM) 
mp: 78.1 – 88.1 °C 
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1
H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.3 Hz, 2H), 7.36 (d, J = 7.9, 0.7 Hz, 2H), 4.85 (s, 1H), 
4.39 (qd, J = 7.1, 3.7 Hz, 2H), 4.20 – 4.07 (m, 1H), 3.93 (dd, J = 10.0, 5.5 Hz, 1H), 3.80 (dd, J = 
10.0, 7.7 Hz, 1H), 3.73 (ddd, J = 11.3, 4.8, 1.9 Hz, 1H), 3.64 (t, J = 11.4 Hz, 1H), 2.46 (s, 3H), 2.36 
– 2.29 (m, 1H), 2.20 – 2.06 (m, 1H), 1.96 – 1.83 (m, 1H), 1.68 – 1.58 (m, 1H), 1.38 (t, J = 7.1 Hz, 
3H). 
13
C NMR (101 MHz, CDCl3) δ 158.8, 153.9, 145.3, 132.7, 130.2, 128.0, 109.6, 70.6, 65.5, 62.7, 
50.6, 34.3, 29.5, 22.6, 21.8, 14.2. 
zHRMS (ESI): calcd. for C18H23
79BrNO7S [M+H]
+: 476.0373; found: 476.0370. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2923, 2852, 1731, 1595, 1492, 1454, 1373, 1305, 1189, 1173, 1155, 1082, 
1008, 919, 813, 780, 714, 698.  
 
 
Alternative synthesis of spiro 3.74: To a solution of tosyl PS8 (47.0 mg, 118 µmol, 1 equiv) in 
dichloromethane (120 µL) was added bromine (1.00 M in dichloromethane, 1.18 mL, 1.18 mmol, 
10.0 equiv) dropwise at 0 °C. The resulting red-brown solution was stirred for 1 h at 0 °C, before 
it was allowed to warm to 23 °C. After 6 h, excess of bromine was quenched by the addition of 
saturated aqueous thiosulfate solution (5 mL). The phases were separated and the aqueous solution 
was extracted with dichloromethane (3×10 mL). The combined organic phases were dried over 
magnesium sulfate, the dried solution was filtered and the filtrate was concentrated under reduced 
pressure. The crude product was purified by flash column chromatography on silica gel (20% ethyl 
acetate in hexane) to afford spiro 3.74 (25.3 mg, 44.9 µmol, 45%, d.r. 2.3:1) as a colorless oil. 
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Synthesis of acetal 3.99: To a solution of diisopropylamine (31.0 mL, 220 mmol, 2.20 equiv) in 
tetrahydrofuran (220 mL, 1.00 M) was added n-butyllithium (2.50 M in n-hexane, 83.9 mL, 
210 mmol, 2.10 equiv) at −78 °C. After 10 min, ethyl acetoacetate (3.13) (12.6 mL, 99.9 mmol, 
1 equiv) was added dropwise at −78 °C. After complete addition, the reaction mixture was slowly 
allowed to warm to 0 °C. After stirring for 1 h at 0 °C, allyl bromide (10.4 mL, 120 mmol, 
1.20 equiv) was added at 0 °C and the resulting yellow reaction mixture was allowed to warm to 
23 °C. After 1 h, saturated aqueous ammonium chloride solution (200 mL) was added to quench 
excess of base. The reaction mixture was extracted with ethyl acetate (3×100 mL), and the 
combined organic phases were washed with water (100 mL) and saturated aqueous sodium chloride 
solution (100 mL), the washed solution was dried over sodium sulfate. The dried solution was 
filtered and the filtrate was carefully concentrated (200 mbar, 42 °C) to give an orange oil, which 
was pure enough to use without further purification. The orange residue was dissolved in benzene 
(100 mL) and ethylene glycol (16.8 mL, 300 mmol, 3.00 equiv) and to the solution was added  p-
toluenesulfonic acid monohydrate (1.90 g, 9.99 mmol, 10.0 mol%) and the reaction mixture was 
heat to 100 °C in a Dean–Stark apparatus. After 16 h, the reaction mixture was allowed to cool to 
23 °C and the acid was neutralized with saturated aqueous sodium hydrogen carbonate solution 
(200 mL) and the phases were separated. The aqueous phase was extracted with diethyl ether 
(3×100 mL) and the combined organic phases were washed with water (100 mL) and saturated 
aqueous sodium chloride solution (100 mL). The washed solution was dried over sodium sulfate 
and the dried solution was concentrated to afford acetal 3.99 (19.5 g, 91.0 mmol, 91%) as a pale 
yellow oil, which was pure enough to use without further purification. 
All analytical data were in agreement with the literature.[138] 
Synthesis of alcohol 3.111: To a suspension of lithium aluminum hydride (816 mg, 21.5 mmol, 
2.00 equiv) in tetrahydrofuran (100 mL) was added dropwise a solution of acetal 3.99 (500 mM in 
tetrahydrofuran, 21.5 mL, 10.8 mmol, 1 equiv) at 0 °C. After 2 h, excess of lithium aluminum 
hydride was quenched carefully by addition of ethyl acetate dropwise at 0 °C. A saturated aqueous 
sodium potassium tartrate solution (200 mL) and ethyl acetate (200 mL) were added and the grey 
suspension was stirred vigorously. After 4 h, the phases were separated and the aqueous phase was 
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extracted with ethyl acetate (3×100 mL) and the combined organic phases were washed with water 
(100 mL) and saturated aqueous sodium chloride solution (100 mL). The washed solution was dried 
over sodium sulfate and the dried solution was concentrated to give a yellow oil. The crude product 
was purified by flash column chromatography on silica gel (2% methanol in dichloromethane) to 
yield alcohol 3.111 (1.66 g, 9.62 mmol, 89%) as a pale yellow oil. 
All analytical data were in agreement with the literature.[138] 
Synthesis of aldehyde 3.94: To a solution of oxalyl chloride (2.00 M in dichloromethane, 9.40 mL, 
18.8 mmol, 2.00 equiv) in dichloromethane (90.0 mL) was added a solution of dimethyl sulfoxide 
(1.00 M in dichloromethane, 37.6 mL, 37.6 mmol, 4.00 equiv) at −78 °C. After 15 min, a solution 
of alcohol 3.111  (1.00 M in dichloromethane, 9.40 mL, 9.40 mmol, 1 equiv) was added dropwise 
and the resulting solution was stirred at −78 °C. After further 30 min, triethylamine (13.0 mL, 
94.0 mmol, 10.0 equiv) was added at −78 ° C and the temperature was kept for 15 min before the 
reaction mixture was slowly allowed to warm to 23 °C. After 1 h, the mixture was diluted with 
water (150 mL). The phases were separated and the aqueous solution was extracted with diethyl 
ether (3×100 mL). The combined organic phases were dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (100% dichloromethane) to afford aldehyde 3.111 (1.54 mg, 
9.02 mmol, 96%) as a pale yellow oil. 
All analytical data were in agreement with the literature.[98] 
Improved synthesis of aldehyde 3.94 from ester 3.99: To a solution of ester 3.99 (1.00 g, 
4.67 mmol, 1 equiv) in toluene (20 mL) was added diisobutylaluminium hydride (1.00 M in 
toluene, 9.33 mL, 9.33 mmol, 2.00 equiv) dropwise at −78 °C. After 3 h, methanol (420 µL) was 
added at −78 °C dropwise. The reaction mixture was stirred for 30 min, before aqueous hydrogen 
chloride solution (1.00 M, 10 mL) was added at −78 °C and the cloudy suspension was allowed to 
warm to 23 C. The reaction mixture was diluted with ethyl acetate (30 mL) and water (100 mL) 
and the phases were separated. The aqueous phase was extracted with ethyl acetate (3×30 mL), the 
combined organic phases were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated to give a yellow oil. The crude product was purified by flash column 
chromatography on silica gel (100% dichloromethane) to yield aldehyde 3.94 (590 mg, 3.47 mmol, 
74%) as a pale yellow oil. 
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Synthesis of isoxazoline 3.92: To a solution of aldehyde 3.94 (590 mg, 3.47 mmol, 1 equiv) in 
ethanol (6.9 mL) was added sodium acetate (569 mg, 6.93 mmol, 2.00 equiv) and hydroxylamine 
hydrochloride (631 mg, 5.20 mmol, 1.50 equiv). After 16 h, the pale yellow solution was filtered 
and the filtrate was concentrated. The residue was diluted with ethyl acetate (25 mL). The organic 
phase was washed with water (3×20 mL) and saturated aqueous sodium hydrogen carbonate 
solution (20 mL), the washed solution was dried over sodium sulfate, the dried solution was filtered 
and the filtrate was concentrated to give crude oxime 3.95, which was used without further 
purification. 
To a solution of crude oxime 3.95 in dichloromethane (6.9 mL) was added a solution of sodium 
hypochlorite (5% in water, 6.82 mL, 5.55 mmol, 1.60 equiv) at 0 °C and the reaction mixture was 
allowed to warm to 23 °C. After 4 h, excess of hypochlorite was quenched by the addition of 
aqueous sodium thiosulfate solution (1.0 M, 20 mL). The phases were separated and the aqueous 
phase was extracted with dichloromethane (3×20 mL). The combined organic phases were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (3% methanol in 
dichloromethane) to afford isoxazoline 3.92 (541 mg, 2.95 mmol, 85%) as a colorless solid. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.10 (CAM) 
mp: 100.2 – 104.1°C 
1
H NMR (400 MHz, CDCl3) δ 4.53 (dd, J = 10.4, 8.0 Hz, 1H), 4.06 – 3.91 (m, 4H), 3.81 (dd, J = 
10.4, 8.0 Hz, 1H), 3.18 (dddd, J = 15.3, 10.4, 7.6, 3.1 Hz, 1H), 2.87 (dd, J = 14.2, 2.5 Hz, 1H), 2.39 
(dd, J = 14.2, 1.6 Hz, 1H), 2.07 (ddt, J = 13.0, 6.7, 3.4 Hz, 1H), 1.91 – 1.71 (m, 2H), 1.69 – 1.53 
(m, 1H). 
13
C NMR (101 MHz, CDCl3) δ 158.4, 108.7, 73.7, 65.1, 64.8, 47.4, 35.1, 34.1, 27.5. 
HRMS (ESI): calcd. for C9H14NO3 [M+H]
+: 184.0968; found: 184.0966. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2955, 2884, 1726, 1629, 1473, 1443, 1422, 1353, 1336, 1296, 1268, 1241, 
1207, 1145, 1110, 1085, 1044, 1006, 971, 951, 921, 893, 856, 833, 803, 780, 733, 689.  
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Synthesis of alcohol 3.88: To a solution of isoxazoline 3.92 (540 mg, 2.95 mmol, 1 equiv) in 
methanol (25 mL) and water (5 mL) was added acetic acid (506 µL, 8.84 mmol, 3.00 equiv) and 
Raney®-Nickel (25.3 mg, 2.95 µmol, 10.0 mol%) and the black reaction mixture was purged for 
20 min with hydrogen. After 16 h, Celite® was added and the reaction mixture was filtered over a 
plug of Celite® and the plug was washed with dichloromethane (3×10 mL). The filtrate was washed 
with saturated aqueous sodium hydrogen carbonate solution (30 mL). The phases were separated 
and the aqueous phase was extracted with dichloromethane (3×10 mL) dried over sodium sulfate, 
the dried solution was filtered and the filtrate was concentrated to give a yellow oil. The crude 
product was purified by flash column chromatography on silica gel (5% methanol in 
dichloromethane) to afford alcohol 3.88 (421 mg, 2.26 mmol, 77%) as a colorless solid. 
TLC (5% methanol in dichloromethane): Rf: 0.14 (CAM) 
mp: 64.1 – 67.3 °C 
1
H NMR (400 MHz, CDCl3) δ 4.01 – 3.90 (m, 4H), 3.77 (dd, J = 11.6, 7.2 Hz, 1H), 3.64 (d, J = 
11.7 Hz, 1H), 2.66 (dd, J = 13.8, 1.1 Hz, 1H), 2.58 (ddd, J = 13.8, 1.9, 1.1 Hz, 2H), 2.48 (dtdd, J = 
10.1, 7.1, 4.0, 1.1 Hz, 1H), 2.01 – 1.95 (m, 2H), 1.94 – 1.85 (m, 1H), 1.61 (tt, J = 13.1, 8.2 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 209.8, 110.3, 65.0, 64.8, 62.3, 51.9, 51.2, 34.2, 23.5. 
HRMS (ESI): calcd. for C9H14NaO4 [M+Na]
+: 209.0784; found:209.0795. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3467, 2953, 2882, 1707, 1443, 1415, 1355, 1296, 1238, 1193, 1165, 1081, 
1032, 997, 946, 919, 865, 789, 707.  
 
 
Synthesis of ketone 3.96: To a solution of alcohol 3.88 (150 mg, 806 µmol, 1 equiv) in 
dichloromethane (4 mL) was added DMAP (9.84 mg, 80.6 µmol, 10.0 mol%), imidazole (82.3 mg, 
1.21 µmol, 1.50 equiv) and tert-butyl(chloro)diphenylsilane (217 µL, 846 µmol, 1.05 equiv) in 
sequence and the resulting mixture was stirred at 23 °C. After 16 h, the mixture was diluted with 
water (10 mL) to hydrolyze unreacted tert-butyl(chloro)diphenylsilane. The aqueous phase was 
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extracted with dichloromethane (3×10 mL), the combined organic phases were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to give a colorless oil. The 
crude product was purified by flash column chromatography on silica gel (10% ethyl acetate in 
hexane) to afford ketone 3.96 (340 mg, 801 µmol, 99%) as a colorless solid. 
TLC (15% ethyl acetate in hexane): Rf: 0.14 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.66 (dt, J = 7.9, 1.5 Hz, 4H), 7.39 (tt, J = 8.0, 5.8 Hz, 6H), 4.05 
(dd, J = 10.5, 4.8 Hz, 1H), 4.00 – 3.90 (m, 4H), 3.69 (dd, J = 10.5, 7.8 Hz, 1H), 2.65 – 2.45 (m, 
3H), 2.29 (ddt, J = 13.3, 6.0, 4.4 Hz, 1H), 2.06 – 1.88 (m, 2H), 1.69 – 1.54 (m, 1H), 1.05 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 207.1, 135.7, 135.7, 133.7, 133.6, 129.8, 127.8, 110.4, 64.9, 64.8, 
63.0, 51.7, 51.6, 34.1, 27.0, 24.4, 19.4. 
HRMS (ESI): calcd. for C25H32NaO4Si [M+Na]
+: 447.1962; found: 447.1955. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3070, 3048, 2956, 2931, 2885, 2857, 1715, 1589, 1472, 1428, 1390, 1358, 
1308, 1242, 1195, 1111, 1090, 1007, 947, 824, 741, 613, 505.  
 
 
Synthesis of diol 3.100: To a solution of acetal 3.99 (1.08 g, 4.12 mmol, 1 equiv) in water (5 mL), 
tetrahydrofuran (5 mL), and acetonitrile (5 mL) was added osmium tetroxide (4% in water, 650 µL, 
82.3 µmol, 2 mol%) and N-methylmorpholine N-oxide (627 mg, 5.35 mmol, 1.30 equiv) at 23 °C. 
After 16 h, the brown reaction mixture was diluted with ethyl acetate (20 mL), water (10 mL) and 
saturated aqueous thiosulfate solution (1 mL) to quench excess of N-oxide. The phases were 
separated and the aqueous phase was extracted with ethyl acetate (3×20 mL), the combined organic 
phases were dried over sodium sulfate and the dried solution was filtered and the filtrate was 
concentrated to give a black oil. The crude product was purified by flash column chromatography 
on silica gel (5% methanol in dichloromethane) to yield diol 3.100 (175 mg, 0.81 mmol, 85%) as a 
yellow oil. 
TLC (7% methanol in dichloromethane): Rf: 0.20 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 4.14 (q, J = 7.1 Hz, 2H), 4.05 – 3.94 (m, 4H), 3.69 (tdd, J = 7.7, 
5.0, 3.2 Hz, 1H), 3.62 (dd, J = 11.1, 3.2 Hz, 1H), 3.44 (dd, J = 11.1, 7.3 Hz, 1H), 2.65 (s, 2H), 2.60 
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– 2.51 (m, 2H), 1.97 (qdd, J = 14.3, 9.0, 6.5 Hz, 2H), 1.57 (dddd, J = 10.6, 7.6, 5.7, 4.0 Hz, 2H), 
1.25 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 169.7, 109.32, 7.12, 66.8, 65.2, 65.2, 60.8, 42.6, 33.6, 27.1, 14.3. 
HRMS (ESI): calcd. for C11H20NaO6 [M+Na]
+: 271.1152; found: 271.1144. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3413, 2937, 2893, 1730, 1447, 1371, 1306, 1218, 1033, 951, 883.  
 
 
Synthesis of ester 3.101: To a solution of diol 3.100 (170 mg, 685 µmol, 1 equiv) in 
dichloromethane (3.4 mL) was added DMAP (8.37 mg, 68.5 µmol, 10.0 mol%), imidazole 
(55.9 mg, 822 µmol, 1.20 equiv) and tert-Butyl(chloro)diphenylsilane (176 µL, 685 µmol, 
1.00 equiv) in sequence and the resulting mixture was stirred at 23 °C. After 16 h, the mixture was 
diluted with water (5 mL) to hydrolyze unreacted tert-Butyl(chloro)diphenylsilane. The aqueous 
phase was extracted with dichloromethane (3×5 mL), the combined organic phases were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give a colorless 
oil. The crude product was purified by flash column chromatography on silica gel (20% ethyl 
acetate in hexane) to afford ester 3.103 (332 mg, 682 µmol, ≥99%) as a colorless oil. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.16 (UV, CAM) 
1
H NMR (600 MHz, CDCl3) δ 7.68 – 7.63 (m, 4H), 7.41 (dt, J = 27.4, 7.4 Hz, 6H), 4.13 (q, J = 7.2 
Hz, 2H), 4.02 – 3.89 (m, 4H), 3.72 (q, J = 7.4, 5.6 Hz, 1H), 3.65 (dd, J = 10.2, 3.7 Hz, 1H), 3.50 
(dd, J = 10.1, 7.2 Hz, 1H), 2.63 (s, 2H), 2.59 (d, J = 3.8 Hz, 1H), 2.00 (ddd, J = 15.3, 9.5, 6.6 Hz, 
1H), 1.89 – 1.80 (m, 1H), 1.54 (q, J = 8.2 Hz, 2H), 1.24 (t, J = 7.1 Hz, 3H), 1.06 (s, 9H). 
13
C NMR (151 MHz, CDCl3) δ 169.5, 135.7, 135.7, 133.3, 133.3, 129.9, 127.9, 109.4, 72.0, 68.1, 
65.3, 65.3, 60.7, 42.9, 33.8, 27.0, 26.9, 19.4, 14.3. 
HRMS (ESI): calcd. for C27H38NaO6Si [M+Na]
+: 509.2330; found: 509.2321. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3520, 3070, 2957, 2931, 2894, 2858, 1735, 1473, 1428, 1370, 1224, 1112, 
1037, 824, 742, 704.  
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Synthesis of aldehyde 3.103: To a solution of alkene 3.99 (522 mg, 2.44 mmol, 1 equiv) in 
tetrahydrofuran (10 mL) and water (5 mL) was added a solution of osmium tetroxide (4% in water, 
760 µL, 97.5 µmol, 4.00 mol%) and sodium periodate (1.30 g, 6.09 mmol, 2.50 equiv) at 23 °C. 
After 16 h, the brown reaction mixture was diluted with ethyl acetate (20 mL), water (10 mL) and 
saturated aqueous thiosulfate solution (1 mL). The phases were separated and the aqueous phase 
was extracted with ethyl acetate (3×30 mL), the combined organic phases were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to give a black oil. The 
crude product was purified by flash column chromatography on silica gel (5% methanol in 
dichloromethane) to yield aldehyde 3.103 (264 mg, 1.22 mmol, 50%) as a pale yellow oil. 
TLC (40% ethyl acetate in cyclohexane): Rf: 0.23 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 9.69 (t, J = 2.1 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 4.02 – 3.96 (m, 
2H), 3.95 – 3.90 (m, 2H), 2.64 (s, 2H), 2.46 (tdd, J = 7.0, 2.1, 0.7 Hz, 2H), 2.29 (td, J = 6.9, 0.7 
Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 201.9, 169.3, 108.5, 65.3, 60.8, 43.1, 38.1, 30.6, 14.3. 
HRMS (ESI): calcd. for C10H16NaO5 [M+Na]
+: 239.0890; found: 239.0886. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2981, 2897, 2730, 1724, 1442, 1370, 1215, 1112, 1035, 970, 951. 
 
 
Synthesis of alcohol 3.104: To a solution of aldehyde 3.103 (95.5 mg, 442 µmol, 1 equiv) in 
tetrahydrofuran (6.0 mL) was added a solution of vinyl magnesium bromide (1.00 M in 
tetrahydrofuran, 442 µL, 442 µmol, 1.00 equiv) dropwise at −78 °C and the reaction mixture was 
slowly allowed to warm to 23 °C. After 1 h, the reaction mixture was diluted with diethyl ether 
(10 mL) and saturated aqueous ammonium chloride solution (20 mL) to quench excess of the 
Grignard reagent. The phases were separated and the aqueous phase was extracted with diethyl 
ether (3×20 mL). The combined organic phases were dried over sodium sulfate and the filtrate was 
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concentrated. The crude product was purified by flash column chromatography (40% ethyl acetate 
in hexane) to afford alcohol 3.105 (49.6 mg, 203 µmol, 46%) as a pale yellow oil. 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.21 (CAM) 
1
H NMR (600 MHz, CDCl3) δ 5.85 (ddd, J = 17.2, 10.4, 5.9 Hz, 1H), 5.23 (dt, J = 17.2, 1.5 Hz, 
1H), 5.10 (dt, J = 10.4, 1.4 Hz, 1H), 4.18 – 4.06 (m, 3H), 4.05 – 3.92 (m, 4H), 2.65 (s, 2H), 2.05 – 
1.99 (m, 1H), 2.01 – 1.86 (m, 2H), 1.74 – 1.59 (m, 2H), 1.25 (t, J = 7.1 Hz, 3H). 
13
C NMR (151 MHz, CDCl3) δ 169.6, 141.0, 114.9, 109.4, 72.9, 65.2, 60.7, 42.8, 33.4, 30.9, 14.3. 
HRMS (ESI): calcd. for C12H20NaO5 [M+Na]
+: 267.1203; found: 267.1199. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3514, 2979, 2963, 2940, 2897, 1733, 1431, 1371, 1303, 1241, 1097, 1056, 
1036, 949.  
 
 
Synthesis of diol 3.105: To a suspension of lithium aluminum hydride (14.0 mg, 370 µmol, 
2.00 equiv) in tetrahydrofuran (740 µL) was added a solution of ester 3.104 (500 mM in 
tetrahydrofuran, 370 µL, 185 µmol, 1 equiv) dropwise at 0 °C. The resulting reaction mixture was 
allowed to warm to 23 °C. After 1 h, excess of lithium aluminum hydride was quenched by the 
dropwise addition of ethyl acetate (10 mL) at 0 °C. The reaction mixture was diluted with saturated 
aqueous sodium potassium tartrate solution (10 mL). After 1 h, the phases were separated and the 
aqueous phase was extracted with ethyl acetate (3×10 mL). The combined organic phases were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
crude product was purified by flash column chromatography on silica gel (5% methanol in 
dichloromethane) to yield diol 3.105 (37.0 mg, 183 µmol, 99%) as a pale yellow oil. 
TLC (5% methanol in dichloromethane): Rf: 0.14 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 5.85 (ddd, J = 17.2, 10.4, 6.0 Hz, 1H), 5.23 (dt, J = 17.2, 1.4 Hz, 
1H), 5.11 (dt, J = 10.5, 1.4 Hz, 1H), 4.11 (q, J = 6.3 Hz, 1H), 4.03 – 3.95 (m, 4H), 3.73 (d, J = 6.2 
Hz, 2H), 2.73 (s, 1H), 2.06 (s, 1H), 1.93 (dd, J = 6.0, 5.1 Hz, 2H), 1.85 – 1.58 (m, 4H). 
13
C NMR (101 MHz, CDCl3) δ 141.0, 115.0, 112.1, 72.9, 65.0, 58.9, 38.4, 32.8, 31.1. 
HRMS (ESI): calcd. for C12H20NaO5 [M+Na]
+: 267.1203; found: 267.1199. 
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Synthesis of lactone 3.106: To a solution of diol 3.105 (17 mg, 82µmol, 1 equiv) in 
dichloromethane (0.80 mL) was added (diacetoxyiodo)benzene (58 mg, 0.18 mmol, 2.2 equiv) and 
TEMPO (1.3 mg, 8.2 µmol, 10 mol%) at 23 °C. After 16 h, the reaction mixture was diluted with 
saturated aqueous hydrogen carbonate solution (3 mL) and saturated aqueous thiosulfate solution 
(3 mL) to quench excess of hypervalent iodine. The phases were separated and the aqueous phase 
was extracted with dichloromethane (3×5 mL). The combined organic phases were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give an orange 
oil. The crude product was purified by flash column chromatography on silica gel (1% methanol in 
dichloromethane) to afford lactone 3.106 (7.2 mg, 36 µmol, 44%) as a colorless oil. 
TLC (1% methanol in dichloromethane): Rf: 0.17 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 5.90 (ddd, J = 17.2, 10.6, 5.7 Hz, 1H), 5.38 (dt, J = 17.2, 1.3 Hz, 
1H), 5.21 (dt, J = 10.6, 1.2 Hz, 1H), 4.83 (ddt, J = 7.0, 5.7, 1.8 Hz, 1H), 4.16 – 4.06 (m, 1H), 4.05 
– 3.92 (m, 3H), 3.11 (d, J = 13.8 Hz, 1H), 2.90 (dd, J = 13.9, 1.9 Hz, 1H), 2.09 – 1.91 (m, 4H). 
13
C NMR (101 MHz, CDCl3) δ 169.2, 136.3, 116.6, 105.5, 80.0, 65.3, 64.8, 44.9, 38.1, 31.0. 
HRMS (ESI): calcd. for C10H14NaO4 [M+Na]
+: 221.0784; found: 221.0787. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2893, 1733, 1433, 1242, 1077, 1018, 948 
 
 
Synthesis of aldehyde 3.111: To a solution of alkene 3.106 (13 mg, 66 µmol, 1 equiv) in 
tetrahydrofuran (5.0 mL) and water (2.5 mL) was added a solution of osmium tetroxide (4% in 
water, 4.3 µL, 3.3 µmol, 4.0 mol%) and sodium periodate (35 mg, 17 µmol, 2.5 equiv) at 23 °C. 
After 16 h, the brown reaction mixture was diluted with ethyl acetate (10 mL), water (5 mL) and 
saturated aqueous thiosulfate solution (1 mL). The phases were separated and the aqueous phase 
was extracted with ethyl acetate (3×10 mL). The combined organic phases were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to give a black oil. The 
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crude product was purified by flash column chromatography on silica gel (1% methanol in 
dichloromethane) to yield aldehyde 3.107 (6.3 mg, 31 mmol, 48%) as a pale yellow oil. 
TLC (1% methanol in dichloromethane): Rf: 0.08 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 9.75 (s, 1H), 4.61 (d, J = 9.1 Hz, 1H), 4.15 – 4.03 (m, 1H), 4.09 – 
3.94 (m, 3H), 3.06 (d, J = 14.0 Hz, 1H), 2.95 (dd, J = 14.0, 2.2 Hz, 1H), 2.41 – 2.25 (m, 2H), 2.09 
– 1.91 (m, 2H). 
13
C NMR (101 MHz, CDCl3) δ 198.4, 168.0, 105.3, 82.7, 65.4, 64.9, 44.8, 37.9, 26.2. 
HRMS (ESI): calcd. for C9H12NaO5 [M+Na]
+: 223.0577; found: 223.0571. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2981, 2897, 2730, 1724, 1442, 1370 1215, 1112, 1036, 970, 951. 
 
 
Synthesis of alkene 3.112: To a solution of alcohol 3.111 (1.60 g, 9.29 mmol, 1 equiv) in 
tetrahydrofuran (40 mL) was added sodium hydride (60% in mineral oil, 446 mg, 11.1 mmol, 
1.20 equiv). The resulting mixture was stirred for 15 min, before benzyl bromide (1.21 mL, 
10.2 mmol, 1.10 equiv) and tetrabutylammonium iodide (343 mg, 929 µmol, 10.0 mol%equiv) 
were added in sequence and the resulting reaction mixture was heat to 65 °C. After 16 h, the 
reaction mixture was allowed to cool to 23 °C and excess of base was quenched by the addition of 
saturated aqueous ammonium chloride solution (100 mL) and the reaction mixture was diluted with 
diethyl ether (70 mL). The phases were separated and the aqueous phases was extracted with diethyl 
ether (3×70 mL). The combined organic phases were dried over sodium sulfate and the dried 
solution was filtered and the filtrate was concentrated. The crude product was purified by flash 
column chromatography (7% ethyl acetate in cyclohexane) to yield alkene 3.112 (2.21 g, 
8.41 mmol, 91%) as a yellow oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.30 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.38 – 7.24 (m, 5H), 5.82 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H), 5.06 – 
4.89 (m, 2H), 4.50 (s, 2H), 3.97 – 3.87 (m, 4H), 3.59 (t, J = 7.1 Hz, 2H), 2.15 (dtt, J = 9.5, 6.4, 1.5 
Hz, 2H), 2.01 (t, J = 7.1 Hz, 2H), 1.79 – 1.68 (m, 2H). 
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13
C NMR (101 MHz, CDCl3) δ 138.6, 138.6, 128.5, 127.8, 127.7, 114.4, 110.5, 73.2, 66.4, 65.1, 
37.2, 37.0, 28.2. 
HRMS (ESI): calcd. for C16H22NaO3 [M+Na]
+: 285.1461; found: 185.1459. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3066, 3029, 2953, 2877, 1716, 1641, 1496, 1478, 1453, 1366, 1305, 1208, 
1152, 1098, 1063, 996, 947, 909, 736.  
 
 
Synthesis of diol 3.113: To a solution of alkene 3.112 (1.08 g, 4.12 mmol, 1 equiv) in a mixture of 
water (5 mL), tetrahydrofuran (5 mL) and acetonitrile (5 mL) was added osmium tetroxide (4% in 
water, 650 µL, 82.3 µmol, 2.00 mol%) and N-methylmorpholine N-oxide (627 mg, 5.35 mmol, 
1.30 equiv) at 23 °C. After 16 h, the brown reaction mixture was diluted with ethyl acetate (20 mL), 
water (10 mL) and saturated aqueous thiosulfate solution (1 mL) to quench excess of N-oxide. The 
phases were separated and the aqueous phase was extracted with ethyl acetate (3×20 mL), the 
combined organic phases were dried over sodium sulfate and the filtrate was concentrated to give 
a black oil. The crude product was purified by flash column chromatography (5% methanol in 
dichloromethane) to yield diol 3.113 (1.16 g, 4.12 mmol, 95%) as a yellow oil. 
TLC (5% methanol in dichloromethane): Rf: 0.14 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 4.49 (s, 2H), 3.94 (p, J = 1.9 Hz, 4H), 3.67 (dt, 
J = 7.6, 3.7 Hz, 1H), 3.58 (t, J = 6.9 Hz, 3H), 3.42 (ddd, J = 11.1, 7.1, 4.1 Hz, 1H), 2.62 (d, J = 4.2 
Hz, 1H), 1.99 (t, J = 6.9 Hz, 2H), 1.93 (d, J = 6.1 Hz, 1H), 1.89 – 1.72 (m, 2H), 1.62 – 1.47 (m, 
2H). 
13
C NMR (101 MHz, CDCl3) δ 138.4, 128.6, 127.9, 127.8, 110.7, 73.3, 72.3, 67.0, 66.4, 65.0, 65.0, 
36.9, 33.6, 27.4. 
HRMS (ESI): calcd. for C16H24NaO5 [M+Na]
+: 319.1516; found: 319.1508. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3412, 2956, 2876, 1454, 1368, 1209, 1072, 949, 898, 740, 699.  
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Synthesis of 3.114: To a solution of alcohol 3.113 (274 mg, 925 µmol, 1 equiv) in dichloromethane 
(4.6 mL) was added DMAP (11.3 mg, 92.5 µmol, 10.0 mol%), imidazole (75.5 mg, 1.11 mmol, 
1.20 equiv) and tert-butyl(chloro)diphenylsilane (237 µL, 925 µmol, 1.00 equiv) in sequence and 
the resulting mixture was stirred at 23 °C. After 16 h, the reaction mixture was diluted with water 
(5 mL) to hydrolyze unreacted tert-butyl(chloro)diphenylsilane. The aqueous phase was extracted 
with dichloromethane (3×5 mL), the combined organic phases were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated to give a colorless oil. The crude 
product was purified by flash column chromatography on silica gel (20% ethyl acetate in hexane) 
to afford acetal 3.114 (425 mg, 795 µmol, 86%) as a colorless oil. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.26 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.65 (dq, J = 6.4, 1.7 Hz, 4H), 7.47 – 7.35 (m, 6H), 7.34 – 7.21 (m, 
5H), 4.47 (s, 2H), 3.90 (s, 4H), 3.69 (qd, J = 6.8, 3.7 Hz, 1H), 3.62 (dd, J = 10.0, 3.6 Hz, 1H), 3.55 
(t, J = 7.1 Hz, 2H), 3.52 – 3.43 (m, 2H), 1.97 (t, J = 7.1 Hz, 2H), 1.88 – 1.78 (m, 1H), 1.70 – 1.59 
(m, 1H), 1.56 – 1.46 (m, 1H), 1.21 (t, J = 7.0 Hz, 1H), 1.06 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 138.5, 135.7, 135.7, 133.4, 133.3, 129.9, 128.5, 127.9, 127.8, 127.7, 
110.6, 73.2, 72.1, 68.1, 66.4, 65.0, 65.0, 37.1, 33.6, 27.0, 19.4, 15.4. 
HRMS (ESI): calcd. for C32H42NaO5Si [M+Na]
+: 557.2694; found: 557.2679. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3466, 3071, 2956, 2930, 2858, 1472, 1428, 1364, 1112, 823, 741, 702.  
 
 
Synthesis of diol 3.115: To a solution of acetal 3.114 (260 mg, 486 µmol, 1 equiv) in a mixture of 
ethanol (4.9 mL) and ethyl acetate (4.0 mL) was added palladium (10.0% wt on charcoal, 51.7 mg, 
48.6 µmol, 10.0 mol%) and the black reaction mixture was purged with hydrogen gas for 20 min. 
After 8 h under hydrogen atmosphere, Celite® was added and the reaction mixture was filtered over 
a pad of Celite®, the pad was washed with dichloromethane (3×10 mL) and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (20% 
ethyl acetate in hexane) to afford diol 3.116 (141 mg, 317 µmol, 65%) as a colorless oil. 
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TLC (5% methanol in dichloromethane): Rf: 0.27 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.66 (dt, J = 8.0, 1.5 Hz, 4H), 7.49 – 7.34 (m, 6H), 4.03 – 3.97 (m, 
2H), 3.97 – 3.90 (m, 2H), 3.73 (t, J = 5.7 Hz, 3H), 3.64 (dd, J = 10.1, 3.6 Hz, 1H), 3.50 (dd, J = 
10.1, 7.3 Hz, 1H), 2.70 (s, 1H), 2.59 (s, 1H), 1.92 – 1.87 (m, 2H), 1.87 – 1.80 (m, 1H), 1.65 (ddd, 
J = 14.0, 9.2, 7.6 Hz, 1H), 1.48 (ddd, J = 8.9, 7.7, 5.9 Hz, 2H), 1.07 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 135.7, 135.7, 133.3, 133.3, 130.0, 127.9, 112.2, 72.0, 68.1, 65.0, 
65.0, 59.0, 38.3, 33.1, 27.1, 27.0, 19.4. 
HRMS (ESI): calcd. for C25H36NaO5Si [M+Na]
+: 467.2224; found: 467.2218. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3406, 3070, 2955, 2930, 2889, 2857, 1472, 1428, 1391, 1361, 1112, 1077, 
948, 823, 741. 
 
 
Synthesis of lactone 3.116: To a solution of diol 3.115 (124 mg, 279 µmol, 1 equiv) in 
dichloromethane (2.8 mL) was added (diacetoxyiodo)benzene (198 mg, 614 µmol, 2.20 equiv) and 
TEMPO (4.36 mg, 27.9 µmol, 10.0 mol%) at 23 °C. After 16 h, the reaction mixture was diluted 
with saturated aqueous hydrogen carbonate solution (5 mL) and saturated aqueous thiosulfate 
solution (5 mL) to quench excess of hypervalent iodine. The phases were separated and the aqueous 
phase was extracted with dichloromethane (3×5 mL). The combined organic phases were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give an 
orange oil. The crude product was purified by flash column chromatography on silica gel (20% 
ethyl acetate in petrol ether) to afford lactone 3.116 (106 mg, 241 µmol, 86%) as a colorless oil. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.20 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.66 (dt, J = 8.0, 1.6 Hz, 4H), 7.49 – 7.35 (m, 6H), 4.38 – 4.24 (m, 
1H), 4.14 – 4.07 (m, 1H), 4.04 – 3.92 (m, 3H), 3.84 (dd, J = 10.5, 5.4 Hz, 1H), 3.61 (dd, J = 10.5, 
6.9 Hz, 1H), 3.01 (d, J = 13.7 Hz, 1H), 2.84 (dd, J = 13.7, 2.3 Hz, 1H), 2.20 – 2.09 (m, 1H), 2.06 – 
1.95 (m, 1H), 1.91 (dd, J = 13.5, 3.8 Hz, 1H), 1.87 – 1.75 (m, 1H), 1.07 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 169.4, 135.7, 135.7, 133.2, 133.2, 130.0, 130.0, 128.0, 127.9, 105.7, 
79.8, 65.7, 65.2, 64.7, 44.6, 38.1, 27.1, 27.0, 19.4. 
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HRMS (ESI): calcd. for C25H32NaO5Si [M+Na]
+: 463.1911; found: 463.1898. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3071, 2931, 1890, 1857, 1737, 1589, 1472, 1428, 1361, 1287, 1242, 1112, 
1075, 1028, 1008, 946, 823, 799, 742, 703, 612, 505. 
 
 
Synthesis of enol ether 3.134: To a solution of 1,2,5,6-di-O-isopropylidene-D-mannitol (3.133) 
(10.0 g, 38.1 mmol, 1 equiv) in dichloromethane (100 mL) was added saturated aqueous sodium 
hydrogen carbonate solution (10 mL) and sodium periodate (16.3 g, 76.3 mmol, 2.00 equiv). After 
2 h, the reaction mixture was filtered over Celite® to remove any salts. To the filtrate was added 
methyl 2-(triphenyl-l5-phosphaneylidene)acetate (38.5 g, 115 mmol, 1.50 equiv) at 0 °C. After 1 h, 
the reaction mixture was concentrated and dissolved in 30% diethyl ether in cyclohexane (400 mL). 
Precipitating triphenylphosphine oxide was removed by filtration and the filtrate was concentrated. 
The crude product was purified by flash column chromatography on silica (10% diethyl ether in 
pentane) to afford the desired (Z)-alkene PS9 (8.29 g, 44.5 mmol, 58% over two steps) and (E)-
alkene PS10 (1.62, 8.72 mmol, 11% over two steps). 
All analytical data were in agreement with the literature[139] 
To a solution of (Z)-alkene PS9 (8.29 g, 44.5 mmol, 1 equiv) in methanol (45 mL) was added 
sulfuric acid (95%, 119 µL, 2.23 mmol, 5.00 mol%) at 23 °C. After 2 h, the reaction mixture was 
concentrated and purified by flash column chromatography on silica (3% methanol in 
dichloromethane) to afford alcohol PS11 (5.08 g, 44.5 mmol, >99%) as a colorless oil. 
All analytical data were in agreement with the literature[139] 
To a solution of alcohol PS11 (5.08 g, 44.5 mmol, 1 equiv) in methanol (450 mL) was added 
palladium on charcoal (10% wt, 4.74 g, 4.45 mmol, 10 mol%) and the reaction mixture was sparged 
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with hydrogen for 20 min. After 16 h, under hydrogen atmosphere, Celite® was added and the 
reaction mixture was filtered over Celite® to give crude alcohol PS12 (5.16 g, 44.5 mmol, >99%) 
as a colorless oil, which was pure enough without further purification. 
All analytical data were in agreement with the literature[140] 
To a solution of alcohol PS12 (5.16 g, 44.5 mmol, 1.0 equiv) in dichloromethane (450 mL) was 
added imidazole (3.64 g, 53.4 mmol, 1.20 equiv) and tert-butyl(chloro)diphenylsilane (11.6 mL, 
44.5 mmol, 1.00 equiv) in sequence and the resulting mixture was stirred at 23 °C. After 16 h, the 
mixture was diluted with water (500 mL) to hydrolyze unreacted tert-butyl(chloro)diphenylsilane 
and the aqueous solution was extracted with dichloromethane (3×100 mL) and the combined 
organic phases were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated to give a colorless oil. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexane) to afford lactone 3.134 (15.6 g, 
44.0 mmol, 99%) as a colorless solid. 
All analytical data were in agreement with the literature.[141] 
To a solution of lactone 3.134 (3.13 g, 8.83 mmol, 1 equiv) in dichloromethane (88 mL) was added 
a solution of diisobutylaluminium hydride (1.00 M in dichloromethane, 17.7 mL, 17.7 mmol, 
2.00 equiv) dropwise at −78 °C. After 1 h, methanol (21 mL) and aqueous hydrogen chloride 
(1.0 M, 44 mL) were added in sequence at −78 °C and the reaction mixture was allowed to warm 
to 23 °C and diluted with saturated aqueous ammonium chloride solution (100 mL). The phases 
were separated and the aqueous phase was extracted with dichloromethane (3×50 mL). The 
combined organic phases were dried over sodium sulfate, the dried solution was filtered over 
Celite® and the filtrate was concentrated to give a pale yellow oil. The crude lactole was dissolved 
in dichloroethane (88 mL) and mesylchloride (2.06 mL, 26.5 mmol, 3.00 equiv) was added in one 
portion. The clear solution was stirred for 3 min at 23 °C before it was heated in a pre-warmed oil 
bath to 75 °C. After 3 min, triethylamine (9.20 mL, 66.2 mmol, 7.50 equiv) was added at 75 °C. 
After 3 min, the reaction mixture was allowed to cool to 23 °C, diluted with saturated aqueous 
sodium hydrogen carbonate solution (100 mL) and the phases were separated. The aqueous phase 
was extracted with diethyl ether (3×50 mL), the combined organic phases were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to give a brown oil. The 
crude product was purified by flash column chromatography on deactivated silica gel (at least 16 h 
of deactivation) (2% diethyl ether in pentane with 1% triethylamine) to afford the desired enol ether 
3.136 (1.97 g, 5.82 mmol, 66%) as a pale yellow oil. 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.42 (UV, CAM) 
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1
H NMR (400 MHz, Benzene-d6) δ 7.86 – 7.72 (m, 4H), 7.27 – 7.18 (m, 6H), 6.17 (q, J = 2.4 Hz, 
1H), 4.62 (q, J = 2.5 Hz, 1H), 4.60 – 4.49 (m, 1H), 3.76 – 3.59 (m, 2H), 2.39 – 2.19 (m, 2H), 1.18 
(s, 9H). 
13
C NMR (101 MHz, C6D6) δ 145.8, 136.1, 134.1, 130.0, 128.3, 98.9, 81.5, 66.3, 31.3, 27.1, 19.6. 
HRMS (ESI): calcd. for C21H27O2Si [M+H]
+: 339.1775; found: 339.1772. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3071, 3050, 2956, 2930, 2858, 1472, 1428, 1390, 1361, 1188, 1111, 1051, 
998, 976, 937, 823, 740, 702.  
[𝜶]𝟐𝟎
𝑫  = +52.6 (c = 1.00 in dichloromethane) 
 
 
Synthesis of cyclobutane 3.138a and 3.138b: To a solution of enol ether 3.136 (1.96 g, 5.80 mmol, 
1 equiv) in n-hexane (30.0 mL) was added 2,2-dichloroacetyl chloride (669 µL, 6.96 mmol, 
1.20 equiv) and the cloudy reaction mixture was heat to 68 °C. After 20 min, triethylamine 
(1.00 mL, 7.54 mmol, 1.30 equiv) was added dropwise at 68 °C. After 15 min, the brown 
suspension was allowed to cool to 23 °C. The reaction mixture was diluted with n-pentane (30 mL) 
and saturated aqueous hydrogen carbonate solution (30 mL) was added in sequence. The phases 
were separated and the aqueous phase was extracted with pentane (3×30 mL), the combined organic 
phases were dried over magnesium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (20% 
diethyl ether in n-pentane) to afford cyclobutane 3.138a (2.13 g, 4.74 mmol, 82%) as a colorless 
oil and cyclobutane 3.138b (469 mg, 1.04 mmol, 18%) as a colorless oil. 
less polar diastereomer 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.37 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.65 (ddd, J = 8.1, 4.4, 1.6 Hz, 4H), 7.47 – 7.34 (m, 6H), 4.89 (d, J 
= 5.9 Hz, 1H), 4.39 – 4.18 (m, 2H), 3.83 (dd, J = 11.2, 3.9 Hz, 1H), 3.74 (dd, J = 11.2, 3.9 Hz, 1H), 
2.40 – 2.26 (m, 1H), 2.06 (dt, J = 12.9, 9.7 Hz, 1H), 1.06 (s, 9H). 
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13
C NMR (101 MHz, CDCl3) δ 197.3, 135.8, 135.7, 133.3, 133.2, 130.0, 130.0, 127.9, 127.9, 87.8, 
83.3, 82.7, 64.7, 62.2, 31.1, 27.00, 19.4. 
HRMS (ESI): calcd. for C23H26Cl2NaO3Si [M+Na]
+: 471.0920; found: 471.0909. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3071, 2932, 2858, 1809, 1472, 1428, 1110, 996, 823, 742, 703.  
[𝛂]𝟐𝟎
𝐃  = +8.80 (c = 0.228 in dichloromethane) 
 
more polar diastereomer 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.26 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.73 – 7.59 (m, 6H), 7.51 – 7.33 (m, 9H), 4.78 (d, J = 5.7 Hz, 1H), 
4.41 (tt, J = 7.3, 4.9 Hz, 1H), 4.35 – 4.17 (m, 1H), 3.69 (d, J = 4.9 Hz, 2H), 2.39 (ddd, J = 13.3, 
7.1, 3.6 Hz, 1H), 2.27 (ddd, J = 13.2, 10.7, 7.4 Hz, 1H), 1.04 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 195.7, 135.6, 135.6, 133.2, 133.0, 129.8, 129.8, 127.8, 127.8, 86.1, 
83.2, 64.7, 61.3, 30.5, 26.7, 19.2. 
HRMS (ESI): calcd. for C23H26Cl2NaO3Si [M+Na]
+: 471.0920; found: 471.0909. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3072, 2934, 2856, 1810, 1472, 1428, 1110, 996, 823, 742, 703.  
[𝜶]𝟐𝟎
𝑫  = +16.0 (c = 0.500 in dichloromethane) 
 
 
Synthesis of cyclobutane 3.140: To a solution of a diastereomeric mixture of butanone 3.138 
(211 mg, 469 µmol, 1 equiv) in methanol (4.70 mL) was added zinc (307 mg, 4.69 mmol, 
10.0 equiv) and ammonium chloride (201 mg, 3.76 mmol, 8.00 equiv) in sequence at 23 °C. After 
16 h, the reaction mixture was filtered over Celite® and concentrated to a volume of approximately 
1 mL and the crude product was purified by flash column chromatography on silica gel (30% 
diethyl ether in pentane) to afford cyclobutane 3.140 (50.2 mg, 132 µmol, 28%, d.r. 1.8:1) as a 
colorless oil and chloride 3.139 (14.2 mg, 34.3 µmol, 7%) as a colorless oil.  
major diastereomer of 3.140 
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TLC (20% ethyl acetate in cyclohexane): Rf: 0.21 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.74 – 7.61 (m, 4H), 7.49 – 7.33 (m, 6H), 4.94 – 4.84 (m, 1H), 4.82 
(dd, J = 5.2, 4.0 Hz, 1H), 4.36 (tt, J = 7.3, 5.0 Hz, 1H), 3.93 – 3.82 (m, 1H), 3.81 – 3.73 (m, 1H), 
3.71 (dd, J = 7.0, 5.0 Hz, 2H), 2.37 (ddd, J = 12.9, 7.2, 2.9 Hz, 1H), 2.29 – 2.14 (m, 1H), 1.05 (s, 
9H). 
13
C NMR (101 MHz, CDCl3) δ 203.0, 135.8, 133.3, 129.8, 127.8, 85.4, 74.7, 65.0, 62.8, 61.4, 31.1, 
26.9, 19.3. 
HRMS (ESI): calcd. for C23H28NaO3Si [M+Na]
+: 403,1700; found: 403.1699. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3071, 2931, 2858, 1801, 1650, 1611, 1472, 1428, 1389, 1253, 1112, 997, 823, 
741, 703. 
 
Mono chloro cyclobutane 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.32 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.74 – 7.59 (m, 4H), 7.49 – 7.33 (m, 6H), 5.04 (t, J = 5.8 Hz, 1H), 
4.84 (dd, J = 6.1, 4.6 Hz, 1H), 4.23 (ddt, J = 9.7, 5.8, 4.0 Hz, 1H), 3.95 (dddd, J = 9.3, 6.0, 4.6, 1.1 
Hz, 1H), 3.83 (dd, J = 11.0, 4.2 Hz, 1H), 3.77 (dd, J = 11.0, 3.9 Hz, 1H), 2.34 (ddt, J = 12.6, 5.7, 
1.0 Hz, 1H), 2.03 (dt, J = 12.6, 9.4 Hz, 1H), 1.06 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 205.2, 135.8, 135.7, 133.4, 133.4, 129.9, 129.9, 127.9, 127.9, 81.9, 
74.1, 65.1, 64.0, 63.1, 32.1, 27.0, 19.4. 
HRMS (ESI): calcd. for C23H27ClNaO3Si [M+Na]
+: 437.1310; found: 437.1310. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3071, 2930, 2858, 1794, 1472, 1428, 1390, 1213, 1105, 992, 935, 823, 742, 
703. 
 
 
Synthesis of aldehyde 3.166: To a solution of aldehyde PS13 (1.10 g, 7.23 mmol, 1 equiv) in 
dimethylformamide (2 mL) was added a solution of N-bromosuccinimide (2.00 M in 
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dimethylformamide, 7.95 mL, 15.9 mmol, 2.20 equiv) dropwise at 0 °C. The resulting mixture was 
stirred 10 min at 0 °C, before it was allowed to warm to 23 °C. After 30 min, the reaction mixture 
was diluted with diethyl ether (50 mL) and the organic phase was washed with water (2x20 mL), 
sodium thiosulfate (2x20 mL) to quench excess of  N-bromosuccinimide and the washed solution 
was dried over sodium sulfate, the dried solution was filtered and the filtrate concentrated to give 
a brown solid. The crude products was recrystallized (50% diethyl ether in cyclohexane) to afford 
aldehyde 3.165 (1.61 g, 5.19 mmol, 72%) as colorless needles. 
All analytical data were in agreement with the literature.[142] 
To a solution of aldehyde 3.165 (668 mg, 2.16 mmol, 1 equiv) in tetrahydrofuran (7.2 mL) was 
added triethylamine (480 µL, 3.45 mmol, 1.60 equiv) and bromo(methoxy)methane (293 µL, 
323 mmol, 1.50 equiv) at 0 °C and the reaction mixture was allowed to warm to 23 °C. After 5 h, 
the reaction mixture was diluted with diethyl ether (50 mL) and the organic phase was washed with 
water (3×10 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% diethyl ether in n-pentane) to afford aldehyde 3.166 (704 mg, 
1.99 mmol, 92%) as a colorless solid. 
All analytical data were in agreement with the literature.[142] 
 
 
Synthesis of ester 3.168: To a solution of ethyl 2-((tert-butyldimethylsilyl)oxy)-2-
(dimethoxyphosphoryl)acetate (974 mg, 2.98 mmol, 1.50 equiv) was added a solution of sodium 
bis(trimethylsilyl)amide (1.00 M in tetrahydrofuran, 2.98 mL, 2.98 mmol, 1.50 equiv) dropwise at 
0 °C. After 20 min, a solution of aldehyde 3.166 (200 mM in tetrahydrofuran, 9.94 mL, 1.99 mmol, 
1 equiv) was added at 0 °C and after complete addition the reaction was allowed to warm to 23 °C. 
After 5 h diethyl ether (50 mL) and saturated aqueous solution of ammonium chloride solution 
(30 mL) was added to quench excess of base and the phases were separated. The aqueous phase 
was extracted with diethyl ether (3×50 mL), the combined phases were dried over sodium sulfate, 
the dried solution was filtered and the filtrate was concentrated to give a pale yellow oil. The crude 
product was purified by flash column chromatography on silica gel (5% diethyl ether in n-pentane) 
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to afford a mixture of (Z)- and (E)-silyl ether 3.167 (978 mg, 1.76 mmol, 88%, E/Z = 1.6:1.0) as a 
pale yellow oil, which was used in the next step without further purification. 
To a solution of crude alkene 3.167 (831 mg, 1.50 mmol, 1 equiv) in methanol (10 mL) was added 
triethylamine trihydrofluoride (290 µL, 1.80 mmol, 1.20 equiv). After 1 h, hydroxylamine 
hydrochloride (208 mg, 3.00 mmol, 2.00 equiv) was added at 23 °C. After 8 h, the reaction mixture 
was diluted with ethyl acetate (60 mL) and the organic phase was washed with water (3×30 mL) 
and saturated aqueous solution of sodium hydrogen carbonate (30 mL), the washed solution was 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to afford 
ester 3.169 (581 mg, 1.28 mmol, 85%) as a colorless solid, which was pure enough to use without 
further purification. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.14 (UV, CAM)  
mp: 104.6 – 112.1 °C 
1
H NMR (400 MHz, CDCl3) δ 9.34 (s, 1H), 7.23 (s, 1H), 5.14 (s, 2H), 4.29 (q, J = 7.1 Hz, 2H), 
4.06 (s, 2H), 3.86 (s, 3H), 3.65 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 163.1, 154.0, 153.5, 150.6, 131.8, 128.5, 114.7, 113.2, 100.0, 62.3, 60.7, 
58.3, 25.4, 14.2. 
HRMS (ESI): calcd. for C14H17
79Br81BrNNaO6 [M+Na]
+: 477.9294; found: 477.9264. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3295, 2981, 2939, 2874, 2846, 1722, 1466, 1426, 1403, 1374, 1300, 1208, 
1151, 1086, 1045, 1023, 975, 920.  
 
 
Synthesis of phenol 3.169: To a solution of oxime 3.168 (535 mg, 1.18 mmol, 1 equiv) in methanol 
(12 mL) was added p-toluenesulfonic acid monohydrate (2.20 mg, 11.8 µmol, 1.00 mol%). After 
16 h, the mixture was concentrated and the residue was diluted with ethyl acetate (40 mL). The 
organic phase was washed with water (30 mL), saturated aqueous sodium hydrogen carbonate 
solution (30 mL) and saturated aqueous sodium chloride solution (30 mL). The washed solution 
was dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to 
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afford phenol 3.169 (4.83 mg, 1.18 mmol, >99%) as an orange solid, which was pure enough to 
use without further purification. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.11 (UV, CAM) 
mp: 95.4 – 96.8 °C 
1
H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 7.42 (s, 1H), 4.34 (q, J = 7.1 Hz, 2H), 3.90 (s, 2H), 
3.84 (s, 3H), 1.35 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 164.1, 153.9, 151.8, 149.8, 133.7, 119.6, 107.8, 107.6, 63.0, 60.7, 
25.6, 14.1. 
HRMS (ESI): calcd. for C12H14
79Br81BrNO5 [M+Na]
+: 411.9213; found: 411.9211. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3285, 2983, 2936, 1721, 1593, 1466, 1433, 1394, 1299, 1233, 1201, 1153, 
1114, 1056, 1016, 966, 908, 851, 780, 760, 728.  
 
 
Synthesis of spiro 3.170: To a solution of phenol 3.169 (200 mg, 487 µmol, 1 equiv) in acetonitrile 
(5 mL) was added (bis(trifluoroacetoxy)iodo)benzene (251 mg, 584 µmol, 1.20 equiv) at 0 °C. 
After 1 h, the reaction mixture was allowed to warm to 23 °C and the solution was diluted with 
dichloromethane (15 mL) and saturated aqueous thiosulfate (10 mL) to quench excess of 
hypervalent iodine, saturated aqueous sodium hydrogen carbonate (10 mL) and water (10 mL). The 
organic phase was separated and the aqueous phase was extracted with dichloromethane 
(3×20 mL), the combined organic phases were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (30% diethyl ether in n-pentane) to afford spiro 3.170 (414 mg, 
344 µmol, 71%) as an orange solid. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.07 (UV, CAM) 
mp: 124.6 – 126.8 °C 
1
H NMR (400 MHz, CDCl3) δ 6.77 (s, 1H), 4.36 (q, J = 7.2 Hz, 2H), 4.17 (s, 3H), 3.61 (d, J = 17.8 
Hz, 1H), 3.29 (d, J = 17.9 Hz, 1H), 1.37 (t, J = 7.1 Hz, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 188.9, 163.3, 159.4, 150.3, 136.2, 120.9, 106.9, 86.9, 62.8, 62.3, 
44.7, 14.2. 
HRMS (ESI): calcd. for C12H13
79Br81Br NNaO6 [M+Na+H2O]
+: 449.8981; found: 449.8778. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3059, 2983, 2942, 1721, 1681, 1602, 1546, 1446, 1379, 1326, 1289, 1289, 
1238, 1129, 991, 947, 900, 831, 776, 741.  
 
 
Synthesis of epoxide 3.181: To a solution of phenol 3.180 (50.0 mg, 160 µmol, 1 equiv) in 
tetrahydrofuran (1 mL) and aqueous hydrogen chloride (1.0 M, 0.10 mL) was added a aqueous 
solution of hydrogen chloride (1.0 M, 0.70 mL) and sodium periodate (500 mM in water, 2.56 mL, 
1.28 mmol, 8.00 equiv) at 23 C. After 1 ×The crude product was purified by flash column 
chromatography (40% diethyl ether in pentane) to yield epoxide 3.181 (29.5 mg, 81.0 µmol, 59%) 
as an orange solid. 
NOTE: compound was found to be instable on silica gel, high temperature and decomposed over 
time (weeks) 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.26 (UV, CAM) 
mp: >48.6 °C (decomposition) 
1
H NMR (400 MHz, CDCl3) δ 6.54 (s, 1H), 4.13 (s, 3H), 3.43 (d, J = 8.0 Hz, 1H), 3.26 (d, J = 7.9 
Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 187.2, 164.5, 138.3, 119.9, 110.9, 61.9, 59.3, 57.6. 
HRMS (ESI): no mass was obtained for this compound. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3521, 3088, 3062, 3029, 3002, 2944, 1760, 1706, 1655, 1626, 1568, 1475, 
1402, 1383, 1285, 1246, 1195, 1093, 1053, 975, 935, 899, 790, 738, 700.  
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Synthesis of epoxide 3.187: To a solution of sodium periodate (1.06 g, 4.97 mmol, 3.10 equiv) in 
water (16 mL) was added a solution of phenol 3.180 (500 mg, 1.60 mmol, 1 equiv) and N-benzyl-
N,N,N-triethylammonium chloride (37.0 mg, 0.160 mmol, 10.0 mol%) in dichloromethane 
(12 mL) at 0 °C. After 1 h, a solution of benzyl hydroxycarbamate (466 mg, 2.80 mmol, 
1.70 equiv) in dichloromethane (8.5 mL) was added over 2 h via syringe pump, maintaining the 
reaction temperature at 0 °C. After complete addition, the reaction was stirred for 1.5 h at 0 °C, 
before the phases were separated and the aqueous phase was extracted with dichloromethane 
(3×20 mL). The combined organic phases were washed with sat aqueous sodium chloride solution 
(20 mL), the washed solution was dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated (Note: the rotary evaporation water bath was maintained at temperature 
below 20 °C). The crude product was purified via flash chromatography on silica gel (gradient 10% 
to 50% of EtOAc in n-pentane). The solvent was removed under reduced pressure, mantaining the 
temperature below 20 °C. (Note complete concentration lead to complete decomposition) The 
material was directly used in the next step. 
To a solution of crude epoxide 3.195 in tetrahydrofuran (16 mL) was added molecular sieves (4 Å, 
1 g) and sodium borohydride (20.0 mg, 529 µmol, 0.33 equiv) at 0 °C. After 1 h, the reaction 
mixture was diluted with sat aqueous ammonium chloride solution (20 mL) and dichloromethane 
(20 mL). The phases were separated and the aqueous phase was extracted with dichloromethane 
(3×20 mL), the combined organic phases were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography (40% diethyl ether in pentane) to yield epoxide 3.187 (482 mg, 1.01 mmol, 63%) 
as a yellow oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.19 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.46 – 7.31 (m, 5H), 5.31 – 5.16 (m, 2H), 4.45 (s, 1H), 3.88 (s, 3H), 
3.82 (s, 1H), 3.21 (d, J = 4.4 Hz, 1H), 2.99 (d, J = 4.3 Hz, 1H), 2.83 (s, 1H). 
13
C NMR (101 MHz, CDCl3) δ 157.7, 151.6, 135.1, 128.8, 128.7, 95.8, 93.3, 70.4, 69.2, 65.8, 61.4, 
60.5, 56.5, 52.4. 
HRMS (ESI): calcd. for C16H15
79Br81BrNNaO6 [M+Na]
+: 499.9138; found: 499.9043. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3459, 2928, 2852, 1726, 1633, 1534, 1498, 1455, 1386, 1279, 1231, 1150, 
1043, 964, 775, 699.  
 
 
Synthesis of carbonate 3.189: To a solution of epoxide 3.187 (99.2 mg, 0.208 mmol, 1 equiv) was 
added lithium bromide (90.4 mg, 1.04 mmol, 5.0 equiv.) in dichloromethane (1.0 mL) at 0 °C. 
After 30 min, the reaction mixture was allowed to warm to 23 °C. After 1 h, the reaction mixture 
was diluted with water (5 mL) and ethyl acetate (5 mL). The phases were separated and the aqueous 
phase was extracted with ethyl acetate (3×5 mL), the combined organic phases were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product 
was purified by flash column chromatography (25% ethyl acetate in n-pentane) to yield carbonate 
3.189 (53.8 mg, 120 µmol, 47%) as a colorless solid. 
Crystals obtained by Dr. Gabriele Prina Cerai were good enough for X-ray analysis. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.11 (CAM) 
mp: 126.4 – 134.3 °C (decomposition) 
1
H NMR (400 MHz, Methylene Chloride-d2) δ 6.14 (s, 1H), 4.48 (s, 1H), 4.24 (s, 1H), 4.07 (s, 3H), 
3.77 (s, 1H), 3.55 (d, J = 12.0 Hz, 1H). 
13
C NMR (101 MHz, Methylene Chloride-d2) δ 151.9, 150.4, 92.7, 89.1, 81.2, 80.8, 65.13, 61.9, 
34.9. 
HRMS (ESI): calcd. for C9H8
79Br2
81BrNNaO5 [M+Na]
+: 471.7824; found: 471.7847. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3228, 2971, 1794, 1626, 1452, 1425, 1401, 1356, 1258, 1163, 1103, 1062, 
987, 903, 823, 790, 764, 747.  
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Synthesis of enol ether 3.214: To a solution of α-D-xylose (3.211) (25.0 g, 167 mmol, 1 equiv) in 
pyridine (120 mL) was added DMAP (12.0 g, 16.7 mmol, 10 mol%) and acetic anhydride (120 mL, 
1.30 mol, 8.00 equiv) in sequence at 0 °C and the resulting yellow mixture was allowed to warm to 
23 °C. After 16 h, the reaction mixture was diluted with ethyl acetate (500 mL) and washed with 
water (200 mL), saturated sodium bicarbonate solution (5x200 mL), aqueous hydrochloric acid 
(1.00 M, 5×200 mL), water (200 mL) and saturated aqueous sodium chloride solution (200 mL). 
The washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate 
was concentrated to give a yellow oil (50.3 g, 158 mmol, 95%) (50.8 g, 160 mmol, 96%), which 
was pure enough and used without further purification. 
All analytical data matches with the literature.[143] 
Traces of water were removed by co-evaporation with toluene and PS13 was dissolved in 
dichloromethane (300 mL). A solution of hydrogen bromide in acetic acid (150 mL, 790 mmol, 
5.00 equiv) was added dropwise over 1 h at 0 °C. After complete addition, the reaction mixture was 
stirred for further 5 min at 0 °C, before the orange reaction mixture was diluted with 
dichloromethane (150 mL) and ice cold water (300°mL). The phases were separated, the aqueous 
phase was extracted with dichloromethane (3×150 mL) and the combined organic phases were 
washed with saturated sodium bicarbonate solution (250 mL). The washed solution was dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give a colorless 
liquid. Traces of water were removed by co-evaporation with toluene. The crude bromide PS13 
was directly used in the next step without further purification. 
To a suspension of zinc (61.9 g, 947 mmol, 6.00 equiv) in tetrahydrofuran (750 mL) was added 
1-methylimidazole (12.7 mL, 160 mmol, 1.01 equiv). After 15 min, a solution of crude bromide 
PS13 in tetrahydrofuran (350 mL) was added and the reaction mixture was heated to 68 °C. After 
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1 h, the reaction mixture was filtered through Celite® and the filtrate was concentrated. The crude 
product was purified by flash column chromatography (40% diethyl ether in n-pentane) to give the 
cyclic enol ether 3.212 as a pale yellow oil (20.3 g, 10.0 mmol, 64% over 2 steps). 
All analytical data matches with the literature.[143] 
To a solution of bis-acetate 3.212 (20.2 g, 101 mmol, 1 equiv) in methanol (500 mL) was added 
potassium carbonate (8.38 g, 60.6 mmol, 60.0 mol%) at 23 °C. After 2 h, the reaction mixture was 
concentrated and the residue was purified by flash column chromatography (10% methanol in 
dichloromethane) to yield diol 3.213 as a yellow oil (11.7 g, 101 mmol, >99%). 
All analytical data matches with the literature.[144] 
To a solution of diol 3.213 (10.2 g, 87.8 mmol, 1 equiv) in N,N-dimethyl formamide (400 mL), was 
added sodium hydride (12.0 g, 307 mmol, 3.50 equiv) at 0 °C. After 30 min, benzyl bromide 
(35.4 mL, 299 mmol, 3.40 equiv) was added dropwise. After complete addition, the reaction 
mixture was allowed to warm to 23 °C. After 2 h, the brownish reaction mixture was diluted with 
dichloromethane (100 mL) and the excess of sodium hydride was quenched by the addition of water 
(1.00 L). The aqueous phase was extracted with dichloromethane (3×150 mL). The combined 
organic phases were washed with aqueous lithium chloride solution (1.00 M, 200 mL). The washed 
solution was dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated to give an orange oil. The crude product was purified by flash column chromatography 
(15% diethyl ether in n-pentane) to yield the enol ether 3.214 as a slightly orange oil (23.7 g, 
79.9 mmol, 91%). 
All analytical data matches with the literature.[144] 
 
 
Synthesis of cyclopropane 3.215: To a solution of enol ether 3.214 (20.0 g, 1.00 equiv, 67.4 mmol) 
in diethyl ether (450 mL) was added a solution of diethyl zinc (1.00 M in hexane, 47.5 mL, 
47.5 mmol, 3.00 equiv) and diiodomethane (3.83 mL, 47.5 mmol, 3.00 equiv) in sequence at 0 °C. 
After 3 h, the excess of diethyl zinc was quenched by the addition of saturated ammonium chloride 
solution (100 mL) at 0 °C. The phases were separated and the aqueous phase was extracted with 
diethyl ether (3×100 mL). The combined organic phases were washed with saturated aqueous 
sodium chloride solution (100 mL), the washed solution was dried over sodium sulfate, the dried 
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solution was filtered and the filtrate was concentrated to give an orange oil. The crude product was 
purified by flash column chromatography (10% diethyl ether in n-pentane) to yield cyclopropane 
3.215 (20.6 g, 66.2 mmol, 98%) as a pale yellow oil. 
TLC (10% ethyl acetate in cyclohexane) Rf: 0.23 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.23 (m, 10H), 4.83 (d, J = 11.8 Hz, 1H), 4.73 (d, J = 11.7 
Hz, 1H), 4.65 (d, J = 11.7 Hz, 1H), 4.62 (d, J = 11.7 Hz, 1H), 4.08 (t, J = 7.2 Hz, 1H), 3.77 (ddd, J 
= 6.8, 5.6, 3.1 Hz, 1H), 3.62 (dd, J = 10.7, 4.1 Hz, 1H), 3.39 (ddd, J = 10.9, 7.1, 4.1 Hz, 1H), 3.17 
(t, J = 10.6 Hz, 1H), 1.37 (dq, J = 9.9, 7.1 Hz, 1H), 0.81 – 0.70 (m, 2H). 
13
C NMR (101 MHz, CDCl3) δ 138.8, 138.6, 128.5, 127.9, 127.8, 127.8, 127.7, 77.9, 77.4, 72.9, 
70.5, 66.5, 55.8, 15.8, 11.8. 
HMRS (ESI) calcd. for C20H22NaO9 [M+Na]
+: 333.1461; found 333.1454 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3028, 2863, 1496, 1454, 1373, 1317, 1214, 1182, 1154, 1073, 1028, 994, 911, 
858, 735, 698, 607, 456. 
[𝛂]𝟐𝟎
𝐃  = −46.4 (c = 0.300 in chloroform) 
 
 
Synthesis of diol PS15: To a solution of cyclopropane 3.215 (4.44 g, 14.3 mmol, 1 equiv) in 
methanol (150 mL) was added palladium (10.0 wt on activated charcoal, 1.50 g, 1.43 mmol, 
10.0 mol%) and the reaction mixture was purged with hydrogen gas for 20 min. After 16 h under 
hydrogen atmosphere, Celite® was added and the black reaction mixture was filtered over Celite®, 
washed with a mixture of 10% methanol in dichloromethane (3×100 mL) and the filtrate was 
concentrated. The crude product was purified by column chromatography on silica-gel (8% 
methanol in dichloromethane) to yield the diol PS15 (1.82 g, 14.0 mmol, 98%). as a colorless solid. 
TLC (10% methanol in dichloromethane) Rf: 0.22 (CAM) 
mp: 96.3 – 97.5 °C 
1
H NMR (400 MHz, CDCl3) δ 4.05 (dd, J = 8.0, 6.9 Hz, 1H), 3.80 – 3.68 (m, 1H), 3.59 (s, 2H), 
3.53 (dd, J = 10.5, 4.0 Hz, 1H), 3.40 (ddd, J = 10.5, 8.0, 4.0 Hz, 1H), 3.17 (t, J = 10.5 Hz, 1H), 1.48 
– 1.34 (m, 1H), 0.72 (dd, J = 8.1, 3.8 Hz, 2H). 
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13
C NMR (101 MHz, CDCl3) δ 72.1, 71.6, 68.6, 55.3, 29.8, 18.6, 11.9. 
HMRS (ESI) calcd. for C6H10NaO3 [M+Na]
+: 153.0522; found 153.0519 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3403, 3026, 2933, 2865, 1468, 1423, 1388, 1256, 1213, 1162, 1108, 1090, 
1061, 1048, 1011, 976, 892, 853, 751, 699, 599. 
[𝛂]𝟐𝟎
𝐃  = −82.4 (c = 1.35 in chloroform) 
 
 
Synthesis of bis-acetate 3.209: To a solution of diol 3.215 (1.80 g, 13.9 mmol, 1 equiv) in 
dichloromethane (15 mL) was added pyridine (5.60 mL, 69.3 mmol, 5.00 equiv), DMAP (169 mg, 
1.39 mmol, 10 mol%) and acetic anhydride (5.24 mL, 55.5 mmol, 4.00 equiv) in sequence at 0 °C 
and the reaction mixture was allowed to warm to 23 °C. After 3 h, the reaction mixture was diluted 
with ethyl acetate (100 mL) and the organic phase was washed with water (50 mL), saturated 
aqueous sodium bicarbonate solution (3×50 mL), water (50 mL), aqueous hydrochloric acid 
(1.0 M, 3×50 mL), water (50 mL) and brine (50 mL). The washed solution was dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was 
purified by flash column chromatography (10% diethyl ether in n-pentane) to yield acetate 3.209 
(2.96 g, 13.8 mmol, quant.) a pale yellow oil. 
TLC (5% ethyl acetate in cyclohexane) Rf = 0.31 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 5.39 – 5.25 (m, 1H), 4.75 (ddd, J = 10.5, 8.1, 4.3 Hz, 1H), 3.78 
(ddd, J = 6.8, 5.6, 3.0 Hz, 1H), 3.63 (dd, J = 10.6, 4.3 Hz, 1H), 3.25 (t, J = 10.5 Hz, 1H), 2.09 (s, 
3H), 2.04 (s, 3H), 1.67 – 1.52 (m, 1H), 0.95 – 0.69 (m, 2H). 
13
C NMR (101 MHz, CDCl3) δ 171.1, 170.2, 71.2, 70.0, 65.6, 55.4, 21.3, 21.1, 15.8, 12.3. 
HMRS (ESI) calcd. for C10H14NaO5 [M+Na]
+: 237.0733; found 273.0729 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 1732, 1438, 1370, 1227, 1191, 1156, 1075, 1030, 920, 852, 813, 760, 605, 
506. 
[𝛂]𝟐𝟎
𝐃  = −88.4 (c = 0.700 in chloroform) 
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Synthesis of nitrile 3.210: To a solution of acetate 3.209 (2.94 g, 13.7 mmol, 1.00 equiv) in 
acetonitrile (68 mL) was added trimethyl-silyl-cyanide (9.20 mL, 69.0 mmol, 5.00 equiv) in one 
portion and trimethyl-silyl-triflate (740 µL, 4.10 mmol, 30.0 mol%) dropwise at −40 °C. After 
2.5 h, excess of Lewis acid was quenched by the addition of saturated aqueous sodium hydrogen 
carbonate solution (50 mL) and the phases were separated. The aqueous phase was extracted with 
diethyl ether (3×150 mL), the combined organic phases were dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The crude product was purified by flash 
column chromatography (40% diethyl ether in n-pentane) to give nitrile 3.210 (2.05 g, 11.3 mmol, 
82%, d.r. 1:1) as a pale yellow oil. 
A analytical sample was purified by HPLC chromatography (5% ethyl acetate in n-hexane grading 
to 25% ethyl acetate in n-hexane in 60 min) to separate both diasteromers. 
less polar diastereomer 
TLC (20% ethyl acetate in cyclohexane) Rf = 0.23 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 5.94 – 5.79 (m, 2H), 5.47 – 5.35 (m, 1H), 4.66 (dd, J = 8.3, 3.8 Hz, 
1H), 4.10 (dd, J = 13.0, 2.9 Hz, 1H), 3.85 – 3.69 (m, 1H), 2.84 – 2.62 (m, 2H), 2.09 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 170.2, 132.7, 127.3, 117.4, 71.8, 69.2, 67.7, 33.8, 21.1. 
HMRS (ESI) calcd. for C9H12NNaO3 [M+Na]
+: 204.0631; found 204.0628. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2930, 1735, 1372, 1236, 1108, 1039, 952, 700. 
[𝛂]𝟐𝟎
𝐃  = +2.7 (c = 0.85 in dichloromethane) 
 
more polar diastereomer 
TLC (20% ethyl acetate in cyclohexane) Rf = 0.22 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 5.94 (dd, J = 11.9, 4.1 Hz, 1H), 5.90 – 5.82 (m, 1H), 5.49 – 5.38 
(m, 1H), 4.68 (dd, J = 6.4, 3.6 Hz, 1H), 4.00 (dd, J = 12.6, 7.4 Hz, 1H), 3.80 (dd, J = 12.6, 3.1 Hz, 
1H), 2.82 – 2.63 (m, 2H), 2.10 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 170.2, 133.9, 126.5, 117.1, 71.8, 71.5, 68.7 67.3, 34.0, 21.1. 
HMRS (ESI) calcd. for C9H12NNaO3 [M+Na]
+: 204.0631; found 204.0628. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2930, 1736, 1372, 1236, 1108, 1039, 952, 700. 
[𝛂]𝟐𝟎
𝐃  = +6.6 (c = 1.7 in dichloromethane)  
 
 
Synthesis of ketone 3.216: To a solution of alcohol 3.221 (230 mg, 1.65 mmol, 1 equiv) in 
dichloromethane (17 mL) was added Dess−Martin periodate (1.75 g, 4.13 mmol, 2.00 equiv) and 
sodium hydrogen carbonate (417 mg, 4.96 mmol, 3.00 equiv) After 4 h, saturated aqueous 
thiosulfate (20 mL) and saturated aqueous sodium hydrogen carbonate (20 mL) were added to 
quench excess of Dess−Martin periodate. The phases were separated and the aqueous phase was 
extracted with dichloromethane (3×10 mL), the combined organic phases were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was 
purified by column chromatography (40% diethyl ether in n-pentane) to afford ketone 3.216 
(155 mg, 1.13 mmol, 68%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.15 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.52 (ddd, J = 12.2, 6.0, 4.1 Hz, 1H), 6.22 – 6.05 (m, 1H), 4.66 (dd, 
J = 9.9, 3.9 Hz, 1H), 4.46 (d, J = 18.2 Hz, 1H), 4.33 (d, J = 18.1 Hz, 1H), 3.08 (dddd, J = 18.7, 9.9, 
4.2, 2.4 Hz, 1H), 2.99 – 2.87 (m, 1H). 
13
C NMR (101 MHz, CDCl3) δ 20010, 139.5, 132.2, 116.7, 76.3, 66.7, 36.9. 
HRMS (ESI): calcd. for C7H9NNaO3 [M+H2O+Na]
+: 178.0475; found: 178.0461 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3482, 2928, 1721, 1663, 1397, 1346, 1277, 1120.  
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Synthesis of ketone 3.217: To a solution of nitrile 3.216 (3.0 mg, 22 µmol. 1 equiv) in 
dichloromethane (0.20 mL) was added iodine (6.7 mg, 26 µmol, 1.2 equiv), DMAP (0.3 mg, 
2.2 µmol, 10 mol%) and pyridine (2.6 µL, 33 mmol, 1.5 equiv) at 23 °C. After 24 h, the reaction 
mixture was concentrated and the crude product was purified by flash column chromatography 
(30% diethyl ether in pentane) to yield nitrile 3.217 (1.5 mg, 11 µmol, 51%) as a yellow oil. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.15 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 6.72 (dd, J = 12.0, 8.0 Hz, 1H), 6.59 (dd, J = 11.9, 0.7 Hz, 1H), 6.22 
(dd, J = 8.0, 0.7 Hz, 1H), 4.59 (d, J = 0.5 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 191.3, 137.9, 135.6, 134.5, 119.1, 114.4, 78.5. 
HRMS (ESI): calcd. for C7H6NO2 [M+H]
+: 136.0393; found: 136.0219. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2963, 2926, 2850, 1734.  
 
 
Synthesis of alcohol 3.221: To a solution of acetate 3.220 (250 mg, 1.40 mmol, 1 equiv) in 
dichloromethane (6 mL) was added sulfuric acid (80.0 µL, 1.40 mmol, 1.00 equiv) at 23 °C. After 
16 h, excess of acid was quenched with saturated sodium bicarbonate solution (10 mL) and the 
mixture was extracted with dichloromethane (3×10 mL). The combined organic phases were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to afford 
alcohol 3.221 (160 mg, 930 µmol, 68%, d.r. 1:1) as a pale yellow oil, which was pure enough to 
use without further purification.  
Mixture of diastereomers 
TLC (5% methanol in dichloromethane) Rf = 0.25 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.07 – 5.98 (m, 1H), 5.98 – 5.90 (m, 1H), 5.89 – 5.69 (m, 2H), 4.67 
(dd, J = 6.4, 3.7 Hz, 1H), 4.60 (dd, J = 9.3, 3.4 Hz, 1H), 4.49 – 4.31 (m, 2H), 4.09 (ddd, J = 12.7, 
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3.0, 0.7 Hz, 1H), 3.95 (dd, J = 12.5, 7.2 Hz, 1H), 3.80 (ddd, J = 12.5, 3.0, 0.8 Hz, 1H), 3.73 – 3.60 
(m, 1H), 2.85 – 2.57 (m, 4H), 1.92 (s, 2H). 
13
C NMR (101 MHz, CDCl3) δ 137.5, 136.7, 124.9, 124.7, 117.8, 117.4, 72.0, 71.5, 70.5, 70.4, 
67.9, 67.4, 33.8, 33.7. 
HMRS (ESI) calcd. for C7H9NNaO2 [M+Na]
+: 162.0525; found 162.0525 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3406, 2924, 1981, 1426, 1217, 1128, 1047, 934, 878, 755, 703. 
 
 
Synthesis of enone 3.222: A solution of alcohol 3.221 (160 mg, 1.20 mmol, 1 equiv) in 
dichloromethane (11 mL) was added bromine (77.0µL, 1.50 mmol, 1.30 equiv) at 0 °C and the red-
brown reaction mixture was allowed to warm to 23 °C. After 2 h, excess of bromine was quenched 
by the addition of saturated aqueous sodium sulfite solution (10 mL) and the phases were separated. 
The aqueous phase was extracted with dichloromethane (3×10 mL). The combined organic phases 
were dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. 
The residue was dissolved in dichloromethane (14 mL) and pyridinium chlorochromate (340 mg, 
1.60 mmol, 1.70 equiv), molecular sieves (4.00 g) and anhydrous sodium acetate (78.0 mg, 
950 µmol, 1.00 equiv) were added in sequence at 23 °C. After 16 h, the brown reaction mixture 
was diluted with diethyl ether (10 mL) and the formed precipitate was removed by filtration through 
a plug of Celite® and the yellow filtrate was concentrated to afford a brown oil. The crude product 
was purified by flash column chromatography (40% diethyl ether in n-pentane) to yield ketone 
3.222 (180 mg, 810 µmol, 85% over two steps) as a yellow oil. 
TLC (7% methanol in dichloromethane) Rf: 0.48 (UV, KMnO4) 
1
H NMR (400 MHz, CDCl3) δ: 7.19 (dd, J = 7.8, 5.6 Hz, 1H), 4.70 (dd, J = 10.0, 5.2 Hz, 1H), 4.47 
(d, J = 7.3 Hz, 2H), 3.09 - 2.87 (m, 2H). 
13
C NMR (101 MHz, CDCl3) δ 194.4, 138.5, 127.9, 116.7, 72.6, 64.3, 34.1. 
HMRS (ESI) calcd. for C7H6BrNNaO2 [M+Na]
+: 237.9474; found 237.9470 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3506, 2926, 1691, 1604, 1423, 1341, 1188, 1110, 1051, 959, 938, 894, 853, 
811, 689, 512, 488. 
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Synthesis of nitrile 3.224: To a solution of alcohol 3.221 (154 mg, 1.11 µmol, 1 equiv) in 
dichloromethane (10 mL) was added DMAP (13.5 mg, 111 µmol, 10.0 mol%), imidazole 
(90.4 mg, 1.33 mmol, 1.20 equiv) and tert-butyldimethylsilyl chloride (175 mg, 1.16 mmol, 
1.05 equiv) in sequence and the resulting mixture was stirred at 23 °C. After 16 h, the mixture was 
diluted with water (30 mL) to hydrolyze unreacted tert-butyldimethylsilyl chloride and the aqueous 
phase was extracted with dichloromethane (3×10 mL) and the combined organic phases were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give a 
colorless oil. The crude product was purified by flash column chromatography on silica gel (10% 
ethyl acetate in cyclohexane) to afford nitrile 3.226 (239 mg, 942 µmol, 85%, d.r. 1:1) as a colorless 
oil. 
Mixture of diastereomers 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.33 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 5.96 (dtd, J = 11.4, 2.8, 1.2 Hz, 1H), 5.86 (dtd, J = 11.8, 2.6, 1.2 
Hz, 1H), 5.75 – 5.61 (m, 2H), 4.75 (dd, J = 5.0, 3.7 Hz, 1H), 4.51 – 4.41 (m, 2H), 4.40 (dd, J = 
10.2, 2.4 Hz, 1H), 3.92 (ddd, J = 12.0, 3.9, 1.2 Hz, 1H), 3.81 (dd, J = 12.1, 9.4 Hz, 1H), 3.70 (ddd, 
J = 12.1, 3.9, 1.3 Hz, 1H), 3.42 (dd, J = 12.0, 8.8 Hz, 1H), 2.83 – 2.64 (m, 2H), 2.64 – 2.46 (m, 
2H), 0.89 (d, J = 2.4 Hz, 18H), 0.16 – 0.02 (m, 12H). 
13
C NMR (101 MHz, CDCl3) δ 141.7, 139.9, 123.6, 122.3, 118.0, 117.0, 74.4, 71.2, 71.1, 70.4, 
68.5, 66.1, 35.0, 33.7, 25.9, 18.2, -4.8, -4.7, -4.7, -4.7. 
HRMS (ESI): calcd. for C13H23NNaO2Si [M+Na]
+: 276.1390; found: 276.1390. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3037, 2955, 2930, 2886, 2857, 1472, 1426, 1399, 1361, 1323, 1253, 1218, 
1090, 1006, 939, 912, 835, 776, 700.  
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Synthesis of diol 3.225: To a solution of alkene 3.224 (102 mg, 402 µmol, 1 equiv) in water (2 mL), 
tetrahydrofuran (2 mL) and acetonitrile (2 mL) was added osmium tetroxide (4% in water, 158 µL, 
20.1 µmol, 5.00 mol%) and N-methylmorpholine N-oxide (61.3 mg, 5.23 µmol, 1.30 equiv). After 
16 h, the reaction mixture was diluted with ethyl acetate (15 mL), water (10 mL) and saturated 
aqueous thiosulfate solution (1 mL) to quench excess of N-oxide. The phases were separated and 
the aqueous phase was extracted with ethyl acetate (3×15 mL), the combined organic phases were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give 
a black oil. The crude product was purified by flash column chromatography (5% methanol in 
dichloromethane) to yield diol 3.226 (103 mg, 359 µmol, 89% (mixture of several diols)) as a 
yellow oil. 
The two major diastereomers are characterized 
More polar diastereomer 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.07 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 4.80 (dd, J = 8.3, 5.8 Hz, 1H), 4.18 (t, J = 9.0 Hz, 1H), 4.06 – 3.98 
(m, 1H), 3.83 – 3.77 (m, 1H), 3.73 (dd, J = 4.8, 1.9 Hz, 2H), 2.90 (d, J = 9.1 Hz, 1H), 2.79 (d, J = 
6.4 Hz, 1H), 2.58 (ddd, J = 15.0, 8.4, 5.8 Hz, 1H), 2.10 (ddd, J = 15.0, 8.4, 2.2 Hz, 1H), 0.91 (s, 
9H), 0.14 (s, 3H), 0.12 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 118.6, 74.6, 73.3, 70.7, 67.3, 64.3, 34.9, 25.8, 18.1, -4.6, -4.9. 
HRMS (ESI): calcd. for C13H25NNaO4Si [M+Na]
+: 310.1445; found: 310.1438. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3397, 2955, 2930, 2895, 2858, 1768, 1471, 1253, 1107, 1045, 893, 838, 780, 
671.  
 
Less polar diastereomer 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.07 (CAM) 3 MeOH  
1
H NMR (400 MHz, CDCl3) δ 4.69 (dd, J = 10.9, 4.3 Hz, 1H), 4.28 (dt, J = 6.6, 2.4 Hz, 1H), 3.91 
(td, J = 8.2, 4.3 Hz, 1H), 3.82 (dd, J = 12.7, 4.3 Hz, 1H), 3.68 – 3.56 (m, 2H), 2.64 – 2.56 (m, 1H), 
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2.43 (d, J = 8.2 Hz, 1H), 2.35 (ddd, J = 15.1, 6.6, 4.2 Hz, 1H), 2.19 (ddd, J = 15.1, 10.9, 2.3 Hz, 
1H), 0.90 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 118.7, 77.3, 71.4, 69.0, 68.0, 62.9, 35.0, 25.8, 18.1, -4.3, -4.7. 
HRMS (ESI): calcd. for C13H25NNaO4Si [M+Na]
+: 310.1445; found: 310.1438. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3459, 2953, 2930, 2887, 2858, 1658, 1471, 1391, 1361, 1255, 1099, 1006, 
871, 837, 778.  
 
 
Synthesis of nitrile 3.226: To a solution of nitrile 3.225 (103 mg, 359 µmol, 1 equiv) in dimethyl 
formamide (6 mL) was added sodium hydride (60% in mineral oil, 31.5 mg, 788 µmol, 2.2 equiv,) 
at 0 °C and the reaction mixture was allowed to warm to 23 °C. After 30 min, the yellow reaction 
mixture was cooled to 0 °C and methyl iodide (98.6 µL, 1.58 mmol, 4.40 equiv) was added 
dropwise at 0 °C and the reaction mixture was allowed to warm to 23 °C. After 16 h, the reaction 
mixture was diluted with diethyl ether (20 mL) and saturated aqueous solution of ammonium 
chloride (20 mL) to quench excess of base. The phases were separated and the aqueous phase was 
extracted with diethyl ether (3×10 mL). The combined organic phases were washed with water 
(20 mL), aqueous lithium chloride (1.0 M, 10 ml) and saturated aqueous sodium chloride solution 
(10 mL), the washed solution was dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated to give a yellow oil. The crude product was purified by flash column 
chromatography (30% diethyl ether in petrol ether) to yield nitrile 3.226 (108 mg, 343 µmol, 96%) 
as a colorless oil. 
Complex mixture of several diastereomers was only characterized by TLC, HRMS and IR and used 
without further purification. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.42 (CAM) 
HRMS (ESI): calcd. for C15H29NNaO4Si [M+Na]
+: 338.1758; found: 338.1755. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2954, 2930, 2895, 2895, 2857, 1464, 1361, 1254, 1100, 1025, 836, 778.  
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Synthesis of alcohol 3.227: To a solution of a mixture of nitrile 3.226 (11 mg, 34 µmol, 1 equiv) in 
tetrahydrofuran (300 µL) was added tetrabutylammonium fluoride (1.0 M in tetrahydrofuran, 
41 µL, 1.2 equiv) at 0 °C and the clear reaction mixture was allowed to warm to 23 °C. After 4 h, 
the mixture was diluted with ethyl acetate (5 mL) and water (5 mL) and the phases were separated. 
The aqueous phase was extracted with ethyl acetate (3×5 mL), the combined phases were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to give a clear 
oil. The residue was dissolved in dichloromethane and filtered over a plug of silica to remove any 
salts and the filtrate was concentrated to yield a mixture of diastereomers of alcohol 3.227 (6.8 mg, 
34 µmol, 99%) as colorless oil. 
Complex mixture of several diastereomers was only characterized by TLC, HRMS and IR and used 
without further purification. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.12 (UV, CAM) 
HRMS (ESI): calcd. for C9H15NNaO4 [M+Na]
+: 224.0893; found: 224.0888. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3456, 2925, 2855, 1734, 1463, 1249, 1194, 1098, 835.  
 
 
Synthesis of ketone 3.228: To a solution of alcohol 3.227 (6.6 mg, 33 µmol, 1 equiv) in 
dichloromethane (0.33 mL) was added Dess−Martin periodate (28 mg, 66 µmol, 2.0 equiv) and 
sodium hydrogen carbonate (8.3 mg, 98 µmol, 3.0 equiv) After 4 h, the reaction mixture was 
diluted with dichloromethane (3 mL), saturated aqueous thiosulfate (1 mL) and saturated aqueous 
sodium hydrogen carbonate (1 mL) were added to quench excess of Dess−Martin periodate. The 
phases were separated and the aqueous phase was extracted with dichloromethane (3×5 mL), the 
combined organic phases were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The crude product was purified by column chromatography (40% diethyl 
ether in n-pentane) to afford mixture of diastereomers of ketone 3.228 (5.5 mg, 28 µmol, 84%) as 
a pale yellow oil. 
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Complex mixture of several diastereomers was only characterized by TLC, HRMS and IR and used 
without further purification. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.18 (CAM) 
HRMS (ESI): calcd. for C9H13NNaO4 [M+Na]
+: 222.0737; found: 222.0734. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2960, 2930, 2874, 2856, 1732, 1462, 1244, 1099.  
 
 
Synthesis of amide 3.236: To a solution of nitrile (210 mg, 1.16 mmol, 1 equiv) in ethanol (4 mL) 
and water (1 mL) was added Ghaffar−Parkins Catalyst (49.8 mg, 116 µmol, 10.0 mol%) and the 
resulting mixture was heated to 80 °C. After 24 h, no further conversion was observed and the 
reaction mixture was allowed to cool to 23 °C and the solution was concentrated. The crude product 
was purified by flash column chromatography on silica gel (2% methanol in dichloromethane 
(100 mL) grading to 4% methanol in dichloromethane (200 mL)) to yield a mixture of 
diastereomers of amide 3.236 (140 mg, 703 µmol, 0.81 mmol, 61%) as a colorless solid and 
recovered starting material 3.220 (79.8 mg, 441 µmol, 38%). 
Mixture of diastereomers  
TLC (5% methanol in dichloromethane): Rf: 0.26 (UV, CAM) 
mp: 82.5 – 94.3 °C 
1
H NMR (400 MHz, CDCl3) δ 6.77 (s, 1H), 6.65 (s, 1H), 6.21 (d, J = 16.4 Hz, 2H), 5.98 – 5.83 (m, 
2H), 5.78 (dddt, J = 11.6, 5.9, 2.0, 0.8 Hz, 1H), 5.71 (dtd, J = 11.7, 2.9, 1.1 Hz, 1H), 5.51 – 5.43 
(m, 1H), 5.32 – 5.25 (m, 1H), 4.14 (ddd, J = 13.6, 3.2, 1.2 Hz, 1H), 4.10 – 4.03 (m, 2H), 4.00 (dd, 
J = 10.7, 2.3 Hz, 1H), 3.81 (dd, J = 13.6, 1.9 Hz, 1H), 3.53 (dd, J = 11.7, 8.8 Hz, 1H), 2.89 – 2.75 
(m, 2H), 2.66 – 2.54 (m, 1H), 2.43 (dddt, J = 17.0, 10.7, 3.6, 2.5 Hz, 1H), 2.07 (s, 3H), 2.06 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 174.4, 174.1, 170.4, 170.1, 132.5, 131.7, 128.2, 127.9, 80.5, 80.1, 
72.3, 72.3, 70.5, 70.3, 32.8, 32.0, 21.2, 21.1. 
HRMS (ESI): calcd. for C9H13NNaO4 [M+Na]
+: 222.0737; found: 222.0733. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3463, 3340, 2928, 1730, 1675, 1585, 1370, 1231, 1143, 1113, 1034, 954, 868.  
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Synthesis of amide 3.237: To a solution of nitrile 3.224 (20 mg, 79 mmol, 1 equiv) in ethanol 
(800 µL) and water (200 µL) was added Ghaffar-Parkins Catalyst (6.8 mg, 16 µmol, 10.0 mol%) 
and the resulting mixture was heat to 80 °C. After 16 h, the reaction mixture was allowed to cool 
to 23 °C and the solution was concentrated. The crude product was purified by flash column 
chromatography on silica gel (30% ethyl acetate in n-pentane) to yield a mixture of diastereomers 
of amide 3.237 (140 mg, 703 µmol, 0.81 mmol, 61%) as a colorless solid and recovered starting 
material 3.224 (13 mg, 46 µmol, 58%). 
Mixture of diastereomers 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.09 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.65 (s, 1H), 5.89 – 5.50 (m, 6H), 4.46 (ddt, J = 9.7, 4.1, 1.9 Hz, 
1H), 4.33 (ddd, J = 24.4, 7.4, 4.2 Hz, 1H), 4.03 – 3.75 (m, 4H), 3.38 (dd, J = 11.6, 9.7 Hz, 1H), 
2.91 – 2.57 (m, 3H), 2.35 (dddd, J = 15.9, 10.7, 4.2, 2.1 Hz, 2H), 0.90 (d, J = 2.2 Hz, 18H), 0.28 – 
-0.10 (m, 12H). 
13
C NMR (101 MHz, CDCl3) δ 175.5, 174.2, 139.1, 133.2, 126.8, 125.4, 80.5, 79.8, 76.1, 74.6, 
71.6, 71.3, 70.5, 33.6, 29.8, 29.5, 25.9, 25.9, 18.3, 18.3, -4.5, -4.7, -4.7, -4.7. 
HRMS (ESI): calcd. for C13H25NNaO3Si [M+Na]
+: 294.1496; found: 294.1488. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3479, 3317, 3030, 2955, 2929, 2891, 2891, 2857, 1685, 1590, 1471, 1399, 
1329, 1253, 1095, 904, 837, 777.  
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9.2.1.2 NMR Spectra 
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9.2.1.3 X-ray  
 
Table 1. Crystal data and structure refinement for diol 3.71. 
 
Empirical formula    C11H17NO5 
Formula weight     243.25 
Temperature     100.(2) K 
Wavelength     0.71073 Å 
Crystal system     Monoclinic 
Space group     'P 1 21/c 1' 
Unit cell dimensions   a = 21.183(2) Å = 90°. 
     b = 4.8334(5) Å = 90.932(4)°. 
     c = 11.5364(12) Å  = 90°. 
Volume     1181.0(2) Å3 
Z     4 
Density (calculated)   1.368 Mg/m3 
Absorption coefficient   9.735 mm-1 
F(000)     192 
Crystal size    0.100 × 0.080 × 0.020 mm3 
Theta range for data collection  3.533–25.026°. 
Index ranges    -9<=h<=9, -10<=k<=10, -14<=l<=14 
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Reflections collected   7700 
Independent reflections   22069 [R(int) = 0.0346] 
Completeness to theta =    25.242° 100.0 %  
Absorption correction   Multi-Scan 
Max. and min. transmission  0.850 and 0.971 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  1720 / 25 / 192 
Goodness-of-fit on F2   0.1566 
Final R indices [I>2sigma(I)]  R1 = 0.01566, wR2 = 0.0450 
R indices (all data)   R1 = 0.0685, wR2 = 0.0464 
Extinction coefficient   0.001 
Largest diff. peak and hole  0.412 and -0.214 e.Å-3 
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Table 2. Crystal data and structure refinement for carbonate 3.193. 
 
Empirical formula    C9H8Br3NO5 
Formula weight     449.89 
Temperature     183(2) K 
Wavelength     0.71073 Å 
Crystal system     Triclinic 
Space group     P-1 (no. 2) 
Unit cell dimensions   a = 7.4190(6) Å = 69.739(2)°. 
     b = 8.2699(7) Å = 71.601(2)°. 
     c = 11.4278(9) Å  = 79.748(2)°. 
Volume     622.28(9) Å3 
Z     2 
Density (calculated)   2.401 Mg/m3 
Absorption coefficient   9.735 mm-1 
F(000)     428 
Crystal size    0.080 x 0.060 x 0.040 mm3 
Theta range for data collection  2.633 to 26.088°. 
Index ranges    -9<=h<=9, -10<=k<=10, -14<=l<=14 
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Reflections collected   17066 
Independent reflections   2476 [R(int) = 0.0346] 
Completeness to theta =    25.242° 100.0 %  
Absorption correction   Semi-empirical from equivalents 
Max. and min. transmission  0.724 and 0.527 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  2476 / 1 / 168 
Goodness-of-fit on F2   1.035 
Final R indices [I>2sigma(I)]  R1 = 0.0195, wR2 = 0.0450 
R indices (all data)   R1 = 0.0232, wR2 = 0.0464 
Extinction coefficient   0.0085(6) 
Largest diff. peak and hole  0.658 and -0.462 e.Å-3 
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9.2.2 Supporting Information for Chapter II 
9.2.2.1 General procedures 
 
General Procedure 1 – Aldol condensation  
To a solution of aldehyde (1 equiv) in ethanol (1.0 M) was added methylketone (1.00–1.50 equiv) 
and finely grinded barium hydroxide monohydrate (0.15 equiv, prepared by drying barium 
hydroxide octahydrate at 200 °C for 3 h) and the suspension was heated at 90 °C. After full 
conversion of the aldehyde as judged by thin layer chromatography (2–4 h), the colored reaction 
mixture (often yellowish-orange-red) was allowed to cool to 23 °C, concentrated under reduced 
pressure, diluted with ethyl acetate/diethylether and filtered over a pad of Celite®. The filtrate was 
concentrated under reduced pressure to give crude enone, which was used in the next step without 
further purification. 
 
General Procedure 2 – Enone reduction 
a) H2/Pd 
To a solution of crude enone (1 equiv) in ethyl acetate (0.1 M) was added palladium on charcoal 
(10% palladium on activated charcoal, 1.0–10 mol% Pd) and the resulting black suspension was 
sparged with hydrogen gas for 20 min. Stirring under hydrogen atmosphere was continued until 
full conversion as judged by thin layer chromatography. After 2–16 h Celite® was added and the 
mixture was filtered through a pad of Celite®. The filtrate was concentrated under reduced pressure 
and the crude product was purified by flash column chromatography on silica gel to yield the 
saturated ketone. 
b) Mg/MeOH 
To solution of crude enone in methanol (0.2 M) were added magnesium turnings (2–4 equiv) at (–
30 – +23 °C). The suspension was stirred in a water or cooling bath until most metal was dissolved. 
Conversion was controlled by thin layer chromatography. If necessary, more magnesium turnings 
were added. Upon full conversion, the reaction was warmed up to ambient temperature and 
neutralized by addition of saturated aqueous ammonium chloride solution. The mixture was 
extracted with ethyl acetate (3×). The organic phases were combined, washes with saturated 
aqueous sodium chloride solution, dried over sodium sulfate and filtered. The filtrate was 
concentrated under reduced pressure and the crude product was purified by flash column 
chromatography on silica gel to afford the saturated ketone.  
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General Procedure 3 – Corey–Chaykovsky epoxidation  
A suspension of sodium hydride (60% in mineral oil, 1.50–2.00 equiv) in dimethyl sulfoxide 
(1.00 M) was heated to 70 °C for 1.5 h (Attention: strong hydrogen evolution!) until a clear solution 
was formed (sometimes greenish). The basic solution was allowed to cool down to 23 °C and 
diluted 1:1 with tetrahydrofuran. After cooling the solution to 0 °C, a solution of 
trimethylsulfonium iodide (1.50–2.00 equiv, 1.0 M in dimethyl sulfoxide) was added dropwise. 
After 5 min, a solution of the ketone (1 equiv, 1.0 M in tetrahydrofuran) was added dropwise at 0 °C 
and the resulting reaction mixture was allowed to warm up to 23 °C. After 3 h, the mixture was 
diluted 3:1 with diethylether and excess base was quenched by addition of water. The aqueous layer 
was extracted with diethylether (3×), washed with water and twice with concentrated aqueous 
sodium chloride solution. The solution was dried over sodium sulfate and filtered. The filtrate was 
concentrated under reduced pressure to give the crude product, which was purified by flash column 
chromatography on silica gel. 
 
General Procedure 4 – Phenol alkylation 
In a pressure tube was added potassium carbonate (1.10 equiv) and α-bromo ketone (1.00 equiv) to 
a solution of phenol (1 equiv, 0.10 M in acetone). The resulting mixture was heated at 70 °C for 
16 h. The resulting reaction mixture was concentrated under reduced pressure and diluted with ethyl 
acetate and water. The aqueous phase was extracted with ethyl acetate (3×) and the combined 
organic layers were dried with sodium sulfate and filtered. The filtrate was concentrated under 
reduced pressure to afford crude phenyl alkyl ether. The crude product was purified by flash column 
chromatography on silica gel to give the desired compound. 
 
General procedure 5 – Cycloisomerization 
To a solution of epoxide (0.200 mmol, 1 equiv) in hexafluoroisopropanol (4 mL, 0.05 M) was added 
a solution of sulfuric acid in hexafluoroisopropanol (0.040 mL, 0.500 M, 10 mol%) at 0 °C under 
vigorous stirring. After 15 min, potassium carbonate (1 equiv) was added and the mixture was 
stirred for further 5 min before the mixture was concentrated under reduced pressure. The crude 
product was purified by flash column chromatography on silica gel. (Note: The solvent is prone for 
strong foaming during evaporation!).  
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9.2.2.2 Optimization of key step 
 
 
 
Table S16: Optimization of reaction conditions for conversion of 11a to 12a 
Entry solvent catalyst temperature yield [%]* comments 
1 HFIP H2SO4 23 °C 77  
2 TFE H2SO4 23 °C 43  
3 MeCN H2SO4 23 °C 2  
4 PhMe H2SO4 23 °C 19 emulsion 
5 THF H2SO4 23 °C 7  
6 DCM H2SO4 23 °C 11  
7 DMSO H2SO4 23 °C n.d.   
8 HFIP CSA 23 °C 77  
9 HFIP p-TsOH 23 °C 77  
10 HFIP Amberlyst® 15 23 °C 12 slow conversion 
11 HFIP HClO4 (60%) 23 °C 52  
12 HFIP HCl (37%) 23 °C 66  
13 HFIP CH3CO2H 23 °C 0  
14 HFIP HCO2H 23 °C 4  
15 HFIP ClCH2CO2H 23 °C 0  
16 HFIP Cl2CHCO2H 23 °C 37  
17 HFIP Cl3CCO2H 23 °C 46  
18 HFIP F3CCO2H 23 °C 55  
19 HFIP Cu(OTf)2 23 °C 63  
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20 HFIP TiCl4 23 °C 66  
21 HFIP BF3 •Et2O 23 °C 20  
22 HFIP AlMe3 23 °C 27  
23 HFIP SnCl2 23 °C n.d.  
24 HFIP MgBr2 23 °C 37 poor solubility of 
catalyst 
25 HFIP Cu(MeCN)4PF6 23 °C 9  
26 HFIP TMSOTf 23 °C 80 copolar byproduct  
27 HFIP H2SO4 58 °C 41  
28 HFIP H2SO4 45 °C 67  
29 HFIP H2SO4 35 °C  76  
30 HFIP H2SO4 15 °C 80  
31 HFIP H2SO4 0 °C 83  
*yield determined by 1H-NMR using 2,3,5,6-tetrachloronitrobenzene as internal standard. HFIP = 1,1,1,3,3,3-
hexafluoroisopropanol, TFE = 1,1,1-trifluoroethanol, THF = tetrahydrofuran, DCM = dichloromethane, DMSO = 
dimethyl sulfoxide, CSA = camphorsulfonic acid. 
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9.2.2.3 Graphical yield representation of screening 
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9.2.2.4 Full analysis of byproduct formation for 11a under optimized conditions 
 
 
 
(6,7-dimethoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12a) was 
prepared according to GP5 from 11a (0.200 mmol, 1 equiv) in 80% yield as a colorless oil 
(42.4 mg). Flash column chromatography on silica gel (20% ethyl acetate in cyclohexane). All less 
polar fractions were collected, combined and purified by high pressure liquid chromatography on 
silica gel (1% ethyl acetate in hexane) to afford tetralin 28f (4.2 mg, 9%) and naphthalene 27f 
(3.9 mg, 8%) as both colorless solids.  
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25% EtOAc in 
cHex 
Figure S12: Thin layer chromatography on silica gel of crude reaction mixture 
after 10 minutes (mobile phase: 25% ethyl acetate in cyclohexane). Note: Rf 
values distorted due to direct spotting from HFIP solution. Visualized by 
staining with ceric ammonium molybdate and subsequent heating.  
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9.2.2.5 Pictural guide of reaction of substrate 11a.  
   
Left: 11a dissolved in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) at 0 °C. Center: Color change 
after first drop of added sulfuric acid solution. Right: Intensive coloring after addition of second 
drop.  
 
   
Left: Color change to orange during addition of approximately 20 µL sulfuric acid solution. 
Center: Color change after addition of approximately 30 µL. Right: Color after complete 
addition (40 µL) 
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Left: Color of reaction mixture after 10 min, reaction control by TLC. Center: Addition of 
potassium carbonate after full conversion (15 min). Right: Color after complete addition of 
potassium carbonate 
   
Right: Color of reaction mixture after 1 min stirring with potassium carbonate. Center: Color 
after stirring with potassium carbonate for 5 min. Right: Removal of solvent (42 °C, 400 mbar) 
– color fades almost entirely to become a colorless to pale yellow oil (solid salts at the bottom) 
 
(6,7-dimethoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12a): 
TLC (25% ethyl acetate in hexanes): Rf: 0.21 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.81 (s, 1H), 6.51 (s, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 3.56 (d, J = 
10.9 Hz, 1H), 3.53 (d, J = 10.9 Hz, 1H), 2.80 – 2.64 (m, 2H), 1.80 (dt, J = 13.6, 6.2 Hz, 1H), 1.71 
(ddd, J = 13.5, 8.3, 6.5 Hz, 1H), 1.50 (s, 1H), 1.23 (s, 3H), 1.20 (s, 3H), 0.98 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.4, 146.9, 137.9, 127.6, 111.2, 110.1, 67.4, 56.2, 55.8, 39.1, 
39.0, 27.8, 27.4, 25.9, 25.4, 19.0. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥 3506 (br m), 2965 (s), 2934 (s), 2848 (w), 1610 (m), 1508 (s), 1462 (s), 1400 
(m), 1363 (w), 1352 (w), 1327 (w), 1250 (s), 1206 (s), 1185 (w), 1156 (s), 1137 (s), 1105 (w), 1074 
(s), 1023 (s), 975 (m), 911 (m), 857 (s), 832 (m), 794 (m), 730 (s), 646 (w), 571 (w), 543 (w), 489 
(w), 439 (w).  
HRMS (ESI) calcd for C16H25O3 [M+H]
+: 265.1798; found: 265.1789 
 
2-(tert-butyl)-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalene (28f): 
TLC (5% ethyl acetate in cyclohexane): Rf: 0.12 (UV, CAM) 
mp: 100.8 -103.1 °C 
1
H NMR (400 MHz, CDCl3) δ 6.59 (s, 1H), 6.58 (s, 1H), 3.84 (s, 6H), 2.84 – 2.63 (m, 3H), 2.56 – 
2.42 (m, 1H), 1.98 (ddq, J = 12.2, 4.8, 2.3 Hz, 1H), 1.43 (tdd, J = 12.0, 4.9, 2.1 Hz, 1H), 1.36 – 
1.24 (m, 1H), 0.94 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 147.1, 147.0, 129.4, 128.9, 112.3, 111.6, 56.1, 56.0, 45.1, 32.6, 
30.7, 30.4, 27.4, 24.9. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2954 (s), 1609 (w), 1517 (s), 1464 (m), 1394 (w), 1364 (w), 1268 (m), 1238 
(m), 1215 (m), 1118 (m), 1030 (w), 847 (w).  
HRMS (ESI): calcd for C16H25O2 [M+H]
+: 249.1849; found: 249.1861. 
 
6-(tert-butyl)-2,3-dimethoxynaphthalene (27f): 
TLC (5% ethyl acetate in cyclohexane): Rf: 0.10 (UV, CAM) 
mp: 124.2 – 127.3 °C 
1
H NMR (400 MHz, CDCl3) δ 7.64 (dd, J = 5.3, 3.2 Hz, 2H), 7.43 (dd, J = 8.6, 1.9 Hz, 1H), 7.12 
(s, 1H), 7.09 (s, 1H), 4.00 (s, 3H), 3.99 (s, 3H), 1.40 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 149.6, 149.2, 147.1, 129.2, 127.3, 126.2, 123.1, 121.8, 106.7, 106.1, 
55.99, 55.97, 34.8, 31.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2959 (s), 2863 (w), 1606 (w), 1515 (m), 1495 (w), 1465 (w), 1261 (w), 1243 
(w), 1195 (w), 1167 (w), 1134 (w), 1006 (w), 856 (w).  
HRMS (ESI): calcd for C16H21O2 [M+H]
+: 245.1536; found: 245.1529. 
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9.2.2.6 Additional products 
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9.2.2.7 Limitations  
 
*110% H2SO4 instead of 10%, **1H NMR yields  
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9.2.2.8 Discussion of mechanism and byproduct formation  
The investigation of the presented scope on the cycloisomerization of 2,2-disubsituted neopentylic 
epoxides led us to following conclusions and assumptions in respect to the reactivity of the 
substrates towards two main pathways that diverge into several possible reactions.  
1) Pathway 1 (see Scheme): The epoxide S1 first gets protonated towards S2 by the catalyst 
and opens by heterolytic cleavage of the C-O bond towards the tertiary carbon, forming a 
tertiary carbenium ion S3. This cation can theoretically be attacked by the distal 
nucleophile forming a five-membered cycle. However, we could not observe any trapping 
products of this proposed tertiary cation S3 – even if the sterically challenging tert-butyl 
group of the investigated scope is replaced by a small methyl group (see substrate 23a – 
proposed intermediate S7). Replacing the arene nucleophile with a less demanding primary 
alcohol in substrate S54 did not lead to the observation of a rearranged oxolane product 
(see proposed intermediate S8). Possible effects that might explain these observations can 
be summarized in following statements: 
a. The alkyl shift from the adjacent center is very quick (S3 to S4), and the positive 
charge prefers the terminal position. However, substrate S63, which underwent 
inverse migration speaks against a terminal preference of the positive charge. A 
charge stabilization after migration by the generated hydroxygroup is unlikely due 
to the small ringsize (n = 4). In this case, a corresponding product from S54 via S9 
should have been observed.  
b. The formation of the sigma-complex towards a 5-membered ring is reversible and 
thermodynamically unfavorable. DFT calculations support this thesis, however, 
the difference between the 6-membered sigma-complex and the 5-membered 
sigma-complex lies in the range of only 5 till 6 kcal mol-1 (see calculations). 
c. Another probable reason might be the possibility that the opening of S2 toward S3 
is highly reversible and favors the formation of opened S3 only if a subsequent 
migration can form the terminal cation S4, which undergoes a kinetically fast 
cyclization towards a six-membered cycle. This is unlikely, as related epoxides 
(e.g. 2,3-oxidosqualene) in polyene cyclizations easily undergo cyclization from a 
tertiary position.  
d. The formation of the sigma-complex towards a 5-membered ring is kinetically 
unfavorable and slow. While it is commonly accepted that cyclizations prefer 6-
membered transition states, we were surprised to not detect any traces of indane 
systems at all. However, a tremendous kinetic difference between the 6 and 5-
membered cyclic system is very likely to be the most important argument for the 
observed product compositions. This argument is underpinned by observations 
regarding the alternative pathway 2 (see underneath). Proposed intermediate S15 
underwent intramolecular cyclization towards the fluorene structure S163 in only 
5%, preferring the bimolecular disproportionation in at least 75% despite the low 
concentration (0.05 M), while proposed intermediate S14 exclusively cyclized to 
form the cis-decaline core of 21. This is also in accordance with the classic Boger–
Cook rearrangement forming a less-stabilized secondary carbo-cation from a 
tertiary one before cyclization.  
After migration, the terminal cation can undergo now several pathways. In case of an 
available intramolecular nucleophile, the investigated molecules exclusively formed 6-
membered cycles as in the desired products. Attempts to generate 5 or 7-membered 
ring systems failed in our hands (see limitations). If no 6-membered cycle can be 
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formed due to the lack of an appropriate nucleophile like with electron-poor arene 
moieties or the wrong placement (other ring sizes), it will react preferably according 
to following possibilities.  
i. Further rearrangements (formally dyotropic): By another alkyl-shift of 
the just formed adjacent quaternary carbon center, the positive charge 
migrates to its previous position – all three different possibilities are 
possible (1) the hydroxymethyl group (2) The just migrated alkyl group, 
or (3) The residue connected to the arene. 
1. In case of the hydroxylmethyl group, a tertiary cation is formed 
that can eliminate to form a trisubstituted double bond as observed 
for pyridine substrate S65, what delivered product S150 in low 
yield.  
2. Most probably, the just migrated alkyl group is also likely to 
move, what would nullify the first migration. An elimination 
product, equivalent to the direct elimination without any 
migrations, could not be identified for any substrate but is likely 
to occur. 
3. For vinyl substrate 17d, we propose that after initial vinyl 
migration, the subsequent phenethyl-migration affords an allylic 
cation that leads to the observed 8-membered cycle of 22 (see 
proposed mechanism in the experimental part).  
ii. By a formal retro-ene reaction, the molecule S4 cleaves off formaldehyde 
to form a tetra substituted double bond (e.g. S151). This new nucleophilic 
moiety can further add nucleophiles like the solvent under the acidic 
conditions (e.g. S149).   
iii. Direct elimination: Besides the formal dyotropic rearranged products, 
phenyl ether S101 delivered the eliminated product S154 in 71%.  
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Scheme S84. Pathway 1 – discussion of mechanism and byproduct formation. 
 
2) Pathway 2 (see Scheme): Intact epoxide S2 can be intramolecularly attacked on the less 
substituted methylene carbon in a 6-exo-tet fashion. In case of an aromatic nucleophile, the 
tertiary homobenzylic alcohol (S10) thus formed, will eliminate under the acidic reaction 
conditions to form a benzylic double bond S11 (dihydronaphthalene or 2H-chromene, e.g. 
Experimental Section 
 
245 
 
26g). Due to its nucleophilicity, this double bond is prone to protonation– but inversed to 
form a benzylic cation S12, which can undergo further reactions.  
a. If no intramolecular nucleophile is available, the cation can react with nucleophiles 
intermolecularly. The solvent is a nucleophile but addition is reversible due to the 
high stabilization of the benzylic cation. An appropriate nucleophile might be the 
electronrich arene core of another product or substrate molecule. However, we did 
not observe a corresponding intermolecular Friedel-Crafts type alkylation of this 
tertiary center, probably due to its high sterically hindrance. However, it can react 
in a different way with another molecule of itself – by disproportionation. 
Hexafluoroisopropanol has proven in our case to be a very potent solvent for the 
disproportionation of the occurring electron-rich dihydronaphthalenes towards 
naphthalenes (e.g. 27c) and tetralins (e.g. 28c). Such an intermolecular hydride 
abstraction happens very quickly and was complete in most cases within 15 
minutes at 0 °C – despite the low concentration (0.05 M). Therefore, we reason that 
hexafluoroisopropanol might be a unique solvent for other ionic reductions 
employing even stronger hydride donors like silanes or Hantzsch esters, too.  
b. In the case of a further distal intramolecular nucleophile another ringclosure is 
possible (S13). In this context, especially substrates 17c and 23c are very 
interesting to compare. Both form related dihydronaphthalenes as intermediates 
(S14 and S15). One with a phenylethyl group (S15), the other one with a 
benzylgroup (S15). Both can undergo with these sidechains subsequent ring 
closure reactions. However, while we could isolate annealed 21 in 41%, proposed 
S15 underwent the second ring alkylation in only 5% (S163), preferring the 
intermolecular disproportion towards the naphthalene 27c (45%) and tetralin 28c 
(30%). The main difference is that the phenethyl group enables the closure to a 6-
membered cycle, S15 needs to form a five-membered cycle. This is an impressive 
example that the intramolecular Friedel-Crafts alkylation towards five-membered 
cycles is kinetically highly disfavored, enabling more than 95% of the proposed 
dihydronapthalene to undergo the intermolecular disproportionation even at 
concentrations of < 0.05 M.  
 
Pathway 2 can be pushed by chelating substituents on the quaternary carbon center what 
was observed with substrate 23g bearing a methoxymethyl group that can stabilize the 
protonated intact epoxide (see S16). Noteworthy, In the case of already discussed substrate 
17c bearing the benzyl group as substituent on the quaternary center we observed the 
mentioned product 21 in 41% yield. In this special case, the second arene core doubles the 
chances of a direct arene alkylation according to pathway 2, even further reinforced by the 
Thorpe–Ingold effect of the gem-dimethyl group (see S17). Replacing the quaternary 
carbon adjacent to the epoxide with less substituted carbons also increases the probability 
of path 2 due to less steric hindrance, less inductive stabilization of the tertiary carbenium 
ion and of course, by impediment of rearrangements according to pathway 1. 
In hexafluoroisopropanol at 0 °C, an expected Meinwald-rearrangement is in the case of most 
substrates strongly suppressed and renders a rarely observed minor side reaction, while 
corresponding aldehydes were observed in other solvents systems more prominently.  
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Scheme S85: Pathway 2 – discussion of mechanism and byproduct formation.   
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9.2.2.9 Substrate syntheses 
 
4,4-dimethyl-1-phenylpentan-3-one (S24) was prepared according to GP1 (t = 2 h) from 
benzaldehyde (10.7 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (1% Pd, t = 16 h) in 49% 
yield as a colorless solid. Purified by flash column chromatography on silica gel (10% ethyl acetate 
in cyclohexane). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.43 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.30 – 7.27 (m, 2H), 7.22 – 7.15 (m, 3H), 2.88 (ddd, J = 8.0, 6.6, 
1.7 Hz, 2H), 2.80 (ddd, J = 8.7, 6.7, 1.7 Hz, 2H), 1.11 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 215.1, 141.8, 128.6, 128.5, 126.2, 44.2, 38.6, 30.3, 26.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3027 (w), 2967 (m), 2869 (w), 1704 (s), 1604 (w), 1496 (w), 1477 (w), 1454 
(w), 1394 (w), 1366 (w), 1084 (w), 1070 (w), 1030 (w), 983 (w), 746 (w), 699 (m). 
HRMS (ESI) calcd for C13H18ONa [M+Na]
+: 213.1256; found: 213.1247 
 
 
2-(tert-butyl)-2-phenethyloxirane (S25) was prepared according to GP3 (1.6 equiv NaH, 1.6 equiv 
Me3SI) from S24 (2.1 mmol, 1 equiv) in 87% yield as a colorless oil. Purified by flash column 
chromatography on silica gel (100% n-pentane).  
TLC (2% diethyl ether in n-pentane) Rf  0.30 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.33 – 7.26 (m, 2H), 7.23 – 7.10 (m, 3H), 2.78 (dd, J = 4.3, 0.7 Hz, 
1H), 2.68 (d, J = 4.2 Hz, 1H), 2.57 (ddd, J = 13.5, 11.6, 5.1 Hz, 1H), 2.46 (ddd, J = 13.5, 11.7, 
5.8 Hz, 1H), 2.14 (ddd, J = 14.6, 11.6, 5.8 Hz, 1H), 2.06 – 1.95 (m, 1H), 0.97 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 142.4, 128.6, 128.4, 126.0, 63.5, 48.1, 34.1, 31.6, 30.8, 26.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3060 (w), 3027 (m), 2959 (s), 2872 (m), 1603 (w), 1497 (m), 1481 (m), 1454 
(m), 1394 (w), 1364 (m), 1210 (w), 1145 (w), 1125 (w),1032 (w), 935 (w), 908 (w), 839 (w), 751 
(m), 700 (s). 
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HRMS (ESI) calcd for C14H20ONa [M+Na]
+: 227.1412; found: 227.1395 
 
 
4,4-dimethyl-1-(m-tolyl)pentan-3-one (S26) was prepared according to GP1 (t = 3 h) from 3-
methylbenzaldehyde (10 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (1% Pd, t = 16 h) in 
76% yield as a colorless solid. Purified by flash column chromatography on silica gel (10% ethyl 
acetate in cyclohexane). 
TLC (5% ethyl acetate in cyclohexanes): Rf: 0.33 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.17 (t, J = 7.7 Hz, 1H), 7.02 – 6.95 (m, 3H), 2.89 – 2.73 (m, 4H), 
2.33 (s, 3H), 1.12 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 215.2, 141.7, 138.2, 129.3, 128.5, 126.9, 125.5, 44.2, 38.7, 30.2, 
26.5, 21.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2966 (m), 2932 (w) 2907 (w), 2869 (w), 1705 (s), 1609 (w), 1477 (m), 1463 
(w), 1408 (w), 1394 (w), 1365 (m), 1294 (w), 1094 (m), 1078 (w), 1041 (w), 982 (m), 778 (m), 700 
(m).  
HRMS (ESI) calcd for C14H21O [M+H]
+: 205.1587; found: 205.1590 
 
 
2-(tert-butyl)-2-(3-methylphenethyl)oxirane (S27) was prepared according to GP3 (1.6 equiv 
NaH, 1.5 equiv Me3SI) from S26 (2.9 mmol, 1 equiv) in 92% yield as a colorless oil. Purified by 
flash column chromatography on silica gel (1% ethyl acetate in cyclohexane). 
TLC (2% diethyl ether in n-pentane) Rf  0.30 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.18 (t, J = 7.7 Hz, 1H), 7.07 – 6.85 (m, 3H), 2.78 (dd, J = 4.2, 0.7 
Hz, 1H), 2.67 (d, J = 4.2 Hz, 1H), 2.53 (ddd, J = 13.4, 11.7, 5.1 Hz, 1H), 2.42 (ddd, J = 13.4, 11.8, 
5.7 Hz, 1H), 2.33 (s, 3H), 2.12 (ddd, J = 14.6, 11.7, 5.7 Hz, 1H), 2.00 (ddd, J = 14.6, 11.7, 5.1 Hz, 
1H), 0.97 (s, 9H). 
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13
C NMR (101 MHz, CDCl3) δ 142.3, 138.1, 129.3, 128.5, 126.7, 125.4, 63.5, 48.1, 34.1, 31.7, 
30.7, 26.2, 21.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥:3013 (w), 2958 (s), 2871 (m), 1706 (m), 1609 (m), 1590 (w), 1480 (m), 1464 
(m), 1394 (m), 1364 (w), 1144 (w), 1124 (w), 1042 (w), 983 (w), 937 (w), 914 (m), 838 (m), 781 
(s), 701 (s).  
HRMS (ESI) calcd for C15H22ONa [M+Na]
+:241.1569; found: 241.1550 
 
 
1-(3-(tert-butyl)phenyl)-4,4-dimethylpentan-3-one (S28) was prepared according to GP1 (t = 
3 h) from 3-(tert-butyl)benzaldehyde (4.0 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2b 
(4 equiv Mg, T = –30 °C, t = 4 h) in 59% yield as a colorless solid. Purified by flash column 
chromatography on silica gel (20% ethyl acetate in cyclohexane). 
TLC (20% ethyl acetate in cyclohexanes) Rf: 0.36 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.23 – 7.18 (m, 3H), 7.04 – 6.95 (m, 1H), 2.91 – 2.84 (m, 2H), 2.79 
(m, 2H), 1.31 (s, 9H), 1.11 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 215.1, 151.3, 141.2, 128.1, 125.4, 123.0, 44.1, 38.7, 34.6, 31.4, 
30.5, 26.3. 
 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2963 (s), 2905 (w), 2869 (w), 1706 (s), 1605 (w), 1489 (w), 1477 (m), 1464 
(w), 1393 (w), 1365 (m), 1273 (w), 1203 (w), 1078 (m), 982 (w), 793 (w), 706 (w). 
HRMS (ESI) calcd for C17H26ONa [M+Na]
+: 269.1882; found: 269.1859 
 
 
2-(tert-butyl)-2-(3-(tert-butyl)phenethyl)oxirane (S29) was prepared according to GP3 
(1.6 equiv NaH, 1.5 equiv Me3SI) from S28 (0.9 mmol; 1 equiv) in 81% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (1% diethyl ether in n-pentane). 
TLC (1% diethyl ether in n-pentane) Rf = 0.33 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 7.31 – 7.25 (m, 2H), 7.24 (q, J = 1.7 Hz, 1H), 7.05 (ddd, J = 5.6, 
3.9, 1.9 Hz, 1H), 2.82 (dd, J = 4.1, 0.7 Hz, 1H), 2.73 (d, J = 4.2 Hz, 1H), 2.61 (ddd, J = 13.5, 11.6, 
5.0 Hz, 1H), 2.51 (ddd, J = 13.4, 11.8, 5.8 Hz, 1H), 2.19 (ddd, J = 14.6, 11.7, 5.8 Hz, 1H), 2.12 – 
2.00 (m, 1H), 1.36 (s, 9H), 1.02 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 151.4, 141.9, 128.2, 125.5, 125.5, 123.0, 63.5, 48.1, 34.1, 31.7, 
31.5, 31.0, 26.2. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2961 (s), 2870 (m), 1707 (m), 1605 (w), 1478 (m), 1393 (w), 1364 (m), 
1273 (w), 1203 (w), 1078 (w), 981 (w), 907 (w), 839 (w), 792 (w), 706 (m). 
HRMS (ESI): calcd for C18H28ONa [M+Na]
+: 283.2038; found: 283.2030. 
 
 
1-(3-methoxyphenyl)-4,4-dimethylpentan-3-one (S30) was prepared according to GP1 (t = 2 h) 
from 3-methoxybenzaldehyde (5 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (1% Pd, t = 
15 h) in 84% yield as a colorless oil. Purified by flash column chromatography on silica gel (5% 
ethyl acetate in cyclohexane). 
TLC (20% ethyl acetate in hexanes): Rf: 0.54 (UV) 
mp: 15.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.23 – 7.16 (m, 1H), 6.78 (dt, J = 7.7, 1.2 Hz, 1H), 6.76 – 6.72 (m, 
2H), 3.79 (s, 3H), 2.88 – 2.76 (m, 4H), 1.11 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 215.0, 159.7, 143.3, 129.5, 120.8, 114.2, 111.4, 55.2, 44.2, 38.5, 
30.2, 26.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3315 (m), 3297 (m), 3256 (m), 3183 (m), 3106 (m), 2957 (m), 2835 (m), 2707 
(m), 2617 (m), 2125 (w), 1703 (w), 1651 (m), 1584 (s), 1517 (s), 1476 (vs), 1394 (s), 1364 (s), 1317 
(w), 1226 (s), 1151 (vs), 1125 (s), 1099 (s), 1025 (s), 978 (s), 928 (s), 787 (s), 762 (s), 723 (s).  
HRMS (EI): calcd for C14H20O2 [M]
+: 220.1458; found: 220.1459. 
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2-(tert-butyl)-2-(3-methoxyphenethyl)oxirane (S31) was prepared according to GP3 (1.6 equiv 
NaH, 1.5 equiv Me3SI) from S30 (3.0 mmol, 1 equiv) in 96% yield as a colorless oil. Purified by 
flash column chromatography on silica gel (5% ethyl acetate in cyclohexane).  
TLC (20% ethyl acetate in hexanes): Rf: 0.57 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.23 – 7.17 (m, 1H), 6.78 (d, J = 7.5 Hz, 1H), 6.76 – 6.71 (m, 2H), 
3.80 (s, 3H), 2.78 (d, J = 4.2 Hz, 1H), 2.67 (d, J = 4.2 Hz, 1H), 2.54 (ddd, J = 13.5, 11.5, 5.1 Hz, 
1H), 2.44 (ddd, J = 13.5, 11.6, 5.8 Hz, 1H), 2.13 (ddd, J = 14.6, 11.6, 5.8 Hz, 1H), 2.02 (ddd, J = 
14.6, 11.7, 5.1 Hz, 1H), 0.97 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 159.8, 144.0, 129.5, 120.8, 114.3, 111.2, 63.5, 55.3, 48.1, 34.1, 
31.4, 30.8, 26.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2958 (m), 2872 (w), 2835 (w), 1602 (s), 1585 (s), 1490 (s), 1465 (s),1455 (s), 
1436 (m), 1394 (w), 1364 (w), 1284 (w), 1261 (vs), 1166 (s), 1153 (vs), 1055 (s), 1039 (vs),910 (m), 
836 (m), 777 (vs), 745 (m), 696 (vs) cm−1. 
HRMS (EI): calcd for C15H22O2 [M]
+: 234.1614; found: 234.1621. 
 
 
1-(2-methoxyphenyl)-4,4-dimethylpentan-3-one (S32) was prepared according to GP1 (t = 3 h) 
from 2-anisaldehyde (6.0 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2b (4.5 equiv Mg, T = 
–30 °C, t = 4 h) in 62% yield as a colorless oil. Purified by flash column chromatography on silica 
gel (20% ethyl acetate in cyclohexane). 
TLC (20% ethyl acetate in cyclohexane) Rf = 0.40 (UV) 
1
H NMR (400 MHz, CDCl3) δ 7.18 (ddd, J = 8.1, 7.4, 1.8 Hz, 1H), 7.14 (dd, J = 7.4, 1.7 Hz, 1H), 
6.94 – 6.74 (m, 2H), 3.82 (s, 3H), 2.86 (tt, J = 7.3, 2.0 Hz, 2H), 2.80 – 2.69 (m, 2H), 1.11 (s, 9H). 
 13
C NMR (101 MHz, CDCl3) δ 215.8, 157.6, 130.3, 130.0, 127.5, 120.6, 110.3, 55.3, 44.3, 36.8, 
26.5, 25.6. 
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IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2966 (m), 2908 (w), 2871 (w), 2836 (w), 1703 (s), 1601 (w), 1588 (w), 1494 
(m), 1477 (m), 1465 (m), 1439 (m), 1365 (w), 1288 (w), 1243 (s), 1161 (w), 1112 (w), 1079 (m), 
1052 (w), 1033 (m), 984 (w), 753 (m). 
HRMS (ESI): calcd for C14H21O2 [M+H]
+: 221.1541; found: 221.1534. 
 
 
2-(tert-butyl)-2-(2-methoxyphenethyl)oxirane (S33) was prepared according to GP3 (1.6 equiv 
NaH, 1.5 equiv Me3SI) from S32 (4 mmol, 1 equiv) in 93% yield as a colorless oil. Purified by flash 
column chromatography on silica gel (10% ethyl acetate in cyclohexane). 
TLC (10% ethyl acetate in cyclohexane) Rf = 0.48 
1
H NMR (400 MHz, CDCl3) δ 7.18 (ddd, J = 8.2, 7.5, 1.8 Hz, 1H), 7.13 (dd, J = 7.4, 1.8 Hz, 1H), 
6.88 (td, J = 7.4, 1.1 Hz, 1H), 6.84 (dd, J = 8.2, 1.1 Hz, 1H), 3.82 (s, 3H), 2.78 (d, J = 4.3 Hz, 1H), 
2.71 (d, J = 4.3 Hz, 1H), 2.53 (dd, J = 9.4, 7.6 Hz, 2H), 2.13 (ddd, J = 14.4, 9.5, 7.7 Hz, 1H), 2.00 
– 1.83 (m, 1H), 0.98 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 157.6, 130.7, 129.8, 127.2, 120.6, 110.4, 63.8, 55.3, 48.3, 34.1, 
30.1, 26.2, 25.7. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2958 (m), 2872 (w), 2835 (w), 1601 (w), 1587 (w), 1493 (m), 1464 (m), 
1439 (w), 1364 (w), 1290 (w), 1241 (s), 1183 (m), 1115 (w), 1033 (m), 928 (m), 896 (w), 831 (w), 
800 (w), 751 (s). 
HRMS (ESI): calcd for C15H23O2 [M+H]
+: 235.1698; found: 235.1691. 
 
 
4,4-dimethyl-1-(3,4-dimethoxyphenyl)pentan-3-one (S34) was prepared according to GP1 (t = 
3.5 h) from 3,4-dimethoxybenzaldehyde (120 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2b 
(4 equiv Mg, T = 23 °C, t = 6 h) in 21% yield as a colorless solid. Purified by flash column 
chromatography on silica gel (20% ethyl acetate in n-pentane). 
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TLC (25% ethyl acetate in hexanes) Rf: 0.38 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.80 – 6.76 (m, 1H), 6.74 – 6.70 (m, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 
2.86 – 2.73 (m, 4H), 1.10 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 215.2, 148.9, 147.5, 134.4, 120.3, 112.0, 111.4, 56.1, 56.0, 44.2, 
38.8, 29.9, 26.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2963 (s), 2935 (w), 2907 (w), 2870 (w), 2834 (w), 1703 (s), 1607 (w), 1590 
(m), 1515 (s), 1464 (s), 1418 (m), 1394 (m), 1365 (m), 1261 (s), 1238 (s), 1191 (w), 1154 (s), 1140 
(s), 1080 (m), 1029 (s), 983 (m), 937 (w), 890 (w), 846 (w), 809 (m),763 (m), 706 (w), 634 (w), 597 
(w), 549 (w), 481 (w), 461 (w), 422 (w), 411 (w).  
HRMS (ESI) calcd for C15H22NaO3 [M+Na]
+: 273.1461; found: 273.1433. 
 
 
2-(tert-butyl)-2-(3,4-dimethoxyphenethyl)oxirane (11a) was prepared according to GP3 
(1.6 equiv NaH, 1.5 equiv Me3SI) from S34 (24.7 mmol, 1 equiv) in 92% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (10% ethyl acetate in n-pentane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.39 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.79 (d, J = 7.9 Hz, 1H), 6.74 – 6.69 (m, 2H), 3.87 (s, 3H), 3.85 (s, 
3H), 2.77 (dd, J = 4.2, 0.8 Hz, 1H), 2.67 (d, J = 4.2 Hz, 1H), 2.55 – 2.36 (m, 2H), 2.12 (ddd, J = 
14.6, 11.5, 5.9 Hz, 1H), 2.04 – 1.95 (m, 1H), 0.97 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.4, 135.0, 120.1, 111.8, 111.4, 63.5, 56.1, 48.1, 34.1, 
31.8, 30.3, 26.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2957 (s), 2872 (w), 2834 (w), 1590 (w), 1515 (s), 1464 (s), 1418 (w), 1394 
(w), 1364 (w), 1343 (w), 1262 (s), 1237 (s), 1190 (w), 1157 (s), 1141 (s), 1030 (s), 921 (w), 895 
(w), 851 (s), 808 (w), 766 (w), 666 (w), 620 (w), 598 (w), 564 (w), 523 (w), 476 (w), 465 (w), 421 
(w). 
HRMS (ESI) calcd for C16H24NaO3 [M+Na]
+: 287.1618; found: 287.1614. 
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1-(benzo[d][1,3]dioxol-5-yl)-4,4-dimethylpentan-3-one (S35) was prepared according to GP1 (t 
= 3 h) from piperonal (3.7 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2b (4 equiv Mg, T = 
–30 °C, t = 4 h) in 48% yield as a colorless solid. Purified by flash column chromatography on 
silica gel (20% ethyl acetate in cyclohexane). 
TLC (20% ethyl acetate in cyclohexanes): Rf: 0.33 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.71 (d, J = 7.9 Hz, 1H), 6.67 (d, J = 1.7 Hz, 1H), 6.63 (dd, J = 7.9, 
1.7 Hz, 1H), 5.91 (s, 2H), 2.84 – 2.69 (m, 4H), 1.10 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 214.9, 147.6, 145.7, 135.4, 121.1, 108.9, 108.2, 100.8, 44.1, 38.7, 
29.8, 26.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2967 (w), 2904 (w), 2873 (w), 1702 (m), 1608 (w), 1503 (m), 1488 (s), 1441 
(m), 1365 (m), 1242 (s), 1189 (m), 1097 (m), 1077 (m), 1037 (s), 982 (m), 929 (m), 861 (w), 809 
(m). 
HRMS (ESI): calcd for C14H18O3Na [M+Na]
+: 257.1154; found: 257.1139 
 
 
5-(2-(2-(tert-butyl)oxiran-2-yl)ethyl)benzo[d][1,3]dioxole (S36) was prepared according to GP3 
(1.6 equiv NaH, 1.5 equiv Me3SI) from S35 (1.75 mmol, 1 equiv) in 82% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% diethyl ether in n-pentane) Rf:  0.55 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.72 (d, J = 7.9 Hz, 1H), 6.67 (d, J = 1.7 Hz, 1H), 6.62 (dt, J = 7.8, 
1.1 Hz, 1H), 5.91 (s, 2H), 2.76 (dd, J = 4.1, 0.8 Hz, 1H), 2.64 (d, J = 4.2 Hz, 1H), 2.48 (ddd, J = 
13.6, 11.5, 5.2 Hz, 1H), 2.38 (ddd, J = 13.6, 11.5, 5.8 Hz, 1H), 2.08 (ddd, J = 14.6, 11.5, 5.8 Hz, 
1H), 1.96 (ddd, J = 14.5, 11.5, 5.2 Hz, 1H), 0.96 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 147.7, 145.8, 136.2, 121.1, 108.9, 108.3, 100.9, 63.4, 48.1, 34.1, 
31.8, 30.5, 26.2. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3051 (w), 3016 (w), 2959 (s), 2928 (m), 2872 (m), 1608 (w), 1503 (m), 1491 
(s), 1443 (m), 1364 (w), 1245 (s), 1189 (w), 1097 (m), 1040 (m), 937 (m), 856 (w), 782 (w), 701 
(w). 
HRMS (ESI) calcd for C15H20O3Na [M+Na]+: 271.1310; found: 271.1296 
 
 
4,4-dimethyl-1-(3,4,5-dimethoxyphenyl)pentan-3-one (S37) was prepared according to GP1 (t = 
3 h) from 3,4,5-trimethoxybenzaldehyde (7.8 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a 
(1% Pd, t = 15 h) in 64% yield as a colorless solid. Purified by flash column chromatography on 
silica gel (20% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in hexanes) Rf: 0.32 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.39 (s, 2H), 3.84 (s, 6H), 3.81 (s, 3H), 2.85 – 2.75 (m, 4H), 1.12 
(s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 215.0, 153.3, 137.6, 136.4 105.5, 61.0, 56.2, 44.3, 38.7, 30.7, 26.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2964 (s), 2838 (w), 1703 (s), 1589 (s), 1508 (s), 1458 (s), 1421 (s), 1365 (m), 
1343 (m), 1286 (w), 1238 (s), 1183 (w), 1125 (s), 1081 (s), 1043 (w), 1010 (s), 938 (w), 895 (w), 
825 (m), 776 (w), 745 (w), 665 (w), 565 (w), 528 (w).  
HRMS (ESI) calcd for C16H24NaO4 [M+Na]
+: 303.1567; found: 303.1561. 
 
 
2-(tert-butyl)-2-(3,4,5-trimethoxyphenethyl)oxirane (S38) was prepared according to GP3 
(1.6 equiv NaH, 1.5 equiv Me3SI) from S37 (4.0 mmol, 1 equiv) in 86% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in hexanes): Rf: 0.36 (CAM) 
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1
H NMR (400 MHz, CDCl3) δ 6.39 (s, 2H), 3.85 (s, 6H), 3.82 (s, 3H), 2.78 (dd, J = 4.2, 0.8 Hz, 
1H), 2.66 (d, J = 4.2 Hz, 1H), 2.55 – 2.35 (m, 2H), 2.12 (ddd, J = 14.6, 11.5, 5.9 Hz, 1H), 2.01 
(ddd, J = 14.5, 11.5, 5.1 Hz, 1H), 0.98 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 153.3, 138.1, 136.3, 105.3, 63.5, 61.0, 56.2, 48.1, 34.1, 31.6, 31.1, 
26.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2957 (s), 2873 (w), 2837 (w), 1589 (s), 1507 (s), 1458 (s), 1420 (s), 1394 (w), 
1364 (w), 1331 (m), 1283 (w), 1237 (s), 1183 (w), 1124 (s), 1045 (w), 1011 (s), 976 (w), 926 (w), 
897 (w), 825 (m), 780 (w), 751 (w), 701 (w), 625 (w), 603 (w), 527 (w).  
HRMS (ESI) calcd for C17H26NaO4 [M+Na]
+: 317.1723; found: 317.1719. 
 
 
1-(3-fluorophenyl)-4,4-dimethylpentan-3-one (S39) was prepared according to GP1 (t = 3 h) 
from 3-fluorobenzaldehyde (6.6 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2b (4 equiv Mg, 
T = –30 °C, t = 4 h) in 59% yield as a colorless solid. Purified by flash column chromatography on 
silica gel (20% ethyl acetate in cyclohexane). 
TLC (1% diethyl ether in n-pentante) Rf 0.43 (UV, KMnO4, Anis) 
1
H NMR (400 MHz, CDCl3) δ 7.26 – 7.17 (m, 1H), 6.98 – 6.94 (m, 1H), 6.91 – 6.82 (m, 2H), 2.92 – 2.84 
(m, 2H), 2.83 – 2.75 (m, 2H), 1.11 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 214.7, 163.0 (d, J = 245.6 Hz), 144.3 (d, J = 7.6 Hz), 130.0 (d, J = 
8.5 Hz), 124.2 (d, J = 2.7 Hz), 115.4 (d, J = 21.0 Hz), 113.0 (d, J = 21.1 Hz), 44.2, 38.2, 29.9, 26.5. 
19
F NMR (376 MHz, CDCl3) δ -113.65 (d, J = 8.9 Hz). 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2954 (m), 2920 (s), 2871 (m), 2853 (w), 2359 (w), 2337 (w), 2238 (w), 2195 
(w), 2143 (w), 2116 (w), 2005 (w), 1976 (w), 1707 (m), 1462 (w), 1378 (w), 1084 (w), 741(w), 701 
(w).  
HRMS (ESI) calcd for C13H17OFNa [M+Na]
+: 231.1161; found: 231.1143. 
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2-(tert-butyl)-2-(3-fluorophenethyl)oxirane (S40) was prepared according to GP3 (1.6 equiv 
NaH, 1.5 equiv Me3SI) from S39 (1.2 mmol, 1 equiv) in 57% yield as a colorless oil. Purified by 
flash column chromatography on silica gel (1% diethyl ether in n-pentane). 
TLC (1% diethyl ether in n-pentane) Rf: 0.40 (UV, KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 7.26 – 7.18 (m, 1H), 6.98 – 6.93 (m, 1H), 6.91 – 6.83 (m, 2H), 2.78 (d, J 
= 4.1, 1H), 2.64 (d, J = 4.1 Hz, 1H), 2.51 (m, 2H), 2.26 – 1.90 (m, 2H), 0.97 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 163.1 (d, J = 245.5 Hz), 144.9 (d, J = 7.2 Hz), 129.9 (d, J = 8.1 
Hz), 124.1 (d, J = 2.6 Hz), 115.3 (d, J = 21.0 Hz), 112.9 (d, J = 21.1 Hz), 63.4, 48.1, 34.1, 31.2, 
30.4, 26.2. 
19
F NMR (376 MHz, Chloroform-d) δ -113.71. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2956 (m), 2924 (s), 2854 (m), 1738 (w), 1596 (w), 1458 (w), 1376 (w), 
1261 (w), 1222 (w), 1182 (w), 1171 (w), 1098 (w), 1051 (w), 1031 (w), 781 (w). 
HRMS (ESI): calcd for C14H19FONa [M+Na]
+: 245.1318; found: 245.1297. 
 
 
1-(4-fluorophenyl)-4,4-dimethylpentan-3-one (S41) was prepared according to GP1 (t = 3 h) 
from 4-fluorobenzaldehyde (10.0 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2b (4 equiv 
Mg, T = –30 °C, t = 4 h) in 58% yield as a colorless oil. Purified by flash column chromatography 
on silica gel (10% diethyl ether in n-pentane). 
 
TLC (10% diethyl ether in n-pentane) Rf = 0.52 (UV, KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 7.17 – 7.09 (m, 2H), 6.95 (t, J = 8.8 Hz, 2H), 2.89 – 2.81 (m, 2H), 
2.80 – 2.70 (m, 2H), 1.09 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 214.9, 161.5 (d, J = 243.4 Hz), 137.3 (d, J = 3.4 Hz), 129.9 (d, J = 
7.9 Hz), 115.3 (d, J = 21.1 Hz), 44.2, 38.6, 29.4, 26.4. 
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19
F NMR (376 MHz, CDCl3) δ -117.48 (t, J = 6.9 Hz). 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥:  (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2969 (w), 2935 (w), 2909 (w), 2872 (w), 1705 (m), 
1602 (w), 1510 (s), 1478 (w), 1366 (w), 1222 (m), 1158 (w), 1096 (w), 1077 (w), 982 (w), 830 (m). 
HRMS (ESI): calcd for C13H17FONa [M+Na]
+: 231.1161; found: 231.1151. 
 
 
4-fluoro-2-(3-methylphenethyl)oxirane (S42) was prepared according to GP3 (1.6 equiv NaH, 
1.5 equiv Me3SI) from S41 (2.9 mmol, 1 equiv) in 71% yield as a yellow oil. Purified by flash 
column chromatography on silica gel (5% diethyl ether in n-pentane). 
TLC (5% diethyl ether in n-pentane) Rf = 0.37 (UV, KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 7.16 – 7.08 (m, 2H), 7.02 – 6.87 (m, 2H), 2.78 (d, J = 4.2, 1H), 2.65 
(d, J = 4.1 Hz, 1H), 2.59 – 2.28 (m, 2H), 2.19 – 1.87 (m, 2H), 0.97 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 161.4 (d, J = 243.4 Hz), 137.9 (d, J = 3.1 Hz), 129.7 (d, J = 7.4 
Hz), 115.3 (d, J = 21.1 Hz), 63.4, 48.0, 34.1, 31.7, 29.9, 26.1. 
19
F NMR (376 MHz, CDCl3) δ -117.70 (t, J = 5.3 Hz). 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2966 (m), 2912 (w), 2873 (w), 1706 (w), 1602 (w), 1510 (s), 1479 (w), 
1465 (w), 1394 (w), 1365 (w), 1222 (m), 1158 (w), 1095 (w), 1076 (w), 830 (m). 
HRMS (ESI): calcd for C14H19FONa [M+Na]
+: 245.1318; found: 245.1307. 
 
 
4,4-dimethyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one (S43) was prepared 
according to GP1 (t = 3 h) from 4-formylphenylboronic acid pinacol ester (4 mmol, 1 equiv) and 
pinacolone (1.5 equiv) and GP2a in methanol instead of ethyl acetate (1% Pd, t = 6 h) in 56% yield 
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as a colorless oil. Purified by flash column chromatography on silica gel (10% diethyl ether in n-
pentane). 
TLC (5% diethyl ether in n-pentane) Rf =0.25 (UV, KMnO4) 
1H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.0 Hz, 2H), 7.20 (d, J = 8.2 Hz, 2H), 2.93 – 2.84 
(m, 2H), 2.82 – 2.75 (m, 2H), 1.33 (s, 12H), 1.10 (s, 9H). 
 
13
C NMR (101 MHz, CDCl3) δ 214.9, 145.2, 135.1, 128.0, 83.8, 44.2, 38.4, 30.4, 26.5, 25.0. 
11
B NMR (128 MHz, CDCl3) δ 31.4. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2975 (m), 2932 (w), 2871 (w), 1706 (m), 1612(w), 1519(w), 1478 (w), 1399 
(m), 1360 (s), 1321 (m), 1272(w), 1214 (w), 1145 (m), 1090 (m), 1022(w), 981 (w), 963 (w), 860 
(w), 828 (w). 
HRMS (ESI): calcd for C19H33BO3N [M+NH4]
+: 334,2554; found: 334.2550. 
 
 
5-(2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oxiran-2-yl)ethyl)benzo[d][1,3]dioxole 
(S44) was prepared according to GP3 (2 equiv NaH, 1.9 equiv Me3SI) from S43 (1.75 mmol, 
1 equiv) in 62% yield as a colorless oil. Purified by flash column chromatography on silica gel 
(10% diethyl ether in n-pentane). 
TLC (5% diethyl ether in n-pentane) Rf : 0.25 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 8.0 Hz, 2H), 7.19 (d, J = 8.0 Hz, 2H), 2.77 (dd, J = 4.1, 
0.8 Hz, 1H), 2.66 (d, J = 4.2 Hz, 1H), 2.61 – 2.36 (m, 2H), 2.20 – 1.88 (m, 2H), 1.33 (s, 12H), 0.96 
(s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 145.8, 135.1, 128.0, 127.9, 83.8, 63.5, 48.1, 34.1, 31.4, 31.0, 26.2, 
25.0. 
11
B NMR (128 MHz, CDCl3) δ 31.00. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2965 (m), 2927 (m), 1780 (w), 1706 (w), 1612 (w), 1465 (w), 1398 (w), 
1361 (s), 1321 (w), 1272 (w), 1214 (w), 1145 (m), 1090 (m), 1022 (w), 963 (w), 860 (w), 827 (w). 
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HRMS (ESI): calcd for C20H31BO3Na [M+Na]
+: 353.2264; found: 353.2241. 
 
 
4,4-dimethyl-1-(thiophen-3-yl)pentan-3-one (S45) was prepared according to GP1 (t = 2 h) from 
thiophene-3-carbaldehyde (8.9 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (0.5% Pd, t = 
16 h) in 34% yield as a colorless solid. Purified by flash column chromatography on silica gel (10% 
ethyl acetate in cyclohexane). 
TLC (10% ethyl acetate in hexanes): Rf: 0.42 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.24 (dd, J = 4.9, 3.0 Hz, 1H), 6.96 – 6.91 (m, 2H), 2.93 – 2.87 (m, 
2H), 2.82 – 2.76 (m, 2H), 1.11 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 215.0, 141.9, 128.3, 125.6, 120.6, 44.2, 37.7, 26.4, 24.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2967 (s), 2933 (w), 2906 (w), 2870 (w), 1703 (vs), 1537 (w), 1477 (s), 1464 
(w), 1445 (w), 1409 (m), 1394 (m), 1465 (s), 1288 (w), 1225 (w), 1154 (w), 1079 (s), 1042 (w), 982 
(m), 936 (w), 899 (w), 854 (w), 831 (w), 7785 (s), 670 (m), 636 (m), 599 (w), 553 (m). 
HRMS (ESI) calcd for C11H16NaOS [M+Na]
+: 219.0814; found: 219.0801. 
 
 
2-(tert-butyl)-2-(2-(thiophen-3-yl)ethyl)oxirane (S46) was prepared according to GP3 (1.6 equiv 
NaH, 1.5 equiv Me3SI) from S45 (0.8 mmol, 1 equiv) in 81% yield as a colorless oil. Purified by 
flash column chromatography on silica gel (5% ethyl acetate in hexanes). 
TLC (10% ethyl acetate in hexanes): Rf: 0.44 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.26 – 7.23 (m, 1H), 6.94 (s, 1H), 6.94 – 6.93 (m, 1H), 2.77 (dd, J 
= 4.1, 0.7 Hz, 1H), 2.64 (d, J = 4.2 Hz, 1H), 2.62 – 2.54 (m, 1H), 2.54 – 2.45 (m, 1H), 2.16 (ddd, J 
= 14.6, 11.1, 6.0 Hz, 1H), 2.04 (dddd, J = 14.5, 11.2, 5.3, 0.8 Hz, 1H), 0.97 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 142.6, 128.3, 125.5, 120.1, 63.4, 48.1, 34.1, 30.4, 26.2, 25.1. 
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IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3101 (w), 3052 (w), 2960 (s), 2871 (m), 1536 (w), 1480 (m), 1466 (w), 
1410 (w), 1394 (w), 1364 (m), 1344 (w), 1210 (w), 1146 (w), 1125 (w), 1103 (w), 1080 (w), 1041 
(w) 1007 (w), 923 (m), 895 (w), 860 (m), 833 (m), 775 (s), 745 (w), 685 (w), 651 (w), 622 (w), 598 
(m), 578 (w), 525 (w), 500 (w), 485 (w), 467 (w), 456 (w), 445 (w), 427 (w), 417 (w), 406 (w). 
HRMS (ESI) calcd for C12H19OS [M+H]
+: 211.1151; found: 211.1145. 
 
 
1-(furan-2-yl)-4,4-dimethylpentan-3-one (S47) was prepared according to GP1 (t = 2 h) from 
furfural (10 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (0.5% Pd, t = 16 h) in 17% yield 
as a colorless oil. Purified by flash column chromatography on silica gel (5% ethyl acetate in 
cyclohexane). 
TLC (10% ethyl acetate in hexanes): Rf: 0.41 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.28 (dd, J = 1.9, 0.9 Hz, 1H), 6.26 (dd, J = 3.1, 1.9 Hz, 1H), 5.98 
(dq, J = 3.2, 0.8 Hz, 1H), 2.90 (ddt, J = 8.4, 6.0, 1.3 Hz, 2H), 2.86 – 2.79 (m, 2H), 1.13 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 214.6, 155.2, 141.1, 110.3, 105.3, 44.3, 35.1, 26.5, 22.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2969 (s), 2934 (w), 2910 (w), 2871 (w), 1706 (vs), 1597 (w), 1508 (m), 1478 
(s), 1466 (w), 142 (w), 1412 (w), 1394 (w), 1365 (s), 1296 (w), 122 (w), 1149 (m), 1084 (s), 1074 
(s), 1043 (w), 1009 (s), 953 (m), 922 (m), 898 (w), 885 (m), 851 (w), 803 (m), 729 (s), 687 (w), 600 
(m), 587 (w), 470 (w), 418 (w).  
HRMS (ESI) calcd for C11H16NaO2 [M+Na]
+: 203.1043; found: 203.1028. 
 
 
2-(2-(2-(tert-butyl)oxiran-2-yl)ethyl)furan (S48) was prepared according to GP3 (1.6 equiv NaH, 
1.5 equiv Me3SI) from S47 (0.5 mmol, 1 equiv) in 77% yield as a colorless oil. Purified by flash 
column chromatography on silica gel (5% ethyl acetate in hexanes). 
TLC (10% ethyl acetate in hexanes): Rf: 0.43 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 7.29 (dd, J = 1.9, 0.9 Hz, 1H), 6.27 (dd, J = 3.2, 1.8 Hz, 1H), 5.98 
(dq, J = 2.9, 0.9 Hz, 1H), 2.76 (d, J = 4.1 Hz, 1H), 2.59 (d, J = 4.1 Hz, 1H), 2.64 – 2.54 (m, 1H), 
2.53 – 2.44 (m, 1H), 2.18 (ddd, J = 14.6, 10.5, 6.1 Hz, 1H), 2.12 – 2.02 (m, 1H), 0.97 (s, 9H) 
13
C NMR (101 MHz, CDCl3) δ 156.0, 141.0, 110.3, 104.8, 63.1, 48.0, 34.1, 27.8, 26.1, 23.1. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3117 (w), 3055 (w), 2962 (s), 2873 (m), 1597 (w), 1508 (m), 1480 (m), 
1467 (w), 1450 (w), 1394 (w), 1365 (m), 1346 (w), 1258 (w), 1212 (w), 1147 (m), 1126 (w), 1103 
(w), 1078 (w), 1040 (w), 1006 (m), 926 (m), 885 (w), 839 (w), 800 (m), 727 (s), 644 (w), 599 (m), 
549 (w), 526 (w), 457 (w), 445 (w), 418 (w). 
HRMS (ESI) calcd for C12H19O2 [M+H]
+: 195.1380; found: 195.1375. 
 
 
4,4-dimethyl-1-(5-methylfuran-2-yl)pentan-3-one (S49) was prepared according to GP1 (t = 2 h) 
from 5-methylfuran-2-carbaldehyde (5 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (2% 
Pd, t = 24 h) in 18% yield as a colorless oil. Purified by flash column chromatography on silica gel 
(5% ethyl acetate in cyclohexane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.26 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 5.84 (d, J = 3.1 Hz, 1H), 5.82 (d, J = 3.1 Hz, 1H), 2.88 – 2.75 (m, 
4H), 2.23 (s, 3H), 1.13 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 214.7, 153.3, 150.6, 106.0, 105.8, 44.3, 35.3, 26.5, 22.7, 13.6. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2967 (m), 2923 (w), 2871 (w), 1706 (s), 1618 (w), 1570 (m), 1478 (m), 
1465 (w), 1438 (w), 1412 (w), 1394 (m), 1366 (w), 1295 (w), 1219 (m), 1147 (w), 1080 (s), 1019 
(s), 983 (w), 957 (m), 934 (w), 905 (w), 851 (w), 780 (s), 700 (w), 653 (w), 622 (w), 566 (w), 499 
(w), 484 (w), 426 (w), 409 (w).  
HRMS (ESI): calcd for C12H19O2 [M+H]
+: 195.1380; found: 195.1376. 
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2-(2-(2-(tert-butyl)oxiran-2-yl)ethyl)-5-methylfuran (S50) was prepared according to GP3 
(1.6 equiv NaH, 1.5 equiv Me3SI) from S49 (0.5 mmol, 1 equiv) in 84% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (1% ethyl acetate in cyclohexane grading to 
5% ethyl acetate in cyclohexane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.31 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 5.84 (d, J = 3.3 Hz, 1H), 5.83 (d, J = 3.3 Hz, 1H), 2.75 (d, J = 4.1 
Hz, 1H), 2.59 (d, J = 4.1 Hz, 1H), 2.57 – 2.49 (m, 1H), 2.47 – 2.38 (m, 1H), 2.24 (s, 3H), 2.20 – 
2.12 (m, 1H), 2.09 – 2.00 (m, 1H), 0.97 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 154.1, 150.4, 105.9, 105.4, 63.1, 48.0, 34.1, 27.9, 26.1, 23.1, 13.6. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3054 (w), 2960 (s), 2873 (w), 1617 (w), 1570 (m), 1480 (m), 1466 (w), 
1451 (w), 1394 (w), 1365 (m), 1293 (w), 1256 (w), 1218 (s), 1146 (w), 1125 (w), 1020 (s), 996 (w), 
939 (m), 894 (w), 837 (w), 812 (w), 778 (s), 670 (w), 623 (w), 548 (w), 526 (w).  
HRMS (ESI): calcd for C13H21O2 [M+H]
+: 209.1536; found: 209.1533. 
 
 
6-hydroxy-2,2-dimethylhexan-3-one (S51): 
To a solution of γ-butyrolactone (2.61 mL, 34 mmol, 1 eq) in diethyl ether (75 mL) was dropwise 
added a solution of t-butyl lithium (1.60 M in n-hexane, 23.4 mL, 37.4 mmol, 1.1 equiv) at –78 °C. 
After 2 h excess base was quenched by addition of saturated aqueous ammonium chloride solution 
(50 mL). The layers were separated and the aqueous layer was extracted with diethyl ether 
(2 × 100 mL). The combined organic layers were dried over anhydrous magnesium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in n-pentane) to yield alcohol S51 (408 mg, 
2.83 mmol, 8%) as a colorless oil.  
The analytical data were in full agreement with those reported in the literature.[145] 
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6-((tert-butyldimethylsilyl)oxy)-2,2-dimethylhexan-3-one (S52): 
A solution of primary alcohol S51 (408 mg, 2.83 mmol, 1 equiv) in dichloromethane (10 mL) was 
treated with imidazole (241 mg, 3.54 mmol, 1.25 equiv) and t-butyldimethylsilyl chloride (469 mg, 
3.11 mmol, 1.10 equiv) sequentially in one portion at 0 °C. The mixture was slowly warmed to 
23 °C. After 14 h saturated aqueous sodium bicarbonate solution (10 mL) was added and the layers 
were separated. The aqueous layer was extracted with diethyl ether (2×15 mL) and the combined 
organic layers were dried over anhydrous magnesium sulfate. The dried solution was filtered and 
the filtrate was concentrated. The residue was purified by flash column chromatography on silica 
gel (5% diethyl ether in n-pentane) to yield silylether S52 (467 mg, 1.81 mmol, 64%) as a colorless 
liquid. 
TLC (5% diethyl ether in n-pentane): Rf: 0.37 (CAM) 
1
H-NMR (400 MHz, CDCl3): δ = 3.59 (t, J = 6.1 Hz, 2H), 2.56 (t, J = 7.2 Hz, 2H), 1.75 (tt, J = 7.2, 
6.1 Hz, 2H), 1.13 (s, 9H), 0.88 (s, 9H), 0.03 (s, 6H). 
13
C-NMR (101 MHz, CDCl3): δ = 216.1, 62.3, 44.3, 32.8, 27.1, 26.6, 26.1, 18.4, –5.2. 
IR (ATR, neat): ?̃? = 2955 (m), 2930 (m), 2858 (w), 1707 (s), 1473 (w), 1390 (w), 1363 (w), 1254 
(m), 1090 (s), 1005 (w), 958 (m), 833 (s), 774 (s), 734 (w). 
HRMS (ESI): calcd for C14H30NaO2Si [M+Na]
+: 281.1907; found: 281.1895. 
 
 
tert-butyl(3-(2-(tert-butyl)oxiran-2-yl)propoxy)dimethylsilane (S53) was prepared according to 
GP3 (2.0 equiv NaH, 1.9 equiv Me3SI) from S52 (1.64 mmol, 1 equiv) in 57% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (5% diethyl ether in n-pentane). 
TLC (5% diethyl ether in n-pentane): Rf: 0.39 (CAM) 
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1
H-NMR (400 MHz, CDCl3): δ = 3.58 (qt, J = 10.1, 6.3 Hz, 2H), 2.72 (d, J = 4.3 Hz, 1H), 2.55 (d, 
J = 4.3 Hz, 1H), 1.89 (ddd, J = 14.5, 10.2, 6.3 Hz, 1H), 1.70 (ddd, J = 14.5, 10.4, 5.6 Hz, 1H), 1.49 
– 1.35 (m, 2H), 0.94 (s, 9H), 0.89 (s, 9H), 0.04 (s, 6H). 
13
C-NMR (101 MHz, CDCl3): δ = 63.5, 63.4, 48.1, 34.1, 27.9, 26.2, 26.1, 26.0, 18.5, –5.1, –5.2. 
IR (ATR, neat): ?̃? = 2956 (m), 2929 (m), 2858 (w), 1472 (w), 1392 (w), 1363 (w), 1254 (m), 1208 
(w), 1100 (s), 1006 (w), 969 (w), 939 (w), 835 (s), 775 (s). 
HRMS (ESI): calcd for C15H33O2Si [M+H]
+: 273.2244; found: 273.2252. 
 
 
3-(2-(tert-butyl)oxiran-2-yl)propan-1-ol (S54): 
A solution of silylether S53 (136 mg, 0.500 mmol, 1 equiv) in tetrahydrofuran (5 mL) was treated 
with a solution of tetra-n-butylammonium fluoride (1.00 M in tetrahydrofuran, 0.750 mL, 
0.750 mmol, 1.50 equiv) at 0 °C. After 30 min further tetra-n-butylammonium fluoride solution in 
tetrahydrofuran (1.00 M, 0.250 mL, 0.250 mmol, 0.50 equiv) was added. After 45 min aqueous 
phosphate buffer solution (5 mL, pH=7) was added and the layers were separated. The aqueous 
layer was extracted with diethyl ether (4 × 10 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate, filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (50% ethyl acetate in n-pentane) to yield primary 
alcohol S54 (78.0 mg, 0.493 mmol, 99%) as pale yellow oil. 
TLC (30% ethyl acetate in n-pentane): Rf: 0.39 (CAM) 
1
H-NMR (400 MHz, CDCl3): δ = 3.60 (t, J = 6.2 Hz, 2H), 2.75 (dd, J = 4.1, 0.8 Hz, 1H), 2.59 (d, 
J = 4.1 Hz, 1H), 1.99 – 1.76 (m, 3H), 1.48 (dddd, J = 12.9, 8.8, 6.3, 3.1 Hz, 2H), 0.95 (s, 9H). 
13
C-NMR (101 MHz, CDCl3): δ = 63.6, 63.3, 48.2, 34.1, 27.5, 26.2, 26.2. 
IR (ATR, neat): ?̃? = 3384 (m, br), 2957 (s), 2873 (m), 1481 (m), 1394 (m), 1364 (m), 1211 (w), 
1131 (w), 1059 (s), 1024 (m), 937 (m), 821 (m). 
HRMS (LTP): calcd for C9H19O2 [M+H]
+: 159.1380; found: 159.1388. 
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3-(3,4-dimethoxyphenyl)-propanal (S57): 
To a solution of Meldrum’s acid (1.00 g, 6.94 mmol, 1 equiv) in water (25 mL) was added 3,4-
dimethoxybenzaldehyde (1.27 g, 7.63 mmol, 1.10 equiv). The mixture was stirred at 75 °C for 2 h. 
The suspension was cooled down to 0 °C and the yellow precipitate (S55) was filtered and washed 
with cold water (50 mL) and cyclohexane (50 mL).  
The crude solid (1.86 g, 6.36 mmol, 1 equiv) was dissolved in a mixture of dichloromethane 
(50 mL) and acetic acid (7 mL) at 0 °C. Sodium borohydride (480 mg, 12.7 mmol, 2.00 equiv) was 
added portionwise at 0 °C. The reaction mixture was allowed to reach 23 °C and stirred for 1 h. By 
careful addition of saturated aqueous sodium bicarbonate solution (50 mL) excess reductant was 
quenched. The mixture was extracted with dichloromethane (3 × 20 mL). The combined organic 
layers were washed with saturated aqueous sodium chloride solution (10 mL) and the washed 
solution was dried over magnesium sulfate. The solution was filtered and the filtrate was 
concentrated under reduced pressure to afford the crude product S56 (1.8 g).  
The crude product (1.8 g, approx. 6.1 mmol, 1 equiv) was dissolved in tetrahydrofuran (40 mL). 
Triethylamine (1.7 mL, 12 mmol, 2.0 equiv) and phenylsilane (2.3 mL, 18 mmol, 3.0 equiv) were 
added to the solution and the reaction mixture was stirred for 3 h at 23 °C. Excess silane was 
quenched by addition of water (6 mL) and stirring for 15 min. The reaction mixture was diluted 
with diethyl ether (200 mL) and washed with water (2 × 100 mL) and saturated aqueous sodium 
chloride solution (100 mL). The organic layer was dried over sodium sulfate and filtered. The 
filtrate was concentrated under reduced pressure and purified by flash column chromatography on 
silica gel to afford 3-(3,4-dimethoxyphenyl)-propanal (S57) (1.16 g, 86% over 3 steps) as a 
colorless oil.  
The analytical data were in full agreement with those reported in the literature.[146] 
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Ethyl (E)-5-(3,4-dimethoxyphenyl)-2-methylpent-2-enoate (S58): 
To a solution of aldehyde S57 (2.03 g, 10.5 mmol, 1 equiv) in dichloromethane (52 mL, 0.20 M) 
was added ethyl 2-(triphenyl-l5-phosphaneylidene)propanoate (7.58 g, 20.9 mmol, 2.00 equiv) at 
23 °C and the resulting pale yellow solution was stirred at 23 C. After 16 h the mixture was 
concentrated and the yellow solid was purified by flash column chromatography (30% diethyl ether 
in petrol ether) to yield ester S58 (2.92 g, 10.5 mmol, >99%) as a colorless oil. 
TLC (15% ethyl acetate in cyclohexane): Rf: 0.15 (UV, CAM) 
1H NMR (400 MHz, CDCl3) δ 6.83 – 6.76 (m, 2H), 6.76 – 6.67 (m, 2H), 4.18 (q, J = 7.1 Hz, 2H), 3.87 (s, 
3H), 3.86 (s, 3H), 2.70 (dd, J = 8.6, 6.8 Hz, 2H), 2.54 – 2.41 (m, 2H), 1.82 – 1.72 (m, 3H), 1.29 (t, J = 7.2 
Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 168.3, 149.0, 147.5, 141.1, 134.0, 128.6, 120.3, 111.9, 111.4, 60.6, 
56.1, 56.0, 34.5, 30.9, 14.4, 12.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2935 (m), 2834 (m), 1707 (s), 1649 (w), 1591 (w), 1516 (s), 1464 (m), 1418 
(m), 1367 (w), 1262 (s), 1240 (s), 1156 (m), 1141 (m), 1112 (m), 1078 (m), 1030 (m), 807 (w), 764 
(w).  
HRMS (ESI): calcd for C16H22NaO4 [M+Na]
+: 301.1410; found: 301.1390. 
 
 
Ethyl 5-(3,4-dimethoxyphenyl)-2-methylpentanoate (S59) 
To a solution of ester S58 (2.91 g, 10.5 mmol, 1 equiv) in ethanol (105 mL, 0.10 M) was added 
palladium on charcoal (10% palladium on activated charcoal, 1.11 g, 1.05 mmol, 10 mol%) and the 
resulting black suspension was sparged with hydrogen gas for 20 min and stirring under hydrogen 
atmosphere was continued until full conversion. After 16 h Celite® was added and the mixture was 
filtered through a pad of Celite®. The filtrate was concentrated under reduced pressure and the crude 
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product was purified by flash column chromatography on silica gel (30% diethyl ether in petrol 
ether) to yield ester S59 (2.73 g, 10.5 mmol, 93%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.31 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.81 – 6.76 (m, 1H), 6.72 – 6.66 (m, 2H), 4.12 (q, J = 7.1 Hz, 2H), 
3.87 (s, 3H), 3.85 (s, 3H), 2.59 – 2.52 (m, 2H), 2.49 – 2.38 (m, 1H), 1.77 – 1.65 (m, 1H), 1.65 – 
1.55 (m, 2H), 1.52 – 1.39 (m, 1H), 1.24 (t, J = 7.1 Hz, 3H), 1.14 (d, J = 7.0 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 176.9, 148.9, 147.3, 135.0, 120.3, 111.9, 111.3, 60.3, 56.1, 56.0, 
40.0, 35.5, 33.5, 29.4, 17.3, 14.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2938 (m), 2859 (m), 2835 (m), 1730 (s), 1590 (w), 1516 (s), 1464 (m), 1418 
(m), 1377 (w), 1260 (m), 1238 (m), 1189 (m), 1156 (m), 1156 (m). 1030 (m), 808 (w), 764 (w).  
HRMS (ESI): calcd for C16H24NaO4 [M+Na]
+: 303.1567; found: 303.1548. 
 
 
Ethyl 5-(3,4-dimethoxyphenyl)-2,2-dimethylpentanoate (S60) 
To a solution of N,N ́-diisopropylamine (1.26 mL, 8.92 mmol, 5.00 equiv) in tetrahydrofuran 
(18 mL, 0.50 M) was added n-butyllithium (2.10 M in hexanes, 4.08 mL, 8.56 mmol, 4.80 equiv) 
dropwise at –78°C. The mixture was warmed to 0 °C. Hexamethylphosphoramide (3.10 mL, 
17.8 mmol, 10.0 equiv) was added dropwise and the solution was stirred for 30 min at 0 °C before 
a solution of ester S59 (500 mg, 1.78 mmol, 1 equiv) in tetrahydrofuran (1.8 mL, 1.0 M) was added 
dropwise at 0 °C. After 60 min, the mixture was cooled to –78 °C and iodomethane (781 µL, 
12.5 mmol, 7.00 equiv) was added dropwise. The reaction mixture was allowed to warm to 23 °C. 
After 16 h, excess of iodomethane was removed by distillation under reduced pressure (200 mbar). 
The solution was diluted with diethyl ether (30 mL) and aqueous hydrochloric acid (2.0 M, 50 mL) 
was added to quench excess of. The layers were separated and the aqueous layer was extracted with 
diethyl ether (3×40 mL). The combined organic layers were washed with water and saturated 
aqueous sodium chloride solution and dried over magnesium sulfate and filtered. The filtrate was 
concentrated under reduced pressure and the crude product was purified by flash column 
chromatography on silica gel (30% diethyl ether in petrol ether) to yield ester S60 (478 mg, 
1.62 mmol, 91%) as a colorless oil. 
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TLC (20% ethyl acetate in cyclohexane): Rf: 0.29 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.78 (d, J = 7.9 Hz, 1H), 6.73 – 6.66 (m, 2H), 4.10 (q, J = 7.1 Hz, 
2H), 3.87 (s, 3H), 3.85 (s, 3H), 2.53 (td, J = 5.6, 4.3, 2.4 Hz, 2H), 1.61 – 1.49 (m, 4H), 1.22 (t, J = 
7.1 Hz, 3H), 1.15 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 178.1, 148.9, 147.3, 135.1, 120.3, 111.9, 111.3, 60.3, 56.1, 56.0, 
42.2, 40.4, 36.0, 27.1, 25.3, 14.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2938 (m), 2872 (m) 1725 (s), 1590 (w), 1516 (s), 1465 (m), 1417 (w), 1386 
(w), 1366 (w), 1261 (m), 1237 (m), 1176 (m), 1141 (m), 1030 (m), 764 (w).  
HRMS (ESI): calcd for C17H26NaO4 [M+Na]
+: 317.1723; found: 317.1703. 
 
 
5-(3,4-dimethoxyphenyl)-N-methoxy-N,2,2-trimethylpentanamide (S61) 
To a solution of ester S60 (471 mg, 1.60 mmol, 1 equiv) and N,O-dimethylhydroxylamine 
hydrochloride (780 mg, 8.00 mmol, 5.00 equiv) in tetrahydrofuran (16 mL, 0.10 M) was added 
isopropylmagnesium chloride (2.00 M in tetrahydrofuran, 7.20 mL, 14.4 mmol, 9.00 equiv) 
dropwise at 0 °C. After 4 h the mixture was diluted with diethyl ether (20 mL) and excess of base 
was quenched with saturated aqueous ammonium chloride solution (40 mL). The layers were 
separated and the aqueous layer was extracted with diethyl ether (3×20mL). The combined organic 
layers were dried over sodium sulfate and filtered. The filtrate was concentrated under reduced 
pressure and the crude product was purified by flash column chromatography on silica gel (60% 
diethyl ether in petrol ether) to yield Weinreb amide S61 (298 mg, 962 µmol, 60%) as a pale yellow 
oil and starting material S60 (160 mg, 543 µmol, 34%). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.10 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.80 – 6.74 (m, 1H), 6.73 – 6.67 (m, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 
3.59 (s, 3H), 3.15 (s, 3H), 2.54 (t, J = 7.3 Hz, 2H), 1.68 – 1.60 (m, 2H), 1.60 – 1.50 (m, 2H), 1.21 
(s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 178.8, 148.9, 147.2, 135.2, 120.4, 111.9, 111.3, 60.5, 56.1, 56.0, 
43.2, 39.6, 36.0, 33.9, 27.0, 25.7. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2934 (s), 2835(m), 1644(s), 1590 (w), 1515 (s), 1464 (m), 1417 (m), 1386 
(w), 1355 (m), 1261 (m), 1236 (m), 1156 (m), 1030 (m), 944 (m), 808 (w), 763 (w), 
HRMS (ESI): calcd for C17H27NNaO4 [M+Na]
+: 332.1832; found: 332.1812. 
 
 
6-(3,4-dimethoxyphenyl)-3,3-dimethylhexan-2-one (S62) 
To a solution of Weinreb amide S61 (250 mg, 808 µmol, 1 equiv) in diethyl ether (8.0 mL, 0.10 M) 
was added a methylmagnesium bromide solution (1.00 M in tetrahydrofuran, 1.62 mL, 1.62 mmol, 
2.00 equiv) dropwise at –78°C and after complete addition the reaction mixture was allowed to 
warm up to 0 °C. After 4 h excess of base was quenched by the addition of aqueous hydrogen 
chloride solution (1.0 M, 20 mL). The layers were separated and the aqueous layer was extracted 
with diethyl ether (3×20mL). The combined organic layers dried over sodium sulfate and filtered. 
The filtrate was concentrated under reduced pressure and the crude product was purified by flash 
column chromatography on silica gel chromatography (30% diethyl ether in petrol ether) to yield 
ketone S62 (148 mg, 560 µmol, 68%) as a yellow oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.23 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.78 (d, J = 7.9 Hz, 1H), 6.72 – 6.63 (m, 2H), 3.86 (s, 3H), 3.84 (s, 
3H), 2.52 (t, J = 7.1 Hz, 2H), 2.05 (s, 3H), 1.57 – 1.40 (m, 4H), 1.09 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 214.1, 148.9, 147.3, 134.8, 120.3, 111.8, 111.3, 56.0, 55.9, 47.8, 
39.5, 36.0, 26.8, 25.1, 24.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2936 (s), 2861 (m), 1703 (s), 1590 (w), 1516 (w), 1464 (m), 1417 (m), 1354 
(w), 1261 (m), 1237 (m), 1141 (m), 1030 (m).  
HRMS (ESI): calcd for C16H24NaO3 [M+Na]
+: 287.1618; found: 287.1601. 
  
Experimental Section 
 
271 
 
 
2-(5-(3,4-dimethoxyphenyl)-2-methylpentan-2-yl)-2-methyloxirane (S63) was prepared 
according to GP3 (2.0 equiv NaH, 2.0 equiv Me3SI) from S62 (548 µmol, 1 equiv) in 92% yield as 
a pale yellow oil. Purified by flash column chromatography on silica gel (30% diethyl ether in 
petrol ether). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.29 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.37 (m, 2H), 7.32 (ddd, J = 7.9, 6.8, 1.2 Hz, 2H), 7.26 – 
7.17 (m, 1H), 6.70 (d, J = 8.1 Hz, 1H), 6.55 – 6.45 (m, 2H), 3.81 (s, 3H), 3.79 (s, 3H), 2.97 (dd, J 
= 4.3, 0.7 Hz, 1H), 2.77 (d, J = 4.3 Hz, 1H), 2.32 (ddd, J = 13.7, 11.3, 5.2 Hz, 1H), 2.21 (ddd, J = 
13.7, 11.3, 6.0 Hz, 1H), 1.86 (ddd, J = 14.8, 11.3, 6.0 Hz, 1H), 1.74 (ddd, J = 14.8, 11.3, 5.3 Hz, 
1H), 1.34 (s, 3H), 1.31 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.9, 147.2, 135.3, 120.3, 111.9, 111.3, 61.3, 56.1, 56.0, 51.3, 
39.5, 36.4, 36.1, 26.4, 23.6, 23.5, 18.7. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2938 (s), 1590 (w), 1515 (s), 1464 (m), 1378 (w), 1261 (m), 1237 (m), 1141 
(m), 1030 (m), 806 (w).  
HRMS (ESI): calcd for C17H26NaO3 [M+Na]
+: 301.1774; found: 301.1756. 
 
9.2.2.10 Unsuccessful substrates 
 
4,4-dimethyl-1-(pyridin-2-yl)pentan-3-one (S64) was prepared according to GP1 (t = 4 h) from 
pyridine-2-carbaldehyde (5 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (1% Pd, t = 5 h) 
in 21% yield as a colorless oil. Purified by flash column chromatography on silica gel (25% ethyl 
acetate in cyclohexane grading to 50% ethyl acetate in cyclohexane). 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.43 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ: 8.48 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 7.54 (td, J = 7.7, 1.8 Hz, 1H), 
7.16 (dt, J = 7.8, 1.1 Hz, 1H), 7.06 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H), 3.04 – 2.95 (m, 4H), 1.10 (s, 
9H). 
Experimental Section 
272 
13
C NMR (101 MHz, CDCl3) δ: 215.2, 161.1, 149.3, 136.4, 123.4, 121.2, 44.2, 36.1, 32.2, 26.5. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2967 (m), 2907 (w), 2871 (w), 1702 (s), 1591 (m), 1569 (w), 1475 (s), 1435 
(m), 1394 (w), 1365 (m), 1295 (w), 1224 (w), 1147 (w), 1078 (m), 1050 (w), 985 (m), 828 (w), 788 
(w), 756 (s), 628 (w), 599 (w), 557 (w), 512 (w), 462 (w).  
HRMS (ESI): calcd for C12H18NO [M+H]
+: 192.1383; found: 192.1382. 
 
 
2-(2-(2-(tert-butyl)oxiran-2-yl)ethyl)pyridine (S65) was prepared according to GP3 (1.6 equiv 
NaH, 1.5 equiv Me3SI) from S64 (1.0 mmol, 1 equiv) in 76% yield as a colorless oil. Purified by 
flash column chromatography on silica gel (10% ethyl acetate in cyclohexane grading to 25% ethyl 
acetate in cyclohexane). 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.50 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ: 8.49 (dd, J = 4.9, 1.2 Hz, 1H), 7.55 (td, J = 7.7, 1.9 Hz, 1H), 7.12 
(d, J = 7.8 Hz, 1H), 7.07 (ddd, J = 7.7, 4.9, 1.1 Hz, 1H), 2.74 (d, J = 4.2 Hz, 1H), 2.73 – 2.57 (m, 
2H), 2.64 (d, J = 4.1 Hz, 1H), 2.27 (ddd, J = 14.6, 10.9, 6.0 Hz, 1H), 2.12 (ddd, J = 14.6, 10.9, 5.6 
Hz, 1H), 0.94 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 162.0, 149.3, 136.5, 122.9, 121.1, 63.4, 47.9, 34.1, 33.1, 29.4, 26.1. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3052 (w), 3008 (w), 2961 (s), 2872 (w), 1593 (s), 1569 (m), 1474 (s), 1434 
(s), 1394 (w), 1364 (m), 1316 (w), 1291 (w), 1257 (w), 1211 (w), 1147 (m), 1126 (w), 1095 (w), 
1051 (w), 992 (m), 932 (w), 896 (m), 829 (m), 794 (w), 769 (s), 749 (s), 670 (w), 627 (w), 591 (w), 
554 (m), 516 (m).  
HRMS (ESI): calcd for C13H20NO [M+H]
+: 206.1539; found: 206.1526. 
 
 
4,4-dimethyl-1-(pyridin-3-yl)pentan-3-one (S66) was prepared according to GP1 (t = 4 h) from 
pyridine-3-carbaldehyde (5.0 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (2% Pd, t = 5 h) 
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in 35% yield as a colorless oil. Purified by flash column chromatography on silica gel (25% ethyl 
acetate in cyclohexane grading to 50% ethyl acetate in cyclohexane). 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.33 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 8.46 (d, J = 2.3 Hz, 1H), 8.44 (dd, J = 4.8, 1.7 Hz, 1H), 7.51 (dt, J 
= 7.8, 2.0 Hz, 1H), 7.19 (dd, J = 7.8, 4.8 Hz, 1H), 2.92 – 2.86 (m, 2H), 2.83 – 2.77 (m, 2H), 1.10 
(s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 214.3, 150.0, 147.7, 137.0, 136.1, 123.4, 44.2, 38.0, 27.2, 26.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3030 (w), 2967 (s), 2933 (w), 2908 (w), 2870 (w), 1702 (s), 1592 (w), 1575 
(w), 1478 (s), 1445 (w), 1423 (m), 1395 (w), 1366 (m), 1294 (w), 1224 (w), 1191 (w), 1158 (w), 
1125 (w), 1105 (w), 1078 (s), 1044 (w), 1026 (m), 982 (m), 939 (w), 867 (w), 826 (w), 802 (m), 756 
(w), 714 (s), 631 (m), 596 (w), 553 (w), 505 (w), 455 (w). 
HRMS (ESI): calcd for C12H18NO [M+H]
+: 192.1383; found: 192.1279. 
 
 
3-(2-(2-(tert-butyl)oxiran-2-yl)ethyl)pyridine (S67) was prepared according to GP3 (1.6 equiv 
NaH, 1.5 equiv Me3SI) from S66 (0.50 mmol, 1 equiv) in 89% yield as yellowish oil. Purified by 
flash column chromatography on silica gel (25% ethyl acetate in cyclohexane grading to 50% ethyl 
acetate in cyclohexane). 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.36 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 8.45 – 8.41 (m, 1H), 7.49 (ddd, J = 7.8, 2.4, 1.6 Hz, 1H), 7.19 (ddd, 
J = 7.7, 4.7, 0.9 Hz, 1H), 2.79 (d, J = 4.2 Hz, 1H), 2.65 (d, J = 4.1 Hz, 1H), 2.60 – 2.40 (m, 2H), 
2.17 – 1.94 (m, 2H), 0.96 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 150.0, 147.6, 137.5, 135.9, 123.5, 63.3, 48.0, 34.1, 31.1, 27.8, 26.1. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3051 (w), 3027 (w), 2960 (s), 2872 (m), 1704 (w), 1591 (w), 1575 (m), 
1479 (s), 1423 (s), 1395 (w), 1365 (m), 1291 (w), 1257 (w), 1210 (w), 1194 (w), 1146 (w), 1126 
(w), 1103 (w), 1079 (w), 1027 (m), 978 (w), 930 (w), 895 (w), 843 (w), 827 (m), 801 (m), 751 (w), 
715 (s), 676 (w), 630 (w), 587 (w), 553 (w), 526 (w).  
HRMS (ESI): calcd for C13H20NO [M+H]
+: 206.1539; found: 206.1536. 
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4,4-dimethyl-1-(1,2,3,4-tetrahydroanthracen-9-yl)pentan-3-one (S68) was prepared according 
to GP1 (t = 2 h) from anthracene-9-carbaldehyde (10 mmol, 1 equiv) and pinacolone (1.5 equiv) 
and GP2a (2% Pd, t = 36 h) in 9% yield as a pale yellow solid. Purified by flash column 
chromatography on silica gel (1% ethyl acetate in cyclohexane grading to 5% ethyl acetate in 
cyclohexane grading to 10% ethyl acetate in cyclohexane). Note: very difficult separation from 
byproducts. 
TLC (10% ethyl acetate in hexanes): Rf: 0.46 (CAM) 
mp: 66.0 – 67.9 °C 
1
H NMR (400 MHz, CDCl3) δ 7.91 (d, J = 8.5 Hz, 1H), 7.74 (dd, J = 8.0, 1.5 Hz, 1H), 7.48 (s, 1H), 
7.45 – 7.36 (m, 2H), 3.37 – 3.28 (m, 2H), 2.99 (t, J = 6.1 Hz, 2H), 2.93 (t, J = 6.5 Hz, 2H), 2.80 – 
2.73 (m, 2H), 1.97 – 1.88 (m, 2H), 1.88 – 1.80 (m, 2H), 1.17 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 215.69, 136.4, 134.6, 133.6, 132.4, 130.5, 128.1, 126.1, 125.4, 
124.9, 123.2, 44.4, 36.6, 31.0, 27.1, 26.5, 23.8, 22.9, 22.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3063 (w), 2965 (w), 2930 (s), 2866 (m), 2835 (w), 1703 (s), 1595 (w), 1566 
(w), 1500 (m), 1476 (s), 1434 (w), 1409 (w), 1393 (w), 1365 (w), 1327 (w), 1316 (w), 1291 (w), 
1252 (w), 1234 (w), 1168 (w), 1078 (s), 1023 (w), 979 (m), 949 (w), 911 (m), 874 (m), 847 (m), 824 
(w), 773 (w), 745 (s), 673 (w), 650 (w), 638 (w), 606 (w), 553 (w), 470 (w), 447 (w), 421 (w), 413 
(w).  
HRMS (ESI) calcd for C21H26NaO [M+Na]
+: 317.1876; found: 317.1834. 
 
 
2-(tert-butyl)-2-(2-(1,2,3,4-tetrahydroanthracen-9-yl)ethyl)oxirane (S69) was prepared 
according to GP3 (1.6 equiv NaH, 1.5 equiv Me3SI) from S68 (0.5 mmol, 1 equiv) in 77% yield as 
a colorless solid. Purified by flash column chromatography on silica gel (5% ethyl acetate in 
cyclohexane grading to 10% ethyl acetate in cyclohexane). 
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TLC (10% ethyl acetate in hexanes): Rf: 0.50 (CAM) 
mp: 109.0 – 112.7 °C 
1
H NMR (400 MHz, CDCl3) δ 7.96 (dd, J = 8.5, 1.2 Hz, 1H), 7.73 (dd, J = 8.0, 1.5 Hz, 1H), 7.47 
(s, 1H), 7.44 (ddd, J = 8.5, 6.8, 1.6 Hz, 1H), 7.39 (ddd, J = 7.9, 6.7, 1.3 Hz, 1H), 3.06 – 2.96 (m, 
3H), 2.96 – 2.84 (m, 5H), 2.12 (ddd, J = 14.9, 12.5, 5.6 Hz, 1H), 2.05 – 1.98 (m, 1H), 1.98 – 1.89 
(m, 2H), 1.89 – 1.81 (m, 2H), 1.01 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 136.3, 135.1, 133.4, 132.4, 130.6, 128.0, 125.9, 125.3, 124.8, 123.4, 
63.8, 48.1, 34.2, 31.0, 29.1, 27.0, 26.2, 23.9, 23.0, 22.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3051 (w), 1956 (w), 2930 (s), 2869 (m), 2834 (w), 1704 (w), 1594 (w), 1567 
(w), 1500 (w), 1476 (m), 1449 (w), 1434 (w), 1393 (w), 1363 (m), 1342 (w), 1327 (w), 1316 (w), 
1252 (w), 1234 (w), 1210 (w), 1176 (w9, 1145 (w), 1124 (w), 1102 (w), 1077 (w), 1058 (w), 1028 
(w), 1002 (w), 973 (w), 938 (w), 911 (w), 874 (w), 844 8m), 825 (w), 806 (w9, 778 (w9, 744 (s), 
706 (w), 582 (w), 658 (w), 639 (w), 596 (w), 559 (w), 524 (w), 483 (w), 455 (w).  
HRMS (ESI) calcd for C22H28NaO [M+Na]
+: 331.2032; found: 331.2023. 
 
 
2-benzyl-2-(tert-butyl)oxirane (S164) To a solution of 1-chloro-3,3-dimethylbutan-2-one 
(1.01 mL, 7.43 mmol, 1 equiv) in diethyl ether (14.8 mL) was added a solution of 
benzylmagnesium bromide (1.00 M in tetrahydrofuran, 9.66 mL, 9.66 mmol 1.30 equiv.) at 0 °C 
and the reaction mixture was slowly allowed to warm to 23 °C. After 5 h the mixture was cooled 
to 0 °C and excess of Grignard reagent was quenched by addition of saturated aqueous ammonium 
chloride solution. x 25 mL) and the combined organic were dried over sodium sulfate, filtered and 
the filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (10% diethyl ether in n-pentane) to afforded epoxide S164 (988 mg, 5.19 mmol, 70%) as 
a pale yellow oil. 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.50 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.30 – 7.10 (m, 5H), 3.05 (s, 2H), 2.59 (d, J = 4.4 Hz, 1H), 2.01 (d, 
J = 4.5 Hz, 1H), 1.03 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 137.0, 130.5, 128.1, 126.4, 63.6, 47.6, 35.8, 34.1, 26.4. 
Experimental Section 
276 
HRMS (ESI): calcd for C13H18NaO [M+Na]
+: 213.1250; found: 213.1241. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3028 (m), 2961 (s), 2872 (m), 1480 (m), 1454 (m), 1394 (m), 1365 (m), 1311 
(m), 1202 (w), 1119 (m), 1078 (w), 1031 (m), 971 (m), 899 (m), 816 (m), 755 (m), 698 (s), 658 (m). 
 
 
4,4-dimethyl-1-(4-(trifluoromethyl)phenyl)pentan-3-one (S70) was prepared according to GP1 
(t = 2 h) from 4-trifluoromethyl benzaldehyde (25 mmol, 1 equiv) and pinacolone (1.5 equiv) and 
GP2b  (4 equiv Mg, T = 0 °C, t = 3  h) in 50% yield as a colorless oil. Purified by flash column 
chromatography on silica gel (5% ethyl acetate in cyclohexane). 
TLC (5% diethyl ether in n–pentane): Rf: 0.46 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.52 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 2.93 (t, J = 7.4 
Hz, 2H), 2.81 (ddd, J = 8.0, 7.0, 1.0 Hz, 2H), 1.11 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 214.5, 145.9, 128.9, 128.6 (q, J = 32.3 Hz), 125.5 (q, J = 3.8 Hz), 
124.4 (q, J = 271.8 Hz), 44.2, 38.1, 29.9, 26.5. 
19
F NMR (376 MHz, Chloroform-d) δ -62.37. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2970 (w,br), 1704 (m), 1618 (w), 1479 (w), 1418 (w), 1367 (w), 1322 (s), 
1162 (m), 1120 (s), 1066 (s), 1018 (m), 982 (w), 832 (m), 735 (w) cm−1. 
HRMS (ESI): calcd for C14H18F3O [M+H]
+: 259.1304; found: 259.1304. 
 
 
2-(tert-butyl)-2-(4-(trifluoromethyl)phenethyl)oxirane (S71) was prepared according to GP3 
(2.0 equiv NaH, 1.9 equiv Me3SI) from S70 (1.50 mmol, 1 equiv) in 60% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (5% diethyl ether in n-pentane). 
TLC (5% diethyl ether in n-pentane) Rf:  0.48 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ: 7.34 (d, J = 7.7 Hz, 2H), 7.10 (d, J = 8.3 Hz, 2H), 2.61 (dd, J = 4.1, 
0.8 Hz, 1H), 2.46 (d, J = 4.1 Hz, 1H), 2.45 – 2.26 (m, 2H), 2.03 – 1.79 (m, 2H), 0.79 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 146.5, 128.8, 128.4 (q, J = 32.3 Hz), 125.5 (q, J = 3.8 Hz), 124.5 
(q, J = 271.9 Hz), 63.3, 48.0, 34.1, 31.2, 30.5, 26.1. 
19
F NMR (376 MHz, Chloroform-d) δ -62.33. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2963 (br w), 1619 (w), 1481 (w), 1417 (w), 1365 (w), 1324 (s), 1163 (m), 
1122 (s), 1068 (s), 1019 (w), 932 (w), 836 (w). 
HRMS (ESI) calcd for C15H19F3O2Na [M+Na]+: 295.1280; found: 295.1274. 
 
 
1-(3-trifluoromethylphenyl)-4,4-dimethylpentan-3-one (S72) was prepared according to GP1 (t 
= 3 h) from 3-trifluoromethylbenzaldehyde (5.0 mmol, 1 equiv) and pinacolone (1.5 equiv) and 
GP2b (4 equiv Mg, T = –30 °C, t = 4 h) in 43% yield as a yellow oil. Purified by flash column 
chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% diethyl ether in n-pentane) Rf: 0.41 (UV, KMnO4) 
1
H NMR (300 MHz, CDCl3) δ 7.49 – 7.34 (m, 4H), 2.99 – 2.89 (m, 2H), 2.87 – 2.72 (m, 2H), 1.11 
(s, 9H). 
13
C NMR (151 MHz, CDCl3) δ 214.5, 142.6, 132.1, 130.9 (d, J = 32.2 Hz), 129.0, 125.2 (d, J = 3.3 
Hz), 124.3 (d, J = 271.9 Hz), 123.1 (d, J = 3.4 Hz), 44.2, 38.2, 29.9, 26.4. 
19
F NMR (376 MHz, CDCl3) δ -62.60. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2970 (w), 2909 (w), 2873 (w), 1705 (m), 1478 (w), 1450 (w), 1329 (s), 
1200 (w), 1163 (m), 1123 (s), 1098 (w), 1074 (m), 983 (w), 802 (w), 703 (w). 
HRMS (ESI): calcd for C14H17F3ONa [M+Na]
+: 281.1129; found: 281.1119. 
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3-trifluoromethyl-2-(3-methylphenethyl)oxirane (S73) was prepared according to GP3 
(3.0 equiv NaH, 2.7 equiv Me3SI) from S72 (1.5 mmol, 1 equiv) in 51% yield as a yellow oil. 
Purified by flash column chromatography on silica gel (5% diethyl ether in n-pentane). 
TLC (10% diethyl ether in n-pentane) Rf 0.55 (UV, KMnO4) 
1
H NMR (300 MHz, CDCl3) δ 7.49 – 7.41 (m, 2H), 7.41 – 7.31 (m, 2H), 2.80 (d, J = 4.1 Hz, 1H), 
2.65 (d, J = 4.1 Hz, 1H), 2.63 – 2.44 (m, 2H), 2.24 – 1.92 (m, 2H), 0.98 (s, 9H). 
13
C NMR (75 MHz, CDCl3) δ 143.2, 131.9, 131.1, 130.9 (d, J = 31.9 Hz), 129.0, 125.1 (q, J = 3.4 
Hz), 124.37 (q, J= 271.87 Hz), 122.9 (q, J = 3.6 Hz), 63.3, 48.1, 34.1, 31.3, 30.5, 26.1. 
19
F NMR (282 MHz, CDCl3) δ -62.57. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥:  2970 (w), 2911 (w), 2874 (w), 1705 (m), 1616 (w), 1479 (w), 1450 (w), 
1330 (s), 1199 (w), 1330 (s), 1199 (w), 1164 (m), 1125 (s), 1098 (w), 1074 (m), 983 (w), 802 (w), 
703 (w).  
HRMS (ESI): calcd for C15H19F3ONa [M+Na]
+: 295.1286; found: 295.1273. 
 
 
4-(4,4-dimethyl-3-oxopentyl)-N,N-diethylbenzamide (S74) A solution of 4-carboxy 
benzaldehyde (3.00 g, 20.0 mmol, 1 equiv) in dichloromethane (40 mL) was treated with N-methyl 
morpholine (3.03 g, 30.0 mmol, 1.50 equiv) and iso-butyl chlorocarbonate (3.55 g, 26.0 mmol, 
1.3 equiv) at –15 °C. The mixture stirred for 30 min before the cooling bath was removed. After 
1 h diethylamine (3.10 mL, 30.0 mmol, 1.50 equiv) was added dropwise at  
–15 °C. After 4.5 h aqueous hydrogen chloride solution (1 M, 30 mL) was added and the layers 
were separated. The organic layer was washed with aqueous hydrogen chloride solution (1 M, 
2×30 mL) and dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate 
was concentrated. The crude amide was subjected to GP1 (t = 2.5 h, 1.5  equiv pinacolone ) and 
GP2b (4 equiv Mg, T = 0 °C, t = 4  h) to yield S74 in 28% yield as a colorless oil. Purified by flash 
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column chromatography on silica gel (10% ethyl acetate in cyclohexane grading to 40% ethyl 
acetate in cyclohexane). 
TLC (30% ethyl acetate in n-pentane): Rf: 0.19 (UV, KMnO4) 
1
H NMR (400 MHz, CDCl3) δ: 7.30 – 7.26 (m, 2H), 7.22 – 7.17 (m, 2H), 3.51 (s, 2H), 3.38 – 3.13 
(m, 2H), 2.96 – 2.84 (m, 2H), 2.82 – 2.73 (m, 2H), 1.31 – 1.11 (m, 6H), 1.10 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 214.8, 171.5, 142.9, 135.1, 128.6, 126.7, 44.2, 43.6 (br), 39.4 (br), 
38.4, 30.0, 26.5, 14.3 (br), 13.1 (br). 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2969 (br m), 1703 (m), 1627 (s), 1512 (w), 1474 (m), 1425 (s), 1365 (m), 
1315 (m), 1286 (m), 1221 (w), 1094 (m), 1079 (m), 983 (w), 835 (m), 790 (w), 761 (w). 
HRMS (ESI): calcd for C18H27NO2Na [M+Na]
+: 312.1934; found: 312.1926. 
 
 
4-(2-(2-(tert-butyl)oxiran-2-yl)ethyl)-N,N-diethylbenzamide (S75) was prepared according to 
GP3 (2.0 equiv NaH, 1.9 equiv Me3SI) from S74 (1.50 mmol, 1 equiv) in 81% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (35% ethyl acetate in n-pentane). 
TLC (5% ethyl acetate in n-pentane) Rf:  0.24 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.31 – 7.26 (m, 2H), 7.21 – 7.16 (m, 2H), 3.61 – 3.42 (m, 2H), 3.27 
(s, 2H), 2.77 (dd, J = 4.1, 0.7 Hz, 1H), 2.65 (d, J = 4.1 Hz, 1H), 2.52 (dddd, J = 39.6, 13.6, 11.4, 
5.5 Hz, 2H), 2.05 (dddd, J = 45.7, 14.7, 11.4, 5.5 Hz, 2H), 1.29 – 1.17 (m, 3H), 1.17 – 1.09 (m, 
3H), 0.96 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ: 171.5, 143.5, 135.0, 128.4, 126.6, 63.4, 48.1, 43.4, 39.3, 34.1, 
31.3, 30.5, 26.2, 14.4, 13.0.
 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2967 (br m), 2873 (w), 1630 (s), 1458 (m), 1425 (m), 1381 (w), 1364 (w), 
1315 (w), 1286 (m), 1220 (w), 1094 (m), 940 (w), 835 (m). 
HRMS (ESI) calcd for C19H29NO2Na [M+Na]+: 326.2091; found: 326.2083. 
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tert-butyl 4-(4,4-dimethyl-3-oxopentyl)benzoate (S76) was prepared according to GP1 (t = 3 h) 
from t-butyl 4-formylbenzoate (10 mmol, 1 equiv) and pinacolone (1.5 equiv) and GP2a (1% Pd, t 
= 16 h) in 23% yield as a colorless solid. Purified by flash column chromatography on silica gel 
(10% ethyl acetate in petrol ether). 
TLC (10% ethyl acetate in petrol ether) Rf 0.21 (UV, KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 8.3 Hz, 2H), 7.22 (d, J = 8.2 Hz, 2H), 2.92 (t, J = 7.4 
Hz, 2H), 2.80 (ddd, J = 8.1, 6.9, 1.0 Hz, 2H), 1.58 (s, 9H), 1.10 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 214.6, 165.9, 146.7, 130.1, 129.8, 128.4, 80.9, 44.2, 38.2, 30.1, 
28.4, 26.5. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2971 (m), 2933 (w), 2871 (w), 1709 (s), 1612 (w), 1367 (m), 1292 (s), 1255 
(w), 1167(m), 1115 (m), 1078 (w). 
HRMS (ESI): calcd for C18H26O3Na [M+Na]
+: 313.1780; found: 313.1761. 
 
 
tert-butyl 4-(2-(2-(tert-butyl)oxiran-2-yl)ethyl)benzoate (S77) was prepared according to GP3 
(3.0 equiv NaH, 2.9 equiv Me3SI) from S76 (1.5 mmol, 1 equiv) in 78% yield as a yellow oil. 
Purified by flash column chromatography on silica gel (10% ethyl acetate in petrol ether). 
TLC (5% ethyl acetate in petrol ether) Rf 0.45 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.93 – 7.87 (m, 2H), 7.24 – 7.17 (m, 2H), 2.78 (dd, J = 4.1, 0.8 Hz, 
1H), 2.65 (d, J = 4.2 Hz, 1H), 2.63 – 2.56 (m, 1H), 2.50 (ddd, J = 13.7, 11.4, 6.0 Hz, 1H), 2.12 
(ddd, J = 14.6, 11.3, 6.0 Hz, 1H), 2.01 (ddd, J = 14.6, 11.4, 5.3 Hz, 1H), 1.58 (s, 9H), 0.96 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 165.9, 147.3, 129.9, 129.8, 128.3, 80.9, 63.4, 48.1, 34.1, 31.2, 30.7, 
28.4, 26.2.  
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IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2970 (m), 2935 (m), 2872 (w), 1711 (s), 1611 (w), 1478 (w), 1458 (w), 
1393 (w), 1367 (w), 1309 (s), 1292 (w), 1255 (w), 1167 (s), 1116 (m), 1020 (w), 851 (w), 769 (w). 
HRMS (ESI): calcd for C19H28O3Na [M+Na]
+: 327.1931; found: 327.1919. 
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9.2.2.11 Chromanes 
 
3,3-dimethyl-1-phenoxybutan-2-one (S78) was prepared according to GP4 from phenol 
(1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 97% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (20% diethyl ether in petrol ether). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.35 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.30 – 7.15 (m, 2H), 6.91 (tt, J = 7.4, 1.0 Hz, 1H), 6.86 – 6.76 (m, 
2H), 4.80 (s, 2H), 1.19 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.6, 158.2, 129.6, 121.6, 114.8, 69.0, 43.3, 26.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3065 (w), 3042 (w), 2967 (s), 2873 (m), 1723 (s), 1599 (s), 1589 (m), 1495 
(s), 1432 (m), 1396 (w), 1368 (w), 1308 (w), 1226 (s), 1174 (w), 1107 (w), 1079 (w), 1049 (m), 988 
(m), 880 (w), 753 (m), 690 (m).  
HRMS (ESI): calcd for C12H16NaO2 [M+Na]
+: 215.1043; found: 215.1042. 
 
 
2-(tert-butyl)-2-(phenoxymethyl)oxirane (S79) was prepared according to GP3 (2.0 equiv NaH, 
2.0 equiv Me3SI) from S78 (1.2 mmol, 1 equiv) in 95% yield as a pale yellow oil. Purified by flash 
column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.47 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.29 – 7.15 (m, 2H), 6.90 (tt, J = 7.3, 1.1 Hz, 1H), 6.87 – 6.82 (m, 
2H), 4.24 (d, J = 10.8 Hz, 1H), 3.96 (d, J = 10.8 Hz, 1H), 2.82 (s, 2H), 1.00 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 158.8, 129.6, 121.25, 114.8, 68.4, 62.5, 48.5, 32.9, 26.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3064 (w), 2962 (s), 2874 (m), 1599 (s), 1588 (m), 1496 (m), 1397 (m), 1366 
(w), 1300 (w), 1242 (s), 1167 (m), 1078 (w), 1046 (m), 940 (w), 902 (w), 831 (w), 787 (w), 752 (m), 
691 (m).  
Experimental Section 
 
283 
 
HRMS (ESI): calcd for C13H18NaO2 [M+Na]
+: 229.1199; found: 229.1199. 
 
 
3,3-dimethyl-1-(p-tolyloxy)butan-2-one (S80) was prepared according to GP4 from p-cresol 
(1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 98% yield as a colorless 
solid. Purified by flash column chromatography on silica gel (10% diethyl ether in petrol ether). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.33 (UV, CAM) 
mp: 44.1 – 44.3 °C 
1
H NMR (400 MHz, CDCl3) δ 7.12 – 7.03 (m, 2H), 6.84 – 6.73 (m, 2H), 4.83 (s, 2H), 2.28 (s, 3H), 
1.24 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.8, 156.1, 130.9, 130.1, 114.7, 69.3, 43.3, 26.5, 20.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3031 (w), 2966 (m), 2872 (m), 1725 (s), 1613 (w), 1587 (w), 1510 (s), 1478 
(m), 1367 (w), 1299 (w), 1229 (w), 1178 (m), 1112 (w), 1048 (m), 991 (m), 817 (w).  
HRMS (ESI): calcd for C13H18NaO2 [M+Na]
+: 229.1199; found: 229.1194. 
 
 
2-(tert-butyl)-2-((p-tolyloxy)methyl)oxirane (S81) was prepared according to GP3 (2.0 equiv 
NaH, 2.0 equiv Me3SI) from S80 (1.3 mmol, 1 equiv) in 92% yield as a colorless solid. Purified by 
flash column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.35 (UV, CAM) 
mp: 48.5 – 50.4 °C 
1
H NMR (400 MHz, CDCl3) δ 7.13 – 7.02 (m, 2H), 6.84 – 6.75 (m, 2H), 4.27 (d, J = 10.8 Hz, 1H), 
3.98 (d, J = 10.8 Hz, 1H), 2.87 (s, 2H), 2.28 (s, 3H), 1.05 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 156.7, 130.4, 130.0, 114.6, 68.6, 62.6, 48.5, 32.9, 26.4, 20.6. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2961 (s), 2873 (m), 1614 (w), 1512 (s), 1480 (w), 1397 (w), 1366 (w), 1290 
(w), 1243 (m), 1168 (w), 1047 (m), 940 (w), 817 (w).  
HRMS (ESI): calcd for C14H20NaO2 [M+Na]
+: 243.1356; found: 243.1355. 
 
 
1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-one (S82) was prepared according to GP4 from 4-
methoxyphenol (1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 83% 
yield as a colorless oil. Purified by flash column chromatography on silica gel (30% diethyl ether 
in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.19 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.88 – 6.77 (m, 4H), 4.81 (s, 2H), 3.76 (s, 3H), 1.24 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 210.0, 154.5, 152.5, 116.1, 114.8, 70.1, 55.8, 43.3, 26.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2965 (m), 2909 (m), 2835 (w), 1723 (s), 1506 (s), 1478 (m), 1506 (s), 1478 
(w), 1465 (w), 1368 (w), 1223 (s), 1181 (w), 1108 (w), 1048 (m), 991 (m), 825 (m), 720 (w).  
HRMS (ESI): calcd for C13H19O3 [M+H]
+: 223.1329; found: 223.1327. 
 
 
2-(tert-butyl)-2-((4-methoxyphenoxy)methyl)oxirane (S83) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S82 (1.2 mmol, 1 equiv) in 99% yield as a colorless solid. 
Purified by flash column chromatography on silica gel (15% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.29 (UV, CAM) 
mp: 53.5 – 54.3 °C 
1
H NMR (400 MHz, CDCl3) δ 6.87 – 6.78 (m, 4H), 4.24 (d, J = 10.8 Hz, 1H), 3.97 (d, J = 10.7 Hz, 
1H), 3.76 (s, 3H), 2.92 – 2.80 (m, 2H), 1.05 (s, 9H). 
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13
C NMR (101 MHz, CDCl3) δ 154.2, 153.1, 115.8, 114.8, 69.2, 62.6, 55.9, 48.5, 32.9, 26.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2961 (w), 2834 (m), 1508 (s), 1465 (m), 1398 (w), 1366 (w), 1230 (s), 1180 
(w), 1107 (w), 1046 (m), 940 (w), 825 (m), 751 (w).  
HRMS (ESI): calcd for C14H20NaO3 [M+Na]
+: 259,1305; found: 259.1303. 
 
 
1-(3-methoxyphenoxy)-3,3-dimethylbutan-2-one (S84) was prepared according to GP4 from 4-
methoxyphenol (1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 99% 
yield as a colorless oil. Purified by flash column chromatography on silica gel (20% diethyl ether 
in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.21 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.20 – 7.07 (m, 1H), 6.52 (ddd, J = 8.3, 2.4, 0.9 Hz, 1H), 6.48 – 
6.40 (m, 2H), 4.83 (s, 2H), 3.76 (s, 3H), 1.23 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.4, 160.9, 159.3, 130.0, 107.2, 106.6, 101.4, 68.90, 55.3, 43.2, 
26.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2965 (m), 2873 (m), 2837 (m), 1723 (s), 1593 (s), 1491 (s), 1457 (m), 1437 
(m), 1396 (m), 1368 (w), 1334 (w), 1283 (m), 1263 (m), 1199 (m), 1156 (s), 1124 (w), 1102 (w), 
1049 (m), 999 (m), 990 (m), 931 (m), 833 (m), 761 (m), 685 (m).  
HRMS (ESI): calcd for C13H18NaO3 [M+Na]
+: 245.1148; found: 245.1144. 
 
 
2-(tert-butyl)-2-((3-methoxyphenoxy)methyl)oxirane (S85) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S84 (1.2 mmol, 1 equiv) in 99% yield as a pale yellow oil. 
Purified by flash column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.33 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 7.17 (t, J = 8.2 Hz, 1H), 6.56 – 6.42 (m, 3H), 4.28 (d, J = 10.8 Hz, 
1H), 3.99 (d, J = 10.8 Hz, 1H), 3.79 (s, 3H), 2.87 (s, 2H), 1.05 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 160.9, 160.0, 130.0, 106.9, 106.8, 101.3, 68.5, 62.5, 55.4, 48.5, 
32.9, 26.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2961 (s), 2875 (m), 2836 (w), 1594 (s), 1492 (s), 1398 (m), 1366 (w), 1334 
(w), 1285 (m), 1265 (m), 1201 (m), 1149 (s), 1082 (w), 1049 (m), 936 (w), 835 (w), 762 (w), 686 
(w).  
HRMS (ESI): calcd for C14H20NaO3 [M+Na]
+: 259,1305; found: 259.1303. 
 
 
1-(2-methoxyphenoxy)-3,3-dimethylbutan-2-one (S86) was prepared according to GP4 from 4-
methoxyphenol (1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 97% 
yield as a colorless solid. Purified by flash column chromatography on silica gel (20% diethyl ether 
in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.21 (UV, CAM) 
mp: 65.9 - 72.8 °C 
1
H NMR (400 MHz, CDCl3) δ 6.99 – 6.80 (m, 3H), 6.73 (dd, J = 7.9, 1.5 Hz, 1H), 4.93 (s, 2H), 
3.86 (s, 3H), 1.22 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.4, 149.8, 147.7, 122.3, 120.8, 114.4, 112.2, 70.1, 56.0, 43.1, 
26.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3074 (w), 2983 (m), 2961 (s), 2931 (m), 2868 (m), 2840 (m), 1714 (s), 1591 
(m), 1502 (s), 1477 (m), 1457 (m), 1427 (m), 1396 (m), 1368 (m), 1331 (m), 1294 (m), 1273 (s), 
1244 (s), 1217 (m), 1179 (m), 1132 (m), 1094 (m), 1057 (m), 1045 (m), 1027 (m), 988 (s), 963 (s), 
782 (m), 747 (m).  
HRMS (ESI): calcd for C13H18NaO3 [M+Na]
+: 245.1148; found: 245.1147. 
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2-(tert-butyl)-2-((2-methoxyphenoxy)methyl)oxirane (S87) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S86 (1.2 mmol, 1 equiv) in 77% yield as a pale yellow solid. 
Purified by flash column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.29 (UV, CAM) 
mp: 49.5 - 51.2 °C 
1
H NMR (400 MHz, CDCl3) δ 6.99 – 6.82 (m, 4H), 4.36 (dd, J = 11.1, 0.7 Hz, 1H), 4.08 (d, J = 
11.1 Hz, 1H), 3.84 (s, 3H), 2.97 (d, J = 4.7 Hz, 1H), 2.86 (d, J = 4.7 Hz, 1H), 1.06 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 150.0, 148.7, 121.8, 121.0, 114.5, 112.3, 69.5, 62.7, 56.1, 48.3, 
32.9, 26.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3064 (w), 2960 (s), 2874 (m), 2835 (m), 1593 (m), 1505 (s), 1455 (m), 1398 
(w), 1455 (w), 1398 (w), 1366 (w), 1330 (w), 1252 (s), 1224 (m), 1179 (m), 1122 (m), 1029 (m), 
940 (w), 904 (w), 831 (w), 742 (w).  
HRMS (ESI): calcd for C14H20NaO3 [M+Na]
+: 259.1305; found: 259.1302. 
 
 
1-(benzo[d][1,3]dioxol-5-yloxy)-3,3-dimethylbutan-2-one (S88) was prepared according to GP4 
from sesamol (1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 97% yield 
as a colorless oil. Purified by flash column chromatography on silica gel (18% diethyl ether in 
petrol ether). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.22 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.68 (d, J = 8.5 Hz, 1H), 6.51 (d, J = 2.6 Hz, 1H), 6.28 (dd, J = 8.5, 
2.5 Hz, 1H), 5.91 (s, 2H), 4.79 (s, 2H), 1.23 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.7, 153.8, 148.5, 142.4, 108.0, 106.2, 101.4, 98.7, 70.2, 43.3, 
26.5. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2967 (m), 2905 (m), 1722 (s), 1630 (w), 1502 (m), 1484 (s), 1396 (w), 1367 
(w), 1243 (w), 1182 (s), 1142 (w), 1077 (m), 1035 (s), 990 (s), 937 (m), 837 (w), 815 (m), 782 (m), 
747 (w), 713 (w), 612 (w).  
HRMS (ESI): calcd for C13H16NaO4 [M+Na]
+: 259.0941; found: 259.0924. 
 
 
5-((2-(tert-butyl)oxiran-2-yl)methoxy)benzo[d][1,3]dioxole (S89) was prepared according to 
GP3 (2.0 equiv NaH, 2.0 equiv Me3SI) from S88 (1.1 mmol, 1 equiv) in 97% yield as a pale yellow 
oil. Purified by flash column chromatography on silica gel (15% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.34 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.69 (d, J = 8.5 Hz, 1H), 6.49 (d, J = 2.5 Hz, 1H), 6.31 (dd, J = 8.5, 
2.5 Hz, 1H), 5.91 (s, 2H), 4.21 (d, J = 10.8 Hz, 1H), 3.94 (d, J = 10.8 Hz, 1H), 2.86 (s, 2H), 1.04 
(s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 154.4, 148.4, 142.0, 108.0, 106.0, 101.3, 98.5, 69.5, 62.5, 48.5, 
32.9, 26.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2963 (m), 2876 (m), 1712 (w), 1631 (w), 1608 (w), 1503 (m), 1487 (s), 1397 
(w), 1366 (w), 1270 (w), 1242 (w), 1186 (s), 1134 (m), 1102 (m), 1037 (m), 939(w), 839 (w), 816 
(w).  
HRMS (ESI): calcd for C14H18NaO4 [M+Na]
+: 273.1097; found: 273.1094. 
 
 
3,3-dimethyl-1-(naphthalen-1-yloxy)butan-2-one (S90) was prepared according to GP4 from 1-
naphthol (1.5 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 90% yield as a 
colorless solid. Purified by flash column chromatography on silica gel (10% diethyl ether in 
n-pentane). 
TLC: (10% ethyl acetate in cyclohexane): Rf: 0.28 (UV, CAM) 
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mp: 54.1 – 55.7 °C 
1
H NMR (400 MHz, CDCl3) δ 8.46 – 8.35 (m, 1H), 7.87 – 7.78 (m, 1H), 7.57 – 7.43 (m, 3H), 7.40 
– 7.30 (m, 1H), 6.66 (dd, J = 7.7, 0.9 Hz, 1H), 5.04 (s, 2H), 1.30 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.4, 154.0, 134.71, 127.51, 126.68, 125.81, 125.60, 125.57, 
122.35, 121.27, 105.14, 69.46, 43.38, 26.48. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3053 (w), 2967 (m), 1725 (s), 1597 (w), 1581 (m), 1509 (m), 1464 (m), 1397 
(s), 1367 (w), 1273 (w), 1234 (m), 1124 (w), 1087 (w), 1059 (m), 989 (w), 791 (w), 771 (m).  
HRMS (ESI): calcd for C16H18NaO2 [M+Na]
+: 265,1199; found: 265.1192. 
 
 
2-(tert-butyl)-2-((naphthalen-1-yloxy)methyl)oxirane (S91) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S90 (1.3 mmol, 1 equiv) in 97% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC: (10% ethyl acetate in cyclohexane): Rf: 0.40 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 8.31 – 8.21 (m, 1H), 7.88 – 7.79 (m, 1H), 7.56 – 7.43 (m, 3H), 7.38 
(dd, J = 8.3, 7.5 Hz, 1H), 6.81 (dd, J = 7.5, 1.0 Hz, 1H), 4.51 (d, J = 10.6 Hz, 1H), 4.16 (d, J = 10.6 
Hz, 1H), 3.05 – 2.93 (m, 2H), 1.15 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 154.5, 134.6, 127.6, 126.6, 125.9, 125.7, 125.4, 122.2, 120.7, 104.8, 
69.0, 62.6, 48.8, 32.9, 26.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3055 (m), 2961 (s), 2873 (m), 1595 (m), 1580 (s), 1509 (m), 1479 (m), 1462 
(m), 1394 (s), 1365 (m), 1267 (s), 1239 (s), 1214 (w), 1178 (w), 1156 (m), 1099 (s), 1069 (m), 1020 
(m), 1001 (m), 940 (w), 790 (m), 769 (m), 572 (m).  
HRMS (ESI) calcd for C17H20NaO2 [M+Na]
+: 279,1356; found: 279,1354. 
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1-(4-fluorophenoxy)-3,3-dimethylbutan-2-one (S92) was prepared according to GP4 from 4-
fluorophenol (1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 95% yield 
as a colorless oil. Purified by flash column chromatography on silica gel (15% diethyl ether in n-
pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.27 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.03 – 6.92 (m, 2H), 6.88 – 6.79 (m, 2H), 4.83 (s, 2H), 1.24 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.6, 157.8 (d, J = 239.3 Hz), 154.4 (d, J = 2.2 Hz), 116.1 (d, J = 
4.8 Hz), 116.0 (d, J = 10.2 Hz), 69.8, 43.3, 26.5. 
19
F NMR (282 MHz, CDCl3) δ -122.95. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2968 (m), 1723 (s), 1505 (s), 1479 (m), 1368 (w), 1297 (m), 1208 (m), 1098 
(w), 1048 (m), 991 (m), 827 (m), 800 (w), 727 (w).  
HRMS (ESI): calcd for C12H16FO2 [M+H]
+: 211.1129; found: 211.1122. 
 
 
2-(tert-butyl)-2-((4-fluorophenoxy)methyl)oxirane (S93) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S92 (1.2 mmol, 1 equiv) in 93% yield as a colorless solid. 
Purified by flash column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.38 (UV, CAM) 
mp: 35.2 – 38.0 °C 
1
H NMR (400 MHz, CDCl3) δ 7.01 – 6.91 (m, 2H), 6.88 – 6.78 (m, 2H), 4.24 (d, J = 10.8 Hz, 1H), 
4.00 (d, J = 10.8 Hz, 1H), 2.87 (s, 2H), 1.05 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 157.6 (d, J = 238.6 Hz), 155.0 (d, J = 2.1 Hz), 116.0 (d, J = 19.2 
Hz), 115.8 (d, J = 4.0 Hz), 69.1, 62.5, 48.4, 32.9, 26.3. 
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19
F NMR (282 MHz, CDCl3) δ -123.63. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2964 (m), 2877 (w), 1507 (s), 1480 (m), 1397 (w), 1366 (w), 1248 (m), 1208 
(s), 1097 (w), 1045 (m), 940 (w), 828 (m), 767 (w).  
HRMS (ESI): calcd for C13H17FNaO2 [M+Na]
+: 247,1105; found: 247.1104. 
 
 
1-(4-chlorophenoxy)-3,3-dimethylbutan-2-one (S94) was prepared according to GP4 from 4-
chlorophenol (1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 99% yield 
as a colorless solid. Purified by flash column chromatography on silica gel (18% diethyl ether in n-
pentane). 
TLC (5% ethyl acetate in cyclohexane): Rf: 0.15 (UV, CAM) 
mp: 60.9 – 63.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.25 – 7.18 (m, 2H), 6.83 – 6.75 (m, 2H), 4.84 (s, 2H), 1.24 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.3, 156.8, 129.5, 126.6, 116.2, 69.2, 43.3, 26.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2968 (m), 1723 (s), 1594 (w), 1491 (s), 1368 (w), 1304 (w), 1233 (m), 1172 
(w), 1093 (w), 1047 (m), 991 (m), 823 (w).  
HRMS (ESI): calcd for C12H15ClNaO2 [M+Na]
+: 249.0653; found: 249.0652. 
 
 
2-(tert-butyl)-2-((4-chlorophenoxy)methyl)oxirane (S95) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S94 (0.9 mmol, 1 equiv) in 86% yield as a colorless solid. 
Purified by flash column chromatography on silica gel (10% diethyl ether in petrol ether). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.45 (UV, CAM) 
mp: 57.3 – 58.1 °C 
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1
H NMR (400 MHz, CDCl3) δ 7.24 – 7.18 (m, 2H), 6.86 – 6.77 (m, 2H), 4.24 (d, J = 10.8 Hz, 1H), 
4.01 (d, J = 10.8 Hz, 1H), 2.91 – 2.82 (m, 2H), 1.04 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 157.4, 129.5, 126.1, 116.1, 68.7, 62.5, 48.4, 32.9, 26.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3063 (w), 2965 (m), 2874 (m), 1728 (w), 1597 (w), 1582 (w), 1492 (s), 1397 
(w), 1365 (w), 1286 (w), 1244 (s), 1167 (w), 1093 (w), 1044 (w), 938 (w), 824 (m).  
HRMS (ESI): calcd for C13H17ClNaO2 [M+Na]
+: 263,0809; found: 263,0809. 
 
 
ethyl 4-(3,3-dimethyl-2-oxobutoxy)benzoate (S96) was prepared according to GP4 from ethyl 4-
hydroxybenzoate (1.5 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 99% 
yield as a colorless solid. Purified by flash column chromatography on silica gel (15% diethyl ether 
in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.17 (UV, CAM) 
mp: 47.8 - 50.0 °C 
1
H NMR (400 MHz, CDCl3) δ 8.03 – 7.95 (m, 2H), 6.91 – 6.83 (m, 2H), 4.93 (s, 2H), 4.34 (q, J = 
7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H), 1.26 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 208.9, 166.3, 161.8, 131.7, 123.9, 114.3, 68.7, 60.8, 43.3, 26.5, 
14.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2971 (m), 1709 (s), 1605 (s), 1583 (w), 1510 (m), 1478 (w), 1419 (m), 1393 
(w), 1367 (m), 1315 (w), 1274 (s), 1238 (s), 1169 (s), 1105 (s), 1047 (m), 1019 (w), 991 (m), 848 
(w), 770 (m), 696 (w).  
HRMS (ESI): calcd for C15H21O4 [M+H]
+: 265,1434; found: 265,1434. 
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ethyl 4-((2-(tert-butyl)oxiran-2-yl)methoxy)benzoate (S97) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S96 (1.5 mmol, 1 equiv) in 22% yield as a pale yellow oil. 
Purified by flash column chromatography on silica gel (15% diethyl ether in petrol ether). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.31 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 8.06 – 7.90 (m, 2H), 6.97 – 6.83 (m, 2H), 4.40 – 4.24 (m, 3H), 4.09 
(d, J = 10.9 Hz, 1H), 2.88 (q, J = 4.6 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H), 1.06 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 166.5, 162.4, 131.7, 123.5, 114.3, 68.5, 62.4, 60.8, 48.4, 32.9, 26.3, 
14.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2964 (m), 1712 (s), 1606 (s), 1581 (w), 1510 (m), 1479 (w), 1421 (w), 1396 
(w), 1367 (w), 1276 (s), 1252 (s), 1167 (m), 1104 (m), 1041 (w), 848 (w), 771 (m), 696 (w).  
HRMS (ESI): calcd for C16H23O4 [M+H]
+: 279,1591; found: 279.1590. 
 
 
3,3-dimethyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)butan-2-one (S98) 
was prepared according to GP4 from 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol 
(1.5 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 99% yield as a colorless 
solid. Purified by flash column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.28 (UV, CAM) 
mp: 110.2 – 112.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.81 – 7.63 (m, 2H), 6.98 – 6.75 (m, 2H), 4.88 (s, 2H), 1.32 (s, 
12H), 1.24 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 209.3, 160.7, 136.7, 114.1, 83.7, 68.7, 43.3, 26.5, 25.0. 
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11
B NMR (128 MHz, CDCl3) δ 30.60. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2975 (m), 1725 (s), 1603 (s), 1572 (w), 1515 (w), 1478 (w), 1396 (m), 1358 
(s), 1320 (m), 1233 (m), 1143 (s), 1088 (m), 1047 (m), 990 (m), 963 (m), 860 (m), 831 (m), 735 (m).  
HRMS (EI): calcd for C18H27BO4 [M+Na]
+: 341.1895; found: 341.1892. 
 
 
2-(4-((2-(tert-butyl)oxiran-2-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(S99) was prepared according to GP3 (2.0 equiv NaH, 2.0 equiv Me3SI) from S98 (1.3 mmol, 
1 equiv) in 64% yield as colorless needles. Purified by flash column chromatography on silica gel 
(15% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.34 (UV, CAM) 
mp: 79.5 – 81.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.83 – 7.64 (m, 2H), 6.98 – 6.77 (m, 2H), 4.31 (d, J = 10.8 Hz, 1H), 
4.03 (d, J = 10.8 Hz, 1H), 2.87 (s, 2H), 1.33 (s, 12H), 1.05 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 161.3, 136.6, 114.1, 83.7, 68.3, 62.5, 48.5, 32.9, 26.4, 25.0. 
11
B NMR (128 MHz, CDCl3) δ 31.63. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2975 (m), 1604 (s), 1571 (w), 1514 (w), 1480 (m), 1396 (m), 1358 (s), 1319 
(m), 1275 (m), 1244 (m), 1143 (m), 1091 (m), 1042 (m), 963 (w), 860 (w), 834 (m), 736 (w).  
HRMS (EI): calcd for C19H29BO4 [M+Na]
+: 355.2051; found: 355.2049. 
 
 
4-(3,3-dimethyl-2-oxobutoxy)benzonitrile (S100) was prepared according to GP4 from 4-
hydroxybenzonitrile (1.5 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one (1.0 equiv) in 
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>99% yield as a colorless solid. Purified by flash column chromatography on silica gel (15% diethyl 
ether in petrol ether). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.19 (UV, CAM) 
mp: 85.9 – 87.4 °C 
1
H NMR (400 MHz, Chloroform-d) δ 7.62 – 7.54 (m, 2H), 6.94 – 6.85 (m, 2H), 4.94 (s, 2H), 1.26 
(s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 208.4, 161.4, 134.2, 119.1, 115.5, 105.0, 68.6, 43.4, 26.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2969, 2871, 2224, 1722, 1605, 1576, 1508, 1479, 1434, 1369, 1310, 1242, 
1174, 1046, 992, 834 cm−1.  
HRMS (ESI): calcd for C13H15NNaO2 [M+Na]
+: 240,0995; found: 240,0993. 
 
 
4-((2-(tert-butyl)oxiran-2-yl)methoxy)benzonitrile (S101) was prepared according to GP3 
(1.6 equiv NaH, 1.6 equiv Me3SI) from S100 (2.1 mmol, 1 equiv) in 84% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (15% diethyl ether in petrol ether).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.21 (UV, CAM) 
mp: 57.7 – 60.8 °C 
1
H NMR (400 MHz, Chloroform-d) δ 7.65 – 7.50 (m, 2H), 7.02 – 6.89 (m, 2H), 4.30 (d, J = 11.0 
Hz, 1H), 4.12 (d, J = 10.9 Hz, 1H), 2.89 (d, J = 4.6 Hz, 1H), 2.84 (d, J = 4.5 Hz, 1H), 1.05 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 161.98, 134.1, 119.2, 115.5, 104.6, 68.6, 62.3, 48.3, 32.9, 26.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3069, 2964, 2874, 2225, 1605, 1575, 1509, 1481, 1398, 1367, 1301, 1258, 
1172, 1113, 1040, 1018, 942, 836 cm−1.  
HRMS (ESI): calcd for C14H17NNaO2 [M+Na]
+: 254,1151; found: 254,1150. 
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N-(4-(3,3-dimethyl-2-oxobutoxy)phenyl)acetamide (S102) was prepared according to GP4 from 
N-(4-hydroxyphenyl)acetamide (1.4 mmol, 1 equiv) and 1-bromo-3,3-dimethylbutan-2-one 
(1.0 equiv) in 99% yield as a colorless solid. Purified by flash column chromatography on silica gel 
(10% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.30 (UV, CAM) 
mp: 123.2 – 124.4 
1
H NMR (400 MHz, CDCl3) δ 7.77 (s, 1H), 7.39 – 7.30 (m, 2H), 6.84 – 6.68 (m, 2H), 4.83 (s, 2H), 
2.09 (s, 3H), 1.23 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 210.0, 168.7, 154.8, 132.1, 121.9, 115.1, 69.3, 43.3, 26.5, 24.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3304 (br m), 3134 (w), 3070 (w), 2968 (m), 1720 (m), 1663 (m), 1605 (m), 
1541 (m), 1509 (s), 1479 (m), 1433 (m), 1410 (m), 1369 (m), 1307 (m), 1280 (m), 1228 (m), 1175 
(m), 1114 (w), 1048 (m), 993 (m), 829 (m). 
HRMS (ESI): calcd for C14H19NNaO3 [M+H]
+: 272.1257; found: 272.1243. 
 
 
N-(4-((2-(tert-butyl)oxiran-2-yl)methoxy)phenyl)-N-methylacetamide (S103) was prepared 
according to GP3 (2.0 equiv NaH, 2.0 equiv Me3SI) from S102 (1.2 mmol, 1 equiv) in 35% yield 
as a pale yellow oil. Purified by flash column chromatography on silica gel (40% diethyl ether in 
n-pentane). 
TLC (30% ethyl acetate in cyclohexane): Rf: 0.07 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.11 – 7.00 (m, 2H), 6.93 – 6.85 (m, 2H), 4.27 (d, J = 10.8 Hz, 1H), 
4.03 (d, J = 10.8 Hz, 1H), 3.19 (s, 3H), 2.90 – 2.81 (m, 2H), 1.82 (s, 3H), 1.04 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ 171.2, 158.0, 137.8, 128.2, 115.7, 68.6, 62.5, 48.4, 37.4, 32.7, 26.3, 
22.4. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2965 (m), 2927 (m), 1726 (w), 1660 (s), 1512 (s), 1380 (m), 1299 (m), 1245 
(m), 1143 (w), 1045 (w), 883 (w).  
HRMS (ESI): calcd for C16H24NO3 [M+H]
+: 278.1751; found: 278.1732. 
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9.2.2.12 Substrates for alkyl migrations.  
 
Two step alkylation procedure: 
1-methylcyclobutane-1-carboxylic acid (S104): To a solution of diisopropylamine (10.7 mL, 
75.3 mmol, 2.40 equiv) in tetrahydrofuran (90 mL) was added n-butyllithium (2.5 M in hexanes, 
30.1 mL, 75.3 mmol, 2.40 equiv.) dropwise at 0 °C. The resulting pale yellow solution was stirred 
at 0 °C. After 15 min a solution of cyclobutanecarboxylic acid (3.00 mL, 31.4 mmol, 1 equiv.) in 
tetrahydrofuran (10 mL, 3.1 M) was added dropwise at 0 °C. After 15 min methyl iodide (1.96 mL, 
31.4 mmol, 1.00 equiv) was added at 0 °C and the pale yellow reaction mixture was slowly allowed 
to warm up to 23 °C. After 3 d the yellow solution was cooled to 0 °C and excess of base was 
quenched by addition of aqueous hydrochloric acid (3.00 M, 300 mL), the aqueous layer was 
extracted with diethyl ether (4 × 250 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (250 mL), dried over sodium sulfate and the filtrate 
was concentrated under reduced pressure to give an orange oil (3.58 g, 31.4 mmol, quant.), which 
was used without further purification. 
1-(1-methylcyclobutyl)ethan-1-one (S105): To an orange solution of crude 1-methylcyclobutane-
1-carboxylic acid (3.58 g, 31.4 mmol, 1 equiv.) in diethyl ether (100 mL, 300 mM) was added 
methyl lithium (1.60 M in diethyl ether, 39.2 mL, 62.7 mmol, 2.00 equiv) dropwise at 0 °C over 3 h 
(syringe pump 13.1 mL/h). After 8 h the cloudy pale yellow reaction mixture was poured into 
queous hydrochloric acid (6 M, 200 mL) at 0 °C to quench excess of lithium reagent. The resulting 
mixture was extracted with diethyl ether (3 × 50 mL) and the combined organic layers were washed 
with water (50 mL) and saturated aqueous sodium hydrogen carbonate solution (2 × 50 mL). The 
washed solution was dried over sodium sulfate and filtered. The filtrate was concentrated under 
reduced pressure and the crude product was purified by flash column chromatography on silica gel 
(10% diethyl ether in n-pentane) to afford the desired ketone S105 (2.58 g, 23.0 mmol, 73% over 
two steps) as a colorless to pale yellow oil. 
TLC (15% ethyl acetate in cyclohexane): Rf: 0.38 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 2.41 – 2.30 (m, 2H), 2.05 (s, 3H), 1.98 – 1.86 (m, 1H), 1.77 – 1.65 
(m, 3H), 1.34 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 212.8, 50.2, 30.3, 24.0, 23.7, 14.4. 
HRMS (ESI): calcd for C7H13O [M+H]
+: 113.0961; found: 113.0965. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2959 (s), 2870 (m), 1703 (s), 1456 (m), 1432 (m), 1354 (w), 1296 (w), 1243 
(w), 1119 (m), 964 (w).  
 
 
1-(1-methylcyclopentyl)ethan-1-one (S106) was prepared from cyclopentanecarboxylic acid 
(40 mmol, 1 equiv) according to the two step alkylation procedure of 1-(1-methylcyclobutyl)ethan-
1-one (S105).  
The analytical data were in full agreement with those reported in the literature.[147] 
 
 
1-(1-methylcyclohexyl)ethan-1-one (S107) was prepared from 1-methylcyclohexane-1-
carboxylic acid (5 mmol, 1 equiv) according to the alkylation procedure of 1-(1-
methylcyclobutyl)ethan-1-one (S105). 
The analytical data were in full agreement with those reported in the literature.[147] 
 
 
trimethyl((1-(1-methylcyclobutyl)vinyl)oxy)silane (S108): To a solution of 1-(1-
methylcyclobutyl)ethan-1-one (S105) (2.24 g, 20.0 mmol, 1 equiv) and oven dried (110 °C, 2 h) 
sodium iodide (3.59 g, 24.0 mmol, 1.20 equiv) in acetonitrile (30 mL, 0.67 M) was added 
triethylamine (4.18 mL, 30.0 mmol, 1.50 equiv) and trimethylsilyl chloride (3.04 mL, 24.0 mmol, 
1.20 equiv) in sequence at 23 °C. After 16 h the mixture was diluted with pentane (30 mL) and 
saturated aqueous ammonium chloride solution (30 mL) was added to quench excess of 
trimethylsilyl chloride. The aqueous layer was extracted with pentane (3 × 20 mL) and the 
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combined organic layers were washed with saturated aqueous sodium chloride solution (20 mL). 
The combined organic layers were dried over magnesium sulfate, filtered and the filtrate was 
concentrated under reduced pressure to give crude trimethylsilyl ether S108 as a colorless oil 
(3.45 g, 18.7 mmol, 94%), which was used without further purification. 
2-bromo-1-(1-methylcyclobutyl)ethan-1-one (S109): To a solution of crude trimethylsilyl ether 
S108 (3.45 g, 18.7 mmol, 1 equiv) in dichloromethane (120 mL, 0.156 M) was added a solution of 
bromine (1.06 mL, 20.6 mmol, 1.10 equiv.) in dichloromethane (41.2 mL, 0.500 M) dropwise at –
40 °C. After 5 min the brown solution was allowed to warm up to 23 °C and after further 15 min 
saturated aqueous thiosulfate solution (20 mL) and water (20 mL) were added to quench excess of 
bromine. The layers were separated and the pale yellow solution was extracted with 
dichloromethane (3 × 25 mL). The combined organic layers were dried over magnesium sulfate, 
filtered and the filtrate was concentrated under reduced pressure to give a yellow oil. Purification 
of the crude product by flash column chromatography on silica gel (150 g silica gel, 10% diethyl 
ether in n-pentane) afforded desired bromoketone S109 (2.35 g, 12.3 mmol, 66%) as a pale yellow 
oil and bisbromoketone S110 (1.21 g, 4.48 mmol, 24%) as yellow needles. 
TLC (15% ethyl acetate in cyclohexane): Rf: 0.49 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 4.06 (s, 2H), 2.49 (tdd, J = 9.4, 6.9, 2.8 Hz, 2H), 2.09 – 1.94 (m, 
1H), 1.91 – 1.73 (m, 3H), 1.47 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 205.0, 49.3, 31.1, 31.0, 23.9, 14.9. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2960 (s), 2870 (m), 1718 (s), 1456 (m), 1393 (w), 1298 (w), 1247 (w), 1052 
(m), 1017 (m).  
HRMS (ESI): calcd for C7H11
79BrNaO [M+Na]+: 212.9885; found: 212.9891. 
 
2,2-dibromo-1-(1-methylcyclobutyl)ethan-1-one (S110): 
TLC (15% ethyl acetate in cyclohexane): Rf: 0.54 (UV, CAM) 
mp: 53.8 °C 
1
H NMR (400 MHz, CDCl3) δ 6.12 (s, 1H), 2.65 – 2.52 (m, 2H), 2.11 – 1.97 (m, 1H), 1.95 – 1.78 
(m, 3H), 1.56 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 200.2, 48.4, 38.0, 31.7, 24.4, 15.0. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2961 (m), 2870 (m), 1720 (s), 1454 (m), 1378 (w), 1292 (m), 1246 (m), 1154 
(m), 1046 (m), 1003 (m), 767 (m).  
HRMS (LTP): calcd for C7H14
79Br2NO [M+NH4]
+: 285.9437; found: 285.9446. 
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3-(3,4-dimethoxyphenyl)-1-(1-methylcyclobutyl)propan-1-one (S111) was prepared according 
to GP1 (t = 3 h) from 3,4-dimethoxybenzaldehyde (2.0 mmol, 1 equiv) and 1-(1-
methylcyclobutyl)ethan-1-one (S105) (1.3 equiv) and GP2a (1% Pd, t = 16 h) in 49% yield as a 
colorless solid. Purified by flash column chromatography on silica gel (10% ethyl acetate in 
cyclohexane). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.29 (UV, CAM) 
mp: 40.4 – 41.9 °C 
1
H NMR (400 MHz, CDCl3) δ 6.78 (d, J = 8.7 Hz, 1H), 6.72 (dd, J = 6.4, 2.0 Hz, 2H), 3.86 (s, 3H), 
3.85 (s, 3H), 2.85 (t, J = 7.5 Hz, 2H), 2.72 – 2.65 (m, 2H), 2.32 (tdd, J = 9.5, 7.3, 3.3 Hz, 2H), 1.98 
– 1.86 (m, 1H), 1.77 – 1.63 (m, 3H), 1.31 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 213.8, 149.0, 147.5, 134.4, 120.3, 111.9, 111.4, 56.1, 56.0, 49.9, 
38.4, 30.3, 29.8, 23.7, 14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2955 (s), 2935 (s), 2868 (m), 2834 (m), 1702 (s), 1590 (m), 1516 (s), 1463 
(m), 1418 (m), 1356 (w), 1262 (s), 1238 (s), 1155 (m), 1141 (m), 1073 (w), 1030 (m). 
HRMS (ESI): calcd for C16H22NaO3 [M+Na]
+: 285.1461; found: 285.1458. 
 
 
2-(3,4-dimethoxyphenethyl)-2-(1-methylcyclobutyl)oxirane (14a) was prepared according to 
GP3 (2.0 equiv NaH, 2.0 equiv Me3SI) from S111 (0.5 mmol, 1 equiv) in 99% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (20% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.17 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.79 (d, J = 7.9 Hz, 1H), 6.75 – 6.66 (m, 2H), 3.87 (s, 3H), 3.85 (s, 
3H), 2.67 (d, J = 4.5 Hz, 1H), 2.59 – 2.40 (m, 3H), 2.23 – 2.12 (m, 1H), 2.05 – 1.79 (m, 4H), 1.71 
– 1.59 (m, 2H), 1.31 (s, 3H), 1.26 (dddd, J = 8.3, 7.5, 5.6, 2.8 Hz, 1H). 
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13
C NMR (101 MHz, CDCl3) δ 149.0, 147.4, 135.0, 120.1, 111.8, 111.4, 62.2, 56.1, 56.0, 48.0, 
42.0, 31.8, 30.2, 30.0, 27.2, 24.1, 14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2954 (m), 2932 (m), 2869 (w), 1591 (w), 1515 (s), 1463 (m), 1418 (w), 1375 
(w), 1260 (s), 1237 (m), 1157 (m), 1140 (m), 1030 (m), 924 (w), 849 (w), 807 (w), 765 (w).  
HRMS (ESI): calcd for C17H24NaO3 [M+Na]
+: 299.1618; found: 299.1609. 
 
 
3-(3,4-dimethoxyphenyl)-1-(1-methylcyclopentyl)propan-1-one (S112) was prepared according 
to GP1 (t = 2 h) from 3,4-dimethoxybenzaldehyde (2.0 mmol, 1 equiv) and 1-(1-
methylcyclopentyl)ethan-1-one (S106) (1.5 equiv) and GP2a (1% Pd, t = 16 h) in 66% yield as a 
colorless solid. Purified by flash column chromatography on silica gel (20% diethyl ether in petrol 
ether). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.32 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.78 (d, J = 8.7 Hz, 1H), 6.75 – 6.67 (m, 2H), 3.86 (s, 3H), 3.84 (s, 
3H), 2.84 (ddd, J = 7.8, 6.6, 1.7 Hz, 2H), 2.80 – 2.69 (m, 2H), 2.03 – 1.88 (m, 2H), 1.70 – 1.49 (m, 
4H), 1.36 (dddd, J = 12.4, 6.7, 3.0, 1.5 Hz, 2H), 1.15 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 214.2, 149.0, 147.4, 134.4, 120.3, 112.0, 111.5, 56.0, 56.0, 56.00, 
39.7, 36.3, 30.1, 25.2, 24.5.  
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2955 (s), 2870 (m), 2834 (m), 1700 (s), 1590 (m), 1515 (s), 1463 (m), 1418 
(m), 1354 (w), 1261 (s), 1237 (s), 1155 (m), 1030 (m), 807 (w), 763 (w).  
HRMS (ESI): calcd for C17H24NaO3 [M+Na]
+: 299.1618; found: 299.1616. 
 
 
2-(3,4-dimethoxyphenethyl)-2-(1-methylcyclopentyl)oxirane (14b) was prepared according to 
GP3 (2.0 equiv NaH, 2.0 equiv Me3SI) from S112 (1.2 mmol, 1 equiv) in 92% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (20% diethyl ether in petrol ether). 
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TLC (20% ethyl acetate in cyclohexane): Rf: 0.42 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.79 (d, J = 7.9 Hz, 1H), 6.74 – 6.68 (m, 2H), 3.87 (s, 3H), 3.85 (s, 
3H), 2.70 (d, J = 4.3 Hz, 1H), 2.62 (dd, J = 4.2, 0.7 Hz, 1H), 2.53 (ddd, J = 13.6, 11.6, 5.1 Hz, 1H), 
2.42 (ddd, J = 13.6, 11.6, 5.8 Hz, 1H), 2.14 (ddd, J = 14.6, 11.6, 5.8 Hz, 1H), 2.01 (ddd, J = 14.6, 
11.6, 5.1 Hz, 1H), 1.76 – 1.47 (m, 6H), 1.43 – 1.33 (m, 1H), 1.16 – 1.08 (m, 1H), 1.07 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.3, 135.0, 120.1, 111.8, 111.4, 62.8, 56.1, 56.0, 48.8, 
46.3, 35.5, 43.0, 32.7, 30.2, 24.8, 24.5, 24.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2955 (s), 2870 (m), 2833 (m), 1591 (w), 1515 (s), 1463 (m), 1418 (m), 1261 
(m), 1236 (m), 1156 (m), 1031 (m), 807 (w), 766 (w).  
HRMS (ESI): calcd for C18H26NaO3 [M+Na]
+: 313.1774; found: 313.1760. 
 
 
3-(3,4-dimethoxyphenyl)-1-(1-methylcyclohexyl)propan-1-one (S113) was prepared according 
to GP1 (t = 4 h) from 3,4-dimethoxybenzaldehyde (3.0 mmol, 1 equiv) and 1-(1-
methylcyclohexyl)ethan-1-one (S107) (1.0 equiv) and GP2b (4 equiv Mg, T = 23 °C, t = 4 h) in 
39% yield as a colorless solid. Purified by flash column chromatography on silica gel (10% ethyl 
acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.26 (UV, CAM) 
mp: 86.7 – 88.6 °C 
1
H NMR (400 MHz, CDCl3) δ 6.79 – 6.74 (m, 1H), 6.74 – 6.69 (m, 2H), 3.85 (s, 3H), 3.83 (s, 3H), 
2.87 – 2.78 (m, 2H), 2.74 (ddd, J = 8.5, 6.7, 1.6 Hz, 2H), 1.97 – 1.86 (m, 2H), 1.58 – 1.47 (m, 2H), 
1.46 – 1.36 (m, 1H), 1.35 – 1.19 (m, 5H), 0.99 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 214.9, 148.9, 147.4, 134.5, 120.3, 112.0, 111.4, 56.0, 55.9, 48.2, 
38.8, 34.7, 29.7, 25.9, 24.7, 23.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3014 (w), 2915 (s), 2855 (m), 1693 (s), 1604 (w), 1590 (m), 1513 (s), 1466 
(w), 1452 (s), 1414 (m), 1381 (w), 1361 (w), 1348 (w), 1336 (w), 1298 (w), 1252 (w), 1231 (s), 
1197 (w), 1169 (w), 1153 (s), 1143 (w), 1132 (w), 1069 (m), 1028 (s), 995 (m), 978 (w), 941 (w), 
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885 (w), 856 (w), 806 (s), 792 (w), 769 M), 758 (m), 704 (w), 646 (w), 630 (w), 598 (w), 549 (m), 
520 (w), 480 (w), 410 (w). 
HRMS (ESI) calcd for C18H26NaO3 [M+Na]
+: 313.1774; found: 313.1765. 
 
 
2-(3,4-dimethoxyphenethyl)-2-(1-methylcyclohexyl)oxirane (14c) was prepared according to 
GP3 (1.6 equiv NaH, 1.5 equiv Me3SI) from S113 (1.0 mmol, 1 equiv) in 96% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.28 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.78 (d, J = 7.9 Hz, 1H), 6.73 – 6.66 (m, 2H), 3.86 (s, 3H), 3.84 (s, 
3H), 2.80 (dd, J = 4.1, 0.7 Hz, 1H), 2.63 (d, J = 4.2 Hz, 1H), 2.49 (ddd, J = 13.6, 11.4, 5.2 Hz, 1H), 
2.41 (ddd, J = 13.6, 11.4, 5.9 Hz, 1H), 2.10 (ddd, J = 14.6, 11.4, 5.9 Hz, 1H), 1.99 (ddd, J = 14.6, 
11.4, 5.2 Hz, 1H), 1.62 – 1.29 (m, 8H), 1.25 – 1.05 (m, 2H), 1.00 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.9, 147.2, 135.0, 120.0, 111.8, 111.4, 64.2, 56.0, 55.9, 47.4, 
36.3, 32.9, 32.0, 31.5, 30.2, 26.2, 22.0, 22.0, 20.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2928 (s), 2858 (m), 2834 (w), 1607 (w), 1590 (w), 1514 (s), 1463 (s), 1449 
(s), 1417 (m), 1378 (w), 1344 (w), 1258 (s), 1235 (s), 1191 (w), 1155 (s), 1139 (s), 1096 (w), 1029 
(s), 970 (w), 921 (w), 886 (w), 850 (m), 805 (m); 765 (m), 675 (w), 632 (w), 596 (w), 547 (w), 514 
(w), 469 (w). 
HRMS (ESI) calcd for C19H28NaO3 [M+Na]
+: 327.1931; found: 327.1926. 
 
 
1-(1-methylcyclobutyl)-3-(m-tolyl)propan-1-one (S114) was prepared according to GP1 (t = 3 h) 
from 2-methylbenzaldehyde (5.0 mmol, 1 equiv) and 1-(1-methylcyclobutyl)ethan-1-one (S105) 
(1.5 equiv) and GP2a (10% Pd, t = 16 h) in 77% yield as a colorless oil. Purified by flash column 
chromatography on silica gel (10% diethyl ether in petrol ether). 
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TLC (10% ethyl acetate in cyclohexane): Rf: 0.39 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.22 – 7.13 (m, 1H), 7.05 – 6.95 (m, 3H), 2.91 – 2.80 (m, 2H), 2.77 
– 2.65 (m, 2H), 2.42 – 2.27 (m, 5H), 2.04 – 1.86 (m, 1H), 1.80 – 1.64 (m, 3H), 1.33 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 213.8, 141.6, 138.2, 129.3, 128.5, 126.9, 125.5, 49.9, 38.2, 30.3, 
30.1, 23.7, 21.5, 14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2957 (s), 2868 (m), 1703 (s), 1609 (w), 1455 (m), 1357 (w), 1071 (m), 780 
(w), 700 (w).  
HRMS (ESI): calcd for C15H20NaO [M+Na]
+: 239.1406; found: 239.1405. 
 
 
2-(3-methylphenethyl)-2-(1-methylcyclobutyl)oxirane (S115) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S114 (3.2 mmol, 1 equiv) in 88% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (4% diethyl ether in petrol ether). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.51 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.23 – 7.14 (m, 1H), 7.06 – 6.94 (m, 3H), 2.69 (d, J = 4.5 Hz, 1H), 
2.63 – 2.43 (m, 3H), 2.34 (s, 3H), 2.26 – 2.13 (m, 1H), 2.06 – 1.81 (m, 4H), 1.73 – 1.57 (m, 2H), 
1.32 (s, 3H), 1.27 (ddt, J = 5.6, 2.6, 1.6 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 142.3, 138.1, 129.2, 128.5, 126.7, 125.4, 62.2, 48.0, 42.0, 31.7, 
30.5, 30.0, 27.2, 24.1, 21.5, 14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2954 (s), 2927 (s), 2868 (m), 1609 (m), 1590 (w), 1488 (m), 2456 (m), 1375 
(m), 1246 (w), 1170 (w), 1091 (w), 1037 (w), 941 (w), 917 (w), 781 (m), 699 (m).  
HRMS (ESI): calcd for C16H22NaO [M+Na]
+: 253.1563; found: 253,1561. 
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1-(1-methylcyclobutyl)-3-(p-tolyl)propan-1-one (S116) was prepared according to GP1 (t = 3 h) 
from 3-methylbenzaldehyde (10.1 mmol, 1 equiv) and 1-(1-methylcyclobutyl)ethan-1-one (S105) 
(1.5 equiv) and GP2a (10% Pd, t = 16 h) in 61% yield as a colorless oil. Purified by flash column 
chromatography on silica gel (10% diethyl ether in petrol ether). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.45 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.08 (s, 4H), 2.85 (dd, J = 8.3, 6.9 Hz, 2H), 2.75 – 2.61 (m, 2H), 
2.42 – 2.24 (m, 5H), 2.04 – 1.85 (m, 1H), 1.79 – 1.63 (m, 3H), 1.32 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 213.8, 138.6, 135.7, 129.7, 128.4, 49.9, 38.3, 30.3, 29.7, 23.7, 21.1, 
14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2956 (s), 2929 (s), 2867 (m), 1703 (s), 1515 (m), 1454 (m), 1356 (w), 1072 
(m), 993 (w), 810 (m). 
HRMS (ESI): calcd for C15H20NaO [M+Na]
+: 239,1406; found: 239,1403. 
 
 
2-(1-methylcyclobutyl)-2-(4-methylphenethyl)oxirane (S117) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S116 (11.4 mmol, 1 equiv) in 77% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (4% diethyl ether in petrol ether). 
TLC (5% ethyl acetate in cyclohexane): Rf: 0.35 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.15 – 7.00 (m, 4H), 2.68 (d, J = 4.5 Hz, 1H), 2.61 – 2.40 (m, 3H), 
2.31 (s, 3H), 2.22 – 2.10 (m, 1H), 2.06 – 1.91 (m, 3H), 1.91 – 1.78 (m, 1H), 1.72 – 1.59 (m, 2H), 
1.30 (s, 3H), 1.27 – 1.22 (m, 1H). 
13
C NMR (101 MHz, CDCl3) δ 139.2, 135.5, 129.2, 128.3, 62.3, 48.0, 43.0, 31.7, 30.1, 30.0, 27.2, 
24.1, 21.1, 14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2955 (s), 2928 (s), 2868 (m), 1515 (m), 1455 (w), 1375 (w), 810 (w).  
HRMS (ESI): calcd for C16H22NaO [M+Na]
+: 253,1563; found: 253,1557. 
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3-(4-methoxyphenyl)-1-(1-methylcyclobutyl)propan-1-one (S118) was prepared according to 
GP4 from 4-methoxyphenol (8.9 mmol, 1 equiv) and 2-bromo-1-(1-methylcyclobutyl)ethan-1-one 
(S109) (1.1 equiv) in 83% yield as a yellow oil. Purified by flash column chromatography on silica 
gel (10% diethyl ether in n-pentane). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.22 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.88 – 6.77 (m, 4H), 4.70 (s, 2H), 3.76 (s, 3H), 2.50 (tdd, J = 9.3, 
7.4, 3.1 Hz, 2H), 2.10 – 1.96 (m, 1H), 1.90 – 1.74 (m, 3H), 1.49 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 209.5, 154.5, 152.4, 115.9, 114.8, 70.5, 55.8, 48.6, 30.8, 23.5, 15.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2956 (m), 2835 (w), 1721 (m), 1508 (s), 1438 (w), 1230 (m), 1108 (w), 1036 
(w), 825 (w).  
HRMS (ESI): calcd for C14H18NaO3 [M+Na]
+: 257,1148; found: 257,1146. 
 
 
2-((4-methoxyphenoxy)methyl)-2-(1-methylcyclobutyl)oxirane (S119) was prepared according 
to GP3 (2.0 equiv NaH, 2.0 equiv Me3SI) from S118 (7.3 mmol, 1 equiv) in 96% yield as a pale 
yellow oil. Purified by flash column chromatography on silica gel (15% diethyl ether in petrol 
ether). 
TLC (15% ethyl acetate in cyclohexane): Rf: 0.42 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.87 – 6.75 (m, 4H), 4.15 (d, J = 10.9 Hz, 1H), 3.96 (d, J = 11.0 Hz, 
1H), 3.76 (s, 3H), 2.85 (d, J = 4.7 Hz, 1H), 2.62 (d, J = 4.7 Hz, 1H), 2.35 – 2.19 (m, 1H), 2.08 – 
1.87 (m, 2H), 1.70 (dddd, J = 10.1, 9.2, 4.8, 2.6 Hz, 2H), 1.38 (s, 3H), 1.35 – 1.26 (m, 1H). 
13
C NMR (101 MHz, CDCl3) δ 154.1, 153.2, 115.7, 114.7, 69.0, 61.5, 55.9, 47.4, 40.3, 30.3, 27.4, 
23.9, 15.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2932 (m), 2870 (m), 1508 (s), 1464 (w), 1230 (s), 1181 (w), 1107 (w), 1043 
(m), 945 (w), 825 (m), 748 (w).  
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HRMS (ESI): calcd for C15H20NaO3 [M+Na]
+: 271.1305; found: 271.1303. 
 
 
(E)-1-(3,4-dimethoxyphenyl)-4-methylpent-1-en-3-one (S120) was prepared according to GP1 
(t = 3 h) from 3,4-dimethoxybenzaldehyde (30.0 mmol, 1 equiv) and 3-methyl-2-butanone 
(1.0 equiv) in 43% yield as a yellow highly viscous oil. Purified by flash column chromatography 
on silica gel (10% ethyl acetate in cyclohexane grading to 25% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.25 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.55 (d, J = 16.0 Hz, 1H), 7.14 (dd, J = 8.3, 2.0 Hz, 1H), 7.08 (d, J 
= 2.0 Hz, 1H), 6.87 (d, J = 8.3 Hz, 1H), 6.68 (d, J = 16.0 Hz, 1H), 3.92 (s, 3H), 3.91 (s, 3H), 2.94 
(hept, J = 6.9 Hz, 1H), 1.18 (d, J = 6.9 Hz, 6H). 
13
C NMR (101 MHz, CDCl3) δ: 204.0, 151.4, 149.4, 142.6, 127.8, 123.1, 122.7, 111.2, 109.9, 56.1, 
56.1, 39.1, 18.8. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2966 (m), 2933 (w), 2871 (w), 2837 (w), 1683 (w), 1656 (w), 1594 (s), 1580 
(m), 1510 (s), 1463 (m), 1421 (w), 1382 (w), 1338 (w), 1302 (w), 1260 (s), 1231 (m), 1203 (m), 
1161 (m), 1139 (s), 1097 (w), 1056 (s), 1024 (s), 984 (w), 845 (w), 807 (w), 768 (w), 746 (w), 604 
(w), 566 (w), 484 (w).  
HRMS (ESI): calcd for C14H19O3 [M+H]
+: 235.1329; found: 235.1323. 
 
 
(E)-1-(3,4-dimethoxyphenyl)-4,4-dimethylhepta-1,6-dien-3-one (S121): 
To a solution of (E)-1-(3,4-dimethoxyphenyl)-4-methylpent-1-en-3-one (S120) (234 mg, 
1.00 mmol, 1 equiv) in tetrahydrofuran (2 mL) at – 78 °C was added lithium 
bis(trimethylsilyl)amide (1.40 mL, 1.40 mmol, 1.40 equiv, 1.0 M in tetrahydrofuran) dropwise via 
syringe over a period of 30 seconds. A yellow solution was formed that was stirred at  
–78 °C for 10 min and then warmed to 0 °C. The red solution was cooled to –78 °C . Allyl bromide 
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(121 µL, 1.40 mmol, 1.40 equiv) was added. After 5 min the solution was allowed to warm to 23 °C 
and stirred for 4 h. Excess base was quenched by addition of saturated aqueous ammonium chloride 
solution (5 mL). The mixture was extracted with ethyl acetate (3×10 mL). The combined organic 
layers were washed with saturated aqueous sodium chloride solution (10 mL) and the washed 
solution was dried over sodium sulfate. The dried solution was filtered and the filtrate was 
concentrated under reduced pressure and purified by flash column chromatography on silica gel 
(5% ethyl acetate in cyclohexane grading to 25% ethyl acetate in cyclohexane) to yield the title 
compound S121 (67.9 mg, 25%) as a pale yellow oil. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.37 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.62 (d, J = 15.5 Hz, 1H), 7.16 (dd, J = 8.3, 2.0 Hz, 1H), 7.06 (d, J 
= 2.0 Hz, 1H), 6.96 (d, J = 15.4 Hz, 1H), 6.86 (d, J = 8.3 Hz, 1H), 5.76 – 5.64 (m, 1H), 5.07 – 5.03 
(m, 1H), 5.01 (t, J = 1.2 Hz, 1H), 3.92 (s, 3H), 3.90 (s, 3H), 2.35 (dt, J = 7.4, 1.2 Hz, 2H), 1.20 (s, 
6H). 
13
C NMR (101 MHz, CDCl3) δ: 203.4, 151.3, 149.3, 143.2, 134.3, 128.0, 122.8, 118.8, 118.0, 
111.2, 110.3, 56.1, 46.6, 44.1, 24.2. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3075 (w), 2964 (m), 2934 (w), 2837 (w), 1675 (m), 1639 (w), 1592 (s), 
1578 (s), 1509 (s), 1463 (s), 1441 (m), 1420 (m), 1385 (w), 1365 (w), 1338 (w), 1306 (w), 1255 (s), 
1234 (s), 1196 (w), 1160 (s), 1138 (s), 1089 (m), 1044 (s), 1023 (s), 1006 (m), 984 (s), 916 (m), 873 
(w), 843 (w), 806 (m), 767 (w), 728 (w), 672 (w), 642 (w), 615 (w), 583 (w), 553 (m), 509 (w), 485 
(w), 461 (w), 421 (w).  
HRMS (ESI): calcd for C17H23O3 [M+H]
+: 275.1642; found: 275.1635. 
 
 
1-(3,4-dimethoxyphenyl)-4,4-dimethylhept-6-en-3-one (S122) was prepared according to GP2b 
(4 equiv Mg, T = 23 °C, t = 4.5 h) from S121 (0.7 mmol, 1 equiv) in 72% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (5% ethyl acetate in cyclohexane grading to 
10% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.49 (CAM) 
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1
H NMR (400 MHz, CDCl3) δ: 6.82 – 6.74 (m, 1H), 6.74 – 6.67 (m, 2H), 5.63 (ddt, J = 16.5, 10.5, 
7.4 Hz, 1H), 5.12 – 4.93 (m, 2H), 3.86 (s, 3H), 3.84 (s, 3H), 2.85 – 2.79 (m, 2H), 2.78 – 2.69 (m, 
2H), 2.23 (d, J = 7.3 Hz, 2H), 1.08 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ: 214.3, 149.0, 147.4, 134.3, 134.2, 120.3, 118.0, 112.0, 111.4, 56.0, 
56.0, 47.6, 44.1, 39.5, 29.7, 24.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3073 (w), 2964 (m), 2933 (m), 2834 (w), 1702 (s), 1639 (w), 1607 (w), 1590 
(w), 1514 (s), 1464 (m), 1451 (m), 1417 (w), 1386 (w), 1365 (w), 1258 (s), 1235 (s), 1191 (w), 1154 
(s), 1140 (s), 1088 (w), 1067 (w), 1028 (s), 995 (m), 916 (m), 848 (w), 805 (m), 762 (m), 634 (w), 
597 (w), 548 (w), 477 (w), 463 (w), 421 (w).  
HRMS (ESI): calcd for C17H24NaO3 [M+Na]
+: 299.1618; found: 299.1612. 
 
 
2-(3,4-dimethoxyphenethyl)-2-(2-methylpent-4-en-2-yl)oxirane (17a) was prepared according 
to GP3 (1.6 equiv NaH, 1.5 equiv Me3SI) from S122 (0.9 mmol, 1 equiv) in 71% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (5% ethyl acetate in cyclohexane grading 
to 10% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.59 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 6.79 (d, J = 8.0 Hz, 1H), 6.74 – 6.68 (m, 2H), 5.82 (ddt, J = 16.6, 
10.5, 7.4 Hz, 1H), 5.08 – 4.99 (m, 2H), 3.87 (s, 3H), 3.85 (s, 3H), 2.75 (d, J = 4.1 Hz, 1H), 2.66 (d, 
J = 4.1 Hz, 1H), 2.49 (ddd, J = 13.5, 11.4, 5.2 Hz, 1H), 2.39 (ddd, J = 13.5, 11.5, 5.9 Hz, 1H), 2.20 
– 1.99 (m, 4H), 0.95 (s, 3H), 0.89 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 149.0, 147.4, 135.1, 134.9, 120.1, 117.3, 111.8, 111.4, 62.8, 56.1, 
56.0, 47.6, 43.7, 37.1, 31.5, 30.1, 23.6, 23.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3072 (w), 2962 (m), 2935 (m), 2834 (w), 1638 (w), 1607 (w), 1590 (w), 1514 
(s), 1464 (m), 1417 (w), 1385 (w), 1365 (w), 1343 (w), 1258 (s), 1235 (s), 1192 (w), 1156 (s), 1139 
(s), 1029 (s), 996 (w), 913 (m), 850 (w), 805 (m), 765 (m), 702 (w), 643 (w), 614 (w), 563 (w), 538 
(w), 463 (w).  
HRMS (ESI): calcd for C18H26NaO3 [M+Na]
+: 313.1774; found: 313.1752. 
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(E)-1-(3,4-dimethoxyphenyl)-4,4,7-trimethylocta-1,6-dien-3-one (S123): 
A solution of lithium hexamethyldisilazide (1.00 M in tetrahydrofuran, 3.00 mmol, 3.00 mL, 
1.50 equiv) was diluted with tetrahydrofuran (40 mL) and cooled to –50 °C. A solution of enone 
S120 (469 mg, 2.00 mmol, 1 equiv) in tetrahydrofuran (10 mL) was added dropwise, whereupon 
the color of the mixture turned intense red. After 90 min prenyl bromide (1.16 mL, 10.0 mmol, 
5.00 equiv) was added dropwise. After 15 min the cooling bath was removed and stirring was 
continued. After 15 h saturated aqueous sodium bicarbonate solution (40 mL) was added and the 
layers were separated. The aqueous layer was extracted with ethyl acetate (2 × 80 mL). The 
combined organic layers were washed with saturated aqueous sodium chloride solution and dried 
over anhydrous magnesium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography (20% diethyl ether in n-
pentane) to yield α-tertiary ketone S123 (475 mg, 1.57 mmol, 79%) as yellow oil. 
TLC (20% diethyl ether in n-pentane): Rf: 0.27 (UV, CAM) 
1
H-NMR (400 MHz, CDCl3): 7.62 (d, J = 15.5 Hz, 1H), 7.17 (ddd, J = 8.3, 2.0, 0.6 Hz, 1H), 7.06 
(d, J = 2.0 Hz, 1H), 6.97 (d, J = 15.5 Hz, 1H), 6.87 (d, J = 8.3 Hz, 1H), 5.04 (tp, J = 7.5, 1.4 Hz, 
1H), 3.93 (d, J = 0.8 Hz, 3H), 3.91 (d, J = 1.0 Hz, 3H), 2.31 (dt, J = 7.7, 1.2 Hz, 2H), 1.67 (d, J = 
1.3 Hz, 3H), 1.60 (d, J = 1.4 Hz, 3H), 1.19 (d, J = 0.7 Hz, 6H). 
13
C NMR (101 MHz, CDCl3) δ 204.0, 151.2, 149.3, 142.8, 134.2, 128.1, 122.8, 120.0, 119.1, 111.2, 
110.4, 56.1, 56.1, 47.3, 38.2, 26.1, 24.3, 18.1. 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2965 (w), 2930 (br w), 1677 (w), 1594 (m), 1511 (s), 1465 (w), 1421 (w), 
1384 (w), 1339 (w), 1309 (w), 1261 (s), 1161 (w), 1139 (m), 1063 (s), 1025 (m), 984 (w), 843 (w), 
807 (w), 767 (w). 
HRMS (ESI): calcd for C19H27O3 [M+H]
+: 303.1955; found: 303.1938. 
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1-(3,4-dimethoxyphenyl)-4,4,7-trimethyloct-6-en-3-one (S124) was prepared according to 
GP2b (4 equiv Mg, T = 23 °C, t = 5 h) from S123 (1.6 mmol, 1 equiv) in 80% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (20% diethyl ether in n-pentane). 
TLC (20% diethyl ether in n-pentane): Rf: 0.22 (UV, CAM) 
1
H-NMR (400 MHz, CDCl3): δ = 6.78 (d, J = 8.6 Hz, 1H), 6.73 – 6.69 (m, 2H), 4.92 (ddq, J = 8.9, 
5.8, 1.4 Hz, 1H), 3.86 (s, 3H), 3.85 (s, 3H), 2.81 (ddd, J = 7.7, 6.5, 1.8 Hz, 2H), 2.76 – 2.68 (m, 
2H), 2.22 – 2.14 (m, 2H), 1.67 (q, J = 1.3 Hz, 3H), 1.58 (d, J = 1.4 Hz, 3H), 1.07 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 214.9, 149.0, 147.4, 134.5, 134.3, 120.3, 119.8, 112.0, 111.4, 56.1, 
56.0, 48.2, 39.5, 38.2, 29.7, 26.1, 24.1, 18.0. 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2964 (m), 2929 (br m), 1702 (s), 1591 (w), 1515 (s), 1465 (m), 1418 (w), 
1384 (w), 1364 (w), 1261 (s), 1237 (s), 1155 (m), 1140 (m), 1071 (w), 1030 (s), 988 (w), 851 (w), 
807 (w), 763 (w). 
HRMS (ESI): calcd for C19H29O3 [M+H]
+: 305.2111; found: 305.2108. 
 
 
2-(3,4-dimethoxyphenethyl)-2-(2,5-dimethylhex-4-en-2-yl)oxirane (17b) was prepared 
according to GP3 (2.0 equiv NaH, 1.9 equiv Me3SI) from S124 (1.1 mmol, 1 equiv) in 93% yield 
as a colorless oil. Purified by flash column chromatography on silica gel (20% diethyl ether in n-
pentane). 
TLC (20% diethyl ether in n-pentane): Rf: 0.27 (UV, CAM) 
1
H-NMR (400 MHz, CDCl3): δ = 6.79 (d, J = 7.9 Hz, 1H), 6.76 – 6.67 (m, 2H), 5.18 (tdq, J = 7.2, 
2.8, 1.4 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 2.76 (dd, J = 4.1, 0.8 Hz, 1H), 2.66 (d, J = 4.2 Hz, 1H), 
2.50 (ddd, J = 13.6, 11.4, 5.2 Hz, 1H), 2.39 (ddd, J = 13.5, 11.4, 5.9 Hz, 1H), 2.17 – 1.96 (m, 4H), 
1.72 (q, J = 1.3 Hz, 3H), 1.60 (d, J = 1.4 Hz, 3H), 0.94 (s, 3H), 0.87 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 149.0, 147.3, 135.0, 133.3, 120.6, 120.1, 111.9, 111.4, 63.0, 56.1, 
56.0, 47.8, 37.8, 37.4, 31.6, 30.2, 26.2, 23.6, 23.1, 18.1. 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2963 (m), 2932 (br m), 1590 (w), 1515 (s), 1464 (m), 1418 (m), 1384 (w), 
1260 (s), 1237 (s), 1156 (m), 1140 (m), 1030 (s), 921 (w), 850 (w), 807 (w), 765 (w) cm-1. 
HRMS (ESI): calcd for C20H31O3 [M+H]
+: 319.2268; found: 319.2264. 
 
 
(1E,6E)-1-(3,4-dimethoxyphenyl)-4,4,7,11-tetramethyldodeca-1,6,10-trien-3-one (S125): 
A solution of lithium hexamethyldisilazide (1.00 M in tetrahydrofuran, 2.25 mmol, 2.25 mL, 
1.50 equiv) was diluted with tetrahydrofuran (30 mL) and cooled to –50 °C. Enone S120 (351 mg, 
1.50 mmol, 1 equiv) in tetrahydrofuran (7.5 mL) was added dropwise, whereupon the color of the 
mixture turned intense red. After 1 h geranyl bromide (1.49 mL, 7.50 mmol, 5.00 equiv) was added 
dropwise. After 10 min the cooling bath was removed and stirring was continued. After 16 h 
saturated aqueous sodium bicarbonate solution (30 mL) was added and the layers were separated. 
The aqueous layer was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution and dried over anhydrous magnesium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography (20% diethyl ether in n-pentane) to yield α-tertiary ketone S125 
(387 mg, 1.04 mmol, 70%) as yellow oil. 
TLC (20% ethyl acetate in n-pentane): Rf: 0.53 (UV, CAM) 
1
H-NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 15.5 Hz, 1H), 7.17 (dd, J = 8.3, 2.0 Hz, 1H), 7.06 (d, 
J = 2.0 Hz, 1H), 6.97 (d, J = 15.5 Hz, 1H), 6.87 (d, J = 8.3 Hz, 1H), 5.05 (ddddd, J = 9.7, 6.8, 5.4, 
2.8, 1.4 Hz, 2H), 3.93 (s, 3H), 3.92 (s, 3H), 2.32 (d, J = 7.5 Hz, 2H), 2.01 (dq, J = 13.4, 7.1 Hz, 
4H), 1.65 (d, J = 1.4 Hz, 3H), 1.60 (d, J = 1.4 Hz, 3H), 1.56 (d, J = 1.4 Hz, 3H), 1.19 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 204.0, 151.2, 149.3, 142.8, 137.8, 131.5, 128.2, 124.4, 122.8, 120.0, 
119.1, 111.3, 110.4, 56.1, 56.1, 47.4, 40.1, 38.0, 26.8, 25.8, 24.2, 17.8, 16.4. 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2963 (m), 2920 (br m), 1677 (m), 1593 (s), 1510 (s), 1464 (m), 1420 (m), 
1384 (w), 1308 (w), 1258 (s), 1160 (m), 1138 (s), 1060 (s), 1025 (s), 983 (m), 842 (w), 805 (m), 766 
(w), 556 (w) cm-1. 
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HRMS (ESI): calcd for C24H34NaO3 [M+Na]
+: 393.2400; found: 393.2395. 
 
 
(E)-1-(3,4-dimethoxyphenyl)-4,4,7,11-tetramethyldodeca-6,10-dien-3-one (S126) was 
prepared according to GP2b (4 equiv Mg, T = 23 °C, t = 4.5 h) from S125 (1.0 mmol, 1 equiv) in 
79% yield as a colorless oil. Purified by flash column chromatography on silica gel (20% diethyl 
ether in n-pentane). 
TLC (20% diethyl ether in n-pentane): Rf: 0.35 (UV, CAM) 
1
H-NMR (400 MHz, CDCl3): δ = 6.81 – 6.69 (m, 3H), 5.05 (ddp, J = 6.9, 5.7, 1.4 Hz, 1H), 4.96 
(tq, J = 7.5, 1.3 Hz, 1H), 3.86 (s, 3H), 3.84 (s, 3H), 2.87 – 2.68 (m, 4H), 2.23 – 2.14 (m, 2H), 2.10 
– 1.92 (m, 4H), 1.66 (q, J = 1.3 Hz, 3H), 1.58 (d, J = 1.3 Hz, 3H), 1.57 (d, J = 1.4 Hz, 3H), 1.07 (s, 
6H). 
13
C NMR (101 MHz, CDCl3) δ 214.9, 149.0, 147.4, 137.9, 134.5, 131.6, 124.3, 120.3, 119.8, 112.0, 
111.4, 56.1, 56.0, 48.2, 40.1, 39.5, 38.0, 29.8, 26.7, 25.8, 24.1, 17.8, 16.3. 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2929 (br m), 1702 (s), 1590 (w), 1515 (s), 1464 (m), 1418 (m), 1384 (w), 
1363 (w), 1260 (s), 1236 (s), 1154 (m), 1140 (m), 1069 (w), 1030 (s), 849 (w), 805 (m), 763 (m), 
637 (w), 551 (w). 
HRMS (ESI): calcd for C24H36NaO3 [M+Na]
+: 395.2557; found: 395.2556. 
 
 
(E)-2-(3,4-dimethoxyphenethyl)-2-(2,5,9-trimethyldeca-4,8-dien-2-yl)oxirane (S127) was 
prepared according to GP3 (1.6 equiv NaH, 1.5 equiv Me3SI) from S126 (0.70 mmol, 1 equiv) in 
88% yield as a pale yellow oil. Purified by flash column chromatography on silica gel (20% diethyl 
ether in n-pentane). 
TLC (20% diethyl ether in n-pentane): Rf: 0.26 (UV, CAM) 
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1
H-NMR (400 MHz, CDCl3): δ = 6.79 (d, J = 7.9 Hz, 1H), 6.76 – 6.67 (m, 2H), 5.19 (tq, J = 7.4, 
1.3 Hz, 1H), 5.08 (tp, J = 6.9, 1.5 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 2.79 – 2.72 (m, 1H), 2.66 (d, 
J = 4.2 Hz, 1H), 2.50 (ddd, J = 13.5, 11.4, 5.2 Hz, 1H), 2.39 (ddd, J = 13.5, 11.5, 5.9 Hz, 1H), 2.13 
– 1.99 (m, 8H), 1.67 (d, J = 1.4 Hz, 3H), 1.60 (dd, J = 3.1, 1.4 Hz, 6H), 0.95 (s, 3H), 0.86 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.3, 136.9, 135.0, 131.5, 124.5, 120.7, 120.1, 111.9, 111.4, 
63.0, 56.1, 56.0, 47.9, 40.2, 37.9, 37.2, 31.6, 30.2, 26.8, 25.9, 23.7, 22.8, 17.8, 16.3. 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2963 (br m), 2931 (w), 1591 (w), 1515 (s), 1464 (m), 1418 (m), 1384 (w), 
1260 (s), 1237 (s), 1157 (m), 1140 (m), 1031 (m), 806 (w), 766 (w). 
HRMS (ESI): calcd for C25H38NaO3 [M+Na]
+: 409.2713; found: 409.2709. 
 
 
(E)-1-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-phenylpent-1-en-3-one (S128): 
To a solution of S120 (234 mg, 1.00 mmol, 1 equiv) in tetrahydrofuran (2 mL) at – 78 °C was added 
lithium bis(trimethylsilyl)amide (1.40 mL, 1.0 M in tetrahydrofuran 1.40 mmol, 1.40 equiv) 
dropwise via syringe over a period of 30 seconds. A yellow solution formed, that was stirred at –
78 °C for 10 min and then warmed to 0 °C. The resulted red solution was cooled to –78 °C again. 
Benzyl bromide (167 µL, 1.40 mmol, 1.40 equiv) was added and stirring was continued at –78 °C 
for 5 min. The solution was allowed to warm to 23 °C and stirred for 3 h. By addition of saturated 
aqueous ammonium chloride solution (5 mL) excess base was quenched. The mixture was extracted 
with ethyl acetate (3×10 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (10 mL) and the washed solution was dried over sodium sulfate. The 
solution was filtered and the filtrate was concentrated under reduced pressure and purified by flash 
column chromatography on silica gel (5% ethyl acetate in cyclohexane to 25% ethyl acetate in 
cyclohexane) to yield compound S128 (87.0 mg, 27%) as a pale yellow oil. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.38 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.65 (d, J = 15.4 Hz, 1H), 7.25 – 7.14 (m, 4H), 7.14 – 7.09 (m, 2H), 
7.05 (d, J = 2.0 Hz, 1H), 6.98 (d, J = 15.4 Hz, 1H), 6.87 (d, J = 8.3 Hz, 1H), 3.92 (s, 3H), 3.91 (s, 
3H), 2.92 (s, 2H), 1.21 (s, 6H). 
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13
C NMR (101 MHz, CDCl3) δ: 203.4, 151.3, 149.2, 143.1, 137.9, 130.4, 128.0, 127.9, 126.4, 
122.9, 119.2, 111.2, 110.3, 56.0, 47.7, 45.5, 24.4. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3061 (w), 3026 (w), 2964 (m), 2933 (w), 2868 (w), 2837 (w), 1674 (m), 
1591 (s), 1578 (s), 1509 (s), 1463 (m), 1453 (m), 1441 (m), 1420 (m), 1385 (w), 1365 (w), 1338 
(w), 1305 (w), 1256 (s), 1233 (s), 1196 (w), 1160 (m), 1137 (s), 1076 (m), 1054 (s), 1022 (s), 1004 
(m), 983 (m), 942 (w), 913 (w), 844 (w), 806 (m), 767 (w), 751 (m), 733 (m), 701 (s), 647 (w), 615 
(w), 574 (w), 553 (m), 505 (w), 476 (w), 421 (w).  
HRMS (ESI): calcd for C21H25O3 [M+H]
+: 325.1798; found: 325.1792. 
 
 
5-(3,4-dimethoxyphenyl)-2,2-dimethyl-1-phenylpentan-3-one (S129) was prepared according to 
GP2b (4 equiv Mg, T = 23 °C, t = 2 h) from S128 (1.0 mmol, 1 equiv) in 77% yield as a colorless 
solid. Purified by flash column chromatography on silica gel (5% ethyl acetate in cyclohexane 
grading to 10% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.53 (CAM) 
mp: 45.3 – 47.0 °C 
1
H NMR (400 MHz, CDCl3) δ: 7.37 – 7.26 (m, 3H), 7.15 – 7.07 (m, 2H), 6.85 (d, J = 8.0 Hz, 1H), 
6.78 – 6.71 (m, 2H), 3.93 (s, 3H), 3.92 (s, 3H), 2.92 – 2.80 (m, 4H), 2.79 – 2.65 (m, 2H), 1.18 (s, 
6H). 
13
C NMR (101 MHz, CDCl3) δ: 214.7, 148.9, 147.4, 137.9, 134.2, 130.3, 128.1, 126.4, 120.3, 
112.0, 111.4, 56.0, 55.9, 48.5, 45.8, 40.6, 29.5, 24.3. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3061 (w), 3027 (w), 2962 (m), 2933 (m), 2833 (w), 1700 (s), 1605 (w), 
1590 (w), 1514 (s), 1464 (m), 1452 (m), 1418 (w), 1387 (w), 1364 (w), 1260 (s), 1235 (s), 1190 (w), 
1154 (m), 1140 (m), 1077 (w), 1028 (s), 991 (w), 941 (w), 889 (w), 849 (w), 805 (w), 763 (w), 746 
(m), 703 (s), 633 (w), 610 (w), 597 (w), 548 (w), 523 (w), 480 (w).  
HRMS (ESI): calcd for C21H26NaO3 [M+Na]
+: 349.1774; found: 349.1766. 
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2-(3,4-dimethoxyphenethyl)-2-(2-methyl-1-phenylpropan-2-yl)oxirane (17c) was prepared 
according to GP3 (1.6 equiv NaH, 1.5 equiv Me3SI) from S129 (0.8 mmol, 1 equiv) in 93% yield 
as a colorless oil. Purified by flash column chromatography on silica gel (10% ethyl acetate in 
cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.58 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.30 – 7.18 (m, 3H), 7.15 – 7.10 (m, 2H), 6.82 (d, J = 8.1 Hz, 1H), 
6.75 (dd, J = 8.1, 2.0 Hz, 1H), 6.72 (d, J = 2.0 Hz, 1H), 3.89 (s, 3H), 3.87 (s, 3H), 2.80 – 2.74 (m, 
1H), 2.69 – 2.60 (m, 3H), 2.53 (ddd, J = 13.5, 11.3, 5.4 Hz, 1H), 2.44 (ddd, J = 13.4, 11.4, 5.9 Hz, 
1H), 2.26 – 2.17 (m, 1H), 2.17 – 2.08 (m, 1H), 0.96 (s, 3H), 0.84 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 149.0, 147.4, 138.5, 134.8, 130.8, 127.9, 126.2, 120.2, 111.9, 
111.5, 63.0, 56.1, 56.0, 48.1, 44.8, 38.2, 31.9, 30.2, 23.6, 22.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3058 (w), 3027 (w), 2959 (w), 2935 (m), 2873 (w), 2834 (w), 1604 (w), 1590 
(w), 1514 (s), 1464 (m), 1453 (m), 1418 (w), 1386 (w), 1364 (w), 1343 (w), 1259 (s), 1235 (s), 1192 
(w), 1155 (m), 1139 (m), 1071 (w), 1028 (s), 910 (m), 850 (w), 806 (m), 765 (w), 729 (s), 702 (s), 
646 (w), 631 (w), 610 (w), 562 (w), 548 (w), 509 (w), 467 (w). 
HRMS (ESI): calcd for C22H28NaO3 [M+Na]
+: 363.1931; found: 363.1903. 
 
 
1-(3,4-dimethoxyphenyl)-4,4-dimethylhex-5-en-3-one (S131): 
Prenyl bromide (0.89 mL, 7.7 mmol, 3.0 equiv) was added dropwise to a stirred suspension of 3-
(3,4-dimethoxyphenyl)-propanal (S57) (500 mg, 2.57 mmol, 1 equiv) and indium (590 mg, 
5.15 mmol, 2.00 equiv) in a mixture of water (3.2 mL) and tetrahydrofuran (3.2 mL) at 0 °C. The 
reaction mixture was allowed to warm to 23 °C. After 16 h, aqueous hydrochloric acid (1.0 M) was 
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added untill the white emulsion clearified and the mixture was extracted with ethyl acetate 
(3 × 10 mL). The combined organic extracts were washed with saturated aqueous sodium chloride 
solution and dried over sodium sulfate. The mixture was filtered and the filtrate was concentrated 
under reduced pressure to afford the crude alcohol S130 that was used without further purification.  
To a solution of the crude alcohol (approx. 2.6 mmol, 1 equiv) in dichloromethane (13 mL) was 
added potassium carbonate (0.71 g, 5.2 mmol, 2.0 equiv) and Dess–Martin periodinane (2.2 g, 
5.2 mmol, 2.0 equiv) at 23 °C. The mixture was stirred for 2 h. The suspension was filtered and the 
filtrate was concentrated under reduced pressure. Purification by flash column chromatography on 
silica gel (10% ethyl acetate in cyclohexane) afforded ketone S131 (391 mg, 58% over 2 steps) as 
a colorless oil.  
TLC (25% ethyl acetate in cyclohexane): Rf: 0.26 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.79 – 6.74 (m, 1H), 6.71 – 6.65 (m, 2H), 5.91 – 5.79 (m, 1H), 5.11 
(s, 1H), 5.08 (dd, J = 6.2, 0.9 Hz, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 2.82 – 2.70 (m, 4H), 1.18 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 212.2, 148.9, 147.4, 142.4, 134.1, 120.3, 114.4, 111.9, 111.3, 56.0, 
55.9, 50.8, 39.6, 29.8, 23.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2969 (m), 2934 (m), 2834 (w), 1706 (s), 1635 (w), 1607 (w), 1590 (w), 1514 
(s), 1464 (m), 1416 (m), 1378 (w), 1363 (w), 1259 (s), 1235 (s) ,1191 (w), 1135 (s), 1074 (s), 1028 
(s), 919 (m), 846 (w), 807 (m), 762 (m), 700 (m); 681 (w), 635 (w), 595 (w), 549 (w), 497 (s). 
HRMS (ESI) calcd for C16H22NaO3 [M+Na]
+: 285.1461; found: 285.1453 
 
 
2-(3,4-dimethoxyphenethyl)-2-(2-methylbut-3-en-2-yl)oxirane (17d) was prepared according to 
GP3 (1.6 equiv NaH, 1.6 equiv Me3SI) from S131 (1.0 mmol, 1 equiv) in 81% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.28 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.77 (d, J = 7.9 Hz, 1H), 6.71 – 6.66 (m, 2H), 5.94 – 5.83 (m, 1H), 
5.06 – 5.03 (m, 1H), 5.01 (s, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 2.74 (d, J = 4.2 Hz, 1H), 2.65 (d, J = 
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4.3 Hz, 1H), 2.47 (ddd, J = 13.6, 11.4, 5.3 Hz, 1H), 2.38 (ddd, J = 13.6, 11.4, 5.9 Hz, 1H), 2.07 
(ddd, J = 14.6, 11.4, 5.9 Hz, 1H), 1.96 (ddd, J = 14.7, 11.4, 5.3 Hz, 1H), 1.05 (s, 3H), 1.03 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.9, 147.2, 144.7, 134.7, 120.0, 112.5, 111.7, 111.3, 62.6, 55.9, 
55.9, 47.6, 40.2, 31.9, 30.1, 23.4, 22.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3080 (w), 3057 (w), 2965 (m), 2935 (m), 2873 (w), 2833 (w), 1637 (w), 1607 
(w), 1590 (w), 1513 (s), 1463 (m), 1416 (m), 1379 (w), 1347 (w), 1259 (s), 1234 (s), 1191 (w), 1156 
(s), 1139 (s), 1029 (s), 914 (s), 850 (w), 836 (w), 807 (m), 765 (m), 695 (w), 657 (w), 619 (w), 598 
(w), 575 (w), 546 (w), 505 (w), 461 (w).  
HRMS (ESI) calcd for C17H25O3 [M+H]
+: 277.1798; found: 277.1792. 
 
 
3-(3,4-dimethoxyphenyl)-1-(1-phenylcyclopentyl)propan-1-one (S132) was prepared according 
to GP1 (t = 4 h) from 3,4-dimethoxybenzaldehyde (2.0 mmol, 1 equiv) and 1-(1-
phenylcyclopentyl)ethan-1-one (1.0 equiv) and GP2a (1% Pd, t = 16 h) in 36% yield as a colorless 
solid. Purified by flash column chromatography on silica gel (20% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.29 (UV, CAM) 
mp: 47.5 – 49.0°C 
1
H NMR (400 MHz, CDCl3) δ 7.30 – 7.24 (m, 2H), 7.24 – 7.17 (m, 3H), 6.69 (d, J = 8.1 Hz, 1H), 
6.53 (dd, J = 8.1, 2.0 Hz, 1H), 6.49 (d, J = 2.0 Hz, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 2.66 (t, J = 7.4 
Hz, 2H), 2.52 (ddd, J = 8.0, 7.1, 1.0 Hz, 2H), 2.48 – 2.38 (m, 2H), 1.93 – 1.82 (m, 2H), 1.72 – 1.54 
(m, 4H). 
13
C NMR (101 MHz, CDCl3) δ 210.5, 148.8, 147.3, 142.8, 134.0, 128.7, 127.1, 126.9, 120.2, 111.7, 
111.2, 65.5, 56.0, 55.9, 39.7, 34.5, 30.3, 23.8. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2951 (s), 2871 (w), 2833 (w), 1702 (s), 1591 (m), 1514 (s), 1493 (w), 1463 
(w), 1448 (m), 1417 (w), 1349 (w), 1259 (s), 1235 (s), 1190 (w), 1153 (s), 1138 (s), 1083 (w), 1065 
(w), 1028 (s), 969 (w), 940 (w), 909 (w), 850 (w), 804 (m), 760 (s), 700 (s), 633 (w), 594 (w), 548 
(m), 461 (w). 
HRMS (ESI) calcd for C22H26NaO3 [M+Na]
+: 361.1774; found: 361.1765. 
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2-(3,4-dimethoxyphenethyl)-2-(1-phenylcyclopentyl)oxirane (S133) was prepared according to 
GP3 (1.6 equiv NaH, 1.5 equiv Me3SI) from S132 (0.5 mmol, 1 equiv) in 95% yield as a colorless 
oil. Purified by flash column chromatography on silica gel (20% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.32 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.28 (m, 4H), 7.25 – 7.18 (m, 1H), 6.70 (d, J = 8.0 Hz, 1H), 
6.53 – 6.46 (m, 2H), 3.81 (s, 3H), 3.79 (s, 3H), 3.02 (d, J = 4.3 Hz, 1H), 2.84 (d, J = 4.3 Hz, 1H), 
2.33 (ddd, J = 13.6, 10.2, 6.1 Hz, 1H), 2.26 – 2.12 (m, 2H), 1.94 (dt, J = 13.3, 8.8 Hz, 1H), 1.88 – 
1.58 (m, 7H), 1.43 (dtt, J = 12.4, 9.7, 7.3 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 148.8, 147.1, 145.8, 134.6, 128.3, 127.2, 126.2, 119.9, 111.6, 111.2, 
62.9, 55.9, 55.8, 55.2, 49.9, 34.8, 33.3, 32.5, 30.0, 23.5, 23.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2951 (s), 2872 (w), 2833 (w), 1591 (m), 1513 (s), 1494 (w), 1452 (s), 1417 
(m), 1331 (w), 1258 (s), 1234 (s), 1191 (w), 1155 (s), 1139 (s), 1028 (s), 972 (w), 910 (m), 848 (m), 
806 (m), 759 (s), 734 (w), 700 (s), 641 (w), 598 (w), 543 (m), 486 (w). 
HRMS (ESI) calcd for C23H28NaO3 [M+Na]
+: 375.1931; found: 375.1929. 
 
 
(E)-1-(3,4-dimethoxyphenyl)-5-methoxy-4,4-dimethylpent-1-en-3-one (S134)  
To a solution of enone S120 (234 mg, 1.00 mmol, 1 equiv) in tetrahydrofuran (2 mL) at – 78 °C 
was added lithium bis(trimethylsilyl)amide (1 M in THF, 1.40 mL, 1.40 mmol, 1.40 equiv) 
dropwise via syringe over a period of 30 seconds. A yellow solution was formed that was stirred at 
–78 °C for 10 min and then warmed to 0 °C. The now red solution was cooled to –78 °C again. 
Methoxymethyl bromide (114 µL, 1.40 mmol, 1.40 equiv) was added and stirring at  
–78 °C was continued for 5 min. The solution was stirred at 23 °C for 3 h. By addition of saturated 
aqueous ammonium chloride solution (5 mL) excess base was quenched. The mixture was extracted 
with ethyl acetate (3×10 mL). The combined organic layers were washed with saturated aqueous 
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sodium chloride solution (10 mL) and the washed solution was dried over sodium sulfate and 
filtered. The filtrate was concentrated under reduced pressure and purified by flash column 
chromatography on silica gel (5% ethyl acetate in cyclohexane grading to 25% ethyl acetate in 
cyclohexane) to yield compound S134 (79.0 mg, 28%) as a pale yellow oil that solidified upon 
storage. Additionally, enol ether S135 (64.0 mg, 23%) was obtained as a pale yellow oil. 
Analytical data of S134: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.40 (CAM) 
mp: 49.5 – 52.0 °C 
1
H NMR (400 MHz, CDCl3) δ: 7.60 (d, J = 15.5 Hz, 1H), 7.14 (dd, J = 8.3, 2.0 Hz, 1H), 7.04 (d, J 
= 2.0 Hz, 1H), 6.97 (d, J = 15.5 Hz, 1H), 6.84 (d, J = 8.3 Hz, 1H), 3.90 (s, 3H), 3.88 (s, 3H), 3.45 
(s, 2H), 3.31 (s, 3H), 1.20 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ: 202.6, 151.2, 149.2, 143.1, 128.0, 122.8, 119.0, 111.1, 110.3, 79.5, 
59.5, 56.0 (2C), 47.7, 22.0. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2966 (w), 2931 (m), 2873 (w), 2836 (m), 1678 (m), 1591 (s), 1578 (s), 1509 
(s), 1462 (m), 1442 (m) 1420 (m), 1393 (w), 1364 (w), 1338 (w), 1308 (w), 1256 (s), 1233 (s), 1199 
(w), 1160 (m), 1138 (s), 1107 (s), 1065 (s), 1021 (s), 983 (s), 963 (m), 927 (w), 845 (w), 807 (m), 
767 (m), 728 (w), 647 (w), 607 (w), 555 (w), 513 (w), 487 (w), 462 (w), 431 (w), 415 (w) cm−1.  
HRMS (ESI): calcd for C16H22NaO4 [M+Na]
+: 301.1410; found: 301.1404. 
 
Analytical data of S135: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.50 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 6.97 (dd, J = 8.2, 2.1 Hz, 1H), 6.94 (d, J = 2.0 Hz, 1H), 6.81 (d, J 
= 8.5 Hz, 1H), 6.78 (d, J = 15.7 Hz, 1H), 6.62 (d, J = 15.7 Hz, 1H), 4.85 (s, 2H), 3.90 (s, 3H), 3.87 
(s, 3H), 3.58 (s, 3H), 1.87 (s, 3H), 1.86 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 149.2, 148.8, 146.4, 130.8, 127.1, 122.8, 119.6, 119.4, 111.4, 
109.1, 97.9, 57.5, 56.0, 55.9, 19.2, 19.0. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3054 (w), 2994 (w), 2932 (m), 2907 (m), 2835 (w), 1637 (w), 1599 (w), 
1580 (w), 1510 (s), 1463 (m), 1441 (m), 1417 (w), 1383 (w), 1332 (w), 1294 (w), 1251 (s), 1228 
(s), 1196 (w), 1156 (s), 1137 (s), 1108 (m), 1071 (s), 1025 (s), 991 (s), 963 (s), 924 (m), 902 (w), 
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864 (w), 837 (w), 803 (m), 765 (w), 728 (w), 684 (w), 612 (w), 591 (w), 562 (w), 534 (w), 474 (w), 
441 (w).  
HRMS (ESI): calcd for C16H22NaO4 [M+Na]
+: 301.1410; found: 301.1406. 
 
 
5-(3,4-dimethoxyphenyl)-1-methoxy-2,2-dimethylpentan-3-one (S136) was prepared according 
to GP2b (4 equiv Mg, T = 23 °C, t = 4.5 h) from S134 (0.6 mmol, 1 equiv) in 64% yield as a 
colorless solid. Purified by flash column chromatography on silica gel (5% ethyl acetate in 
cyclohexane grading to 25% ethyl acetate in cyclohexane). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.49 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 6.78 – 6.73 (m, 1H), 6.72 – 6.66 (m, 2H), 3.83 (s, 3H), 3.81 (s, 3H), 
3.33 (s, 2H), 3.25 (s, 3H), 2.83 – 2.73 (m, 4H), 1.07 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ: 213.3, 148.8, 147.3, 134.4, 120.2, 111.9, 111.3, 79.7, 59.2, 55.9, 
55.8, 48.4, 39.7, 29.3, 21.9. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2963 (w), 2932 (m), 2874 (w), 2834 (w), 1704 (s), 1607 (w), 1590 (w), 1514 
(s), 1463 (m), 1418 (w), 1394 (w), 1363 (w), 1258 (s), 1235 (s), 1195 (w), 1141 (s), 1107 (s), 1075 
(m), 1027 (s), 981 (w), 961 (w), 928 (w), 890 (w), 850 (w), 803 (m), 763 (m), 710 (w), 636 (w), 597 
(w), 550 (w), 462 (w), 416 (w) cm−1.  
HRMS (ESI): calcd for C16H24NaO4 [M+Na]
+: 303.1567; found: 303.1559. 
 
 
2-(3,4-dimethoxyphenethyl)-2-(1-methoxy-2-methylpropan-2-yl)oxirane (23g) was prepared 
according to GP3 (1.6 equiv NaH, 1.5 equiv Me3SI) from S136 (0.40 mmol, 1 equiv) in 58% yield 
as a colorless oil. Purified by flash column chromatography on silica gel (10% ethyl acetate in 
cyclohexane). 
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TLC (25% ethyl acetate in cyclohexane): Rf: 0.52 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 6.77 (d, J = 7.9 Hz, 1H), 6.72 – 6.68 (m, 2H), 3.85 (s, 3H), 3.83 (s, 
3H), 3.30 (s, 3H), 3.17 (q, J = 9.2 Hz, 2H), 2.79 (d, J = 4.2 Hz, 1H), 2.67 (d, J = 4.2 Hz, 1H), 2.48 
(ddd, J = 13.6, 11.4, 5.2 Hz, 1H), 2.40 (ddd, J = 13.6, 11.4, 5.8 Hz, 1H), 2.11 (ddd, J = 14.5, 11.4, 
5.9 Hz, 1H), 1.97 (ddd, J = 14.5, 11.4, 5.2 Hz, 1H), 0.97 (s, 3H), 0.91 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 148.9, 147.2, 134.9, 120.1, 111.8, 111.4, 79.4, 61.7, 59.2, 56.0, 
55.9, 48.3, 38.4, 31.8, 29.9, 21.4, 21.4. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2958 (w), 2934 (m), 2873 (w), 2833 (w), 1607 (w), 1590 (w), 1514 (s), 1463 
(m), 1417 (w), 1396 (w), 1364 (w), 1347 (w), 1259 (s), 1235 (s), 1201 (w), 1156 (s), 1139 (s), 1104 
(s), 1028 (s), 963 (w), 947 (w), 921 (w), 849 (w), 806 (m), 765 (m), 622 (w), 599 (w), 588 (w), 560 
(w), 521 (w), 465 (w), 421 (w), 413 (w) cm−1.  
HRMS (ESI): calcd for C17H26NaO3 [M+Na]
+: 317.1723; found: 317.1699. 
 
 
3-(3,4-dimethoxyphenyl)-N-methoxy-N-methylpropanamide (S137) 
To a solution of 3-(3,4-dimethoxyphenyl)propanoic acid (2.50 g, 11.9 mmol, 1 equiv) in 
dichloromethane (60 mL, 0.20 M) was added triethylamine (1.81 mL, 13.1 mmol, 1.10 equiv), 4-
dimethylaminopyridine (145 mg, 1.19 mmol, 0.100 equiv.), 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (2.51 g, 13.1 mmol, 1.10 equiv) and N,O-dimethyl-
hydroxylamine hydrochloride (1.39 g, 14.3 mmol, 1.20 equiv.) in sequence and the pale yellow 
solution was stirred at 23 °C. After 16 h aqueous hydrochloric acid (1 M, 60 mL) was added to 
neutralize excess of base. The aqueous layer was extracted with dichloromethane (3 × 50 mL). The 
combined organic layers were washed with saturated aqueous sodium bicarbonate solution and 
saturated aqueous sodium chloride solution, dried over sodium sulfate and concentrated under 
reduced pressure to give a pale yellow oil. The crude product was purified by flash column 
chromatography on silica gel (50% diethyl ether in petrol ether) to afford amide S137 (2.82 g, 
11.1 mmol, 94%) as a colorless oil. 
TLC (40% ethyl acetate in cyclohexane): Rf: 0.09 (UV, CAM) 
Experimental Section 
 
325 
 
1
H NMR (400 MHz, CDCl3) δ 6.82 – 6.71 (m, 3H), 3.85 (s, 3H), 3.84 (s, 3H), 3.59 (s, 3H), 3.16 
(s, 3H), 2.89 (dd, J = 8.7, 6.8 Hz, 2H), 2.71 (t, J = 7.8 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 173.8, 148.9, 147.5, 134.1, 120.3, 112.0, 111.4, 61.3, 56.0, 55.9, 
34.1, 32.3, 30.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2936 (m), 2834 (m), 1657 (s), 1590 (m), 1514 (s), 1450 (m), 1416 (s), 1383 
(m), 1330 (w), 1259 (s), 1233 (s), 1139 (s), 1026 (s), 989 (w), 852 (m), 763 (m).  
HRMS (ESI): calcd for C13H20NO4 [M+H]
+: 254.1387; found: 254.1385. 
  
4-(3,4-dimethoxyphenyl)butan-2-one (S138) 
To a solution of amide S137 (253 mg, 1.00 mmol, 1 equiv) in tetrahydrofuran (10 mL, 0.10 M) was 
added a methylmagnesium bromide solution (1.00 M in diethyl ether, 2.00 mL, 2.00 mmol 
2.00 equiv.) at –78 °C dropwise. After 5 min the mixture was allowed to warm up to 0 °C and after 
3x 25 mL), the combined organic were dried over sodium sulfate, filtered and the filtrate was 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography on silica gel (50% diethyl ether in petrol ether) to afford ketone S138 (208 mg, 
1.00 mmol, >99%) as a colorless solid.TLC (30% ethyl acetate in cyclohexane): Rf: 0.21 (UV, 
CAM) 
mp: 54.6 – 56.3 °C 
1
H NMR (400 MHz, CDCl3) δ 6.78 (d, J = 8.6 Hz, 1H), 6.71 (dq, J = 4.3, 1.9 Hz, 2H), 3.86 (s, 
3H), 3.85 (s, 3H), 2.88 – 2.79 (m, 2H), 2.78 – 2.70 (m, 2H), 2.13 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 208.2, 149.0, 147.5, 133.8, 120.2, 111.8, 111.4, 56.1, 56.0, 45.6, 
30.3, 29.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2936 (m), 2835 (m), 1713 (s), 1590 (m), 1515 (s), 1464 (m), 1419 (m), 1363 
(m), 1259 (s), 1235 (m), 1155 (m), 1028 (m), 804 (w), 755 (w).  
HRMS (LTP): calcd for C12H17O3 [M+H]
+: 209,1172; found: 209,1180. 
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2-(3,4-dimethoxyphenethyl)-2-methyloxirane (23a) was prepared according to GP3 (2.0 equiv 
NaH, 2.0 equiv Me3SI) from S138 (0.9 mmol, 1 equiv) in 99% yield as a colorless solid. Purified 
by flash column chromatography on silica gel (40% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.08 (UV, CAM) 
mp: 41.5 °C 
1
H NMR (400 MHz, CDCl3) δ 6.83 – 6.76 (m, 1H), 6.75 – 6.67 (m, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 
2.70 – 2.63 (m, 2H), 2.63 – 2.60 (m, 1H), 2.58 (dd, J = 4.8, 0.7 Hz, 1H), 1.95 – 1.77 (m, 2H), 1.37 
(d, J = 0.6 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.4, 134.4, 120.2, 111.7, 111.4, 56.8, 56.1, 56.0, 54.1, 
38.9, 31.1, 21.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3037 (w), 2934 (m), 2834 (m), 1590 (w), 1515 (s), 1464 (m), 1418 (m), 1389 
(w), 1262 (m), 1236 (m), 1156 (m), 1142 (m), 1073 (w), 1029 (m), 900 (w), 806 (w), 765 (w).  
HRMS (LTB): calcd for C13H19O3 [M+H]
+: 223,1329; found: 223.1339. 
 
 
1-(3,4-dimethoxyphenyl)pentan-3-one (S139): 
To a solution of Weinreb amide S137 (253 mg, 1.00 mmol, 1 equiv.) in tetrahydrofuran (10 mL, 
0.10 M) was added ethylmagnesium bromide solution (2.00 M in diethyl ether, 1.00 mL, 2.00 mmol 
2.00 equiv.) at –78 °C dropwise. After 5 min the mixture was allowed to warm up to 0 °C and 
stirred for 3x 25 mL), the combined organic were dried over sodium sulfate, filtered and the filtrate 
was concentrated under reduced pressure. The crude product was purified by flash column 
chromatography on silica gel (50% diethyl ether in petrol ether) to afford ketone S139 (222 mg, 
1.00 mmol, >99%) as a colorless oil. 
TLC (30% ethyl acetate in cyclohexane): Rf: 0.33 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.81 – 6.76 (m, 1H), 6.73 – 6.69 (m, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 
2.85 (dd, J = 8.2, 6.8 Hz, 2H), 2.75 – 2.66 (m, 2H), 2.40 (q, J = 7.3 Hz, 2H), 1.04 (t, J = 7.3 Hz, 
3H). 
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13
C NMR (101 MHz, CDCl3) δ 211.0, 149.0, 147.5, 134.0, 120.2, 111.9, 111.4, 56.0, 56.0, 44.3, 
36.4, 29.7, 7.9. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2936 (m), 2835 (m), 1712 (s), 1590 (w), 1515 (s), 1463 (m), 1418 (m), 1364 
(w), 1260 (s), 1236 (m), 1155 (m), 1028 (m), 807 (w), 764 (w).  
HRMS (LTB): calcd for C13H19O3 [M+H]
+: 223.1329; found: 223.1334. 
 
 
2-(3,4-dimethoxyphenethyl)-2-ethyloxirane (23b) was prepared according to GP3 (2.0 equiv 
NaH, 2.0 equiv Me3SI) from S139 (1.0 mmol, 1 equiv) in 99% yield as a colorless oil. Purified by 
flash column chromatography on silica gel (30% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.11 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.81 – 6.76 (m, 1H), 6.74 – 6.68 (m, 2H), 3.87 (s, 3H), 3.85 (s, 3H), 
2.67 – 2.56 (m, 4H), 1.99 – 1.79 (m, 2H), 1.77 – 1.56 (m, 2H), 0.96 (t, J = 7.5 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.4, 134.5, 120.1, 111.7, 111.4, 60.0, 56.1, 56.0, 52.3, 
36.1, 30.7, 27.3, 9.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2937 (m), 2835 (s), 1590 (w), 1515 (s), 1464 (m), 1418 (w), 1261 (m), 1236 
(m), 1156 (m), 1141 (m), 1029 (m), 902 (w), 807 (w), 765 (w).  
HRMS (LTB): calcd for C14H21O3 [M+H]
+: 237.1485; found: 237.1497. 
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4-(3,4-dimethoxyphenyl)-1-phenylbutan-2-one (S140) 
To a solution of amide S137 (1.00 g, 3.95 mmol, 1 equiv.) in tetrahydrofuran (40 mL, 0.10 M) was 
added a benzylmagnesium bromide (1.00 M in tetrahydrofuran, 3.95 mL, 7.90 mmol 2.00 equiv.) 
dropwise at –78 °C. After 5 min the mixture was allowed to warm up to 0 °C and after 3x 50 mL), 
the combined organic layers were dried over sodium sulfate, filtered and the filtrate was 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography on silica gel (40% diethyl ether in petrol ether) to afford ketone S140 (845 mg, 
2.97 mmol, 75%) as a colorless oil. 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.31 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.34 – 7.22 (m, 3H), 7.18 – 7.13 (m, 2H), 6.76 (d, J = 8.0 Hz, 1H), 
6.69 – 6.61 (m, 2H), 3.84 (s, 3H), 3.83 (s, 3H), 3.66 (s, 2H), 2.85 – 2.79 (m, 2H), 2.78 – 2.72 (m, 
2H). 
13
C NMR (101 MHz, CDCl3) δ 207.7, 149.0, 147.5, 134.2, 133.7, 129.5, 128.9, 127.2, 120.2, 111.8, 
111.4, 56.1, 55.9, 50.6, 43.9, 29.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3030 (w), 3000 (w), 2935 (m), 2834 (m), 1713 (s), 1590 (m), 1515 (s), 1454 
(m), 1418 (m), 1360 (w), 1261 (s), 1236 (m), 1142 (m), 1082 (m), 1029 (m), 806 (w), 763 (w), 700 
(m). 
HRMS (ESI): calcd for C18H20NaO3 [M+Na]
+: 307.1305; found: 307.1285. 
 
 
4-(3-benzylbut-3-en-1-yl)-1,2-dimethoxybenzene (S141) 
To a solution of methyltriphenylphosphonium bromide (2.68 g, 7.50 mmol, 5.00 equiv) in 
tetrahydrofuran (7.5 mL, 1.0 M) was added potassium tert-butoxide (842 mg, 7.50 mmol, 
5.00 equiv) and the resulting orange solution was stirred at 23 °C. After 2 h a solution of ketone 
S140 (427 mg, 1.50 mmol, 1 equiv) in tetrahydrofuran (3.0 mL, 0.50 M) was added at 23 °C. After 
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1 h the mixture was filtered over a pad of silica and concentrated to give a red oil. The crude product 
was purified by flash column chromatography on deactivated silica gel (1% triethylamine and 20% 
diethyl ether in petrol ether) to afford alkene S141 (394 mg, 1.39 mmol, 93%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.32 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.37 – 7.25 (m, 2H), 7.25 – 7.16 (m, 3H), 6.78 (d, J = 8.1 Hz, 1H), 
6.72 – 6.63 (m, 2H), 4.89 (s, 1H), 4.82 (s, 1H), 3.86 (s, 3H), 3.85 (s, 3H), 3.38 (s, 2H), 2.78 – 2.62 
(m, 2H), 2.28 (dd, J = 8.9, 7.2 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 148.9, 148.6, 147.3, 139.8, 134.8, 129.1, 128.4, 126.2, 120.2, 111.8, 
111.7, 111.3, 56.0, 55.9, 43.5, 37.4, 34.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3061 (w), 3025 (m), 2998 (m), 2933 (m), 2833 (m), 1644 (m), 1590 (m), 1514 
(s), 1495 (m), 1463 (m), 1452 (m), 1417 (m), 1332 (w), 1260 (s), 1235 (s), 1191 (m), 1154 (m), 
1075 (m), 1030 (m), 893 (m), 805 (m), 764 (w), 734 (m), 700 (m). 
HRMS (ESI): calcd for C19H22NaO2 [M+Na]
+: 305.1512; found: 305.1493. 
 
 
To a suspension of alkene S141 (390 mg, 1.38 mmol, 1 equiv.) and sodium bicarbonate (348 mg, 
4.14 mmol, 3.00 equiv.) in dichloromethane (14 mL, 0.10 M) was added m-chloroperoxybenzoic 
acid (~70% wt., 681 mg, 2.76 mmol, 2.00 equiv) at 0 °C and the resulting pale yellow solution was 
slowly allowed to warm up to 23 °C. After 16 h the mixture was diluted with saturated aqueous 
sodium bicarbonate (10 mL) and saturated aqueous thiosulfate solution (10 mL) to quench excess 
of m-chloroperoxybenzoic acid. The aqueous layer was extracted with dichloromethane 
(3 x 15 mL). The combined organic layers were dried over sodium sulfate, filtered and the filtrate 
was concentrated under reduced pressure to give a yellow oil. The crude product was purified by 
flash column chromatography on silica gel (20% diethyl ether in petrol ether) to afford epoxide 23c 
(286 mg, 0.960 mmol, 70%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.25 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.35 – 7.19 (m, 5H), 6.77 (d, J = 8.1 Hz, 1H), 6.70 – 6.61 (m, 2H), 
3.85 (s, 3H), 3.84 (s, 3H), 2.98 (d, J = 14.4 Hz, 1H), 2.90 (d, J = 14.3 Hz, 1H), 2.69 – 2.57 (m, 4H), 
1.94 – 1.74 (m, 2H). 
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13
C NMR (101 MHz, CDCl3) δ 149.0, 147.4, 137.0, 134.3, 129.8, 128.5, 126.8, 120.2, 111.7, 111.4, 
59.6, 56.1, 56.0, 52.1, 41.1, 36.0, 30.7. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3028 (m), 2999 (m), 2932 (m), 2834 (m), 1724 (m), 1590 (m), 1514 (s), 1453 
(m), 1418 (m), 1322 (w), 1260 (s), 1235 (s), 1155 (m), 1076 (w), 1028 (m), 921 (w), 852 (w), 805 
(m), 764 (m), 703 (m).  
HRMS (ESI): calcd for C19H22NaO3 [M+Na]
+: 321.1461; found: 321.1445. 
 
 
1-(3,4-dimethoxyphenyl)-4-methylpentan-3-one (S142) was prepared accoriding to GP2a (10% 
Pd, t = 16 h) from S120 (1.7 mmol, 1 equiv) in 57% yield as a colorless oil. Purified by flash column 
chromatography on silica gel (10% diethyl ether in petrol ether). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.23 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.83 – 6.73 (m, 1H), 6.73 – 6.67 (m, 2H), 3.85 (s, 3H), 3.84 (s, 3H), 
2.83 (ddd, J = 8.2, 6.9, 1.8 Hz, 2H), 2.74 (ddd, J = 8.4, 7.1, 1.7 Hz, 2H), 2.55 (p, J = 6.9 Hz, 1H), 
1.07 (s, 3H), 1.05 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 214.0, 149.0, 147.4, 134.1, 120.2, 111.9, 111.4, 56.0, 55.9, 42.3, 
41.2, 29.6, 18.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2968 (s), 2933 (s), 2835 (m), 1709 (s), 1590 (w), 1516 (s), 1465 (m), 1418 
(w), 1363 (w), 1261 (s), 1237 (m), 1156 (m), 1140 (m), 1073 (w), 1029 (m), 805 (w), 764 (w). 
HRMS (LTP): calcd for C14H21O3 [M+H]
+: 237.1485; found: 237.1493. 
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2-(3,4-dimethoxyphenethyl)-2-isopropyloxirane (23d) was prepared according to GP3 
(2.0 equiv NaH, 2.0 equiv Me3SI) from S142 (1.0 mmol, 1 equiv) in 99% yield as a colorless oil. 
Purified by flash column chromatography on silica gel (20% diethyl ether in n-pentane). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.17 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.81 – 6.77 (m, 1H), 6.74 – 6.68 (m, 2H), 3.87 (s, 3H), 3.85 (s, 3H), 
2.67 – 2.60 (m, 2H), 2.60 – 2.46 (m, 2H), 2.01 – 1.88 (m, 2H), 1.79 (p, J = 6.9 Hz, 1H), 1.00 (d, J 
= 6.8 Hz, 3H), 0.95 (d, J = 6.9 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.3, 134.7, 120.1, 111.8, 111.4, 62.4, 56.1, 56.0, 50.6, 
33.2, 32.5, 30.2, 18.4, 18.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2960 (s), 2834 (m), 1590 (m), 1515 (s), 1464 (m), 1418 (s), 1261 (s), 1236 
(m), 1156 (m), 1141 (m), 1030 (m), 930 (w), 863 (w), 808 (w), 766 (w).  
HRMS (LTB): calcd for C15H23O3 [M+H]
+: 251.1642; found: 251.1651. 
 
 
4-(3,4-dimethoxyphenyl)-1,1-diphenylbutan-2-one (S143) was prepared according to GP1 (t = 
3 h) from 3,4-dimethoxybenzaldehyde (3.0 mmol, 1 equiv) and 1,1-diphenylpropan-2-one 
(1.1 equiv) and GP2a (10% Pd, t = 16 h) in 53% yield as a colorless oil. Purified by flash column 
chromatography on silica gel (10% diethyl ether in petrol ether). 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.27 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.39 – 7.20 (m, 6H), 7.21 – 7.12 (m, 4H), 6.76 (d, J = 8.2 Hz, 1H), 
6.67 (dd, J = 8.1, 2.0 Hz, 1H), 6.62 (d, J = 2.0 Hz, 1H), 5.05 (s, 1H), 3.86 (s, 3H), 3.81 (s, 3H), 2.87 
(s, 4H). 
13
C NMR (101 MHz, CDCl3) δ 207.9, 149.0, 147.5, 138.3, 133.6, 129.1, 128.8, 127.3, 120.4, 111.9, 
111.4, 64.6, 56.1, 55.9, 44.7, 29.9. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3059 (w), 3026 (w), 3001 (m), 2931 (m), 2834 (m), 1717 (s), 1591 (m), 1515 
(s), 1495 (m), 1452 (m), 1418 (m), 1358 (w), 1262 (s), 1237 (m), 1154 (m), 1080 (w), 1029 (m), 748 
(w), 701 (m).  
HRMS (ESI): calcd for C24H24NaO3 [M+Na]
+: 383.1618; found: 383.1599. 
 
 
(4-(3,4-dimethoxyphenyl)-2-methylenebutane-1,1-diyl)dibenzene (S144): 
To a solution of methyltriphenylphosphonium bromide (1.34 g, 3.75 mmol, 5.00 equiv) in 
tetrahydrofuran (3.75 mL, 1.00 M) was added potassium t-butoxide (420 mg, 3.75 mmol, 
5.00 equiv) and the resulting orange solution was stirred at 23 °C. After 2 h a solution of ketone 
S143 (270 mg, 0.749 mmol, 1 equiv) in tetrahydrofuran (1.5 mL, 0.50 M) was added dropwise and 
the resulting solution was stirred at 65 °C. After 5 h the mixture was filtered over a pad of silica 
and concentrated to give a red oil. The crude product was purified by flash column chromatography 
on deactivated silica gel (1% triethylamine and 20% diethyl ether in petrol ether) to afford alkene 
S144 (252 mg, 0.703 mmol, 94%) as a colorless solid. 
TLC (15% ethyl acetate in cyclohexane): Rf: 0.31 (UV, CAM) 
mp: 65.5 - 71.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.31 – 7.26 (m, 3H), 7.23 – 7.10 (m, 7H), 6.77 (d, J = 8.1 Hz, 1H), 
6.71 – 6.60 (m, 2H), 5.14 (s, 1H), 4.73 (s, 1H), 4.55 (s, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 2.82 – 2.65 
(m, 2H), 2.45 – 2.27 (m, 2H). 
13
C NMR (101 MHz, CDCl3) δ 151.5, 148.9, 147.3, 142.4, 134.7, 129.5, 128.4, 126.5, 120.4, 114.3, 
111.9, 111.3, 57.8, 56.1, 55.9, 38.1, 34.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3060 (m), 3025 (m), 2933 (m), 2834 (m), 1592 (m), 1515 (s), 1493 (m), 1417 
(m), 1261 (m), 1237 (m), 1155 (m), 1030 (m), 758 (m), 701 (m).  
HRMS (ESI): calcd for C25H27O2 [M+H]
+: 359.2006; found: 359.1999. 
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2-benzhydryl-2-(3,4-dimethoxyphenethyl)oxirane (23e): 
To a suspension of alkene S144 (229 mg, 0.639 mmol, 1 equiv.) and sodium bicarbonate (80.5 mg, 
0.958 mmol, 1.50 equiv.) in dichloromethane (6.4 mL, 0.10 M) was added m-chloroperoxybenzoic 
acid (~70% wt., 205 mg, 0.805 mmol, 1.30 equiv) at 0 °C and the resulting pale yellow solution 
was slowly allowed to warm up to 23 °C. After 16 h the mixture was diluted with saturated aqueous 
sodium bicarbonate (10 mL) and saturated aqueous thiosulfate solution (10 mL) to quench excess 
of m-chloroperoxybenzoic acid. The aqueous layer was extracted with dichloromethane 
(3 x 15 mL). The combined organic layers were dried over sodium sulfate and filtered. The filtrate 
was concentrated under reduced pressure to give a yellow oil. The crude product was purified by 
flash column chromatography on silica gel (20% diethyl ether in petrol ether) to afford epoxide 23e 
(99.5 mg, 0.639 mmol, 42%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.30 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.41 – 7.20 (m, 10H), 6.78 (d, J = 8.1 Hz, 1H), 6.75 – 6.56 (m, 2H), 
4.37 (s, 1H), 3.91 – 3.88 (m, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 3.68 (d, J = 10.3 Hz, 1H), 2.59 (d, J = 
4.7 Hz, 1H), 2.26 (dd, J = 4.6, 0.8 Hz, 1H), 2.20 – 2.08 (m, 1H), 1.91 (ddd, J = 14.3, 9.0, 7.5 Hz, 
1H). 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.4, 140.5, 140.2, 134.1, 129.7, 129.6, 128.5, 128.3, 126.9, 
126.8, 120.2, 111.7, 111.3, 60.5, 56.1, 55.9, 54.1, 49.0, 36.1, 31.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3026 (m), 2928 (s), 2850 (m), 1726 (m), 1590 (m), 1515 (s), 1452 (m), 1261 
(m), 1237 (m), 1156 (m), 1030 (m), 703 (m).  
HRMS (ESI): calcd for C25H26NaO3 [M+Na]
+: 397.1774; found: 397.1765. 
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9.2.2.13 Epoxide Rearrangements 
 
 
(1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12b) was prepared according to 
GP5 from S25 (0.200 mmol, 1 equiv) in 70% yield as a colorless oil (28.4 mg). Purified by flash 
column chromatography on silica gel (20% ethyl acetate in cyclohexane). 
TLC (20% diethyl ether in n-pentane) Rf  0.30 (UV, CAM)  
1
H NMR (400 MHz, CDCl3) δ 7.35 (dd, J = 7.9, 1.4 Hz, 1H), 7.15 (tdd, J = 7.8, 1.8, 0.9 Hz, 1H), 
7.09 (td, J = 7.2, 1.4 Hz, 1H), 7.07 – 7.03 (m, 1H), 3.59 (d, J = 10.8 Hz, 1H), 3.55 (d, J = 10.8 Hz, 
1H), 2.90 – 2.74 (m, 2H), 1.83 (dt, J = 13.7, 6.3 Hz, 1H), 1.74 (ddd, J = 13.6, 8.3, 6.7 Hz, 1H), 1.32 
(s, 1H), 1.26 (s, 3H), 1.23 (s, 3H), 1.01 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 146.0, 135.2, 128.8, 126.8, 126.0, 125.2, 67.3, 39.2, 39.1, 27.7, 
27.0, 26.2, 25.2, 19.0. 
HRMS (ESI) calcd for C14H20ONa [M+Na]+: 227.1412; found: 227.1396 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3405 (br), 3055 (w), 3026 (w), 2967 (s), 2929 (s), 1490 (m), 1460 (m), 1446 
(w), 1365 (w), 1244 (w), 1084 (m), 1036 (m), 942 (w), 760 (m), 722 (w), 703 (w). 
 
 
(1,1,2,6-tetramethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12c) was prepared 
according to GP5 from S27 (0.200 mmol, 1 equiv) in 76% yield as a colorless oil (33.0 mg). 
Purified by flash column chromatography on silica gel (20% ethyl acetate in cyclohexane). 
TLC (10% ethyl acetate in cyclohexane) Rf  0.21 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.24 (d, J = 8.1 Hz, 1H), 6.98 (d, J = 8.1 Hz, 1H), 6.88 (s, 1H), 3.58 
(d, J = 10.8 Hz, 1H), 3.54 (d, J = 10.9 Hz, 1H), 2.87 – 2.65 (m, 2H), 2.29 (s, 3H), 1.82 (dt, J = 13.6, 
6.3 Hz, 1H), 1.73 (dd, J = 13.6, 6.6 Hz, 1H), 1.33 (s, 1H), 1.25 (s, 3H), 1.22 (s, 3H), 1.00 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 143.2, 135.2, 134.7, 129.5, 127.1, 126.8, 67.5, 39.2, 39.0, 27.9, 
27.2, 26.2, 25.4, 20.9, 19.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3371 (br), 2969 (s), 2925 (s), 1614 (w), 1499 (m), 1459 (m), 1434 (w), 1388 
(w), 1365 (w), 1291 (w), 1232 (w), 1160 (w), 1024 (m), 1004 (w), 873 (w), 814 (w). 
HRMS (ESI) calcd for C15H22ONa [M+Na]+: 241.1569; found: 241.1551 
 
 
(6-(tert-butyl)-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12d) was 
prepared according to GP5 from S29 (0.200 mmol, 1 equiv) in 83% yield as a colorless oil 
(43.0 mg). Purified by flash column chromatography on silica gel (20% ethyl acetate in 
cyclohexane). 
TLC (30% diethyl ether in n-pentane) Rf  0.19 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 8.4 Hz, 1H), 7.17 (dd, J = 8.5, 2.3 Hz, 1H), 7.06 – 6.99 (m, 
1H), 3.56 (d, J = 1.1 Hz, 2H), 2.80 (q, J = 7.4, 6.4 Hz, 2H), 1.82 (dt, J = 13.7, 6.2 Hz, 1H), 1.74 (ddd, J = 
13.6, 8.3, 6.6 Hz, 1H), 1.31 (s, 9H), 1.25 (s, 3H), 1.22 (s, 3H), 1.00 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.8, 143.0, 134.6, 126.5, 125.6, 123.3, 67.5, 39.2, 38.9, 34.2, 
31.5, 27.9, 27.4, 26.5, 25.3, 19.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 1500 (w), 1461 (m), 1407 (w), 1392 (w), 1363 (m), 1299 (w), 1271 (w), 1128 
(w), 1069 (w), 1024 (m), 1004 (w), 883 (w), 822 (w), 753 (w), 713 (w), 681 (w). 
HRMS (ESI): calcd for C18H28ONa [M+Na]
+: 283.2038; found: 283.2018 
 
 
(6-methoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12e) was prepared 
according to GP5 from S31 (0.200 mmol, 1 equiv) in 69% yield as a colorless solid (32.3 mg). 
Purified by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane). 
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TLC (25% ethyl acetate in hexanes): Rf: 0.37 (CAM) 
mp: 80.5 – 81.4 °C 
1
H NMR (400 MHz, CDCl3) δ: 7.25 (d, J = 8.9 Hz, 1H), 6.74 (dd, J = 8.7, 2.9 Hz, 1H), 6.58 (d, J 
= 2.7 Hz, 1H), 3.78 (s, 3H), 3.57 (d, J = 10.8 Hz, 1H), 3.54 (d, J = 10.8 Hz, 1H), 2.88 – 2.68 (m, 
2H), 1.87 – 1.65 (m, 2H), 1.45 (s, 1H), 1.23 (s, 3H), 1.20 (s, 3H), 0.99 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 157.0, 138.3, 136.7, 128.0, 112.9, 112.6, 67.3, 55.2, 39.2, 38.7, 
27.9, 27.2, 26.6, 25.4, 19.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3358 (m), 2973 (m), 2956 (m), 2929 (m), 1609 (s), 1500 (s) 1459 (s), 1448 
(s), 1432 (m), 1361 (m), 1317 (s), 1246 (s), 1232 (s), 1198 (m), 1164 (m), 1084 (m), 1047 (s), 1033 
(vs), 1022 (vs), 993 (s), 948 (m), 889 (m), 848 (s), 823 (vs), 754 (m), 714 (m).  
HRMS (EI): calcd for C15H22O2 [M]
+: 234.1614; found: 234.1617. 
 
 
(2-methoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12f) was prepared 
according to GP5 from S33 (0.200 mmol, 1 equiv) in 70% yield as a colorless oil (32.8 mg). 
Purified by flash column chromatography on silica gel (20% ethyl acetate in cyclohexane).  
TLC (20% ethyl acetate in cyclohexane) Rf  = 0.45 (CAM, UV) 
1
H NMR (400 MHz, CDCl3) δ 7.24 – 7.08 (m, 1H), 6.98 (dd, J = 8.1, 1.1 Hz, 1H), 6.67 (d, J = 1.0 
Hz, 1H), 3.82 (s, 3H), 3.55 (s, 2H), 2.73 – 2.59 (m, 2H), 1.82 (dt, J = 13.8, 6.3 Hz, 1H), 1.71 (ddd, 
J = 13.7, 8.0, 6.9 Hz, 1H), 1.25 (s, 3H), 1.23 (s, 4H), 0.99 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 156.7, 147.4, 126.4, 124.6, 119.0, 106.4, 77.2, 67.5, 55.4, 39.3, 
38.8, 27.7, 26.6, 25.4, 20.2, 19.0. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3387 (br), 2968 (m), 2936 (m), 1769 (w), 1580 (m), 1459 (s), 1435 (m), 
1365 (w), 1349 (w), 1311 (w), 1255 (s), 1169 (w), 1061 (s), 1022 (m), 943 (w), 850 (w), 779 (m), 
745 (w), 716 (w). 
HRMS (ESI): calcd for C15H22O2Na [M+Na]
+: 257.1518; found: 257.1509 
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(6,7-dimethoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12a) was 
prepared according to GP5 from 11a (0.200 mmol, 1 equiv) in 83% yield as a colorless oil 
(44.0 mg). Purified by flash column chromatography on silica gel (20% ethyl acetate in 
cyclohexane). 
TLC (25% ethyl acetate in hexanes): Rf: 0.21 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.81 (s, 1H), 6.51 (s, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 3.56 (d, J = 
10.9 Hz, 1H), 3.53 (d, J = 10.9 Hz, 1H), 2.80 – 2.64 (m, 2H), 1.80 (dt, J = 13.6, 6.2 Hz, 1H), 1.71 
(ddd, J = 13.5, 8.3, 6.5 Hz, 1H), 1.50 (s, 1H), 1.23 (s, 3H), 1.20 (s, 3H), 0.98 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.4, 146.9, 137.9, 127.6, 111.2, 110.1, 67.4, 56.2, 55.8, 39.1, 
39.0, 27.8, 27.4, 25.9, 25.4, 19.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥 3506 (br m), 2965 (s), 2934 (s), 2848 (w), 1610 (m), 1508 (s), 1462 (s), 1400 
(m), 1363 (w), 1352 (w), 1327 (w), 1250 (s), 1206 (s), 1185 (w), 1156 (s), 1137 (s), 1105 (w), 1074 
(s), 1023 (s), 975 (m), 911 (m), 857 (s), 832 (m), 794 (m), 730 (s), 646 (w), 571 (w), 543 (w), 489 
(w), 439 (w).  
HRMS (ESI) calcd for C16H25O3 [M+H]
+: 265.1798; found: 265.1789. 
 
 
(5,5,6-trimethyl-5,6,7,8-tetrahydronaphtho[2,3-d][1,3]dioxol-6-yl)methanol (12g) was 
prepared according to GP5 from S36 (0.200 mmol, 1 equiv) in 82% yield as a colorless oil 
(40.7 mg). Purified by flash column chromatography on silica gel (20% ethyl acetate in 
cyclohexane). 
TLC (20% ethyl acetate in cyclohexane) Rf  0.25 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.81 (s, 1H), 6.50 (s, 1H), 5.88 (s, 2H), 3.55 (d, J= 10.8 Hz, 1H), 
3.54 (d, J = 10.8 Hz, 1H), 2.82 – 2.58 (m, 2H), 1.78 (dt, J = 13.6, 6.2 Hz, 1H), 1.69 (ddd, J = 13.6, 
8.3, 6.5 Hz, 1H), 1.21 (s, 3H), 1.18 (s, 3H), 0.98 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 146.2, 145.3, 139.1, 128.5, 108.2, 106.7, 100.7, 67.4, 39.4, 39.1, 
27.9, 27.3, 26.5, 25.5, 19.1.  
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3385 (br), 2968(m), 1504 (m), 1484 (s), 1369 (w), 1237 (s), 1110 (w), 1039 
(s), 939 (m), 861 (m), 842 (w). 
HRMS (ESI): calcd for C15H20O3Na [M+Na]
+: 271.1310; found: 271.1292 
 
 
(6,7,8-trimethoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12h) was 
prepared according to GP5 from S38 (0.200 mmol, 1 equiv) in 57% yield as a colorless oil 
(33.8 mg). Purified by flash column chromatography on silica gel (20% ethyl acetate in 
cyclohexane).  
TLC (20% ethyl acetate in hexanes): Rf: 0.21 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.35 (d, J = 0.9 Hz, 1H), 3.89 (s, 3H), 3.82 (s, 3H), 3.81 (s, 3H), 
3.58 (s, 2H), 2.89 – 2.41 (m, 2H), 1.78 – 1.61 (m, 2H), 1.31 (s, 3H), 1.45 (s, 1H), 1.30 (s, 3H), 0.98 
(s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 154.3, 151.2, 141.2, 132.0, 131.3, 107.1, 67.0, 60.7, 60.5, 55.8, 
40.4, 39.3, 27.4, 27.2, 24.9, 23.1, 18.9. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3441 (br m), 2968 (m), 2936 (s), 2851 (w), 1597 (m), 1573 (w), 1488 (s), 1463 
(m), 1447 (m), 1431 (w), 1397 (s), 1348 (m), 1338 (m), 1326 (m), 1244 (m), 1194 (m), 1022 (s), 
974 (w), 936 (w), 859 (w), 831 (w), 794 (w).  
HRMS (ESI): calcd for C17H26O4Na [M+Na]
+: 317.1729; found: 317.1713. 
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(7-fluoro-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12i) was prepared 
according to GP5 from S42 (0.200 mmol, 1 equiv) in 41% yield as a colorless oil (18.4 mg). 
Purified by flash column chromatography on silica gel (10% diethyl ether in n-pentane). 
TLC (10% diethyl ether in n-pentane) Rf 0.35 (UV, KMnO4) 
1
H NMR (300 MHz, CDCl3) δ 7.08 – 6.94 (m, 2H), 6.78 (td, J = 8.3, 2.7 Hz, 1H), 3.65 – 3.38 (m, 
2H), 2.76 (m, 2H), 1.93 – 1.63 (m, 2H), 1.23 (s, 3H), 1.21 (s, 3H), 0.99 (s, 3H). 
13
C NMR (151 MHz, CDCl3) δ 161.6 (d, J = 241.0 Hz), 148.4 (d, J = 4.3 Hz), 130.8 , 130.2 (d, J 
= 8.5 Hz), 113.2 (d, J = 21.0 Hz), 112.5 (d, J = 21.2 Hz), 67.4, 39.6, 39.0, 27.7, 27.2, 25.6, 25.3, 
19.1. 
19
F NMR (282 MHz, CDCl3) δ -117.31 (dt, J = 12.8, 7.1 Hz). 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3378 (br m), 2971 (s), 2933 (s), 1613 (m), 1587 (m), 1499 (s), 1480 (m), 
1436 (w), 1411 (w), 1367 (w), 1252 (m), 1190 (w), 1023 (m), 945 (w), 867 (w), 816 (w). 
HRMS (ESI): calcd for C14H19FONa [M+Na]
+: 245.1318; found: 245.1304 
 
 
(6-fluoro-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (12j) was prepared 
according to GP5 from S40 (0.200 mmol, 1 equiv) in 35% yield as a colorless oil (15.7 mg). 
Purified by flash column chromatography on silica gel (20% ethyl acetate in cyclohexane).  
TLC (10% diethyl ether in n-pentane): Rf: 0.35 (UV, KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 7.32 – 7.24 (m, 1H), 6.89 – 6.78 (m, 1H), 6.77 – 6.69 (m, 1H), 3.57 
(d, J = 10.9 Hz, 1H), 3.52 (d, J = 10.8 Hz, 1H), 2.87 – 2.70 (m, 2H), 1.82 (dt, J = 13.7, 6.3 Hz, 1H), 
1.78 – 1.65 (m, 1H), 1.23 (s, 3H), 1.21 (s, 3H), 0.99 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 160.6 (d, J = 243.4 Hz), 141.8 (d, J = 3.0 Hz), 137.6 (d, J = 7.2 
Hz), 128.5 (d, J = 8.0 Hz), 114.7 (d, J = 20.2 Hz), 113.2 (d, J = 20.6 Hz), 67.3, 39.2, 39.0, 27.9, 
27.0, 26.4, 25.5, 19.1. 
.IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3371 (br m), 2970 (m), 2941 (m), 2882 (w), 1612 (m), 1589 (w),1495 (s), 
1461 (m), 1434 (w), 1420 (w), 1366 (w), 1247 (m), 1150 (w), 1127 (w), 11025 (m), 1005 (m), 862 
(m), 813 (w). 
HRMS (ESI): calcd for C14H19FONa [M+Na]
+: 245.1318; found: 245.1297. 
 
 
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-
2-yl)methanol (12k) was prepared according to GP5 from S44 (0.200 mmol, 1 equiv) in 29% yield 
as a colorless oil (19.3 mg). Purified by flash column chromatography on silica gel (20% diethyl 
ether in n-pentane).  
TLC (15% diethyl ether in n-pentane) Rf =0.25 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ 7.78 (s, 1H), 7.52 (dd, J = 7.5, 1.2 Hz, 1H), 7.06 (d, J = 7.5 Hz, 
1H), 3.55 (q, J = 10.9 Hz, 3H), 2.83 (q, J = 7.3, 6.5 Hz, 2H), 1.82 (dt, J = 12.7, 6.3 Hz, 1H), 1.78 – 
1.67 (m, 1H), 1.33 (s, 12H), 1.28 (s, 3H), 1.27 (s, 3H). 
13
C NMR (151 MHz, CDCl3) δ 145.3, 138.8, 133.4, 131.6, 128.3, 83.5, 67.3, 39.2, 27.6, 26.9, 26.5, 
25.1, 24.9, 19.0. 
11
B NMR (128 MHz, CDCl3) δ 31.77. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3469 (br), 2974 (m), 2926 (m), 1609 (w), 1460 (w). 1390 (m), 1361 (s), 
1315 (w), 1273 (w), 1228 (w), 1146 (m), 1100 (w), 1026 (w), 964 (w), 874 (w), 851 (w), 827 (w). 
HRMS (ESI): calcd for C20H31BO3Na [M+Na]
+: 353.2264; found: 353.2249 
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(6,7,7-trimethyl-4,5,6,7-tetrahydrobenzo[b]thiophen-6-yl)methanol (12l) was prepared 
according to GP5 from S46 (0.200 mmol, 1 equiv) in 77% yield as a pale yellow oil (31.2 mg). 
Purified by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane). 
TLC (10% ethyl acetate in hexanes): Rf: 0.19 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.06 (d, J = 5.1 Hz, 1H), 6.68 (d, J = 5.1 Hz, 1H), 3.58 (d, J = 5.2 
Hz, 2H), 2.64 – 2.59 (m, 2H), 1.82 (dt, J = 13.6, 6.2 Hz, 1H), 1.71 (dt, J = 13.8, 7.0 Hz, 1H), 1.32 
(s, 3H), 1.27 (s, 3H), 1.01 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.0, 133.6, 127.2, 122.0, 67.5, 40.3, 39.3, 28.8, 28.1, 27.0, 22.7, 
18.5. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3375 (br s), 2964 (s), 2934 (s), 1456 (s), 1365 (m), 1337 (w), 1321 (w), 
1242 (m), 1192 (w), 1167 (w), 1116 (w), 1029 (s), 968 (m), 885 (w), 828 (m), 789 (w), 711 (s), 692 
(m), 637 (m), 556 (m). 
HRMS (ESI) calcd for C12H19OS [M+H]
+: 211.1151; found: 211.1146. 
 
 
(4,4,5-trimethyl-4,5,6,7-tetrahydrobenzofuran-5-yl)methanol (12m) was prepared according to 
GP5 from S48 (0.200 mmol, 1 equiv) in 24% yield as a colorless oil (9.3 mg). Purified by flash 
column chromatography on silica gel (10% ethyl acetate in cyclohexane).  
TLC (10% ethyl acetate in hexanes): Rf: 0.17 (CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.23 (dt, J = 1.8, 0.9 Hz, 1H), 6.22 (d, J = 1.9 Hz, 1H), 3.56 (d, J = 
10.8 Hz, 1H), 3.52 (d, J = 10.8 Hz, 1H), 2.60 – 2.53 (m, 2H), 1.84 (dt, J = 13.6, 6.2 Hz, 1H), 1.76 
– 1.68 (m, 1H), 1.55 (s, 1H), 1.13 (s, 3H), 1.08 (s, 3H), 0.96 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.4, 140.8, 126.2, 108.6, 67.4, 39.9, 35.8, 28.1, 26.2, 24.5, 20.3, 
18.1. 
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IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3407 (br s), 2965 (s), 2936 (m), 2877 (w), 1632 (w), 1508 (w), 1458 (m), 
1365 (w), 1338 (w), 1219 (w), 1192 (w), 1170 (w), 1134 (m), 1096 (w), 1058 (s), 1026 (s), 963 (w), 
939 (w), 894 (w), 807 (w), 728 (m), 696 (m), 671 (w), 632 (w), 601 (w), 537 (w), 502 (w), 491 (w); 
471 (w), 448 (w).  
HRMS (ESI) calcd for C12H19O2 [M+H]
+: 195.1380; found: 195.1375. 
 
 
(2,4,4,5-tetramethyl-4,5,6,7-tetrahydrobenzofuran-5-yl)methanol (12n) was prepared 
according to GP5 from S50 (0.200 mmol, 1 equiv) in 54% yield as a colorless oil, that slowly 
crystallized upon storage (22.3 mg). Besides, hydrolyzed furan S145 (5.0 mg, 11%) was isolated 
as a colorless oil. Purified by flash column chromatography on silica gel (10% ethyl acetate in 
cyclohexane grading to 25% ethyl acetate in cyclohexane).  
Analytical data of 12n: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.37 (CAM) 
mp: 48.2 °C 
1
H NMR (400 MHz, CDCl3) δ: 5.80 (s, 1H), 3.54 (d, J = 5.3 Hz, 2H), 2.60 – 2.45 (m, 2H), 2.24 (s, 
3H), 1.80 (dt, J = 13.4, 6.2 Hz, 1H), 1.74 – 1.64 (m, 1H), 1.28 (t, J = 5.5 Hz, 1H), 1.10 (s, 3H), 1.05 
(s, 3H), 0.94 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 150.3, 146.4, 126.9, 104.4, 67.5, 39.8, 35.8, 28.2, 26.1, 24.5, 20.2, 
18.2, 13.8. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3384 (m), 2963 (m), 2924 (m), 2880 (w), 1640 (w), 1618 (w), 1583 (w), 
1456 (m), 1381 (m), 1364 (w), 1340 (w), 1272 (w), 1254 (w), 1218 (m), 1193 (m), 1177 (w), 1140 
(w), 1099 (w), 1065 (m), 1024 (s), 1001 (m), 950 (m), 907 (w), 890 (w), 792 (m), 756 (w), 703 (w), 
687 (w), 672 (w), 620 (w), 586 (w), 514 (w), 463 (w).  
HRMS (ESI): calcd for C13H21O2 [M+H]
+: 209.1536; found: 209.1532. 
The structure was validated by single crystal X-ray analysis (see X-ray Data). 
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Analytical data of S145: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.05 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 3.66 (d, J = 10.8 Hz, 1H), 3.53 (d, J = 10.8 Hz, 1H), 3.29 (dd, J = 
9.8, 2.7 Hz, 1H), 2.99 (dd, J = 17.2, 9.7 Hz, 1H), 2.61 – 2.49 (m, 1H), 2.30 (dt, J = 14.0, 3.9 Hz, 
1H), 2.23 (s, 3H), 2.13 (dd, J = 17.2, 2.7 Hz, 1H), 1.85 (dd, J = 3.5, 1.5 Hz, 1H), 1.82 (d, J = 3.6 
Hz, 1H), 1.36 (s, 1H), 1.33 (s, 3H), 0.97 (s, 3H), 0.76 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 211.5, 208.1, 69.2, 52.1, 43.4, 41.0, 37.8, 37.3, 32.6, 30.7, 23.1, 
19.2, 17.4. 
2D-NMR in appendix 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3449 (m), 2969 (m), 2882 (w), 1706 (s), 1460 (w), 1427 (w), 1356 (m), 
1321 (w), 1266 (w), 1233 (w), 1177 (w), 1143 (w), 1032 (m), 1004 (w), 975 (w), 917 (w), 895 (w), 
873 (w), 783 (w), 762 (w), 714 (w), 653 (w), 621 (w), 565 (w), 523 (w), 482 (w), 454 (w), 420 (w) 
cm−1.  
HRMS (ESI): calcd for C13H22NaO3 [M+Na]
+: 249.1461; found: 249.1457. 
 
 
(2,2,3-trimethyltetrahydro-2H-pyran-3-yl)methanol (12o) was prepared according to GP5 from 
S54 (0.200 mmol, 1 equiv) in 43% yield as a pale yellow oil (13.6 mg). Purified by flash column 
chromatography on silica gel (33% ethyl acetate in n-pentane).  
TLC (40% ethyl acetate in n-pentane): Rf: 0.28 (CAM) 
1
H-NMR (400 MHz, CDCl3): δ = 3.75 (d, J = 10.8 Hz, 1H), 3.72 – 3.64 (m, 2H), 3.50 (d, J = 10.9 
Hz, 1H), 2.17 – 1.92 (m, 1H), 1.88 – 1.79 (m, 1H), 1.68 – 1.63 (m, 1H), 1.57 – 1.50 (m, 2H), 1.23 
(s, 3H), 1.20 (s, 3H), 0.86 (s, 3H). 
13
C-NMR (101 MHz, CDCl3): δ = 69.3, 61.4, 39.1, 29.8, 28.5, 23.3, 23.0, 22.6, 20.5. 
IR (ATR, neat): ?̃? = 3430 (br m), 2927 (s), 2859 (s), 1731 (w), 1456 (m), 1366 (m), 1219 (w), 1201 
(w), 1159 (w), 1117 (w), 1085 (s), 1025 (s), 963 (w), 864 (w), 822 (w), 777 (w). 
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HRMS (ESI): calcd for C9H19O2 [M+H]
+: 159.1380; found: 159.1376. 
 
 
2-(6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)-2-methylpropan-1-ol (12p) 
was prepared according to GP5 from S63 (0.200 mmol, 1 equiv) in 63% yield as a colorless oil 
(34.8 mg). Further products: S146 (6.7 mg, 16%, colorless solid), S147 (6.2 mg, 11%, colorless oil) 
and S148 (2.9 mg, 5%, colorless oil). Purified by flash column chromatography on silica gel (1% 
ethyl acetate in cyclohexane grading to 25% ethyl acetate in cyclohexane). 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.12 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.95 (s, 1H), 6.53 (s, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 3.47 – 3.36 (m, 
2H), 2.63 – 2.52 (m, 2H), 1.96 (td, J = 13.1, 3.6 Hz, 1H), 1.86 (ddt, J = 12.0, 9.3, 4.0 Hz, 1H), 1.56 
(dddd, J = 13.5, 5.4, 3.1, 1.3 Hz, 1H), 1.47 (tddd, J = 12.6, 9.6, 6.0, 3.2 Hz, 1H), 1.32 (s, 3H), 1.13 
(s, 1H), 1.04 (s, 3H), 0.95 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 146.8, 146.4, 134.5, 132.1, 113.0, 111.7, 69.9, 56.1, 55.8, 43.0, 
41.9, 35.8, 31.6, 26.1, 21.7, 21.7. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3461 (br m), 2938 (s), 1609 (w), 1511 (s), 1464 (m), 1398 (w), 1341 (w), 1255 
(m), 1216 (m), 1115 (w), 1029 (w).  
HRMS (ESI): calcd for C17H26NaO3 [M+Na]
+: 301.1774; found: 301.1755. 
 
6,7-dimethoxy-4-methyl-1,2-dihydronaphthalene (S146): 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.35 (UV, CAM) 
mp: 61.2 °C 
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1
H NMR (400 MHz, CDCl3) δ 6.80 (s, 1H), 6.70 (d, J = 0.9 Hz, 1H), 5.75 (ddt, J = 4.5, 3.0, 1.5 
Hz, 1H), 3.89 (s, 3H), 3.89 (s, 3H), 2.76 – 2.60 (m, 2H), 2.22 (dddd, J = 9.5, 6.2, 4.5, 1.9 Hz, 2H), 
2.04 (q, J = 1.7 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.7, 147.3, 131.9, 129.2, 128.9, 123.5, 111.5, 107.6, 56.4, 56.2, 
28.2, 23.5, 19.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2936 (m), 2829 (m), 1602 (w), 1511 (s), 1464 (m), 1365 (w), 1327 (w), 1265 
(m), 1218 (m), 1194 (m), 1145 (s), 1057 (m), 863 (w).  
HRMS (ESI): calcd for C13H17O2 [M+H]
+: 205.1223; found: 205.1214. 
 
6-(3,4-dimethoxyphenyl)-2,3,3-trimethylhexanal (S147): 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.24 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 9.78 (d, J = 3.0 Hz, 1H), 6.79 (d, J = 7.9 Hz, 1H), 6.74 – 6.67 (m, 
2H), 3.88 (s, 3H), 3.86 (s, 3H), 2.57 – 2.48 (m, 2H), 2.25 (qd, J = 6.9, 3.0 Hz, 1H), 1.67 – 1.47 (m, 
2H), 1.44 – 1.22 (m, 2H), 1.01 (s, 3H), 1.00 (d, J = 6.9 Hz, 3H), 0.95 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 206.5, 149.0, 147.3, 135.1, 120.3, 111.8, 111.4, 56.1, 56.0, 54.0, 
40.6, 36.3, 35.6, 26.0, 25.2, 25.0, 9.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2937 (s), 1718 (s), 1590 (w), 1515 (s), 1464 (m), 1260 (m), 1236 (m), 1142 
(m), 1030 (m).  
HRMS (ESI): calcd for C17H26NaO3 [M+Na]
+: 301.1774; found: 301.1757. 
 
6-(3,4-dimethoxyphenyl)-2,3,3-trimethylhexan-1-ol (S148): 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.06 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.81 – 6.76 (m, 1H), 6.71 (d, J = 7.3 Hz, 2H), 3.88 (s, 3H), 3.86 (s, 
3H), 3.79 (dd, J = 10.4, 3.7 Hz, 1H), 3.32 (dd, J = 10.4, 8.9 Hz, 1H), 2.52 (t, J = 7.7 Hz, 2H), 1.65 
– 1.40 (m, 4H), 1.32 (ddd, J = 13.5, 10.4, 6.4 Hz, 1H), 1.21 (ddd, J = 13.5, 10.0, 7.0 Hz, 1H), 0.92 
(d, J = 6.8 Hz, 3H), 0.85 (s, 3H), 0.82 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.8, 147.1, 135.4, 120.1, 111.7, 111.2, 65.1, 55.9, 55.9, 43.4, 
40.5, 36.4, 34.5, 25.9, 24.9, 24.8, 12.0. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3507 (br m), 2937 (s), 1591 (w), 1515 (s), 1464 (m), 1417 (m), 1261 (m), 1235 
(m), 1142 (m), 1029 (m), 805 (w).  
HRMS (ESI): calcd for C17H28NaO3 [M+Na]
+: 303.1931; found: 303.1931. 
 
Proposed reaction mechanism:  
 
 
 
 
 
Experimental Section 
 
347 
 
No reaction of epoxide S65 was observed under the conditions of GP5.  
By increasing the catalyst amount to 110% sulfuric acid under otherwise identical conditions to 
GP5, three main products (S149, S150, S151) could be isolated. Yields were determined via 1H-
NMR using 1,2,4,5-tetrachloro-3-nitrobenzene (15.6 mg) as internal standard. Purified by flash 
column chromatography on silica gel (5% ethyl acetate in cyclohexane grading to 50% ethyl acetate 
in cyclohexane). 
Analytical data of S149: 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.58 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ: 8.54 – 8.50 (m, 1H), 7.62 – 7.56 (m, 1H), 7.16 (dd, J = 7.8, 1.2 Hz, 
1H), 7.12 – 7.07 (m, 1H), 4.27 (hept, J = 6.0 Hz, 1H), 2.94 (ddd, J = 13.7, 10.5, 5.2 Hz, 1H), 2.69 
(ddd, J = 13.7, 10.0, 6.6 Hz, 1H), 2.12 – 2.02 (m, 1H), 1.70 – 1.61 (m, 1H), 1.49 – 1.38 (m, 1H), 
1.17 (s, 6H), 1.02 (d, J = 6.8 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 162.4, 149.4, 136.5, 122.9, 121.2, 84.4, 69.6, 43.2, 37.0, 31.7, 22.8, 
22.4, 14.4. 
2D-NMR in appendix (HSQC, HMBC) 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2977 (w), 1591 (w), 1570 (w), 1474 (w), 1435 (w), 1396 (w), 1356 (w), 
1285 (m), 1258 (w), 1221 (m), 1190 (s), 1126 (m), 1099 (m), 1051 (w), 951 (w), 889 (w), 750 (w), 
686 (w). 
HRMS (ESI): calcd for C15H20F6NO [M+H]
+: 344.1444; found: 344.1419. 
 
Analytical data of S150: 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.12 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ: 8.51 – 8.47 (m, 1H), 7.62 – 7.56 (m, 1H), 7.16 (d, J = 7.9 Hz, 1H), 
7.13 – 7.07 (m, 1H), 5.65 – 5.57 (m, 1H), 3.62 (d, J = 7.3 Hz, 2H), 3.39 (s, 2H), 1.67 (s, 3H), 1.18 
– 1.15 (m, 1H), 1.09 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ: 160.9, 149.4, 141.1, 136.6, 122.9, 122.6, 121.3, 69.8, 42.0, 36.9, 
23.9, 12.9. 
2D-NMR in appendix (HSQC, HMBC, COSY) 
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IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3365 (m), 3304 (m), 2962 (s), 2923 (m), 2871 (m), 1593 (s), 1569 (m), 1475 
(s), 1435 (s), 1376 (w), 1284 (w), 1222 (w), 1191 (w), 1150 (w), 1051 (s), 1003 (w), 892 (w), 758 
(m), 634 (w), 609 (w), 601 (w), 586 (w), 547 (w). 
HRMS (ESI): calcd for C13H20NO [M+H]
+: 206.1539; found: 206.1526. 
 
Analytical data of S151 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.68 (KMnO4) 
1
H NMR (400 MHz, CDCl3) δ: 8.54 – 8.50 (m, 1H), 7.59 – 7.54 (m, 1H), 7.13 – 7.06 (m, 2H), 2.85 
– 2.79 (m, 2H), 2.47 – 2.39 (m, 2H), 1.70 – 1.67 (m, 3H), 1.63 (s, 3H), 1.58 – 1.54 (m, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 162.4, 149.4, 136.3, 126.8, 125.3, 123.0, 121.0, 37.2, 35.2, 20.7, 
20.2, 18.5. 
2D-NMR in appendix (HSQC, HMBC, COSY) 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3064 (w), 3007 (w), 2960 (m), 2920 (s), 2862 (m), 1589 (s), 1569 (m), 1473 
(s), 1434 (s), 1373 (w), 1307 (w), 1217 (w), 1182 (w), 1149 (w), 1118 (w), 1084 (w), 1050 (w), 994 
(w), 889 (w), 748 (s), 606 (w), 551 (w), 508 (w). 
HRMS (ESI): calcd for C12H18N [M+H]
+: 176.1434; found: 176.1423. 
 
Proposed reaction mechanism for formation of S149, S150 and S151.  
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No reaction of epoxide S67 was observed under the conditions of GP5.  
By increasing the catalyst amount to 110% sulfuric acid under otherwise identical conditions to 
GP5, two main products S152 (12%, 5.0 mg) and S153 (13%, 4.7 mg) could be isolated. Purified 
by flash column chromatography on silica gel (5% ethyl acetate in cyclohexane grading to 50% 
ethyl acetate in cyclohexane). 
Analytical data of S152: 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.15 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 8.46 – 8.41 (m, 2H), 7.52 – 7.43 (m, 1H), 7.21 (ddd, J = 7.8, 4.8, 
0.9 Hz, 1H), 5.47 (td, J = 7.1, 1.4 Hz, 1H), 3.44 (s, 2H), 3.41 (d, J = 7.1 Hz, 2H), 1.72 (q, J = 1.0 
Hz, 3H), 1.07 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ: 150.0, 147.6, 141.3, 136.9, 135.8, 123.6, 123.1, 70.0, 41.9, 31.8, 
24.0, 13.0. 
2D-NMR in appendix (HSQC, HMBC, COSY) 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3325 (m), 2961 (s), 2870 (m), 1654 (w), 1577 (w), 1478 (m), 1423 (s), 1376 
(w), 1283 (w), 1256 (w), 1219 (w), 1190 (m), 1125 (w), 1100 (w), 1050 (s), 1029 (m), 890 (w), 798 
(w), 713 (s), 686 (w), 637 (w), 584 (w), 452 (w). 
HRMS (ESI): calcd for C13H20NO [M+H]
+: 206.1539; found: 206.1536. 
 
Analytical data of S153 
TLC (50% ethyl acetate in cyclohexane): Rf: 0.69 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 8.44 – 8.40 (m, 2H), 7.47 (dt, J = 7.8, 2.0 Hz, 1H), 7.18 (ddd, J = 
7.7, 4.8, 0.9 Hz, 1H), 2.65 (dd, J = 8.9, 6.7 Hz, 2H), 2.31 (dd, J = 9.0, 6.8 Hz, 2H), 1.67 (d, J = 1.1 
Hz, 3H), 1.63 (s, 3H), 1.50 (d, J = 1.5 Hz, 3H). 
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13
C NMR (101 MHz, CDCl3) δ: 150.1, 147.3, 137.8, 136.0, 126.1, 125.8, 123.3, 36.4, 31.7, 20.7, 
20.1, 18.6. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3026 (w), 2990 (w), 2959 (w), 2921 (s), 2861 (m), 1575 (w), 1478 (m), 
1447 (w), 1422 (s), 1373 (w), 1193 (w), 1176 (w), 1154 (w), 1127 (w), 1096 (w), 1027 (m), 889 (w), 
833 (w), 796 (m), 713 (s), 631 (w), 602 (w), 435 (w).  
HRMS (ESI): calcd for C12H18N [M+H]
+: 176.1434; found: 176.1432. 
 
 
2-benzyl-3,3-dimethylbutanal (S165) was prepared according to GP5 from S164 (0.200 mmol, 
1 equiv) in 9% yield as a colorless oil (3.4 mg). Purified by flash column chromatography on silica 
gel (15% diethyl ether in n-pentane – approx. 70% purity achieved) and by high pressure liquid 
chromatography (1% ethyl acetate in n-hexane) 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.43 (UV, CAM) 
1
H NMR (600 MHz, CDCl3) δ 9.76 (d, J = 2.6 Hz, 1H), 7.24 (d, J = 8.1 Hz, 2H), 7.16 (t, J = 7.4 
Hz, 1H), 7.12 (d, J = 7.5 Hz, 2H), 3.03 (dd, J = 14.1, 11.1 Hz, 1H), 2.88 – 2.79 (m, 1H), 2.52 – 
2.37 (m, 1H), 1.09 (s, 9H). 
13
C NMR (151 MHz, CDCl3) δ 205.6, 140.6, 129.0, 128.7, 126.3, 63.9, 34.1, 31.2, 28.2. 
HRMS (ESI): calcd for C13H18NaO [M+Na]
+: 213.1250; found: 213.1241. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3028 (w), 2961 (s), 2926 (s), 2854 (m), 1724 (s), 1497 (w), 1497 (w), 1455 
(w), 1369 (w), 699 (w).  
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(3,4,4-trimethylchroman-3-yl)methanol (13a) was prepared according to GP5 from S79 
(0.200 mmol, 1 equiv) in 60% yield as a colorless oil (24.6 mg). Purified by flash column 
chromatography on silica gel (15% ethyl acetate in cyclohexane).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.24 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.25 (dd, J = 7.8, 1.7 Hz, 1H), 7.08 (ddd, J = 8.3, 7.2, 1.6 Hz, 1H), 
6.90 (td, J = 7.5, 1.4 Hz, 1H), 6.78 (dd, J = 8.1, 1.4 Hz, 1H), 4.11 (d, J = 11.1 Hz, 1H), 3.90 (d, J = 
11.1 Hz, 1H), 3.62 (d, J = 11.0 Hz, 1H), 3.48 (d, J = 11.0 Hz, 1H), 1.68 (s, 1H), 1.27 (s, 3H), 1.22 
(s, 3H), 0.98 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 153.6, 131.6, 127.4, 127.1, 121.0, 116.7, 67.5, 65.0, 39.0, 36.5, 
29.3, 23.2, 14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3449 (br m), 3031 (w), 2970 (s), 2883 (m), 1600 (m), 1580 (m), 1490 (s), 1448 
(m), 1366 (w), 1300 (m), 1276 (m), 1226 (s), 1164 (w), 1088 (w), 1050 (m), 753 (m).  
HRMS (ESI): calcd for C13H18NaO2 [M+Na]
+: 229.1199; found: 229.1199. 
 
 
(3,4,4,7-tetramethylchroman-3-yl)methanol (13b) was prepared according to GP5 from S81 
(0.200 mmol, 1 equiv) in 74% yield as a colorless oil (32.7 mg). Purified by flash column 
chromatography on silica gel (10% ethyl acetate in petrol ether).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.18 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.03 (d, J = 2.1 Hz, 1H), 6.93 – 6.85 (m, 1H), 6.68 (d, J = 8.2 Hz, 
1H), 4.07 (d, J = 11.0 Hz, 1H), 3.87 (d, J = 11.1 Hz, 1H), 3.62 (d, J = 11.0 Hz, 1H), 3.47 (d, J = 
11.2 Hz, 1H), 2.27 (s, 3H), 1.62 (s, 1H), 1.26 (s, 3H), 1.21 (s, 3H), 1.00 – 0.93 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 151.3, 131.3, 130.1, 127.8, 127.7, 116.4, 67.6, 65.1, 39.1, 36.5, 
29.3, 23.1, 21.0, 14.6. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3433 (br m), 3025 (w), 2969 (s), 2883 (m), 1499 (s), 1463 (m), 1406 (w), 1279 
(m), 1230 (m), 1106 (w), 1084 (w), 1029 (m), 814 (m), 786 (w).  
HRMS (ESI): calcd for C14H20NaO2 [M+Na]
+: 243.1356; found: 243.1350. 
 
 
(7-methoxy-3,4,4-trimethylchroman-3-yl)methanol (13c) was prepared according to GP5 from 
S83 (0.200 mmol, 1 equiv) in 49% yield as a colorless oil (23.3 mg). Purified by flash column 
chromatography on silica gel (20% ethyl acetate in cyclohexane).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.22 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.79 (d, J = 2.9 Hz, 1H), 6.74 – 6.64 (m, 2H), 4.05 (d, J = 11.1 Hz, 
1H), 3.86 (d, J = 11.1 Hz, 1H), 3.76 (s, 3H), 3.61 (d, J = 11.0 Hz, 1H), 3.46 (d, J = 11.0 Hz, 1H), 
1.73 (s, 1H), 1.26 (s, 3H), 1.21 (s, 3H), 0.96 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 153.9, 147.6, 132.6, 117.0, 112.9, 112.5, 67.6, 65.0, 55.8, 39.0, 
36.9, 29.2, 23.1, 14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3484 (br m), 2970 (s), 2834 (m), 1499 (s), 1418 (w), 1274 (m), 1201 (m), 1179 
(m), 1049 (m).  
HRMS (ESI): calcd for C14H20NaO3 [M+Na]
+: 259.1305; found: 259.1302. 
 
 
(6-methoxy-3,4,4-trimethylchroman-3-yl)methanol (13d) was prepared according to GP5 from 
S85 (0.200 mmol, 1 equiv) in 31% yield as a colorless oil (14.7 mg). Purified by flash column 
chromatography on silica gel (20% ethyl acetate in cyclohexane). Additionally, regioisomer 13e 
was isolated in 7% yield as a colorless oil (3.3 mg) 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.15 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 7.13 (d, J = 8.7 Hz, 1H), 6.50 (dd, J = 8.7, 2.7 Hz, 1H), 6.33 (d, J = 
2.6 Hz, 1H), 4.09 (d, J = 11.1 Hz, 1H), 3.90 (d, J = 11.2 Hz, 1H), 3.75 (s, 3H), 3.61 (d, J = 11.3 
Hz, 1H), 3.47 (d, J = 11.0 Hz, 1H), 1.55 (s, 1H), 1.24 (s, 3H), 1.19 (s, 3H), 0.96 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 158.8, 154.4, 128.0, 123.9, 108.1, 101.1, 67.8, 64.9, 55.4, 39.0, 
36.1, 29.2, 23.3, 14.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3433 (br m), 2967 (s), 2835 (m), 1617 (m), 1582 (m), 1503 (s), 1464 (m), 
1440 (m), 1418 (m), 1396 (w), 1316 (w), 1285 (m), 1249 (m), 1194 (m), 1167 (m), 1149 (s), 1088 
(m), 1030 (s), 936 (w), 833 (m), 802 (w), 727 (w).  
HRMS (ESI): calcd for C14H20NaO3 [M+Na]
+: 259,1305; found: 259.1303. 
 
(5-methoxy-3,4,4-trimethylchroman-3-yl)methanol (13e) 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.23 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.04 (t, J = 8.2 Hz, 1H), 6.46 (d, J = 8.2 Hz, 2H), 4.02 (d, J = 10.8 
Hz, 1H), 3.80 (d, J = 10.8 Hz, 1H), 3.80 (s, 3H), 3.67 (d, J = 11.1 Hz, 1H), 3.47 (d, J = 11.1 Hz, 
1H), 1.51 – 1.44 (m, 1H), 1.33 (s, 3H), 1.31 (s, 3H), 0.95 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 160.1, 155.7, 127.2, 119.8, 110.3, 104.3, 67.3, 64.9, 55.3, 40.5, 
36.9, 24.5, 20.6, 14.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3437 (br m) 2972 (s), 2934 (s), 1603 (m), 1583 (m), 1472 (m), 1438 (m), 1308 
(m), 1251 (s), 1139 (m), 1109 (m), 1080 (m), 1032 (m), 786 (m), 730 (w).  
HRMS (ESI): calcd for C14H20NaO3 [M+Na]
+: 259,1305; found: 259.1292. 
 
 
(6-methoxy-3,4,4-trimethylchroman-3-yl)methanol (13f) was prepared according to GP5 from 
S87 (0.200 mmol, 1 equiv) in 58% yield as a colorless oil (27.6 mg). Purified by flash column 
chromatography on silica gel (25% ethyl acetate in cyclohexane).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.19 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 6.90 – 6.80 (m, 2H), 6.70 (dd, J = 6.8, 2.7 Hz, 1H), 4.20 (d, J = 11.1 
Hz, 1H), 4.00 – 3.90 (m, 1H), 3.85 (s, 3H), 3.63 (d, J = 11.2 Hz, 1H), 3.46 (d, J = 11.1 Hz, 1H), 
1.73 (s, 1H), 1.26 (s, 3H), 1.21 (s, 3H), 0.98 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.0, 143.0, 132.4, 120.4, 119.2, 108.6, 67.9, 64.8, 55.9, 38.9, 
36.6, 29.2, 23.2, 14.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3488 (br m), 2969 (s), 2835 (m), 1583 (m), 1477 (s), 1439 (m), 1328 (w), 1260 
(s), 1223 (m), 1177 (w), 1116 (w), 1058 (s), 1032 (m), 779 (w), 733 (m).  
HRMS (ESI): calcd for C14H20NaO3 [M+Na]
+: 259.1305; found: 259.1298. 
 
 
(7,8,8-trimethyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-7-yl)methanol (13g) was 
prepared according to GP5 from S89 (0.200 mmol, 1 equiv) in 76% yield as a pale yellow oil (38.1 
mg). Purified by flash column chromatography on silica gel (20% ethyl acetate in cyclohexane).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.17 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.69 (s, 1H), 6.31 (s, 1H), 5.86 (q, J = 1.4 Hz, 2H), 4.03 (d, J = 11.0 
Hz, 1H), 3.83 (d, J = 11.0, 1H), 3.61 (d, J = 11.2 Hz, 1H), 3.45 (d, J = 11.0 Hz, 1H), 1.57 (s, 1H), 
1.22 (s, 3H), 1.16 (s, 3H), 0.95 (d, J = 0.6 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.3, 146.2, 142.1, 123.3, 106.1, 101.0, 98.2, 67.7, 65.0, 38.9, 
36.7, 29.3, 23.4, 14.5. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3455 (br m), 2970 (s), 2883 (m), 1630 (w), 1503 (m), 1483 (s), 1427 (m), 1346 
(w), 1246 (m), 1166 (s), 1129 (m), 1038 (m), 938 (w), 834 (w).  
HRMS (ESI): calcd for C14H18NaO4 [M+Na]
+: 273.1097; found: 273.1096. 
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(3,4,4-trimethyl-3,4-dihydro-2H-benzo[h]chromen-3-yl)methanol (13h) was prepared 
according to GP5 from S91 (0.200 mmol, 1 equiv) in 76% yield as a colorless oil (39.1 mg). 
Purified by flash column chromatography on silica gel (10% ethyl acetate in petrol ether).  
TLC: (20% ethyl acetate in cyclohexane): Rf: 0.24 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 8.22 – 8.15 (m, 1H), 7.77 – 7.70 (m, 1H), 7.47 – 7.40 (m, 2H), 7.40 
– 7.33 (m, 2H), 4.32 (d, J = 11.0 Hz, 1H), 4.05 (d, J = 11.0 Hz, 1H), 3.69 (d, J = 11.0 Hz, 1H), 3.52 
(d, J = 11.1 Hz, 1H), 1.55 (s, 1H), 1.34 (s, 3H), 1.28 (s, 3H), 1.04 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.5, 132.9, 127.3, 126.0, 125.4, 125.1, 125.0, 124.8, 122.1, 120.4, 
68.0, 65.1, 39.1, 36.6, 29.1, 23.2, 14.6. 
IR (ATR, neat): 3441 (br m), 3055 (w), 2970 (s), 2885 (m), 1596 (w), 1574 (m), 1507 (m), 1471 
(m), 1430 (m), 1394 (m), 1367 (m), 1350 (m), 1283 (m), 1222 (m), 1207 (w), 1155 (w), 1094 (m), 
1019 (m), 806 (m), 748 (w), 735 (w), 677 (w). 
HRMS (ESI) calcd for C17H20NaO2 [M+Na]
+: 279,1356; found: 279,1354. 
 
 
(6-fluoro-3,4,4-trimethylchroman-3-yl)methanol (13i) was prepared according to GP5 from S93 
(0.200 mmol, 1 equiv) in 73% yield as a colorless oil (32.9 mg). Purified by flash column 
chromatography on silica gel (15% ethyl acetate in petrol ether).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.19 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.98 – 6.87 (m, 1H), 6.77 (ddd, J = 8.9, 7.7, 3.0 Hz, 1H), 6.71 (dd, 
J = 8.9, 5.1 Hz, 1H), 4.08 (d, J = 11.1 Hz, 1H), 3.86 (d, J = 11.2 Hz, 1H), 3.58 (d, J = 11.0 Hz, 1H), 
3.47 (d, J = 11.0 Hz, 1H), 1.72 (s, 1H), 1.25 (s, 3H), 1.20 (s, 3H), 0.96 (s, 3H). 
Experimental Section 
356 
13
C NMR (101 MHz, CDCl3) δ 157.5 (d, J = 237.3 Hz), 149.5 (d, J = 1.9 Hz), 133.0 (d, J = 6.3 
Hz), 117.5 (d, J = 8.1 Hz), 113.9 (d, J = 23.2 Hz), 113.4 (d, J = 23.1 Hz), 67.7, 64.9, 38.8, 36.9, 
29.15, 23.1, 14.5. 
19
F NMR (282 MHz, CDCl3) δ –123.30. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3435 (br m), 2971 (m), 1494 (s), 1417 (m), 1262 (m), 1177 (m), 1031 (m), 
940 (w), 867 (w), 813 (w), 789 (w), 724 (w).  
HRMS (ESI): calcd for C13H17FNaO2 [M+Na]
+: 247.1105; found: 247.1103. 
 
 
(6-chloro-3,4,4-trimethylchroman-3-yl)methanol (13j) was prepared according to GP5 from 
S95 (0.200 mmol, 1 equiv) in 68% yield as a colorless oil (32.9 mg). Purified by flash column 
chromatography on silica gel (20% ethyl acetate in petrol ether).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.29 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.19 (d, J = 2.6 Hz, 1H), 7.02 (dd, J = 8.7, 2.6 Hz, 1H), 6.71 (d, J = 
8.6 Hz, 1H), 4.10 (d, J = 11.1 Hz, 1H), 3.88 (d, J = 11.1 Hz, 1H), 3.57 (d, J = 11.0 Hz, 1H), 3.48 
(d, J = 11.0 Hz, 1H), 1.54 (s, 1H), 1.26 (s, 3H), 1.21 (s, 3H), 0.97 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 152.1, 133.2, 127.1, 127.0, 125.6, 118.0, 67.6, 64.7, 38.7, 36.7, 
29.0, 23.0, 14.4. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3411 (br m), 2972 (s), 2885 (m), 1572 (w), 1486 (s), 1402 (m), 1266 (s), 1227 
(m), 1158 (w), 1104 (m), 1028 (s), 877 (m), 816 (m), 789 (m), 736 (m), 703 (m).  
HRMS (ESI): calcd for C13H17ClNaO2 [M+Na]
+: 263.0809; found: 263.0808. 
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ethyl 3-(hydroxymethyl)-3,4,4-trimethylchromane-6-carboxylate (13k) was prepared 
according to GP5 from S97 (0.200 mmol, 1 equiv) in 23% yield as a colorless oil (12.6 mg). 
Purified by flash column chromatography on silica gel (20% ethyl acetate in petrol ether).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.17 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 2.1 Hz, 1H), 7.77 (dd, J = 8.6, 2.1 Hz, 1H), 6.79 (d, J = 
8.6 Hz, 1H), 4.34 (q, J = 7.1 Hz, 2H), 4.18 (d, J = 11.1 Hz, 1H), 3.94 (d, J = 11.1 Hz, 1H), 3.62 – 
3.43 (m, 2H), 1.60 (s, 1H), 1.37 (t, J = 7.1 Hz, 3H), 1.29 (s, 3H), 1.26 (s, 3H), 0.99 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 166.8, 157.7, 131.5, 129.7, 128.9, 123.3, 116.7, 67.9, 64.7, 60.8, 
38.9, 36.6, 28.9, 23.2, 14.6, 14.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3457 (br m), 2973 (m), 1710 (s), 1609 (m), 1578 (m), 1496 (m), 1465 (m), 
1391 (m), 1367 (m), 1291 (m), 1253 (s), 1172 (m), 1106 (m), 1028 (s), 915 (w), 836 (w), 770 (m), 
738 (w), 626 (w).  
HRMS (ESI): calcd for C16H23O4 [M+H]
+: 279.1591; found: 279.1576. 
 
 
(3,4,4-trimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chroman-3-yl)methanol (13l) 
was prepared according to GP5 from S99 (0.200 mmol, 1 equiv) in 39% yield as a colorless oil 
(25.7 mg). Purified by flash column chromatography on silica gel (10% ethyl acetate in petrol ether 
– approx. 80% purity achieved) and by high pressure liquid chromatography (0.1% i-propanol in 
n-hexane grading to 2% i-propanol in n-hexane) 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.19 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 1.6 Hz, 1H), 7.54 (dd, J = 8.1, 1.5 Hz, 1H), 6.76 (d, J = 
8.1 Hz, 1H), 4.13 (d, J = 11.0 Hz, 1H), 3.91 (d, J = 11.1 Hz, 1H), 3.58 (d, J = 10.9 Hz, 1H), 3.47 
(d, J = 11.0 Hz, 1H), 1.73 (s, 1H), 1.33 (s, 12H), 1.28 (s, 3H), 1.26 (s, 3H), 0.97 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 156.4, 136.6, 134.5, 134.0, 130.9, 116.2, 83.6, 67.6, 64.8, 39.0, 
36.5, 29.0, 25.0, 23.1, 14.6. 
11
B NMR (128 MHz, CDCl3) δ 30.13. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3477 (br m), 2975 (s), 2928 (m), 1606 (m), 1572 (w), 1466 (m), 1371 (m), 
1352 (s), 1315 (m), 1272 (m), 1237 (m), 1145 (m), 1097 (m), 1035 (m), 964 (w), 856 (w), 683 (w).  
HRMS (ESI): calcd for C19H29BO4 [M+Na]
+: 355.2051; found: 355.2030. 
 
 
Exposing of S101 (0.200 mmol, 1 equiv) to the conditions of the GP5 led to the formation of alkene 
S154 (33.0 mg, 71%) and alcohol S155 (3.9 mg, 8%). Purified by high pressure liquid 
chromatography on silica gel (15% ethyl acetate in hexane grading to 25% ethyl acetate in hexane 
over 30 min). 
4-((2-(hydroxymethyl)-2,3-dimethylbut-3-en-1-yl)oxy)benzonitrile (S154) 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.09 (UV, CAM) 
1
H NMR (400 MHz, Chloroform-d) δ 7.61 – 7.53 (m, 2H), 7.02 – 6.94 (m, 2H), 5.05 (p, J = 1.3 
Hz, 1H), 4.87 (t, J = 0.9 Hz, 1H), 4.06 (d, J = 8.9 Hz, 1H), 3.99 (d, J = 8.9 Hz, 1H), 3.68 (d, J = 6.1 
Hz, 2H), 1.81 (dd, J = 1.5, 0.7 Hz, 3H), 1.59 (s, 1H), 1.19 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 162.4, 146.0, 134.1, 119.3, 115.4, 113.2, 104.3, 72.1, 66.1, 45.1, 
20.1, 19.2. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3503 (br m), 2972 (m), 2943 (m), 2887 (m), 1605 (s), 1509 (s), 1469 (w), 
1303 (m), 1259 (s), 1172 (m), 1024 (m), 897 (m), 835 (m).  
HRMS (ESI): calcd for C14H17NNaO2 [M+Na]
+: 254.1151; found: 254.1142. 
4-(3-((1,1,1,3,3,3-hexafluoropropan-2-yl)oxy)-2-(hydroxymethyl)-2,3-
dimethylbutoxy)benzonitrile (S155) 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.10 (UV, CAM) 
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1
H NMR (400 MHz, Chloroform-d) δ 7.64 – 7.52 (m, 2H), 7.00 – 6.92 (m, 2H), 4.35 (p, J = 5.7 
Hz, 1H), 4.19 (d, J = 9.3 Hz, 1H), 4.06 (d, J = 9.4 Hz, 1H), 3.89 (dd, J = 11.6, 4.9 Hz, 1H), 3.71 
(dd, J = 11.6, 7.4 Hz, 1H), 1.98 (dd, J = 7.4, 5.0 Hz, 1H), 1.36 (s, 3H), 1.34 (s, 3H), 1.08 (s, 3H). 
13
C NMR (101 MHz, Chloroform-d) δ 162.1, 134.2, 121.6 (q, J = 284.6 Hz), 119.3, 115.4, 104.4, 
86.3, 70.1, 69.0 (hept, J = 32.2 Hz), 65.4, 46.4, 22.2, 21.9, 16.3. 
19
F NMR (376 MHz, Chloroform-d) δ -72.79 (d, J = 5.8 Hz). 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3492 (br m), 2981 (m), 2951 (m), 2919 (m), 1606 (s), 1510 (s), 1474 (s), 1356 
(m), 1284 (s), 1259 (s), 1228 (s), 1191 (s), 1173 (s), 1124 (m), 1099 (m), 1030 (w), 885 (m), 834 
(m), 686 (m).  
HRMS (ESI): calcd for C17H19F6NNaO3 [M+Na]
+: 422.1161; found: 422.1146. 
 
 
(7,8-dimethoxy-9b-methyl-1,2,3,9b-tetrahydrocyclopenta[c]chromen-3a(4H)-yl)methanol 
(16a) was prepared according to GP5 from 14a (0.200 mmol, 1 equiv) in 76% yield as a colorless 
oil (42.1 mg). Purified by flash column chromatography on silica gel (20% ethyl acetate in 
cyclohexane).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.13 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.78 (s, 1H), 6.52 (s, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 3.66 – 3.53 (m, 
2H), 2.83 – 2.61 (m, 2H), 2.07 – 1.99 (m, 1H), 1.88 – 1.58 (m, 6H), 1.56 – 1.39 (m, 2H), 1.22 (s, 
3H). 
13
C NMR (101 MHz, CDCl3) δ 147.5, 146.9, 136.8, 127.7, 111.1, 110.5, 67.6, 56.2, 55.8, 47.1, 
47.1, 42.6, 32.6, 26.3, 26.0, 24.0, 21.1.  
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3502 (br m), 2952 (s), 2932 (s), 2872 (m), 2851 (m), 1610 (m), 1510 (s), 1463 
(m), 1399 (w), 1399 (w), 1374 (w), 1353 (w), 1311 (w), 1257 (s), 1232 (m), 1211 (m), 1146 (m), 
1129 (m), 1087 (m), 1072 (m), 1030 (m), 987 (m), 859 (m), 731 (m).  
HRMS (ESI): calcd for C17H24NaO3 [M+Na]
+: 299.1618; found: 299.1604. 
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Exposing of 14b (0.200 mmol, 1 equiv) to the conditions of the GP5 led to the formation of a 
inseperable mixture of spiran 15b and benzodecaline 16b (34.8 mg, 60%, 9:1 ratio). Purified by 
flash column chromatography on silica gel (30% diethyl ether in petrol ether) 
Yields were determined by 1H-NMR 
Analytical data of 16b (major compound) 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.09 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.75 (s, 1H), 6.54 (s, 1H), 3.84 (s, 6H), 3.73 – 3.53 (m, 2H), 2.94 – 
2.64 (m, 2H), 2.17 – 1.93 (m, 1H), 1.95 – 1.79 (m, 1H), 1.72 (dt, J = 13.0, 6.0 Hz, 1H), 1.65 – 1.34 
(m, 8H), 1.21 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.5, 146.9, 137.8, 127.6, 111.5, 109.6, 77.5, 77.2, 76.8, 66.9, 
56.2, 55.8, 39.0, 38.7, 29.7 (br, assigned by HSQC), 25.9, 24.8 (br, assigned by HSQC), 22.8, 21.3. 
HRMS (ESI): calcd for C18H26NaO3 [M+Na]
+: 313.1774; found: 313.1756. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3500 (br m), 2931 (s), 2858 (m), 1609 (w), 1513 (s), 1465 (m), 1446 (m), 1399 
(w), 1351 (w), 1251 (s), 1222 (m), 1205 (m), 1161 (m), 1075 (w), 1018 (m), 910 (w), 856 (w), 785 
(w), 731 (w).  
 
 
(6',7'-dimethoxy-2'-methyl-3',4'-dihydro-2'H-spiro[cyclohexane-1,1'-naphthalen]-2'-
yl)methanol (15c) was prepared according to GP5 from 14c (0.200 mmol, 1 equiv) in 71% yield 
as a colorless oil (42.1 mg). Purified by flash column chromatography on silica gel (20% ethyl 
acetate in cyclohexane).  
TLC (20% ethyl acetate in cyclohexane) Rf  0.25 (UV, CAM) 
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1
H NMR (600 MHz, CDCl3) δ 7.11 (s, 1H), 6.56 (s, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 3.44 (d, J = 
10.9 Hz, 1H), 3.35 (d, J = 10.9 Hz, 1H), 2.86 – 2.73 (m, 2H), 1.84 (ddd, J = 13.7, 8.8, 4.7 Hz, 1H), 
1.81 – 1.67 (m, 7H), 1.60 – 1.45 (m, 2H), 1.42 – 1.15 (m, 3H)., 0.98 (s, 3H). 
13
C NMR (151 MHz, CDCl3) δ 146.6, 145.9, 137.5, 129.0, 112.5, 112.2, 67.6, 56.3, 55.8, 42.5, 
42.1, 32.1, 29.5, 26.9, 25.9, 25.8, 24.7, 22.8, 19.7. 
HRMS (ESI): calcd for C19H28NaO3 [M+Na]
+: 327.1936; found 327.1926 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3536 (br), 2929 (s), 2853 (m), 1609 (w), 1511 (s), 1464 (m), 1452 (m), 1257 
(m), 1200 (m), 1155 (w), 1083 (m), 1016 (m), 856 (w). 
 
 
(7,9b-dimethyl-1,2,3,4,5,9b-hexahydro-3aH-cyclopenta[a]naphthalen-3a-yl)methanol (16d) 
was prepared according to GP5 from S115 (0.200 mmol, 1 equiv) in 82% yield as a colorless oil 
(37.9 mg). Purified by flash column chromatography on silica gel (20% ethyl acetate in 
cyclohexane).  
On 2.3 mmol scale product 16d was afforded in 75% yield (396 mg). 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.09 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.1 Hz, 1H), 6.98 (ddq, J = 8.2, 2.1, 0.7 Hz, 1H), 6.91 
– 6.84 (m, 1H), 3.62 (qd, J = 10.7, 5.6 Hz, 2H), 2.82 (ddd, J = 17.2, 7.9, 5.8 Hz, 1H), 2.71 (dt, J = 
17.2, 6.3 Hz, 1H), 2.28 (s, 3H), 2.04 (ddd, J = 12.9, 9.1, 5.9 Hz, 1H), 1.92 – 1.73 (m, 4H), 1.72 – 
1.60 (m, 2H), 1.57 – 1.46 (m, 2H), 1.23 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 142.1, 135.4, 134.7, 129.4, 127.4, 127.1, 67.6, 47.3, 47.1, 42.9, 
33.1, 26.4, 26.3, 23.9, 21.1, 20.9. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3464 (br w), 2922 (s), 2854 (s), 1609 (w), 1499 (m), 1457 (w), 1377 (w), 1286 
(w), 1217 (m), 1192 (w), 1100 (w), 1042 (w), 937 (w), 817 (w).  
HRMS (ESI): calcd for C16H22NaO [M+Na]
+: 253.1563; found: 253,1562. 
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((3aS,9bR)-8-methoxy-9b-methyl-1,2,3,9b-tetrahydrocyclopenta[c]chromen-3a(4H)-
yl)methanol (16e) was prepared according to GP5 from S119 (0.200 mmol, 1 equiv) in 87% yield 
as a brownish oil (43.0 mg). Purified by flash column chromatography on silica gel (30% diethyl 
ether in petrol ether).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.13 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.79 (d, J = 3.0 Hz, 1H), 6.76 (d, J = 8.8 Hz, 1H), 6.66 (dd, J = 8.8, 
3.0 Hz, 1H), 4.05 (d, J = 11.0 Hz, 1H), 3.78 (d, J = 11.1 Hz, 1H), 3.76 (s, 3H), 3.71 (d, J = 10.8 
Hz, 1H), 3.62 (d, J = 10.8 Hz, 1H), 2.11 – 1.98 (m, 1H), 1.97 – 1.65 (m, 4H), 1.64 – 1.49 (m, 2H), 
1.27 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 154.0, 147.7, 132.6, 117.4, 113.1, 112.4, 68.2, 65.6, 55.8, 46.5, 
44.7, 43.3, 30.4, 22.7, 21.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3439 (br m), 2954 (s), 2874 (s), 1614 (w), 1497 (s), 1419 (m), 1377 (w), 1272 
(m), 1203 (s), 1055 (m), 1028 (m), 811 (m).  
HRMS (ESI): calcd for C15H20NaO3 [M+Na]
+: 271.1305; found: 271.1300. 
 
 
(8,9b-dimethyl-1,2,3,4,5,9b-hexahydro-3aH-cyclopenta[a]naphthalen-3a-yl)methanol (S158) 
was prepared according to GP5 from S117 (0.200 mmol, 1 equiv) in 80% yield as a colorless oil 
(36.8 mg). Purified by flash column chromatography on silica gel (20% diethyl ether in petrol 
ether).  
TLC (20% ethyl acetate in cyclohexane): Rf: 0.24 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.11 (d, J = 1.8 Hz, 1H), 6.96 (d, J = 7.7 Hz, 1H), 6.94 – 6.86 (m, 
1H), 3.62 (q, J = 10.7 Hz, 2H), 2.90 – 2.76 (m, 1H), 2.71 (dt, J = 17.0, 6.2 Hz, 1H), 2.30 (t, J = 0.7 
Hz, 3H), 2.06 (ddd, J = 12.8, 9.0, 6.0 Hz, 1H), 1.91 – 1.73 (m, 4H), 1.72 – 1.60 (m, 2H), 1.60 – 
1.46 (m, 2H), 1.24 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 144.9, 135.4, 132.4, 128.8, 128.0, 126.3, 67.6, 47.3, 47.3, 42.9, 
33.2, 26.4, 26.0, 23.9, 21.4, 21.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3367 (br m), 2952 (s), 2873 (m), 1613 (w), 1502 (w), 1460 (w), 1375 (w), 
1027 (w), 1002 (w), 809 (w).  
HRMS (ESI): calcd for C16H22NaO [M+Na]
+: 253,1563; found: 253,1554. 
 
 
(2-allyl-6,7-dimethoxy-1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (18a) was 
prepared according to GP5 from 17a (0.200 mmol, 1 equiv) in 38% yield as a colorless oil (22.0 
mg). Purified by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane 
grading to 30% ethyl acetate in cyclohexane). Byproduct S159 (5.5 mg, 6%) was isolated as a 
colorless oil.  
Analytical data of 18a: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.22 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 6.82 (s, 1H), 6.52 (s, 1H), 6.09 (dddd, J = 16.8, 10.0, 8.4, 6.5 Hz, 
1H), 5.22 – 5.15 (m, 1H), 5.14 – 5.09 (m, 1H), 3.86 (s, 3H), 3.84 (s, 3H), 3.74 (dd, J = 11.6, 5.2 
Hz, 1H), 3.57 (dd, J = 11.6, 7.0 Hz, 1H), 2.78 – 2.72 (m, 2H), 2.41 (dd, J = 14.0, 8.4 Hz, 1H), 2.11 
(dd, J = 14.0, 6.5 Hz, 1H), 1.87 (dt, J = 13.5, 6.6 Hz, 1H), 1.66 (dt, J = 13.8, 7.0 Hz, 1H), 1.45 (dd, 
J = 7.1, 5.3 Hz, 1H), 1.31 (s, 3H), 1.28 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 147.5, 147.0, 137.9, 137.0, 127.5, 117.6, 111.1, 110.1, 66.5, 56.2, 
55.9, 42.1, 40.1, 37.4, 27.7, 26.4, 25.7, 24.8. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3511 (w), 3451 (w), 2934 (m), 2850 (w), 1610 (w), 1509 (s), 1464 (m), 
1399 (w), 1374 (w), 1353 (w), 1329 (w), 1254 (s), 1219 (m), 1160 (w), 1145 (w), 1133 (w), 1074 
(w), 1031 (m), 984 (w), 895 (w), 856 (w), 796 (w), 740 (w).  
HRMS (ESI): calcd for C18H26NaO3 [M+Na]
+: 363.1774; found: 313.1751. 
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Analytical data of S159: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.51 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 6.57 (s, 1H), 6.56 (s, 1H), 4.19 (hept, J = 6.0 Hz, 1H), 4.00 – 3.90 
(m, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 2.96 (dt, J = 13.4, 4.3 Hz, 1H), 2.81 (ddd, J = 16.8, 5.9, 1.9 Hz, 
1H), 2.70 (ddd, J = 17.4, 12.2, 6.5 Hz, 1H), 2.12 – 2.04 (m, 1H), 1.88 – 1.81 (m, 1H), 1.75 – 1.63 
(m, 1H), 1.68 – 1.60 (m, 1H), 1.60 – 1.50 (m, 2H), 1.51 – 1.44 (m, 1H), 1.47 – 1.38 (m, 1H), 1.07 
(s, 3H), 1.04 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 147.6, 147.4, 132.4, 128.0, 111.8, 111.5, 80.8, 74.1, 56.2, 56.0, 
43.3, 39.8, 37.3, 36.0, 34.6, 29.7, 29.7, 28.1, 18.8. 
19
F NMR (376 MHz, CDCl3) δ -74.04 – -74.22 (m). 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2944 (m), 2858 (w), 1610 (w), 1512 (m), 1467 (w), 1389 (w), 1368 (w), 
1285 (m), 1261 (m), 1215 (s), 1190 (s), 1126 (m), 1100 (m), 1035 (w), 994 (w), 944 (w), 923 (w), 
896 (w), 871 (w), 801 (w), 755 (w), 739 (w), 687 (w) cm−1.  
HRMS (ESI): calcd for C21H26F6NaO3 [M+Na]
+: 463.1678; found: 463.1643. 
 
Proposed reaction mechanism for S159 formation: 
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6,7-dimethoxy-1,1,6',6'-tetramethyl-3,4,5',6'-tetrahydro-1H,2'H,4'H-spiro[naphthalene-2,3'-
pyran] (19) was prepared according to GP5 from 17b (0.200 mmol, 1 equiv) in 39% yield as a 
colorless oil (24.7 mg). Purified by high pressure liquid chromatography on silica gel (0.1% i-
propanol in n-hexane grading to 1.5% i-propanol in n-hexane).  
TLC (20% diethyl ether in n-pentane): Rf: 0.19 (UV, CAM) 
1
H-NMR (400 MHz, CDCl3): δ = 6.80 (s, 1H), 6.52 (s, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 3.75 (d, J = 
11.7 Hz, 1H), 3.32 (dd, J = 11.8, 2.4 Hz, 1H), 2.84 – 2.60 (m, 2H), 1.96 (t, J = 6.9 Hz, 2H), 1.80 
(dd, J = 13.1, 4.0 Hz, 1H), 1.72 (dd, J = 13.2, 4.0 Hz, 1H), 1.38 – 1.30 (m, 2H), 1.26 (s, 3H), 1.24 
(s, 3H), 1.22 (s, 3H), 1.21 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.4, 147.0, 137.9, 127.4, 111.3, 110.0, 71.2, 65.2, 56.2, 55.9, 
38.9, 36.4, 32.5, 31.2, 26.3, 26.3, 25.3, 23.5, 23.1, 22.3. 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2967 (s), 1609 (w), 1513 (s), 1463 (m), 1365 (w), 1255 (s), 1205 (m), 1153 
(m), 1077 (m), 1047 (m), 856 (w), 798 (w) cm-1. 
HRMS (ESI): calcd for C20H30NaO3 [M+Na]
+: 341.2087 ; found: 341.2072. 
 
  
6'-(3-((1,1,1,3,3,3-hexafluoropropan-2-yl)oxy)-3-methylbutyl)-6,7-dimethoxy-1,1,6'-
trimethyl-3,4,5',6'-tetrahydro-1H,2'H,4'H-spiro[naphthalene-2,3'-pyran] (S160) was 
prepared according to GP5 from S127 (0.200 mmol, 1 equiv) in 31% yield as a colorless oil (34.6 
mg) as single diastereomer. Purified by high pressure liquid chromatography on silica gel (0.1% i-
propanol in n-hexane grading to 1.5% i-propanol in n-hexane).  
TLC (20% diethyl ether in n-pentane): Rf: 0.17 (UV, CAM) 
1
H-NMR (600 MHz, CDCl3): δ = 6.80 (s, 1H), 6.51 (s, 1H), 4.27 (hept, J = 6.0 Hz, 1H), 3.85 (s, 
3H), 3.83 (s, 3H), 3.75 (d, J = 11.7 Hz, 1H), 3.31 (dd, J = 11.6, 2.3 Hz, 1H), 2.73 (dt, J = 17.3, 6.4 
Hz, 1H), 2.71 – 2.63 (m, 1H), 2.00 – 1.88 (m, 2H), 1.82 (td, J = 13.5, 4.0 Hz, 1H), 1.68 (td, J = 
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13.4, 4.2 Hz, 1H), 1.46 (d, J = 4.9 Hz, 4H), 1.38 – 1.28 (m, 4H), 1.26 (s, 3H), 1.25 (s, 6H), 1.21 (s, 
3H), 1.18 (s, 3H). 
13
C NMR (151 MHz, CDCl3) δ 147.4, 147.0, 137.9, 127.4, 111.3, 110.0, 81.8, 70.3 – 69.1 (m), 
69.6, 65.0, 56.2, 55.9, 44.2, 42.7, 38.9, 36.5, 30.5, 26.4, 26.2, 25.5, 25.4, 25.3, 23.2, 23.1, 20.3, 
18.1. 
19
F-NMR (376 MHz, CDCl3) δ –73.15 (d, J = 5.8 Hz). 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2924 (br m), 2852 (w), 1730 (w), 1610 (w), 1510 (m), 1465 (w), 1356 (m), 
1284 (s), 1255 (s), 1219 (s), 1188 (s), 1152 (m), 1123 (m), 1098 (m), 1080 (s), 1046 (m), 971 (w), 
890 (w), 857 (w), 797 (w), 730 (w), 686 (m). 
HRMS (ESI): calcd for C28H40F6NaO4 [M+Na]
+: 577.2723; found: 577.2719. 
 
  
(2-benzyl-6,7-dimethoxy-1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (18c) was 
prepared according to GP5 from 17c (0.200 mmol, 1 equiv) in 36% yield as a colorless oil 
(24.4 mg). Further products: 21 (26.2 mg, 41%, colorless solid), 20a (5.2 mg, 8%, colorless oil) and 
20b (7.5 mg, 11%, colorless oil). Purified by flash column chromatography on silica gel (1% ethyl 
acetate in cyclohexane grading to 25% ethyl acetate in cyclohexane). 
Analytical data of 18c: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.34 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.37 – 7.29 (m, 4H), 7.26 – 7.22 (m, 1H), 6.83 (s, 1H), 6.51 (s, 1H), 
3.85 (s, 3H), 3.82 (s, 3H), 3.82 – 3.77 (m, 1H), 3.46 – 3.38 (m, 1H), 3.03 (d, J = 13.1 Hz, 1H), 2.83 
– 2.67 (m, 2H), 2.54 (d, J = 13.1 Hz, 1H), 1.97 (ddd, J = 13.5, 6.0, 4.2 Hz, 1H), 1.68 (ddd, J = 13.5, 
9.8, 7.1 Hz, 1H), 1.35 (s, 3H), 1.33 (s, 3H), 0.49 (dd, J = 9.2, 3.8 Hz, 1H). 
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13
C NMR (101 MHz, CDCl3) δ: 147.4, 147.0, 139.6, 137.6, 130.4, 128.8, 127.8, 126.6, 111.1, 
110.2, 65.3, 56.2, 55.8, 43.2, 40.2, 39.8, 29.3, 26.0, 24.7, 24.3. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3530 (w), 3026 (w), 2933 (m), 2850 (w), 1609 (w), 1509 (s), 1463 (m), 
1452 (m), 1491 (w), 1357 (w), 1325 (w), 1252 (s), 1207 (m), 1182 (w), 1153 (s), 1079 (m), 1065 
(m), 1028 (m), 968 (w), 910 (w), 858 (w), 823 (w), 795 (w), 767 (w), 732 (s), 706 (s), 646 (w), 599 
(w), 478 (w), 415 (w).  
HRMS (ESI): calcd for C22H28NaO3 [M+Na]
+: 363.1931; found: 363.1904. 
 
Analytical data of 21: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.69 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.19 (dd, J = 7.5, 1.2 Hz, 1H), 7.11 – 7.02 (m, 3H), 6.86 (s, 1H), 
6.63 (s, 1H), 4.08 – 4.01 (m, 1H), 3.94 (s, 3H), 3.87 (s, 3H), 2.76 (d, J = 16.8 Hz, 1H), 2.73 – 2.62 
(m, 2H), 2.55 (d, J = 16.8 Hz, 1H), 1.93 – 1.85 (m, 1H), 1.79 (dt, J = 11.8, 4.1 Hz, 1H), 1.42 – 1.30 
(m, 1H), 1.12 (s, 3H), 1.08 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 147.7, 146.5, 138.0, 135.8, 130.7, 129.5, 129.4, 128.2, 125.8, 
125.7, 115.1, 111.9, 56.3, 56.0, 43.9, 40.78, 40.59, 32.31, 29.13, 28.51, 28.06, 20.88. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2930 (m), 2866 (w), 2835 (w), 1608 (w), 1510 (s), 1489 (w), 1462 (m), 
1450 (m), 1405 (w), 1385 (w), 1365 (w), 1356 (w), 1338 (w), 1276 (m), 1236 (s), 1226 (s), 1193 
(w), 1158 (w), 1138 (w), 1115 (s), 1097 (w), 1076 (w), 1027 (m), 1009 (w), 975 (w), 910 (m), 880 
(w), 858 (w), 843 (w), 811 (w), 797 (w), 730 (s), 702 (w), 673 (w), 647 (w), 622 (w), 580 (w), 533 
(w), 501 (w), 465 (w), 440 (w), 412 (w). 
HRMS (ESI): calcd for C22H26NaO2 [M+Na]
+: 345.1825; found: 345.1801. 
 
Analytical data of 20a: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.24 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.13 – 7.06 (m, 3H), 6.64 – 6.60 (m, 2H), 6.55 (s, 1H), 5.66 (s, 1H), 
3.90 (d, J = 10.8 Hz, 1H), 3.84 (s, 3H), 3.77 (d, J = 10.9 Hz, 1H), 3.27 (s, 3H), 2.87 – 2.80 (m, 3H), 
2.72 (d, J = 12.5 Hz, 1H), 2.13 – 2.02 (m, 1H), 1.72 – 1.64 (m, 1H), 1.41 – 1.37 (m, 1H), 1.30 (s, 
3H), 0.97 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ: 146.8, 145.5, 139.3, 133.4, 131.7, 127.4, 127.3, 125.9, 112.4, 
110.9, 69.4, 55.8, 55.3, 45.0, 43.9, 39.9, 27.3, 25.7, 20.1, 18.7. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3498 (w), 3026 (w), 2922 (m), 2850 (w), 1609 (w), 1510 (s), 1495 (w), 1464 
(m), 1452 (m), 1400 (w), 1375 (w), 1353 (w), 1254 (s), 1212 (s), 1159 (m), 1115 (m), 1093 (w), 
1077 (w), 1034 (s), 974 (w), 911 (w), 859 (w), 798 (m), 756 (w), 729 (s), 702 (s), 669 (w), 646 (w), 
547 (w), 500 (w), 435 (w). 
HRMS (ESI): calcd for C22H28NaO3 [M+Na]
+: 363.1931; found: 363.1905 
 
Analytical data of 20b: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.18 (CAM) 
1
H NMR (400 MHz, CDCl3) δ:.13 – 7.07 (m, 3H), 6.63 – 6.59 (m, 2H), 6.54 (s, 1H), 5.64 (s, 1H), 
3.84 (s, 3H), 3.58 – 3.47 (m, 2H), 3.28 (s, 3H), 2.87 – 2.71 (m, 4H), 2.05 – 1.95 (m, 1H), 1.87 (ddd, 
J = 14.1, 7.0, 2.1 Hz, 1H), 1.25 – 1.21 (m, 1H), 1.19 (s, 3H), 1.18 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 146.8, 145.5, 138.8, 132.9, 131.8, 128.1, 127.4, 125.9, 112.4, 
111.0, 66.6, 55.8, 55.3, 45.4, 42.8, 40.5, 26.8, 26.1, 19.8, 19.1. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3542 (w), 3514 (w), 3025 (w), 2930 (m), 2850 (w), 1609 (w), 1513 (s), 1495 
(w), 1464 (m), 1453 (m), 1417 (w), 1400 (w), 1353 (w), 1331 (w), 1254 (s), 1211 (s), 1151 (m), 
1107 (m), 1077 (w), 1029 (s), 979 (w), 940 (w), 909 (w), 858 (w), 795 (w), 755 (w), 728 (m), 702 
(m), 669 (w), 646 (w), 609 (w), 548 (w), 498 (w), 438 (w), 421 (w). 
HRMS (ESI): calcd for C22H28NaO3 [M+Na]
+: 363.1931; found: 363.1902. 
 
 
Exposing of 17d (0.200 mmol, 1 equiv) to the conditions of GP5 led to the formation of tetralin 
18d (22%, colorless oil) and cycloctene 22 (7%*, colorless oil). Purified by high pressure liquid 
chromatography on silica gel (15% ethyl acetate in n-hexane grading to 25% ethyl acetate in n-
hexane in 30 min). 
*yield determined by 1H-NMR 
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(6,7-dimethoxy-1,2-dimethyl-1-vinyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (18d) 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.19 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.80 (s, 1H), 6.55 (s, 1H), 6.01 (dd, J = 17.7, 11.1 Hz, 1H), 5.36 (d, 
J = 11.1 Hz, 1H), 5.22 (d, J = 17.9 Hz, 1H), 3.85 (s, 3H), 3.84 (s, 3H), 3.69 (d, J = 11.1 Hz, 1H), 
3.53 (t, J = 10.2 Hz, 1H), 2.86 (ddd, J = 17.8, 11.7, 6.4 Hz, 1H), 2.74 (ddd, J = 17.2, 6.4, 2.4 Hz, 
1H), 2.02 (ddd, J = 13.6, 6.5, 2.6 Hz, 1H), 1.87 (td, J = 12.5, 6.4 Hz, 1H), 1.58 (s, 1H), 1.27 (s, 
3H), 1.16 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ: 147.6, 147.3, 141.6, 137.2, 127.5, 116.2, 111.5, 110.1, 63.1, 56.3, 
55.9, 46.4, 38.8, 30.5, 25.6, 23.7, 23f.1. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 3503 (w,br), 2957 (m), 1610 (w), 1510 (s), 1464 (m), 1400 (w), 1354 (w), 
1254 (s), 1207 (m), 1155 (m), 1078 (m), 1027 (m), 967 (w), 913 (w), 857 (w), 797 (w).  
HRMS (ESI): calcd for C17H24O3Na [M+Na]
+: 299.1623; found: 299.1612. 
 
(E)-(2,3-dimethoxy-8,8-dimethyl-5,8,9,10-tetrahydrobenzo[8]annulen-7-yl)methanol (22) 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.13 (UV, CAM) 
1
H NMR (600 MHz, CDCl3) δ 6.66 (s, 1H), 6.61 (s, 1H), 5.78 (tt, J = 6.0, 1.3 Hz, 1H), 3.85 (s, 
3H), 3.85 (s, 3H), 3.42 (dt, J = 6.1, 1.9 Hz, 2H), 3.35 (s, 2H), 2.94 – 2.88 (m, 2H), 2.35 (dddd, J = 
7.9, 4.8, 3.4, 1.7 Hz, 2H), 1.21 (s, 1H), 1.02 (s, 6H). 
13
C NMR (151 MHz, CDCl3) δ 147.3, 146.7, 143.6, 133.5, 132.8, 122.9, 112.4, 112.2, 69.9, 56.2, 
56.1, 42.2, 33.2, 31.9, 28.0, 24.3. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥:3493 (br m), 2932 (s), 1608 (w), 1516 (s), 1463 (m), 1341 (w), 1265 (m), 
1226 (m), 1200 (m), 1039 (m) 
HRMS (ESI): calcd for C17H24O3Na [M+Na]
+: 299.1623; found: 299.1608. 
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Proposed reaction mechanism for formation of 22: 
 
 
 
 
Exposing of S133 (0.200 mmol, 1 equiv) to the conditions of the GP5 led to the formation of S161 
(24.1 mg, 34%, colorless oil) and S162 (10.1 mg, 14%, colorless oil). Purified by flash column 
chromatography on silica gel (20% ethyl acetate in petrol ether). 
Analytically pure samples of S161 and S162 were obtained by normal-phase semi-preparative 
HPLC purification using 15% ethyl acetate in n-hexane as eluent initially, grading to 25% ethyl 
acetate in n-hexane as eluent over 30 min. 
Analytical data of S161:  
TLC (20% ethyl acetate in petrolether) Rf: 0.11 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.56 (dd, J = 8.5, 1.3 Hz, 2H), 7.40 (dd, J = 8.4, 7.0 Hz, 2H), 7.31 
– 7.26 (m, 1H), 4.25 (d, J = 11.0 Hz, 1H), 3.86 (s, 3H), 3.85 (s, 3H), 3.78 (dd, J = 12.3, 9.4 Hz, 
1H), 3.08 – 2.93 (m, 1H), 2.90 (dd, J = 6.6, 2.4 Hz, 1H), 2.58 (td, J = 12.3, 6.6 Hz, 1H), 2.21 – 2.10 
(m, 2H), 1.98 (dt, J = 13.1, 6.8 Hz, 1H), 1.92 – 1.82 (m, 1H), 1.72 (dt, J = 12.8, 7.9 Hz, 1H), 1.51 
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(dd, J = 12.9, 6.7 Hz, 1H), 1.43 (dt, J = 12.7, 6.2 Hz, 1H), 1.11 (dd, J = 9.8, 3.4 Hz, 1H), 0.64 (dt, 
J = 12.6, 7.1 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 147.2, 146.9, 141.9, 139.4, 129.2, 128.4, 128.2, 127.0, 
126.7, 111.2, 110.8, 62.7, 56.1, 55.9, 51.9, 49.3, 41.3, 34.5, 28.0, 27.7, 26.5, 25.5. 
2D-NMR in appendix 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥:  3481 (br), 2947 (m), 2868 (m), 1609(w), 1514 (s), 1463 (m), 1369 
(w), 1337 (w), 1254 (m), 1239 (w), 1208 (m), 1158 (w), 1096 (w), 1023 (m), 911 (w), 856 
(w), 706 (m), 647 (m). 
HRMS (ESI): calcd for C23H28O3Na [M+Na]+: 375.1936; found: 375.1916 
 
Analytical data of S162:  
TLC (20% ethyl acetate in petrolether) Rf 0.11 (UV, CAM) 
1
H NMR (600 MHz, Chloroform-d) δ 7.33 (t, J = 7.6 Hz, 2H), 7.29 – 7.26 (m, 2H), 7.25 – 7.22 (m, 
1H), 6.78 (d, J = 8.1 Hz, 1H), 6.69 (dd, J = 8.1, 2.0 Hz, 1H), 6.67 (d, J = 1.9 Hz, 1H), 5.73 (t, J = 
2.1 Hz, 1H), 4.14 – 3.92 (m, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 2.43 (ddt, J = 7.4, 4.6, 2.3 Hz, 2H), 
2.41 – 2.32 (m, 2H), 2.28 (td, J = 12.6, 4.7 Hz, 1H), 2.16 – 1.99 (m, 3H), 1.88 – 1.71 (m, 2H), 1.13 
(t, J = 6.7 Hz, 1H). 
13
C NMR (151 MHz, CDCl3) δ 149.0, 147.3, 147.1, 143.5, 135.7, 128.6, 127.4, 127.3, 126.7, 120.2, 
111.9, 111.4, 65.7, 56.1, 56.0, 50.0, 35.9, 32.7, 32.5, 30.5, 23.4. 
2D-NMR in appendix 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥:  3493 (br), 2863 (m), 2845 (m), 1591 (w), 1514 (s), 1495 (w), 1463 (m), 
1445 (w), 1417 (w), 1261 (s), 1261 (m), 1155 (m), 1140 (m), 1030(m), 765 (m), 702 (m). 
HRMS (ESI): calcd for C23H28O3Na [M+Na]
+: 375.1936; found: 375.1915 
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Exposing of 23g (0.200 mmol, 1 equiv) to the conditions of GP5 led to the formation of tetralin 
26g (44%*, colorless oil), tetraline 28g (19%, colorless oil) and naphthalene 27g (23%*, colorless 
oil). Yields were determined via 1H-NMR using 1,2,4,5-Tetrachloro-3-nitrobenzene (15.8 mg) as 
internal standard. Analyticaly pure samples were isolated by flash column chromatography on silica 
gel (1% ethyl acetate in cyclohexane grading to 5% ethyl acetate in cyclohexane). 
Analytical data of 26g: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.45 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 6.65 (s, 1H), 6.61 (s, 1H), 6.23 (s, 1H), 3.86 (s, 3H), 3.85 (s, 3H), 
3.34 (s, 3H), 3.29 (s, 2H), 2.72 – 2.66 (m, 2H), 2.28 – 2.21 (m, 2H), 1.14 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ: 147.4, 147.4, 144.9, 127.9, 127.2, 120.7, 111.0, 110.1, 80.8, 59.5, 
56.2, 56.1, 40.1, 28.5, 24.2, 24.1. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2958 (w), 2932 (w), 2871 (w), 2829 (w), 1606 (w), 1512 (s), 1462 (m), 1450 
(m), 1406 (w), 1391 (w), 1359 (w), 1337 (w), 1322 (w), 1303 (w), 1277 (w), 1256 (m), 1234 (s), 
1213  (m), 1193 (m), 1166 (w), 1152 (w), 1125 (s), 1106 (s), 1062 (w), 1030 (w), 999 (m), 960 (w), 
915 (w), 876 (m), 850 (w), 825 (w), 772 (w), 753 (w), 732 (w), 598 (w), 479 (w), 433 (w), 416 (w) 
cm−1. 
HRMS (ESI): calcd for C17H24NaO3 [M+Na]
+: 299.1618; found: 299.1596. 
 
Analytical data of 28g: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.49 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 6.59 (s, 1H), 6.57 (s, 1H), 3.84 (s, 3H), 3.84 (s, 3H), 3.34 (s, 3H), 
3.24 – 3.14 (m, 2H), 2.76 – 2.64 (m, 3H), 2.60 – 2.49 (m, 1H), 1.99 – 1.89 (m, 1H), 1.69 (tdd, J = 
11.9, 5.0, 2.2 Hz, 1H), 1.39 – 1.27 (m, 1H), 0.96 (s, 3H), 0.91 (s, 3H). 
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13
C NMR (101 MHz, CDCl3) δ: 147.1, 147.0, 129.2, 128.9, 112.3, 111.6, 81.1, 59.5, 56.1, 56.0, 
40.9, 36.7, 30.4, 30.3, 24.5, 22.7, 22.0. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2929 (m), 2871 (w), 2832 (w), 1609 (w), 1515 (s), 1463 (m), 1450 (m), 
1407 (w), 1393 (w), 1362 (w), 1330 (w), 1294 (w), 1267 (m), 1249 (m), 1224 (m), 1191 (m), 1109 
(s), 1068 (w), 1025 (m), 1000 (w), 972 (w), 918 (w), 899 (w), 847 (m), 813 (w), 775 (w), 740 (w), 
550 (w), 439 (w) cm−1. 
HRMS (ESI): calcd for C17H26NaO3 [M+Na]
+: 301.1774; found: 301.1752 
 
Analytical data of 27g: 
TLC (25% ethyl acetate in cyclohexane): Rf: 0.40 (CAM) 
1
H NMR (400 MHz, CDCl3) δ: 7.66 – 7.62 (m, 2H), 7.41 (dd, J = 8.6, 1.9 Hz, 1H), 7.12 (s, 1H), 
7.09 (s, 1H), 4.00 (s, 3H), 3.99 (s, 3H), 3.48 (s, 2H), 3.32 (s, 3H), 1.41 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ: 149.6, 149.3, 143.6, 129.2, 127.6, 126.2, 123.2, 123.1, 106.8, 
106.1, 83.1, 59.6, 56.0, 56.0, 39.2, 26.3. 
IR (ATR, CDCl3) ?̃?𝑚𝑎𝑥: 2960 (w), 2933 (w), 2870 (w), 2828 (w), 1632 (w), 1607 (w), 1510 (s), 1490 
(s), 1462 (m), 1436 (m), 1416 (m), 1393 (w), 1362 (w), 1320 (w), 1252 (s), 1196 (s), 1165 (s), 1134 
(s), 1106 (s), 1034 (w), 1006 (s), 962 (w), 916 (w), 885 (m), 849 (s), 831 (w), 808 (w), 753 (m), 731 
(w), 640 (w), 618 (w), 506 (w), 478 (m) cm−1. 
HRMS (ESI): calcd for C17H22NaO3 [M+Na]
+: 297.1461; found: 297.1440. 
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Exposing of 23a (0.200 mmol, 1 equiv) to the conditions of the GP5 led to the formation of tetraline 
28a (20.1 mg, 49%, colorless oil) and naphthalene 27a (19.0 mg, 47%, colorless solid). Purified by 
flash column chromatography on silica gel (5% diethyl ether in petrol ether). 
6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydronaphthalene (28a): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.26 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.58 (s, 1H), 6.55 (s, 1H), 3.84 (s, 6H), 2.80 – 2.62 (m, 3H), 2.42 – 
2.23 (m, 1H), 1.95 – 1.71 (m, 2H), 1.46 – 1.30 (m, 1H), 1.05 (d, J = 6.5 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.1, 147.1, 128.8, 128.5, 112.0, 111.8, 56.0, 37.8, 31.8, 29.5, 
29.0, 22.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2994 (w), 2948 (s), 2910 (s), 2832 (m), 1610 (w), 1516 (s), 1454 (m), 1407 
(w), 1351 (w), 1326 (w), 1288 (w), 1268 (m), 1247 (m), 1230 (m), 1212 (m), 1116 (m), 1027 (w), 
994 (w), 847 (w).  
HRMS (LTB): calcd for C13H19O2 [M+H]
+: 207.1380; found: 207.1386. 
 
2,3-dimethoxy-6-methylnaphthalene (27a): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.17 (UV, CAM) 
mp: 90.1 °C 
1
H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.3 Hz, 1H), 7.47 (s, 1H), 7.18 (dd, J = 8.2, 1.7 Hz, 1H), 
7.07 (d, J = 15.9 Hz, 2H), 3.99 (s, 3H), 3.99 (s, 3H), 2.47 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.7, 149.0, 133.8, 129.5, 127.3, 126.5, 126.3, 125.7, 106.3, 106.0, 
56.0, 21.7. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2998 (w), 2937 (m), 1631 (m), 1610 (m), 1512 (m), 1492 (m), 1461 (m), 1438 
(m), 1414 (m), 1318 (w), 1254 (s), 1207 (m), 1162 (m), 1130 (m), 1015 (w), 856 (m), 750 (w).  
HRMS (LTP): calcd for C13H15O2 [M+H]
+: 203.1067; found: 203.1067. 
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Exposing of 23b (0.200 mmol, 1 equiv) to the conditions of the GP5 led to the formation of tetraline 
28b (20.1 mg, 49%, colorless oil) and naphthalene 27b (19.0 mg, 47%, colorless solid). Purified by 
flash column chromatography on silica gel (5% diethyl ether in petrol ether). 
6,7-dimethoxy-2-ethyl-1,2,3,4-tetrahydronaphthalene (28b): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.25 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.57 (d, J = 2.6 Hz, 2H), 3.84 (s, 6H), 2.84 – 2.68 (m, 3H), 2.41 – 
2.27 (m, 1H), 1.99 – 1.85 (m, 1H), 1.66 – 1.53 (m, 1H), 1.45 – 1.28 (m, 3H), 0.98 (t, J = 7.4 Hz, 
3H). 
13
C NMR (101 MHz, CDCl3) δ 147.1, 147.1, 128.8, 128.8, 112.1, 111.8, 56.0, 36.3, 35.6, 29.5, 
29.38, 29.0, 11.7. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2958 (m), 2914 (s), 2874 (m), 2851 (m), 1610 (w), 1517 (s), 1464 (m), 1407 
(w), 1353 (w), 1324 (w), 1261 (m), 1223 (m), 1118 (m), 1016 (w), 847 (w).  
HRMS (ESI): calcd for C14H21O2 [M+H]
+: 221.1536; found: 221.1541. 
 
2,3-dimethoxy-6-ethylnaphthalene (27b): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.17 (UV, CAM) 
mp: 108.4 °C 
1
H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.3 Hz, 1H), 7.50 – 7.47 (m, 1H), 7.21 (dd, J = 8.3, 1.8 
Hz, 1H), 7.09 (d, J = 6.8 Hz, 2H), 4.00 (s, 3H), 3.99 (s, 3H), 2.77 (q, J = 7.6 Hz, 2H), 1.31 (t, J = 
7.6 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.6, 149.0, 140.3, 129.5, 127.6, 126.4, 125.4, 124.4, 106.3, 106.2, 
56.0, 29.1, 15.8. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3052 (w), 2998 (m), 2962 (s), 2931 (m), 2851 (m), 1631 (w), 1609 (m), 1578 
(w), 1512 (s), 1492 (m), 1461 (m), 1437 (m), 1421 (m), 1407 (m), 1318 (w), 1255 (s), 1206 (m), 
1163 (s), 1130 (s), 1031 (w), 1005 (m), 898 (w), 857 (m).  
HRMS (ESI): calcd for C14H17O2 [M+H]
+: 217.1223; found: 217.1218. 
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Exposing of 23c (0.200 mmol, 1 equiv) to the conditions of the GP5 led to the formation of tetraline 
28c (17.1 mg, 30%, colorless oil), naphthalene 27c (25.0 mg, 45%, colorless solid) and 
benzofluorene S163 (2.90 mg, 5%). Purified by HPLC column chromatography on silica gel (2% 
ethyl acetate in hexane). 
2-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalene (28c): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.26 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.35 – 7.28 (m, 2H), 7.25 – 7.19 (m, 3H), 6.58 (s, 1H), 6.53 (s, 1H), 
3.84 (s, 3H), 3.82 (s, 3H), 2.83 – 2.57 (m, 5H), 2.48 – 2.33 (m, 1H), 2.11 – 1.98 (m, 1H), 1.98 – 
1.88 (m, 1H), 1.52 – 1.34 (m, 1H). 
13
C NMR (101 MHz, CDCl3) δ 147.1, 147.1, 140.9, 129.3, 128.5, 128.4, 128.3, 126.0, 112.0, 111.7, 
56.0, 56.0, 43.1, 36.5, 35.7, 29.5, 28.9. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥:3061 (w), 3025 (m), 2998 (m), 2914 (s), 2831 (m), 1608 (m), 1515 (s), 1452 
(m), 1408 (w), 1353 (m), 1408 (m), 1353 (m), 1326 (m), 1249 (m), 1224 (m), 1115 (s), 1018 (m), 
978 (w), 924 (w), 848 (m), 794 (w), 749 (m), 700 (m).  
HRMS (ESI): calcd for C19H23O2 [M+H]
+: 283.1693; found: 283.1675. 
 
2,3-dimethoxy-6,6a,7,11b-tetrahydro-5H-benzo[c]fluorene (S163):   
TLC (10% ethyl acetate in cyclohexane): Rf: 0.21 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.24 – 7.19 (m, 1H), 7.07 – 7.01 (m, 3H), 6.72 (s, 1H), 6.53 (s, 1H), 
3.85 (s, 4H), 3.78 (s, 3H), 3.24 (ddd, J = 30.3, 17.5, 7.4 Hz, 2H), 2.72 (d, J = 18.0 Hz, 1H), 2.69 – 
2.61 (m, 2H), 2.08 (t, J = 3.1 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 147.5, 147.2, 142.7, 135.1, 134.1, 129.5, 127.3, 126.5, 126.0, 125.7, 
112.3, 110.8, 56.2, 56.0, 39.8, 37.1, 36.8, 29.3, 25.5. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3056 (w), 2996 (m), 2922 (s), 2852 (m), 2830 (m), 1733 (w), 1609 (w), 1511 
(s), 1489 (m), 1450 (m), 1405 (w), 1352 (w), 1254 (m), 1222 (m), 1152 (w), 1123 (m), 1110 (m), 
1049 (w), 975 (w), 846 (w), 798 (w), 736 (w).  
HRMS (ESI): calcd for C19H21O2 [M+H]
+: 281.1536; found: 281.1519. 
 
6-benzyl-2,3-dimethoxynaphthalene (27c):  
TLC (10% ethyl acetate in cyclohexane): Rf: 0.18 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.3 Hz, 1H), 7.50 – 7.46 (m, 1H), 7.34 – 7.27 (m, 2H), 
7.26 – 7.16 (m, 4H), 7.10 (s, 1H), 7.07 (s, 1H), 4.12 (s, 2H), 3.99 (s, 3H), 3.98 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.7, 149.2, 141.4, 137.1, 129.5, 129.2, 128.6, 127.8, 126.6, 126.2, 
126.0, 125.9, 106.3, 106.3, 56.0, 55.9, 42.1. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3057 (m), 3000 (m), 2933 (m), 2828 (m), 1631 (w), 1609 (m), 1511 (s), 1490 
(s), 1462 (m), 1436 (m), 1419 (m), 1253 (s), 1205 (m), 1162 (m), 1130 (m), 1075 (m), 1009 (m), 
855 (m), 739 (m), 700 (m).  
HRMS (ESI): calcd for C19H19O2 [M+H]
+: 279.1380; found: 279.1361. 
 
 
(6,7-dimethoxy-1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (24d) was prepared 
according to GP5 from 23d (0.200 mmol, 1 equiv) in 37% yield as a colorless oil (18.3 mg). Further 
products: 28d (15.3 mg, 33%, colorless oil) and 27d (13.1 mg, 28%, colorless solid). Purified by 
flash column chromatography on silica gel (5% diethyl ether in petrol ether grading to 25% diethyl 
ether in petrol ether). 
 
(6,7-dimethoxy-1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (24d): 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.09 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 6.81 (s, 1H), 6.53 (s, 1H), 3.96 (dd, J = 10.5, 3.4 Hz, 1H), 3.86 (s, 
3H), 3.84 (s, 3H), 3.54 – 3.45 (m, 1H), 2.80 – 2.71 (m, 2H), 2.12 – 2.03 (m, 1H), 1.74 – 1.60 (m, 
2H), 1.38 (s, 3H), 1.30 (s, 1H), 1.15 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.4, 147.1, 137.9, 128.3, 111.4, 110.0, 63.9, 56.2, 55.9, 47.6, 
36.1, 30.7, 29.0, 26.5, 22.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3484 (br m), 2932 (s), 1610 (w), 1510 (s), 1464 (m), 1401 (w), 1349 (w), 1254 
(s), 1207 (m), 1152 (m), 1073 (m), 1026 (m), 1005 (m), 970 (m), 860 (w), 830 (w), 777 (w).  
HRMS (LTB): calcd for C15H23O3 [M+H]
+: 251.1642; found: 251.1644. 
 
2-isopropyl-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalene (28d): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.24 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 6.58 (d, J = 2.9 Hz, 2H), 3.84 (s, 6H), 2.77 – 2.66 (m, 3H), 2.45 
(ddd, J = 16.2, 11.3, 1.6 Hz, 1H), 1.99 – 1.83 (m, 1H), 1.66 – 1.52 (m, 1H), 1.52 – 1.42 (m, 1H), 
1.43 – 1.29 (m, 1H), 0.96 (dd, J = 6.7, 1.8 Hz, 6H) 
13
C NMR (101 MHz, CDCl3) δ 147.1, 147.0, 129.1, 128.9, 112.2, 111.7, 56.0, 41.1, 32.8, 32.4, 
29.6, 27.0, 20.1, 19.8. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 2954 (s), 2929 (s), 2870 (m), 1610 (w), 1517 (s), 1464 (m), 1408 (w), 1385 
(w), 1365 (w), 1264 (m), 1239 (m), 1226 (m), 1116 (m), 1018 (w), 847 (w).  
HRMS (LTB): calcd for C15H23O2 [M+H]
+: 235.1693; found: 235.1693. 
 
6-isopropyl-2,3-dimethoxynaphthalene (27d): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.21 (UV, CAM) 
mp: 108.8 °C 
1
H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.3 Hz, 1H), 7.51 (d, J = 1.8 Hz, 1H), 7.24 (d, J = 1.8 
Hz, 1H), 7.10 (s, 2H), 4.00 (s, 3H), 3.99 (s, 3H), 3.03 (hept, J = 6.9 Hz, 1H), 1.33 (d, J = 6.9 Hz, 
6H) 
13
C NMR (101 MHz, CDCl3) δ 149.6, 149.1, 144.9, 129.5, 127.7, 126.4, 124.1, 122.9, 106.3, 106.3, 
56.0, 56.0, 34.3, 24.2. 
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IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3057 (w), 2998 (w), 2958 (s), 2925 (m), 2866 (w), 1609 (m), 1514 (m), 1493 
(m), 1455 (m), 1409 (w), 1302 (w), 1256 (s), 1214 (w), 1195 (w), 1164 (m), 1147 (m), 1127 (m), 
1005 (m), 897 (w), 855 (m).  
HRMS (ESI): calcd for C15H19O2 [M+H]
+: 231.1380; found: 231.1375. 
 
 
(6,7-dimethoxy-1,2-diphenyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (24ea) was 
prepared according to GP5 from 23e (0.200 mmol, 1 equiv) in 24% yield as a colorless oil 
(17.6 mg). Further products: 24eb (12.2 mg, 12%, colorless oil), 28e (18.3 mg, 26%, colorless oil) 
and 27e (16.9 mg, 24%, colorless oil). Purified by flash column chromatography on silica gel (1% 
ethyl acetate in cyclohexane grading to 25% ethyl acetate in cyclohexane). 
 
2-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalene (28e): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.19 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.36 – 7.26 (m, 8H), 7.22 – 7.15 (m, 2H), 6.58 (s, 1H), 6.44 (s, 1H), 
3.84 (s, 3H), 3.77 (s, 3H), 3.63 (d, J = 10.8 Hz, 1H), 2.72 (dd, J = 8.4, 4.5 Hz, 2H), 2.67 – 2.56 (m, 
2H), 2.35 (dd, J = 17.2, 10.8 Hz, 1H), 1.87 (ddt, J = 11.1, 4.7, 2.3 Hz, 1H), 1.37 (ddt, J = 13.1, 
10.7, 8.5 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 147.2, 147.1, 144.3, 144.2, 128.7, 128.7, 128.4, 128.3, 128.2, 128.2, 
126.3 (2x), 112.1, 111.6, 58.6, 56.0, 56.0, 38.3, 35.1, 28.9, 28.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3059 (w), 3025 (m), 2998 (w), 2931 (m), 2832 (m), 1608 (w), 1516 (s), 1493 
(m), 1463 (m), 1450 (m), 1408 (w), 1353 (w), 1250 (m), 1217 (m), 1117 (m), 1020 (w), 977 (w), 
853 (w), 809 (w), 747 (w), 705 (w).  
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HRMS (ESI): calcd for C25H26NaO2 [M+Na]
+: 381.1825; found: 381.1823. 
 
6-benzyl-2,3-dimethoxynaphthalene (27e): 
TLC (10% ethyl acetate in cyclohexane): Rf: 0.17 (UV, CAM) 
1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.4 Hz, 1H), 7.35 – 7.27 (m, 5H), 7.27 – 7.19 (m, 2H), 
7.19 – 7.14 (m, 5H), 7.10 (s, 1H), 7.01 (s, 1H), 5.68 (s, 1H), 3.99 (s, 3H), 3.95 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 149.7, 149.5, 144.1, 140.1, 129.7, 129.2, 128.5, 127.9, 126.6, 126.5, 
126.4, 106.6, 106.2, 57.0, 56.0, 56.0. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3057 (m), 3025 (m), 3002 (m), 2931 (m), 1607 (m), 1510 (s), 1490 (s), 1462 
(m), 1451 (m), 1436 (m), 1418 (m), 1256 (s), 1239 (m), 1201 (m), 1163 (m), 1131 (m), 1030 (w), 
1009 (m), 898 (w), 854 (m), 752 (w), 701 (m).  
HRMS (ESI): calcd for C25H22NaO2 [M+Na]
+: 377.1512; found: 377.1507. 
 
6,7-dimethoxy-1,2-diphenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethanol (24ea): 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.10 (UV, CAM) 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 7.38 (m, 2H), 7.33 – 7.23 (m, 4H), 7.25 – 7.11 (m, 4H), 6.48 
(s, 1H), 6.44 (s, 1H), 4.83 (s, 1H), 3.78 (s, 3H), 3.73 (s, 3H), 3.52 – 3.45 (m, 1H), 3.29 (dd, J = 
11.3, 9.6 Hz, 1H), 2.78 (dd, J = 17.6, 5.8 Hz, 1H), 2.45 (ddd, J = 17.6, 11.9, 6.6 Hz, 1H), 2.04 (ddd, 
J = 13.8, 12.0, 6.2 Hz, 1H), 1.89 (dd, J = 13.8, 6.5 Hz, 1H), 1.01 (dd, J = 9.6, 3.8 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 147.5, 147.4, 143.3, 142.4, 130.9, 130.5, 128.5, 128.2, 127.8, 127.7, 
126.3, 124.1, 112.7, 110.8, 70.0, 55.8, 55.6, 48.6, 47.1, 25.12, 24.6. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3537 (br w), 3057 (w), 2924 (s), 2852 (m), 1739 (w), 1609 (w), 1512 (m), 
1464 (m), 1359 (w), 1257 (m), 1229 (m), 1114 (m), 1033 (m), 850 (w), 761 (w), 701 (w).  
HRMS (ESI): calcd for C25H26NaO3 [M+Na]
+: 397.1774; found: 397.1753. 
 
6,7-dimethoxy-1,2-diphenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethanol (24eb): 
TLC (20% ethyl acetate in cyclohexane): Rf: 0.07 (UV, CAM) 
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1
H NMR (400 MHz, CDCl3) δ 7.24 – 7.11 (m, 5H), 6.95 – 6.85 (m, 3H), 6.73 (s, 1H), 6.54 – 6.48 
(m, 2H), 6.35 (s, 1H), 4.20 – 4.11 (m, 1H), 3.96 (s, 1H), 3.90 (s, 4H), 3.70 (s, 3H), 3.18 – 3.01 (m, 
2H), 2.42 – 2.29 (m, 1H), 2.16 (dd, J = 13.6, 5.5 Hz, 1H), 1.09 (dd, J = 10.7, 3.0 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 147.8, 147.6, 143.2, 142.8, 130.1, 129.9, 128.5, 127.6, 127.2, 127.0, 
126.6, 125.6, 113.1, 111.0, 67.1, 56.0, 55.9, 53.39, 46.9, 25.6, 21.3. 
IR (ATR, neat) ?̃?𝑚𝑎𝑥: 3498 (br m), 3059 (m), 3025 (m), 2934 (s), 1724 (m), 1608 (m), 1511 (s), 
1451 (m), 1405 (m), 1330 (m), 1260 (m), 1232 (m), 1115 (m), 1032 (m), 766 (m), 702 (m).  
HRMS (ESI): calcd for C25H26NaO3 [M+Na]
+: 397.1774; found: 397.1753. 
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9.2.2.14 Thiirane 
 
2-(tert-butyl)-2-(3,4-dimethoxyphenethyl)thiirane (29): 
To a solution of epoxide 11a (206 mg, 780 µmol, 1 equiv) in i-PrOH (10 mL) was added potassium 
thiocyanate (682 mg, 7.02 mmol, 9.00 equiv) in water (4 mL). The mixture was heated in a sealed 
glass vial at 85 °C. After 22  The residue was purified by flash column chromatography (5% diethyl 
ether in n-pentane) to yield thiirane 29 (190 mg, 679 µmol, 87%) as colorless oil. 
TLC (10% diethyl ether in n-pentane) = 0.22 (UV, CAM)  
1
H-NMR (400 MHz, CDCl3): δ 6.79 (d, J = 8.1 Hz, 1H), 6.71 (dd, J = 8.0, 2.0 Hz, 1H), 6.68 (d, J 
= 2.0 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 2.73 – 2.63 (m, 1H), 2.47 (d, J = 1.7 Hz, 1H), 2.46 – 2.37 
(m, 1H), 2.36 (d, J = 1.7 Hz, 1H), 2.33 (dd, J = 12.0, 4.4 Hz, 1H), 2.10 (ddd, J = 14.0, 11.8, 4.2 Hz, 
1H), 1.06 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.4, 135.0, 120.2, 111.9, 111.4, 58.2, 56.1, 56.0, 35.9, 
32.6, 28.6, 28.0.  
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2955 (br m), 2832 (w), 1590 (w), 1514 (s), 1463 (m), 1417 (m), 1392 (w), 
1364 (w), 1334 (w), 1259 (s), 1235 (s), 1191 (w), 1156 (s), 1139 (s), 1029 (s), 930 (br w), 852 (w), 
805 (m). 
HRMS (ESI): calcd for C16H24NaO2S [M+Na]
+: 303.1389; found: 303.1375. 
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Note: Thiol 30 disproportionates to disulfide 32 and tetralin 31 under conditions of GP5 and is 
hence not observed. 
1,2-bis((6,7-dimethoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methyl)disulfane 
(32) was prepared according to GP5 from 29 (0.200 mmol, 1 equiv) in 22% yield as a colorless oil 
(12.1 mg, mixture of diastereomers). Purified by high pressure liquid chromatography on silica gel 
(0.5% isopropanol in hexane grading to 2.5% isopropanol in hexane). Besides decalin 31 (20.6 mg, 
41%) was isolated as a colorless oil. 
Note: Usage of trimethylsilyl trifluoromethanesulfonate instead of sulfuric acid resulted in higher 
yield in this special case: Disulfide 32 (26.3 mg, 47%) and tetraline 31 (22.3 mg, 45%) 
Analytical data of 32: 
TLC (10% diethyl ether in n-pentane) = 0.08 (UV, CAM)  
1
H-NMR (400 MHz, CDCl3): δ = 6.80 (d, J = 2.2 Hz, 2H), 6.51 (d, J = 4.5 Hz, 2H), 3.86 (s, 6H), 
3.83 (d, J = 4.0 Hz, 6H), 3.10 (d, J = 4.5 Hz, 4H), 2.78 (dddd, J = 15.9, 9.5, 6.5, 3.4 Hz, 2H), 2.66 
(dt, J = 17.4, 5.8 Hz, 2H), 1.90 – 1.70 (m, 4H), 1.25 (d, J = 9.1 Hz, 6H), 1.22 (d, J = 5.8 Hz, 6H), 
1.06 (d, J = 7.3 Hz, 6H). 
13
C NMR (101 MHz, CDCl3) δ 147.6, 147.1, 137.3, 127.2, 111.2, 110.2, 56.2, 55.9, 49.2, 49.0, 
40.6, 40.6, 39.1, 29.9, 28.9, 28.9, 28.1, 25.9, 25.1, 25.0, 20.9, 20.9. 
IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2967 (m), 2926 (m), 2849 (w), 1610 (w), 1509 (s), 1462 (m), 1400 (w), 1373 
(w), 1353 (w), 1327 (w), 1253 (s), 1232 (m), 1206 (s), 1181 (w), 1151 (m), 1122 (m), 1102 (w), 
1075 (m), 1038 (m), 976 (w), 910 (w), 856 (w), 831 (w). 
HRMS (ESI): calcd for C32H46O4NaS2 [M+Na]
+: 581.2730; found: 581.2714. 
 
Analytical data of 31: 
TLC (10% diethyl ether in n-pentane) = 0.63 (UV, CAM)  
1
H-NMR (400 MHz, CDCl3): δ = 6.84 (s, 1H), 6.51 (s, 1H), 3.86 (s, 3H), 3.84 (s, 3H), 2.72 (t, J = 
6.8 Hz, 2H), 1.65 (t, J = 6.8 Hz, 2H), 1.21 (s, 6H), 0.94 (s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 147.3, 146.7, 138.5, 127.3, 111.2, 110.3, 56.2, 55.8, 39.6, 34.6, 
33.4, 26.6, 26.3, 24.6. 
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IR (ATR, neat): ?̃?𝑚𝑎𝑥 = 2967 (m), 2926 (m), 2849 (w), 1610 (w), 1509 (s), 1462 (m), 1400 (w), 1373 
(w), 1353 (w), 1327 (w), 1253 (s), 1232 (m), 1206 (s), 1181 (s), 1151 (s), 1122 (w), 1102 (s), 1075 
(w), 1038 (w), 976 (w), 910 (w), 856 (m), 831 (m). 
HRMS (ESI): calcd for C16H24NaO2 [M+Na]+ 271.1669; found: 271.1663. 
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9.2.2.15 Asymmetric attempts for desymmetrization of epoxide 17c 
Substrate 17c was chosen as modell substrate for desymmetrization experiments with chiral 
catalysts due to expected π-stacking effects of the benzylgroup. Attempts with 11a are not shown 
(no ee values were observed for 13a).  
 
Table S17: Screening of chiral catalyst for desymmetrization of 17c.  
Entry solvent conditions, reaction time temperature yield [%]* ee 
1 HFIP L1, 4 d 0 °C 11 <1 
2 PhMe L1, 14 d 23 °C 6 <1 
3 PhMe TiCl4, L2, 3 d 23 °C 16 <1 
4 PhMe L2, MeLi, then TiCl4, 3 d  23 °C n.d. - 
5 PhMe L3, 2 d 23 °C n.d. - 
6 PhMe, THF L3, 2 d 23 °C n.d. - 
7 PhMe Cu(OTf)2, L4 23 °C n.d. - 
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In the shown transformation, starting from racemic epoxide 17c we investigated if chirality can be 
induced (Table S2). Therefore asymmetric Brønsted and Lewis acids were employed. Using chiral 
phosphoric acid L1[148] under standard conditions (GP5) led to a slow product formation, but no 
observable enantiomeric excess (Entry 1). The same result was obtained by switching the solvent 
to toluene (Entry 2). Unfortunately, most Lewis acids react with the best performing, but Lewis 
basic solvent 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) to release Brønsted acids. Hence, HFIP is 
incompatible and a switch to aprotic toluene was inevitable (Entries 3–7). Titanium tetrachloride 
in combination with L2 led indeed to product formation, but despite our expectations to no 
enantiomeric excess (Entry 3).[133] However, by formation of the complex under water free 
conditions (preform alkoxide in situ with methyl lithium and addition of titanium tetrachloride in 
sequence) the reactions showed no conversion at all (Entry 4). Neither chromium salen complex 
L3[149] in toluene/toluene–tetrahydrofuran (Entries 5 and 6) nor copper(II) with Box ligand L4 
(Entry 7) were able to catalyze the reaction at all.[150]  
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9.2.2.16 Computational Details 
All calculations were carried out with the Gaussian 16 package* Investigated structures were fully 
optimized in implicit solvent the ωB97X-D range-separated hybrid functional[151] and 6-311G(d,p) 
basis set on all atoms. Bulk solvent effects were modelled (implicitly) by SMD polarizable 
continuum model of Cramer and Truhlar[152] as implemented in Gaussian 16. The internally stored 
parameters for 2,2,2-trifluoro ethanol (ε = 26.726) were used. All species were calculated 
considering closed-shell electronic configurations (singlet). The possibility of different 
conformations was taken into account for all structures. Frequency analyses were carried out with 
ωB97X-D/6-311G(d,p)/SMD to ensure localized stationary points corresponds to energy minima. 
Zero-point energy and thermal corrections were calculated using the standard rigid-
rotator/harmonic oscillator model to obtain Gibbs energies at 273.15 K, no scaling of the 
frequencies was applied. Gibbs free energies (ΔG273K) were used for the discussion on the relative 
stabilities of the considered structures. Cartesian coordinates, electronic energies, entropies, 
enthalpies and Gibbs free energies of the low energy conformations are given as the Supporting 
Information. 
 
 
 
 
 
 
 
*Gaussian 16, Revision C.01, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. 
Cheeseman, G. Scalmani, V. Barone, G. A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A. V. Marenich, J. 
Bloino, B. G. Janesko, R. Gomperts, B. Mennucci, H. P. Hratchian, J. V. Ortiz, A. F. Izmaylov, J. L. 
Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. 
Henderson, D. Ranasinghe, V. G. Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. 
Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. 
Throssell, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. J. Bearpark, J. J. Heyd, E. N. Brothers, K. N. 
Kudin, V. N. Staroverov, T. A. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. P. Rendell, J. C. 
Burant, S. S. Iyengar, J. Tomasi, M. Cossi, J. M. Millam, M. Klene, C. Adamo, R. Cammi, J. W. Ochterski, 
R. L. Martin, K. Morokuma, O. Farkas, J. B. Foresman, and D. J. Fox, Gaussian, Inc., Wallingford CT, 2016. 
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Scheme S3. Energetical overview of proposed intermediates in the Brønsted acid catalyzed cycloisomerization of 11e, according to a 
stepwise mechanism including epoxide opening, 1,2-methyl shift and Friedel–Crafts type alkylation, calculated at the 
SMD(F3CCH2OH)/ ωB97X-D/6-311(d+p) level. Free energies are given in kcal mol-1. 
We assume that epoxide 11e is protonated whereupon it opens up to give carbocation II. 
Carbocation II can then either undergo a Friedel–Crafts alkylation directly to form the five-
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membered σ-complexes IIIa and IIIb or a 1,2-methyl shift precedes this event. In that case 
carbocation IV is formed which is trapped by the arene to give rise to the six-membered 
σ-complexes Va and Vb. As exclusively six-membered products are observed, we assume 
that the five-membered σ-complexes IIIa and IIIb are formed only temporary and 
equilibrate with cation IV (which reacts to energetically favored Va and Vb. Another 
conceiveable theory is that the ring strain of the corresponding five-membered π-
complexes (not shown) is too high and therefore these intermediates are not crossed at 
all. (Note: Transition states are very hard to predict in these cases, especially in the cage 
of 1,1,1,3,3,3-hexafluoro-2-propanol and are therefore not calculated.) 
 
Table S3. Energies, enthalpies, Gibbs free energies and entropies of the structures calculated at the SMD/ωB97X-D/6-311G(d+p) level. 
Compound E0 E0+ZPE H S G 
(Hartree)b (Hartree)b (Hartree)b,c (cal mol-1 K-1) (Hartree)b,c 
Ia -735.623786 -735.267264 -735.251420 134.8 -735.307485 
IIa -735.628775 -735.275758 -735.259177 137.7 -735.316405 
IIIa -735.642819 -735.288599 -735.272378 133.1 -735.327652 
IVaa -735.659722 -735.302406 -735.287268 126.9 -735.339906 
IVba -735.659320 -735.302403 -735.286989 128.3 -735.340240 
Vaa -735.668080 -735.310300 -735.294960 128.0 -735.348109 
Vba -735.669578 -735.311697 -735.296386 128.1 -735.349561 
a2,2,2-Trifluoro ethanol (ε = 26.726) as solvent. b 1 Hartree = 627.5 kcal mol-1. cThermal corrections at 273.15 K. 
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Cartesian coordianates of lowest energy structures optimized at the SMD/ωB97X-D/6-311G(d+p) 
level
 
Structure I 
C 3.998958 -1.24364 -0.44384 
C 3.652505 0.04803 -0.0349 
C 2.343745 0.321869 0.356911 
C 1.381906 -0.69136 0.343529 
C 1.73106 -1.97338 -0.06312 
C 3.041198 -2.24153 -0.45549 
C -0.04437 -0.37307 0.722987 
C -0.81968 0.112846 -0.51584 
C -2.20824 0.598615 -0.19547 
C -3.33519 -0.37423 0.172059 
C -2.3593 2.025234 0.080666 
C -4.71813 0.14209 -0.25891 
C -3.10752 -1.74726 -0.47292 
C -3.31911 -0.49219 1.710338 
C 4.357324 2.287526 0.351664 
H -3.52822 1.631012 -1.54725 
H 5.021862 -1.43824 -0.74328 
H 2.055062 1.315309 0.67816 
H 0.985552 -2.76143 -0.07245 
H 3.316737 -3.24144 -0.77103 
H -0.51152 -1.26769 1.137426 
H -0.06491 0.396662 1.499873 
H -0.26645 0.939231 -0.9672 
H -0.87276 -0.68547 -1.25706 
H -3.25334 2.400068 0.562018 
H -1.48134 2.651484 0.166952 
H -5.47559 -0.54234 0.125194 
H -4.96372 1.127338 0.146866 
H -4.83662 0.145856 -1.34735 
H -3.93961 -2.4033 -0.21109 
H -2.19067 -2.22372 -0.12122 
H -3.06709 -1.67428 -1.56273 
H -3.55727 0.46101 2.188056 
H -4.07875 -1.21746 2.008498 
H -2.36013 -0.84022 2.093962 
H 5.288992 2.841778 0.260701 
H 3.601436 2.74149 -0.29722 
H 4.01598 2.322005 1.391222 
O -2.57835 1.654793 -1.34294 
O 4.652272 0.960833 -0.05045 
 
 
 
Structure II 
C 3.130354 -1.16568 -1.17857 
C 3.19389 -0.0829 -0.29773 
C 2.214509 0.067368 0.683955 
C 1.174135 -0.85927 0.79046 
C 1.120361 -1.93791 -0.0867 
C 2.100411 -2.0822 -1.06595 
C 0.121892 -0.67482 1.865205 
C -1.31705 -0.77341 1.356483 
C -1.84733 0.195846 0.389818 
C -3.16113 -0.04492 -0.25664 
C -1.01812 1.366436 0.115629 
C -3.83927 -1.35586 0.15538 
C -4.10238 1.140669 0.098719 
C -2.89397 -0.07946 -1.79168 
C 4.341163 1.885211 0.389544 
H 3.896639 -1.26699 -1.93751 
H 2.245151 0.902701 1.372332 
H 0.328154 -2.67415 -0.01065 
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H 2.059317 -2.92383 -1.74775 
H 0.23432 -1.45791 2.619002 
H 0.283249 0.269836 2.389556 
H -1.54458 -1.77737 0.985789 
H -2.02439 -0.67088 2.201033 
H -0.68588 1.752215 1.094811 
H -0.09834 0.909317 -0.30849 
H -4.80774 -1.40805 -0.34467 
H -3.26713 -2.23347 -0.15379 
H -4.02103 -1.41136 1.230798 
H -5.0467 0.965053 -0.41997 
H -3.69729 2.097961 -0.21713 
H -4.2999 1.164818 1.172466 
H -0.87635 3.008753 -0.865 
H -2.20597 -0.8882 -2.04694 
H -3.85277 -0.28044 -2.27345 
H -2.501 0.865443 -2.15852 
H 5.232038 2.421535 0.070518 
H 3.471122 2.543554 0.300628 
H 4.460318 1.572566 1.431582 
O -1.55377 2.349507 -0.69935 
O 4.230508 0.766036 -0.47468 
 
 
Structure III 
C -2.5493 1.374447 -0.86098 
C -2.49698 0.171045 -0.15341 
C -1.51957 -0.01252 0.824724 
C -0.59447 1.000524 1.104017 
C -0.68064 2.209669 0.422722 
C -1.65399 2.387367 -0.55875 
C 0.517711 0.738098 2.0862 
C 1.383554 -0.47393 1.712147 
C 1.966909 -0.46704 0.267496 
C 0.950239 -0.83936 -0.75871 
C 2.665192 0.87361 0.000492 
C 0.298439 -2.15397 -0.72323 
C 0.710699 -0.01371 -1.93549 
C 3.02676 -1.61468 0.191786 
C -3.53747 -1.918 0.321972 
H -3.30673 1.499342 -1.62485 
H -1.47618 -0.93575 1.38901 
H 0.019931 3.007145 0.64271 
H -1.71067 3.325646 -1.09811 
H 1.139115 1.631236 2.179845 
H 0.102382 0.544764 3.079762 
H 2.240269 -0.51931 2.388573 
H 0.824388 -1.39737 1.871504 
H 3.265688 1.11161 0.886187 
H 1.926923 1.67211 -0.12832 
H 0.893193 -2.76295 -1.42534 
H 0.299213 -2.65286 0.241815 
H -0.69964 -2.10489 -1.15983 
H 0.117954 -0.51329 -2.69705 
H 0.172762 0.885491 -1.59007 
H 1.664329 0.36484 -2.31684 
H 3.900706 1.604995 -1.30692 
H 2.622271 -2.55153 0.573639 
H 3.39536 -1.75926 -0.82282 
H 3.867389 -1.31315 0.818774 
H -4.38142 -2.47452 -0.07857 
H -2.64177 -2.54422 0.272978 
H -3.73832 -1.64644 1.362513 
O 3.486201 0.755874 -1.14531 
O -3.41366 -0.76099 -0.49275 
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Structure IVa 
C 1.83108 -1.65277 0.057535 
C 2.663886 -0.48658 0.023909 
C 2.160513 0.785551 -0.3482 
C 0.853419 0.875423 -0.70304 
C -0.02592 -0.30358 -0.80031 
C 0.535717 -1.57056 -0.29967 
C 0.070441 2.104155 -1.02384 
C -1.39315 1.62832 -1.13299 
C -1.47936 0.201879 -0.50567 
C -2.4773 -0.605 -1.34669 
C -1.84865 0.250623 1.02997 
C -1.59712 -1.08084 1.760038 
C -1.04181 1.325145 1.77944 
C -3.34313 0.585235 1.184834 
C 4.864056 0.370461 0.371666 
H -0.03686 -0.47874 -1.89914 
H 2.286982 -2.58128 0.374484 
H 2.786126 1.666148 -0.30633 
H -0.10394 -2.44338 -0.31414 
H 0.220587 2.846939 -0.23774 
H 0.436711 2.554617 -1.9501 
H -1.67444 1.570784 -2.1871 
H -2.08342 2.326653 -0.66248 
H -3.47349 -0.15809 -1.26012 
H -2.175 -0.52324 -2.39892 
H -2.01271 -1.01296 2.769624 
H -2.06691 -1.9177 1.246926 
H -0.52949 -1.28629 1.872272 
H -1.29645 1.280622 2.841344 
H -1.2647 2.337462 1.435444 
H 0.036841 1.159208 1.70619 
H -3.6349 1.473836 0.618486 
H -3.97329 -0.24871 0.86767 
H -3.56133 0.780359 2.237883 
H -3.08972 -2.43765 -1.53322 
H 5.798981 -0.09863 0.660096 
H 4.947191 0.796695 -0.6281 
H 4.582466 1.129672 1.101249 
O -2.49087 -1.96523 -0.95295 
O 3.89646 -0.69741 0.373425 
 
 
 
 
 
Structure IVb 
C -2.01592 -1.61967 0.351011 
C -2.86755 -0.4952 0.074489 
C -2.34936 0.732442 -0.40447 
C -1.0131 0.817924 -0.62649 
C -0.10208 -0.33948 -0.50534 
C -0.69823 -1.54633 0.100651 
C -0.22148 2.048166 -0.92349 
C 1.246393 1.596984 -0.83598 
C 1.252206 0.281753 -0.01337 
C 1.043373 0.603372 1.477162 
C 2.525367 -0.60434 -0.28693 
C 3.785117 0.281126 -0.36255 
C 2.759997 -1.63468 0.830214 
C 2.406711 -1.35676 -1.62234 
C -5.10765 0.325516 0.087905 
H 0.075344 -0.62661 -1.56041 
H -2.4831 -2.51139 0.747262 
H -2.98606 1.598597 -0.51905 
H -0.07052 -2.41241 0.268671 
H -0.47018 2.812624 -0.18221 
H -0.4903 2.463224 -1.898 
H 1.630568 1.405173 -1.83988 
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H 1.881262 2.350562 -0.37395 
H 0.924352 -0.33013 2.039124 
H 0.108337 1.168528 1.597855 
H 4.666953 -0.35942 -0.45435 
H 3.767641 0.93965 -1.23408 
H 3.890255 0.89075 0.533938 
H 3.602871 -2.27508 0.557201 
H 1.900365 -2.28743 0.99899 
H 3.007949 -1.1437 1.77358 
H 1.654685 -2.15054 -1.59177 
H 2.171419 -0.68818 -2.45631 
H 3.362502 -1.83358 -1.8536 
H 1.979787 1.52579 2.900241 
H -6.05616 -0.13377 0.345608 
H -4.9157 1.183777 0.731652 
H -5.09706 0.610182 -0.96402 
O 2.131602 1.356343 1.969334 
O -4.12135 -0.69903 0.32949 
 
 
 
 
 
Structure Va 
C 2.400638 1.585933 -0.08033 
C 2.868036 0.237137 0.031841 
C 2.031954 -0.86021 -0.29063 
C 0.751671 -0.63863 -0.68973 
C 0.170988 0.72634 -0.7475 
C 1.130807 1.812591 -0.44951 
C -0.15692 -1.75485 -1.06662 
C -1.44311 -1.69074 -0.23494 
C -2.14388 -0.32377 -0.30862 
C -1.16444 0.834068 0.127313 
C -1.78767 2.215256 -0.12762 
C -0.76759 0.743287 1.609096 
C -3.40524 -0.40208 0.577208 
C -2.67752 -0.08737 -1.7351 
C 4.714623 -1.17722 0.569936 
H -0.14903 0.885981 -1.78799 
H 3.098266 2.383657 0.137035 
H 2.413677 -1.8705 -0.23868 
H 0.780946 2.833029 -0.54442 
H 0.340359 -2.71669 -0.9374 
H -0.39763 -1.65015 -2.13071 
H -2.13042 -2.46306 -0.59072 
H -1.21529 -1.93443 0.803119 
H -1.20137 3.004721 0.34559 
H -2.78577 2.269067 0.309181 
H -1.87217 2.445378 -1.19184 
H -1.64703 0.850245 2.241664 
H -0.29917 -0.21034 1.859854 
H -0.06323 1.540101 1.860632 
H -3.862 0.589989 0.672524 
H -4.12507 -1.04031 0.049062 
H -3.19583 -0.98164 -2.08928 
H -3.39052 0.739672 -1.76118 
H -1.89312 0.137129 -2.46095 
H -3.9589 -1.06691 2.309005 
H 5.721225 -0.96806 0.916406 
H 4.173536 -1.76517 1.310834 
H 4.743762 -1.68508 -0.3939 
O -3.12441 -0.9489 1.853531 
O 4.096991 0.11825 0.4219 
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Structure Vb 
C -2.44675 1.41742 -0.65723 
C -2.89457 0.13439 -0.20443 
C -1.99677 -0.95323 -0.07101 
C -0.67708 -0.77558 -0.34427 
C -0.12462 0.548303 -0.72511 
C -1.14171 1.609097 -0.90195 
C 0.3049 -1.88754 -0.24593 
C 1.437189 -1.49826 0.711232 
C 2.118791 -0.16626 0.351641 
C 1.063 0.996988 0.248715 
C 0.462274 1.326245 1.624091 
C 1.690639 2.277412 -0.32645 
C 2.881958 -0.31022 -0.98065 
C 3.15967 0.113033 1.450434 
C -4.76173 -1.17128 0.504835 
H 0.344569 0.413002 -1.71107 
H -3.18698 2.195731 -0.786 
H -2.36021 -1.92724 0.226352 
H -0.80458 2.577383 -1.25073 
H -0.18221 -2.80645 0.08163 
H 0.719829 -2.0716 -1.24371 
H 2.187908 -2.28818 0.704476 
H 1.041058 -1.4443 1.728546 
H -0.3266 2.075623 1.527479 
H 1.226032 1.745194 2.280514 
H 0.031765 0.452754 2.117878 
H 2.618939 2.513386 0.195331 
H 1.91438 2.192294 -1.39242 
H 1.029205 3.134546 -0.18867 
H 2.195336 -0.32985 -1.83781 
H 3.541109 0.555092 -1.1094 
H 2.722079 0.051143 2.448204 
H 3.947009 -0.63955 1.380791 
H 3.627333 1.093666 1.340339 
H 4.220485 -1.50938 -1.7097 
H -5.81257 -0.93667 0.637748 
H -4.63934 -1.94893 -0.24877 
H -4.31548 -1.46659 1.454111 
O 3.639296 -1.50657 -0.94842 
O -4.16308 0.057291 0.04233 
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9.2.2.18 X-ray  
Methylfuran (12n) 
 
 
Identification code mar19-24 
Empirical formula C13H20O2 
Formula weight 208.29 
Temperature 183(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group P-1 (no. 2) 
Unit cell dimensions a = 8.1230(4) Å                = 73.708(2)°. 
b = 10.0358(6) Å              = 85.670(2)°. 
c = 15.3076(9) Å                = 81.399(2)°. 
Volume 1183.57(12) Å3 
Z 4 
Density (calculated) 1.169 Mg/m3 
Absorption coefficient 0.077 mm-1 
F(000) 456 
Crystal size 0.180 x 0.120 x 0.060 mm3 
Theta range for data collection 2.133 to 24.998°. 
Index ranges -9 <= h <= 9, -11 <= k <=11, -18 <= l <= 18 
Experimental Section 
 
649 
 
Reflections collected 25848 
Independent reflections 4169 [R(int) = 0.0332] 
Completeness to theta = 24.998° 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.977 and 0.962 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4169 / 4 / 290 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0421, wR2 = 0.1086 
R indices (all data) R1 = 0.0514, wR2 = 0.1136 
Extinction coefficient 0.026(3) 
Largest diff. peak and hole 0.273 and -0.190 e.Å-3 
  
 
The structure was deposited in the Cambridge Crystallographic Data Center (CCDC) – deposition 
number 2010932.  
Klicken oder tippen Sie hier, um Text einzugeben. 
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